Transcript
Page 1: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

Anexa 2FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

SUBLISTA A - MEDICAMENTE CU NIVEL DE COMPENSARE 90% DIN PREŢUL DE REFERINŢĂ

1 RANITIDINUMA02BA02

Terapia de eradicare a infectiei cu Helicobacter pylori trebuie avuta in vedere inaintea initierii tratamentului ulcerului peptic cu acest medicament.NOTA:

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

150mgA02BA02 RANITIDINUM CAPS.ULCORAN 150mg EUROPHARM SA

150mgA02BA02 RANITIDINUM COMPR.RANITIDIN 150mg ARENA GROUP SA

RANITIDINA 150 mg 150mg MAGISTRA C & C

150mgA02BA02 RANITIDINUM COMPR. EFF.DIGEN EFF 150 mg 150mg OZONE LABORATORIES LTD.

150mgA02BA02 RANITIDINUM COMPR. FILM.GERTOCALM 150mg FARAN LABORATORIES S.A.

RANITIDIN 150 mg 150mg AC HELCOR SRL

RANITIDINA 150 mg 150mg FILDAS TRADING SRL

RANITIDINA ANTIBIOTICE 150 mg 150mg ANTIBIOTICE SA

RANITIDINA LPH 150 mg 150mg LABORMED PHARMA SA

ZANTAC 150 mg 150mg GLAXO WELLCOME UK LTD.

25mg/mlA02BA02 RANITIDINUM SOL. INJ.ARNETIN 25mg/ml MEDOCHEMIE LTD.

ZANTAC SOLUTIE INJECTABILA 25mg/ml GLAXO WELLCOME UK LTD.

300mgA02BA02 RANITIDINUM COMPR. FILM.RANITIDIN 300 mg 300mg AC HELCOR SRL

RANITIDINA 300 mg 300mg FILDAS TRADING SRL

RANITIDINA LPH 300 mg 300mg LABORMED PHARMA SA

2 FAMOTIDINUMA02BA03

Terapia de eradicare a infectiei cu Helicobacter pylori trebuie avuta in vedere inaintea initierii tratamentului ulcerului peptic cu acest medicament.NOTA:

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

10mgA02BA03 FAMOTIDINUM COMPR. FILM.FAMODAR ABR 10mg DAR AL DAWA PHARMA S.R.L.

20mgA02BA03 FAMOTIDINUM COMPR. FILM.FAMODAR 20 20mg DAR AL DAWA PHARMA S.R.L

FAMODIN 20 20mg AC HELCOR PHARMA SRL

FAMOTAK 20mg SEDICO IMPEX S.R.L.

QUAMATEL® 20 mg 20mg GEDEON RICHTER PLC

20mgA02BA03 FAMOTIDINUM COMPR. FILM.FAMODAR 20 20mg DAR AL DAWA PHARMA S.R.L

FAMODIN 20 20mg AC HELCOR PHARMA SRL

FAMOTAK 20mg SEDICO IMPEX S.R.L.

QUAMATEL® 20 mg 20mg GEDEON RICHTER PLC

20mgA02BA03 FAMOTIDINUM LIOF. + SOLV. PT. SOL. INJ.QUAMATEL® 20 mg 20mg GEDEON RICHTER PLC

40mgA02BA03 FAMOTIDINUM COMPR. FILM.FAMODAR 40 40mg DAR AL DAWA PHARMA SRL

FAMODIN 40 40mg AC HELCOR PHARMA SRL

FAMOTAK 40mg SEDICO IMPEX S.R.L.

FAMOTIDINA ZENTIVA 40 mg 40mg ZENTIVA S.A

GASTROSIDIN 40mg ECZACIBASI PHARMACEUTICALS S.R.L.

QUAMATEL® 40 mg 40mg GEDEON RICHTER PLC

3 NIZATIDINUMA02BA04

Terapia de eradicare a infectiei cu Helicobacter pylori trebuie avuta in vedere inaintea initierii tratamentului ulcerului peptic cu acest medicament.NOTA:

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

150mgA02BA04 NIZATIDINUM CAPS.NIZATIDIN 150 mg 150mg VIM SPECTRUM SRL

NIZATIDINA LAROPHARM 150 mg 150mg LAROPHARM S.R.L.

4 OMEPRAZOLUMA02BC01

Terapia de eradicare a infectiei cu Helicobacter pylori trebuie avuta in vedere inaintea initierii tratamentului ulcerului peptic cu acest medicament.NOTA:

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

10mgA02BC01 OMEPRAZOLUM CAPS. GASTROREZ.ORTANOL® S 10mg LEK PHARMACEUTICALS D.D.

Boala de reflux gastro-esofagian. Se aplica pentru toate denumirile comerciale si formele farmaceutice ale concentratiei de 10 mg.Prescriere limitata:

10mgA02BC01 OMEPRAZOLUM COMPR. FILM. GASTROREZ.LOSEC MUPS 10 mg 10mg ASTRAZENECA AB

20mgA02BC01 OMEPRAZOLUM CAPS GASTROREZ.HELICID 20 20mg ZENTIVA AS

OMEPRAZOL 20 mg 20mg GEDEON RICHTER ROMANIA SA

OMEPRAZOL BIOFARM 20 mg 20mg BIOFARM S.A.

OMEPRAZOL LPH 20 mg 20mg LABORMED PHARMA SA

OMEPRAZOL TERAPIA 20 mg 20mg TERAPIA S.A.

OMERAN 20 20mg EUROPHARM SA

OMEZ 20mg DR. REDDY'S LABORATORIES

ORTANOL® 20 mg 20mg LEK PHARMACEUTICALS D.D.

ULTOP 20mg KRKA D.D.

Boala de reflux gastro-esofagianPrescriere limitata:

Sclerodermia esofagului.Prescriere limitata:

Sindromul Zollinger-EllisonPrescriere limitata:

Tratamentul ulcerului gastric si duodenal.Prescriere limitata:

Profilaxia ulcerului gastro-duodenal la pacientii in tratament cu AINS pe termen lung si care prezinta factori de risc gastrointestinal.Prescriere limitata:

1 153/

Page 2: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

NOTA: Se aplica pentru toate denumirile comerciale si formele farmaceutice corespunzatoare concentratiilor de 20 mg..

20mgA02BC01 OMEPRAZOLUM CAPS. ENTER.RISEK 20mg GULF PHARMACEUTICAL INDUSTRIES S.R.L.

20mgA02BC01 OMEPRAZOLUM COMPR. FILM. GASTROREZ.LOSEC MUPS 20 mg 20mg ASTRAZENECA AB

OMEDAR® 20mg DAR AL DAWA PHARMA S.R.L

40mgA02BC01 OMEPRAZOLUM CAPS. GASTROREZ.OMERAN 40 40mg EUROPHARM SA

ORTANOL® 40mg LEK PHARMACEUTICALS D.D.

ULTOP 40mg KRKA D.D. NOVO MESTO

Boala de reflux gastro-esofagianPrescriere limitata:

Sclerodermia esofagului.Prescriere limitata:

Sindromul Zollinger-EllisonPrescriere limitata:

Tratamentul ulcerului gastric si duodenal.Prescriere limitata:

NOTA: Se aplica pentru toate denumirile comerciale si formele farmaceutice corespunzatoare concentratiilor de 40mg..

5 LANSOPRAZOLUMA02BC03

15mgA02BC03 LANSOPRAZOLUM CAPS. GASTROREZ.LEVANT 15 mg 15mg RANBAXY UK LTD.

Boala de reflux gastro-esofagianPrescriere limitata:

30mgA02BC03 LANSOPRAZOLUM CAPS. GASTROREZ.LANZAP 30mg 30mg DR. REDDY'S LABORATORIES

LANZUL 30mg KRKA D.D. NOVO MESTO

LEVANT 30 mg 30mg RANBAXY UK LTD.

Boala de reflux gastro-esofagianPrescriere limitata:

Sindromul Zollinger-Ellison.Prescriere limitata:

Tratamentul ulcerului gastric si duodenal.Prescriere limitata:

Profilaxia ulcerului gastro-duodenal la pacientii in tratament cu AINS pe termen lung si care prezinta factori de risc gastrointestinal.Prescriere limitata:

NOTA: Se aplica pentru toate denumirile comerciale si formele farmaceutice corespunzatoare concentratiiei de 30 mg..

6 MEBEVERINUMA03AA04

200mgA03AA04 MEBEVERINUM CAPS. ELIB. PREL.DUSPATALIN® 200 mg 200mg SOLVAY PHARMACEUTICALS BV

7 TRIMEBUTINUMA03AA05

100mgA03AA05 TRIMEBUTINUM COMPR.COLOBUTINE® 100mg LAB. FOURNIER SA

COLPERIN 100 mg 100mg GEDEON RICHTER ROMANIA S.A.

PROMEBUTIN® 100 mg 100mg TERAPIA SA

TRIMEBUTIN 100 100mg MAGISTRA C & C

100mgA03AA05 TRIMEBUTINUM COMPR. FILM.DEBRIDAT 100 mg 100mg PFIZER EUROPE MA EEIG

24mg/5mlA03AA05 TRIMEBUTINUM GRAN. PT. SUSP. ORALADEBRIDAT 24mg/5ml PFIZER EUROPE MA EEIG

300mgA03AA05 TRIMEBUTINUM COMPR. FILM. ELIB. PREL.IBUTIN® 300 mg 300mg ZENTIVA SA

8 PAPAVERINI HYDROCHLORIDUMA03AD01

100mgA03AD01 PAPAVERINI HYDROCHLORIDUM COMPR.PAPAVERINA 100 mg 100mg SINTOFARM SA

200mgA03AD01 PAPAVERINI HYDROCHLORIDUM COMPR.PAPAVERINA 200mg FARMACOM SA

9 METOCLOPRAMIDUMA03FA01

10mgA03FA01 METOCLOPRAMIDUM COMPR.METOCLOPRAMID 10mg SLAVIA PHARM SRL

METOCLOPRAMID 10 mg 10mg TERAPIA SA

N - METOCLOPRAMID 10mg MEDUMAN SA

1mg/5mlA03FA01 METOCLOPRAMIDUM SIROPMETOCLOPRAMID BIOFARM 1mg/5ml 1mg/5ml BIOFARM S.A.

5mg/mlA03FA01 METOCLOPRAMIDUM SOL. INJ.METOCLOPRAMID 10 mg 5mg/ml TERAPIA SA

7mg/mlA03FA01 METOCLOPRAMIDUM PIC. ORALE-SOL.METOCLOPRAMID 7mg/ml BIOFARM SA

10 DOMPERIDONUMA03FA03

10mgA03FA03 DOMPERIDONUM COMPR. FILM.MOTILIUM 10mg JANSSEN PHARMACEUTICA NV

MOTILIUM 10 mg 10mg TERAPIA SA

11 ACIDUM URSODEOXYCHOLICUM *A05AA02

Nu se va prescrie in regim compensat pentru tratamentul litiazei biliare.NOTA:

250mgA05AA02 ACIDUM URSODEOXYCHOLICUM CAPS.URSOFALK® 250mg DR. FALK PHARMA GMBH

URSOSAN 250mg PRO. MED. CS PRAHA AS

12 LACTULOSUMA06AD11

Prescriere limitata: Tratamentul encefalopatiei cronice porto-sistemice

Tratamentul constipatiei la pacientii neoplazici.

66.7%A06AD11 LACTULOSUM LICHID ORALDUPHALAC® 66.7% SOLVAY PHARMACEUTICALS BV

66.7%A06AD11 LACTULOSUM SIROPLACTULOSE AL SIROP 66.7% ALIUD PHARMA GMBH & CO.KG

670mg/mlA06AD11 LACTULOSUM SOL. ORALALAEVOLAC 670mg/ml 670mg/ml FRESENIUS KABI AUSTRIA GMBH

66.7%A06AD11 LACTULOSUM SIROPLACTULOSE AL SIROP 66.7% ALIUD PHARMA GMBH & CO.KG

670mg/mlA06AD11 LACTULOSUM SOL. ORALA

2 153/

Page 3: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

LAEVOLAC 670mg/ml 670mg/ml FRESENIUS KABI AUSTRIA GMBH

66.7%A06AD11 LACTULOSUM SIROPLACTULOSE AL SIROP 66.7% ALIUD PHARMA GMBH & CO.KG

670mg/mlA06AD11 LACTULOSUM SOL. ORALALAEVOLAC 670mg/ml 670mg/ml FRESENIUS KABI AUSTRIA GMBH

66.7%A06AD11 LACTULOSUM LICHID ORALDUPHALAC® 66.7% SOLVAY PHARMACEUTICALS BV

65%A06AD11 LACTULOSUM SIROPLACTULOSE 65% E.I.P.I.CO. MED S.R.L.

13 NYSTATINUMA07AA02

500.000uiA07AA02 NYSTATINUM COMPR. FILM.NISTATINA 500.000ui ANTIBIOTICE SA

500000uiA07AA02 NYSTATINUM COMPR. FILM.STAMICIN® 500000 U.I. 500000ui ZENTIVA SA

14 SULFASALAZINUMA07EC01

500mgA07EC01 SULFASALAZINUM COMPR. FILM.SALAZIDIN 500mg AC HELCOR SRL

500mgA07EC01 SULFASALAZINUM COMPR. FILM. GASTROREZ.SULFASALAZIN EN 500mg KRKA D.D. NOVO MESTO

15 MESALAZINUM **A07EC02

1gA07EC02 MESALAZINUM SUPOZ.PENTASA 1g FERRING A/S

Episod acut de proctita ulcerativa forma moderataPrescriere limitata:

NOTA: A nu se administra in tratamentul bolii Crohn..

250mgA07EC02 MESALAZINUM COMPR. GASTROREZ.SALOFALK 250 mg COMPRIMATE GASTROREZISTENTE 250mg DR. FALK PHARMA GMBH

Colita ulcerativa asociata cu hipersensibilitate la sulfonamideCod restrictie 1708:

Colita ulcerativa asociata cu intoleranta la sulfasalazinumCod restrictie 1709:

Boala Crohn in cazul in care exista hipersensibilitate la sulfonamideCod restrictie 2268:

Boala Crohn in cazul in care exista intoleranta la sulfasalazinumCod restrictie 2269:

250mgA07EC02 MESALAZINUM SUPOZ.SALOFALK® 250 mg 250mg DR. FALK PHARMA GMBH

Episod acut de proctita ulcerativa forma moderataPrescriere limitata:

4g/60mlA07EC02 MESALAZINUM SUSP. RECTALASALOFALK 4 g/ 60 ml 4g/60ml DR. FALK PHARMA GMBH

Episod acut de colita ulcerativa forma moderataCod restrictie 1707:

500mgA07EC02 MESALAZINUM COMPR. ELIB. PREL.PENTASA 500mg FERRING A/S

Colita ulcerativa asociata cu hipersensibilitate la sulfonamideCod restrictie 1708:

Colita ulcerativa asociata cu intoleranta la sulfasalazinumCod restrictie 1709:

Boala Crohn in cazul in care exista hipersensibilitate la sulfonamideCod restrictie 2268:

Boala Crohn in cazul in care exista intoleranta la sulfasalazinumCod restrictie 2269:

500mgA07EC02 MESALAZINUM COMPR. GASTROREZ.SALOFALK 500 mg COMPRIMATE GASTROREZISTENTE 500mg DR. FALK PHARMA GMBH

Colita ulcerativa asociata cu hipersensibilitate la sulfonamideCod restrictie 1708:

Colita ulcerativa asociata cu intoleranta la sulfasalazinumCod restrictie 1709:

Boala Crohn in cazul in care exista hipersensibilitate la sulfonamideCod restrictie 2268:

Boala Crohn in cazul in care exista intoleranta la sulfasalazinumCod restrictie 2269:

500mgA07EC02 MESALAZINUM SUPOZ.SALOFALK® 500 mg 500mg DR. FALK PHARMA GMBH

Episod acut de proctita ulcerativa forma moderataPrescriere limitata:

16 ACENOCUMAROLUMB01AA07

2mgB01AA07 ACENOCUMAROLUM COMPR.TROMBOSTOP 2 mg 2mg TERAPIA SA

4mgB01AA07 ACENOCUMAROLUM COMPR.SINTROM® 4mg NOVARTIS PHARMA GMBH

17 TICLOPIDINUM (1)B01AC05

250mgB01AC05 TICLOPIDINUM COMPR. FILM.IPATON 250mg EGIS PHARMACEUTICALS PLC

TICLID® 250 mg 250mg SANOFI-SYNTHELABO FRANCE

TICLODIN 250mg AC HELCOR SRL

TICLOPIDIN SANDOZ 250mg HEXAL AG

Preventia recurentei accidentului vascular ischiemic sau a accidentului ischemic tranzitor la pacientii cu istoric de episoade ischiemice cererbrovasculare in timpul

terapiei cu doze reduse de aspirina

Cod restrictie 1719:

Preventia recurentei accidentului vascular ischiemic sau a accidentului ischemic tranzitor la pacientii la care terapia cu doze reduse de aspirina prezinta un risc major

(inacceptabil) de sangerare gastrointestinala;

Cod restrictie 1720:

Preventia recurentei accidentului vascular ischiemic sau a accidentului ischemic tranzitor la pacientii cu istoric de reactie anafilactica , urticarie sau astm bronsic in

decurs de 4 ore de la administrarea de aspirina, alţi salicilati sau AINS

Cod restrictie 1721:

Neutropenia severa este un efect advers comun in primele luni de terapie. Monitorizarea hematologica se impune la inceputul tratamentului si apoi la fiecare doua saptamani in primele

patru luni de tratament.

18 PHYTOMENADIONUMB02BA01

10mg/mlB02BA01 PHYTOMENADIONUM SOL. INJ.FITOMENADION 10 mg/ml 10mg/ml TERAPIA SA

19 FERROSI SULFASB03AA07

105mgB03AA07 FERROSI SULFAS COMPR. ELIB. PREL.FERROGRADUMET® 105mg TEOFARMA SRL

80mgB03AA07 FERROSI SULFAS DRAJ. ELIB. PREL.TARDYFERON 80 mg 80mg LAB. PIERRE FABRE

B03AA07 FERROSI SULFAS COMPR.FILM.ELIB.PRELFERRO-GRADUMET POLIPHARMA INDUSTRIES S.R.L.

3 153/

Page 4: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

20 COMPLEX DE HIDROXID DE FER (III) POLIMALTOZATB03AB05

100mgB03AB05 COMPLEX DE HIDROXID DE FER (III)

POLIMALTOZAT

COMPR. MAST.

MALTOFER 100mg VIFOR FRANCE S.A.

10mg/mlB03AB05 COMPLEX DE HIDROXID DE FER (III)

POLIMALTOZAT

SIROP

FERRUM HAUSMANN® 10mg/ml VIFOR FRANCE S.A.

50mg/5mlB03AB05 COMPLEX DE HIDROXID DE FER (III)

POLIMALTOZAT

SIROP

FERGLUROM 50mg/5ml 50mg/5ml BIOFARM S.A.

5%B03AB05 COMPLEX DE HIDROXID DE FER (III)

POLIMALTOZAT

PICATURI ORALE-SOL.

PHARMA-FERRUM® 5% TERAPIA SA

50mg/mlB03AB05 COMPLEX DE HIDROXID DE FER (III)

POLIMALTOZAT

PICATURI ORALE-SOL.

FERRUM HAUSMANN® 50mg/ml VIFOR FRANCE S.A.

21 COMBINATII (FERROSI SULFAS+ACIDUM ASCORBICUM)B03AEN1

B03AEN1 COMBINATII (FERROSI SULFAS+ACIDUM

ASCORBICUM)

COMPR. FILM.

SORBIFER DURULES EGIS PHARMACEUTICALS LTD.

22 ACIDUM FOLICUMB03BB01

5mgB03BB01 ACIDUM FOLICUM COMPR. FILM.ACIFOL 5 mg 5mg ZENTIVA S.A.

23 DIGOXINUMC01AA05

0.05mg/mlC01AA05 DIGOXINUM SOL. ORALALANOXIN SOLUTIE ORALA 0.05mg/ml THE WELLCOME FOUNDATION LTD.

0.25mgC01AA05 DIGOXINUM COMPR.DIGOXIN 0,25 mg 0.25mg ZENTIVA S.A.

0.5mg/mlC01AA05 DIGOXINUM SOL. INJ.DIGOXIN 0,5 mg/2 ml 0.5mg/ml ZENTIVA S.A.

24 CHINIDINI SULFASC01BA01

200mgC01BA01 CHINIDINI SULFAS COMPR.CHINIDINA LAROPHARM 200 mg 200mg LAROPHARM SRL

CHINIDINA SULFAT 200 mg 200mg ARENA GROUP SA

25 PROPAFENONUMC01BC03

150mgC01BC03 PROPAFENONUM COMPR.PROPAFENONA 150 mg 150mg ARENA GROUP SA

150mgC01BC03 PROPAFENONUM COMPR. FILM.PROPAFENON AL 150 150mg ALIUD® PHARMA GMBH & CO.KG

PROPAFENON SANDOZ 150 mg 150mg HEXAL AG

RYTMONORM® 150mg ABBOTT GMBH&CO.KG

70mg/20mlC01BC03 PROPAFENONUM SOL. INJ.RYTMONORM 70mg/20ml ABBOTT GMBH&CO.KG

26 AMIODARONUMC01BD01

Prescriere limitata: Tratamentul tulburarilor de ritm severe care nu raspund la alte terapii sau cand alte antiaritmice nu pot fi folosite: a) tahiaritmii asociate sidromului

Wolff-Parkinson-White; .b) flutter/fibrilatie atriala, atunci cand alte antiaritmice nu pot fi folosite; c) toate tahiaritmiile paroxistice, incluzand tahicardii

supraventriculare, tahicardii ventriculare si nodale, fibrilatie ventriculara, atunci cand alte antiaritmice nu pot fi folosite.

Exista dovezi ca amiodarona poate produce toxicitate frecventă şi potenţial severă. Se recomandă monitorizarea periodică a funcţiilor hepatice şi tiroidiene.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

200mgC01BD01 AMIODARONUM COMPR.AMIODARONA 200 mg 200mg ARENA GROUP SA

AMIODARONA LPH 200 mg 200mg LABORMED PHARMA SA

DARITMIN® 200 mg 200mg GEDEON RICHTER ROMANIA SA

SEDACORON® 200mg EBEWE PHARMA GMBH NFG. KG

200mgC01BD01 AMIODARONUM COMPR. DIVIZ.CORDARONE 200 mg 200mg SANOFI-AVENTIS FRANCE

27 NITROGLYCERINUMC01DA02

0.4mg/dozaC01DA02 NITROGLYCERINUM SPRAY SUBLINGUALNITROMINT 0.4mg/doza EGIS PHARMACEUTICALS P.L.C.

NOTA: Sprayul nu trebuie inhalat..

0.5mgC01DA02 NITROGLYCERINUM COMPR. SUBLING.NITROGLICERINA 0,5 mg 0.5mg ZENTIVA SA

2.6mgC01DA02 NITROGLYCERINUM COMPR. ELIB. PREL.NITROMINT 2,6 mg 2.6mg EGIS PHARMACEUTICALS LTD.

25mgC01DA02 NITROGLYCERINUM SIST. TERAP. TRANSDERM.NITRODERM® TTS 5 25mg NOVARTIS PHARMA GMBH

28 ISOSORBIDI DINITRASC01DA08

10mgC01DA08 ISOSORBIDI DINITRAS COMPR.ISOSORBIDE DINITRATE 10 mg 10mg E.I.P.I.CO. MED S.R.L.

20mgC01DA08 ISOSORBIDI DINITRAS CAPS. ELIB. PREL.DINITER SR 20 mg 20mg TERAPIA SA

20mgC01DA08 ISOSORBIDI DINITRAS COMPR. ELIB. PREL.ISODINIT® RETARD 20mg BALKAN PHARMA DUPNITZA AD

40mgC01DA08 ISOSORBIDI DINITRAS CAPS. ELIB. PREL.DINITER SR 40 mg 40mg TERAPIA SA

29 ISOSORBIDI MONONITRASC01DA14

40mgC01DA14 ISOSORBIDI MONONITRAS CAPS. ELIB. PREL.OLICARD 40 mg RETARD 40mg SOLVAY PHARMACEUTICALS GMBH

4 153/

Page 5: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

60mgC01DA14 ISOSORBIDI MONONITRAS CAPS. ELIB. PREL.OLICARD 60 mg RETARD 60mg SOLVAY PHARMACEUTICALS GMBH

60mgC01DA14 ISOSORBIDI MONONITRAS COMPR. FILM. ELIB. PREL.MONONITRON® EP 60 mg 60mg ZENTIVA S.A

30 ALPROSTADILUM *** Protocol: C002IC01EA01

20µgC01EA01 ALPROSTADILUM CONC. PT. SOL. PERF.ALPROSTADIL "PINT" 20 µg 20µg PINT-PHARMA GMBH

20µgC01EA01 ALPROSTADILUM LIOF. PT. SOL. PERF.VASAPROSTAN 20 20µg SCHWARZ PHARMA AG

31 TRIMETAZIDINUMC01EB15

20mgC01EB15 TRIMETAZIDINUM CAPS.TRIMETAZIDIN 20 mg 20mg VIM SPECTRUM SRL

20mgC01EB15 TRIMETAZIDINUM COMPR. FILM.DILATAN 20 mg 20mg TERAPIA SA

MODUXIN® 20 mg 20mg GEDEON RICHTER ROMANIA SA

PREDOZONE 20 mg 20mg OZONE LABORATORIES LTD.

PREDUCTAL® 20mg LES LAB. SERVIER IND.

TRIMETAZIDINA LPH® 20 mg 20mg LABORMED PHARMA SA

TRIVEDON 20 20mg CIPLA (UK) LIMITED

20mgC01EB15 TRIMETAZIDINUM DRAJ.TRIMETAZIDINA 20 mg 20mg TERAPIA SA

35mgC01EB15 TRIMETAZIDINUM COMPR. FILM. ELIB. MODIF.DILATAN MR 35 mg 35mg TERAPIA SA

PREDUCTAL MR 35 mg 35mg LES LAB. SERVIER IND.

TRIMETAZIDINA LPH® 35 mg 35mg LABORMED PHARMA SA

32 METHYLDOPUMC02AB01

250mgC02AB01 METHYLDOPUM COMPR.DOPEGYT 250mg EGIS PHARMACEUTICALS PLC

33 CLONIDINUMC02AC01

0.15mgC02AC01 CLONIDINUM COMPR.CLONIDINA 0,15 mg 0.15mg ARENA GROUP SA

CLONIDINA SINTOFARM 0,15 mg 0.15mg SINTOFARM SA

34 DOXAZOSINUMC02CA04

1mgC02CA04 DOXAZOSINUM COMPR.DOXAZOSIN 1 MEDOCHEMIE 1mg MEDOCHEMIE ROMANIA SRL

DOXAZOSIN AL 1 1mg ALIUD® PHARMA GMBH & CO.KG

KAMIREN 1mg KRKA D.D. NOVO MESTO

MAGUROL 1mg MEDOCHEMIE LTD.

2mgC02CA04 DOXAZOSINUM COMPR.DOXAZOSIN 2 MEDOCHEMIE 2mg MEDOCHEMIE ROMANIA SRL

DOXAZOSIN AL 2 2mg ALIUD® PHARMA GMBH & CO.KG

DOXAZOSIN SANDOZ 2 mg 2mg HEXAL AG

KAMIREN 2mg KRKA D.D. NOVO MESTO

MAGUROL 2mg MEDOCHEMIE LTD.

4mgC02CA04 DOXAZOSINUM COMPR.DOXAZOSIN 4 MEDOCHEMIE 4mg MEDOCHEMIE ROMANIA SRL

DOXAZOSIN AL 4 4mg ALIUD® PHARMA GMBH & CO.KG

KAMIREN 4mg KRKA D.D. NOVO MESTO

MAGUROL 4mg MEDOCHEMIE LTD.

4mgC02CA04 DOXAZOSINUM COMPR. ELIB. MODIF.CARDURA XL 4 mg 4mg PFIZER H.C.P. CORPORATION

4mgC02CA04 DOXAZOSINUM COMPR. FILM. ELIB. PREL.KAMIREN XL 4 mg 4mg KRKA D.D. NOVO MESTO

1mgC02CA04 DOXAZOSINUM COMPR.DOXAZOSIN 1 MEDOCHEMIE 1mg MEDOCHEMIE ROMANIA SRL

DOXAZOSIN AL 1 1mg ALIUD® PHARMA GMBH & CO.KG

KAMIREN 1mg KRKA D.D. NOVO MESTO

MAGUROL 1mg MEDOCHEMIE LTD.

2mgC02CA04 DOXAZOSINUM COMPR.DOXAZOSIN 2 MEDOCHEMIE 2mg MEDOCHEMIE ROMANIA SRL

DOXAZOSIN AL 2 2mg ALIUD® PHARMA GMBH & CO.KG

DOXAZOSIN SANDOZ 2 mg 2mg HEXAL AG

KAMIREN 2mg KRKA D.D. NOVO MESTO

MAGUROL 2mg MEDOCHEMIE LTD.

4mgC02CA04 DOXAZOSINUM COMPR.DOXAZOSIN 4 MEDOCHEMIE 4mg MEDOCHEMIE ROMANIA SRL

DOXAZOSIN AL 4 4mg ALIUD® PHARMA GMBH & CO.KG

KAMIREN 4mg KRKA D.D. NOVO MESTO

MAGUROL 4mg MEDOCHEMIE LTD.

4mgC02CA04 DOXAZOSINUM COMPR. ELIB. MODIF.CARDURA XL 4 mg 4mg PFIZER H.C.P. CORPORATION

4mgC02CA04 DOXAZOSINUM COMPR. FILM. ELIB. PREL.KAMIREN XL 4 mg 4mg KRKA D.D. NOVO MESTO

35 HYDROCHLOROTHIAZIDUMC03AA03

25mgC03AA03 HYDROCHLOROTHIAZIDUM COMPR.NEFRIX 25 mg 25mg ZENTIVA SA

36 INDAPAMIDUMC03BA11

1,5mgC03BA11 INDAPAMIDUM COMPR. FILM. ELIB. PREL.IMPAMID SR 1,5 mg 1,5mg GEDEON RICHTER ROMANIA S.A.

INDATER SR 1,5 mg 1,5mg TERAPIA SA

1.5 mgC03BA11 INDAPAMIDUM COMPR. FILM. ELIB. PREL.INDAPAMID SR 1,5 mg LAROPHARM 1.5 mg LAROPHARM SRL

5 153/

Page 6: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

1.5mgC03BA11 INDAPAMIDUM COMPR. ELIB. PREL.INDAPAMID MCC 1,5 mg 1.5mg MAGISTRA C & C SRL

1.5mgC03BA11 INDAPAMIDUM COMPR. FILM. ELIB. PREL.INDAPAMID LPH® 1,5 mg 1.5mg LABORMED PHARMA SA

RAWEL SR 1,5 mg 1.5mg KRKA D.D. NOVO MESTO

TERTENSIF® SR 1.5mg LES LAB. SERVIER IND.

2.5mgC03BA11 INDAPAMIDUM COMPR.IMPAMID® 2,5 mg 2.5mg GEDEON RICHTER ROMANIA SA

2.5mgC03BA11 INDAPAMIDUM COMPR. FILM.INDAPAMID LPH® 2,5 mg 2.5mg LABORMED PHARMA SA

INDAPAMIDE 2,5 mg 2.5mg HEMOFARM S.R.L.

INDATER® 2,5 mg 2.5mg TERAPIA SA

37 FUROSEMIDUMC03CA01Electroliţii serici trebuie să fie verificaţi periodic.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului

10mg/mlC03CA01 FUROSEMIDUM SOL. INJ.FUROSEMID 20 mg/2 ml 10mg/ml ZENTIVA SA

40mgC03CA01 FUROSEMIDUM COMPR.FUROSEMID ARENA 40 mg 40mg ARENA GROUP S.A.

FUROSEMID EEL 40mg BIO EEL SRL

FUROSEMID LPH 40 mg 40mg LABORMED PHARMA SA

FUROSEMID MCC 40 mg 40mg MAGISTRA C & C SRL

FUROSEMID SLAVIA 40mg SLAVIA PHARM SRL

FUROSEMID ZENTIVA 40mg ZENTIVA SA

38 SPIRONOLACTONUMC03DA01

Electroliţii serici trebuie să fie verificaţi periodic.

Femeile la varsta fertila la care s-a initiat tratament cu spironolactona trebuie sa ia masuri adecvate de contraceptie.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului

100mgC03DA01 SPIRONOLACTONUM CAPS.VEROSPIRON 100mg GEDEON RICHTER LTD.

25mgC03DA01 SPIRONOLACTONUM COMPR.SPIRONOLACTONA 25 mg 25mg BIO EEL SRL

25mgC03DA01 SPIRONOLACTONUM COMPR. FILM.ALSPIRON 25 mg 25mg AC HELCOR PHARMA SRL

SPIRONOLACTONA 25 mg 25mg TERAPIA SA

50mgC03DA01 SPIRONOLACTONUM CAPS.VEROSPIRON 50mg GEDEON RICHTER LTD.

50mgC03DA01 SPIRONOLACTONUM COMPR. FILM.ALSPIRON 50 mg 50mg AC HELCOR PHARMA SRL

39 COMBINATII (SPIRONOLACTONUM+FUROSEMIDUM) C03EB01

C03EB01 COMBINATII

(SPIRONOLACTONUM+FUROSEMIDUM)

CAPS.

DIUREX 50 TERAPIA SA

40 PENTOXIFYLLINUMC04AD03

400mgC04AD03 PENTOXIFYLLINUM COMPR. FILM. ELIB. PREL.ANGIOPENT 400 mg 400mg AC HELCOR PHARMA SRL

PENTOXI RETARD 400 mg 400mg TERAPIA SA

400mgC04AD03 PENTOXIFYLLINUM DRAJ. ELIB. PREL.TRENTAL® 400mg AVENTIS PHARMA DEUTSCHLAND GMBH

600mgC04AD03 PENTOXIFYLLINUM COMPR. FILM. ELIB. PREL.ANGIOPENT 600 mg 600mg AC HELCOR PHARMA SRL

41 PROPRANOLOLUMC07AA05

10mgC07AA05 PROPRANOLOLUM COMPR.N - PROPRANOLOL 10 mg 10mg SC MEDUMAN SA

PROPRANOLOL 10mg BIO EEL SRL

PROPRANOLOL 10 mg 10mg SINTOFARM SA

40mgC07AA05 PROPRANOLOLUM COMPR.PROPRANOLOL 40 mg 40mg SINTOFARM SA

PROPRANOLOL EEL 40 mg 40mg BIO EEL SRL

42 SOTALOLUMC07AA07

Prescriere limitata: Tratamentul aritmiilor ventriculare severe.

Tratamentul aritmiilor supraventriculare.

Se aplica pentru toate denumirile comerciale si formele farmaceutice corespunzatoare denumirii comune internationale.

160mgC07AA07 SOTALOLUM COMPR.ALS-SOTALOL 160 mg 160mg ALSIFCOM INTERMED SRL

DAROB® 160 mg 160mg ABBOTT GMBH&CO.KG

SOTAGAMMA 160 160mg WORWAG PHARMA GMBH & CO. KG

SOTALOL AL 160 160mg ALIUD PHARMA GMBH & CO.KG

80mgC07AA07 SOTALOLUM COMPR.ALS-SOTALOL 80 mg 80mg ALSIFCOM INTERMED SRL

DAROB® 80 mg 80mg ABBOTT GMBH&CO.KG

SOTAGAMMA 80 80mg WORWAG PHARMA GMBH & CO. KG

43 METOPROLOLUMC07AB02

100mgC07AB02 METOPROLOLUM COMPR.BETAPROL 100 mg 100mg AC HELCOR PHARMA SRL

BLOXAN 100mg KRKA D.D. NOVO MESTO

EGILOK 100 mg 100mg EGIS PHARMACEUTICALS P.L.C.

METOPRO TAD 100 100mg TAD PHARMA GMBH

METOPROLOL 100 mg 100mg MAGISTRA C & C SRL

METOPROLOL AL 100 100mg ALIUD® PHARMA GMBH & CO.KG

METOPROLOL LPH 100 mg 100mg LABORMED PHARMA SA

METOPROLOL MEDICO UNO 100 mg 100mg MEDICO UNO PHARMACEUTICAL S.R.L.

6 153/

Page 7: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

METOPROLOL TERAPIA 100 mg 100mg TERAPIA SA

VASOCARDIN® 100 100mg SLOVAKOFARMA

100mgC07AB02 METOPROLOLUM COMPR. ELIB. PREL.METOPROLOL RETARD 100 mg 100mg TERAPIA S.A.

100mgC07AB02 METOPROLOLUM COMPR. FILM. ELIB. PREL.BETALOC® ZOC 100 mg 100mg ASTRAZENECA AB

190mgC07AB02 METOPROLOLUM COMPR.FILM.ELIB.MOD.METOSUCCINAT SANDOZ 190 mg 190mg HEXAL AG

200mgC07AB02 METOPROLOLUM COMPR. ELIB. PREL.VASOCARDIN® SR 200 200mg ZENTIVA AS

25mgC07AB02 METOPROLOLUM COMPR.EGILOK 25 mg 25mg EGIS PHARMACEUTICALS P.L.C.

METOPROLOL 25 mg 25mg ARENA GROUP S.A.

METOPROLOL LPH 25 mg 25mg LABORMED PHARMA SA

METOPROLOL MEDICO UNO 25 mg 25mg MEDICO UNO PHARMACEUTICAL S.R.L.

47.5mgC07AB02 METOPROLOLUM COMPR.FILM.ELIB.MOD.METOSUCCINAT SANDOZ 47,5 mg 47.5mg HEXAL AG

50mgC07AB02 METOPROLOLUM COMPR.BETAPROL 50 mg 50mg AC HELCOR PHARMA SRL

EGILOK 50 mg 50mg EGIS PHARMACEUTICALS P.L.C.

METOPRO TAD 50 50mg TAD PHARMA GMBH

METOPROLOL 50 mg 50mg MAGISTRA C & C SRL

METOPROLOL AL 50 50mg ALIUD PHARMA GMBH & CO.KG

METOPROLOL LPH 50 mg 50mg LABORMED PHARMA SA

METOPROLOL MEDICO UNO 50 mg 50mg MEDICO UNO PHARMACEUTICAL S.R.L.

METOPROLOL TERAPIA 50 mg 50mg TERAPIA SA

50mgC07AB02 METOPROLOLUM COMPR. FILM. ELIB. PREL.BETALOC® ZOC 50 mg 50mg ASTRAZENECA AB

95mgC07AB02 METOPROLOLUM COMPR.FILM.ELIB.MOD.METOSUCCINAT SANDOZ 95 mg 95mg HEXAL AG

44 ATENOLOLUMC07AB03

100mgC07AB03 ATENOLOLUM COMPR.ATECOR 100mg WIN - MEDICARE LTD.

ATENOCOR 100 mg 100mg AC HELCOR SRL

ATENOLOL 100 mg 100mg ARENA GROUP SA

ATENOLOL LPH 100 mg 100mg LABORMED PHARMA SA

100mgC07AB03 ATENOLOLUM COMPR. FILM.ATENOLOL 100 mg 100mg TERAPIA SA

ATENOLOL 100 mg MEDO 100mg MEDOCHEMIE ROMANIA SRL

VASCOTEN 100mg MEDOCHEMIE LTD.

50mgC07AB03 ATENOLOLUM COMPR.ATENOCOR 50 mg 50mg AC HELCOR SRL

ATENOLOL 50 mg 50mg SLAVIA PHARM SRL

ATENOLOL LPH 50 mg 50mg LABORMED PHARMA SA

50mgC07AB03 ATENOLOLUM COMPR. FILM.ATENOLOL 50 mg 50mg TERAPIA SA

45 BETAXOLOLUMC07AB05

20mgC07AB05 BETAXOLOLUM COMPR. FILM.BETAC 20mg MEDOCHEMIE LTD.

LOKREN 20 mg 20mg SANOFI-AVENTIS FRANCE

46 BISOPROLOLUMC07AB07

10mgC07AB07 BISOPROLOLUM COMPR.BISOBLOCK 10 mg 10mg KERI PHARMA GENERICS LTD.

10mgC07AB07 BISOPROLOLUM COMPR. FILM.BISOGAMMA® 10 10mg WORWAG PHARMA GMBH & CO. KG

BISOTENS 10 mg 10mg ANTIBIOTICE S.A.

CONCOR 10 mg 10mg MERCK KGAA

2.5mgC07AB07 BISOPROLOLUM COMPR. FILM.CONCOR COR 2,5 mg 2.5mg MERCK KGAA

5mgC07AB07 BISOPROLOLUM COMPR.BISOBLOCK 5 mg 5mg KERI PHARMA GENERICS LTD.

5mgC07AB07 BISOPROLOLUM COMPR. FILM.BISOGAMMA® 5 5mg WORWAG PHARMA GMBH & CO. KG

BISOTENS 5 mg 5mg ANTIBIOTICE S.A.

CONCOR 5 mg 5mg MERCK KGAA

47 CARVEDILOLUMC07AG02

12,5 mgC07AG02 CARVEDILOLUM COMPR.CARVEDILOL SANDOZ 12,5 mg HEXAL AG

12.5mgC07AG02 CARVEDILOLUM COMPR.ATRAM 12,5 12.5mg ZENTIVA AS

CARVEDILOL 12,5 mg 12.5mg VIM SPECTRUM SRL

CARVEDILOL HELCOR 12,5 mg 12.5mg AC HELCOR PHARMA SRL

CARVEDILOL LPH 12,5 mg 12.5mg LABORMED PHARMA SA

CARVEDILOL TEVA 12,5 mg 12.5mg TEVA PHARMACEUTICAL S.R.L.

CORYOL® 12.5mg KRKA D.D.

DILATREND® 12,5 mg 12.5mg ROCHE ROMANIA S.R.L.

TALLITON® 12,5 mg 12.5mg EGIS PHARMACEUTICALS LTD.

12.5mgC07AG02 CARVEDILOLUM COMPR. FILM.CARVEDIGAMMA 12,5 mg 12.5mg WORWAG PHARMA GMBH & CO. KG

25mgC07AG02 CARVEDILOLUM COMPR.ATRAM 25 25mg ZENTIVA AS

CARVEDILOL HELCOR 25 mg 25mg AC HELCOR PHARMA SRL

CARVEDILOL LPH 25 mg 25mg LABORMED PHARMA SA

7 153/

Page 8: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

CARVEDILOL SANDOZ 25mg HEXAL AG

CARVEDILOL TEVA 25 mg 25mg TEVA PHARMACEUTICAL S.R.L.

CORYOL® 25mg KRKA D.D.

DILATREND® 25 mg 25mg ROCHE ROMANIA S.R.L.

TALLITON® 25 mg 25mg EGIS PHARMACEUTICALS LTD.

25mgC07AG02 CARVEDILOLUM COMPR. FILM.CARVEDIGAMMA 25 mg 25mg WORWAG PHARMA GMBH & CO. KG

3.125mgC07AG02 CARVEDILOLUM COMPR.CORYOL® 3,125 mg 3.125mg KRKA D.D.

6.25mgC07AG02 CARVEDILOLUM COMPR.ATRAM 6,25 6.25mg ZENTIVA AS

CARVEDILOL 6,25 mg 6.25mg VIM SPECTRUM SRL

CARVEDILOL LPH 6,25 mg 6.25mg LABORMED PHARMA SA

CARVEDILOL SANDOZ 6.25mg HEXAL AG

CARVEDILOL TEVA 6,25 mg 6.25mg TEVA PHARMACEUTICAL S.R.L.

CORYOL® 6.25mg KRKA D.D.

DILATREND® 6,25 mg 6.25mg ROCHE ROMANIA S.R.L.

TALLITON 6,25 mg 6.25mg EGIS PHARMACEUTICALS LTD.

6.25mgC07AG02 CARVEDILOLUM COMPR. FILM.CARVEDIGAMMA 6,25 mg 6.25mg WORWAG PHARMA GMBH & CO. KG

48 AMLODIPINUMC08CA01

10mgC08CA01 AMLODIPINUM COMPR.ALOZUR 10 mg 10mg OZONE LABORATORIES BV

AMLO TAD 10 mg 10mg TAD PHARMA GMBH

AMLODIPIN 10 mg 10mg VIM SPECTRUM SRL

AMLODIPINE-TEVA 10 mg 10mg TEVA PHARMACEUTICAL S.R.L.

AMLOHEXAL 10 mg 10mg HEXAL AG

NORVASC 10 mg 10mg PFIZER EUROPE MA EEIG

STAMLO M 10 mg 10mg DR. REDDY'S LABORATORIES

TENOX® 10 10mg KRKA D.D.

VASOREX 10 mg 10mg LABORMED PHARMA S.A.

5mgC08CA01 AMLODIPINUM COMPR.ALOZUR 5 mg 5mg OZONE LABORATORIES BV

AMLO TAD 5 mg 5mg TAD PHARMA GMBH

AMLODIPIN 5 mg 5mg VIM SPECTRUM SRL

AMLODIPINE-TEVA 5 mg 5mg TEVA PHARMACEUTICAL S.R.L.

AMLOHEXAL 5 mg 5mg HEXAL AG

NORVASC 5 mg 5mg PFIZER EUROPE MA EEIG

STAMLO M 5 mg 5mg DR. REDDY'S LABORATORIES

TENOX® 5 5mg KRKA D.D.

VASOREX 5 mg 5mg LABORMED PHARMA S.A.

49 FELODIPINUMC08CA02

10mgC08CA02 FELODIPINUM COMPR. ELIB. MODIF.FELODIPIN AL 10 RETARD 10mg ALIUD® PHARMA GMBH & CO.KG

10mgC08CA02 FELODIPINUM COMPR. ELIB. PREL.PLENDIL 10mg ASTRAZENECA AB

10mgC08CA02 FELODIPINUM COMPR. FILM. ELIB. MODIF.SISTAR 10 mg 10mg GEDEON RICHTER ROMANIA SA

10mgC08CA02 FELODIPINUM COMPR. FILM. ELIB. PREL.AURONAL 10 mg 10mg EGIS PHARMACEUTICALS PLC

MIVARA 10 mg 10mg STADA ARZNEIMITTEL AG

PRESID® 10 mg 10mg IVAX - PHARMACEUTICALS S.R.O.

2.5mgC08CA02 FELODIPINUM COMPR. ELIB. MODIF.FELODIPIN AL 2,5 RETARD 2.5mg ALIUD® PHARMA GMBH & CO.KG

2.5mgC08CA02 FELODIPINUM COMPR. ELIB. PREL.PLENDIL 2.5mg ASTRAZENECA AB

2.5mgC08CA02 FELODIPINUM COMPR. FILM. ELIB. MODIF.SISTAR 2,5 mg 2.5mg GEDEON RICHTER ROMANIA SA

2.5mgC08CA02 FELODIPINUM COMPR. FILM. ELIB. PREL.AURONAL 2,5 mg 2.5mg EGIS PHARMACEUTICALS PLC

PRESID® 2,5 mg 2.5mg IVAX - PHARMACEUTICALS S.R.O.

5mgC08CA02 FELODIPINUM COMPR. ELIB. MODIF.FELODIPIN AL 5 RETARD 5mg ALIUD® PHARMA GMBH & CO.KG

5mgC08CA02 FELODIPINUM COMPR. ELIB. PREL.PLENDIL 5mg ASTRAZENECA AB

5mgC08CA02 FELODIPINUM COMPR. FILM. ELIB. MODIF.SISTAR 5 mg 5mg GEDEON RICHTER ROMANIA SA

5mgC08CA02 FELODIPINUM COMPR. FILM. ELIB. PREL.AURONAL 5 mg 5mg EGIS PHARMACEUTICALS PLC

MIVARA 5 mg 5mg STADA ARZNEIMITTEL AG

PRESID® 5 mg 5mg IVAX - PHARMACEUTICALS S.R.O.

50 NIFEDIPINUMC08CA05

20mgC08CA05 NIFEDIPINUM COMPR. ELIB. MODIF.ADALAT CR 20 20mg BAYER HEALTHCARE AG

20mgC08CA05 NIFEDIPINUM COMPR. FILM. ELIB. PREL.ADALAT® RETARD 20mg BAYER HEALTHCARE AG

NIFEDIPIN RETARD TERAPIA 20 mg 20mg TERAPIA SA

20mgC08CA05 NIFEDIPINUM DRAJ.EPILAT RETARD 20mg E.I.P.I.CO. MED S.R.L.

30mgC08CA05 NIFEDIPINUM COMPR. ELIB. MODIF.ADALAT CR 30 30mg BAYER HEALTHCARE AG

20mgC08CA05 NIFEDIPINUM COMPR. ELIB. MODIF.ADALAT CR 20 20mg BAYER HEALTHCARE AG

20mgC08CA05 NIFEDIPINUM COMPR. FILM. ELIB. PREL.

8 153/

Page 9: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

ADALAT® RETARD 20mg BAYER HEALTHCARE AG

NIFEDIPIN RETARD TERAPIA 20 mg 20mg TERAPIA SA

51 VERAPAMILUMC08DA01Efectele de inhibare a funcţiei miocardice ale acestui medicament se cumulează cu cele ale beta-blocantelor

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului

240mgC08DA01 VERAPAMILUM COMPR. FILM. ELIB. PREL.ISOPTIN RR 240mg ABBOTT GMBH&CO.KG

VEROGALID® ER 240 mg 240mg IVAX - PHARMACEUTICALS S.R.O.

40mgC08DA01 VERAPAMILUM COMPR. FILM.ISOPTIN® 40 mg 40mg ABBOTT GMBH&CO.KG

VERAPAMIL AL 40 40mg ALIUD® PHARMA GMBH & CO.KG

80mgC08DA01 VERAPAMILUM COMPR. FILM.ISOPTIN® 80 mg 80mg ABBOTT GMBH&CO.KG

VERAPAMIL AL 80 80mg ALIUD® PHARMA GMBH & CO.KG

52 DILTIAZEMUMC08DB01Efectele de inhibare a funcţiei miocardice ale acestui medicament se cumulează cu cele ale beta-blocantelor

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului

60mgC08DB01 DILTIAZEMUM COMPR.DILTIAZEM ALKALOID 60 mg 60mg ALKALOID DOO

DILTIAZEM EIPICO 60 mg 60mg E.I.P.I.CO. MED S.R.L.

DILTIAZEM LPH 60 mg 60mg LABORMED PHARMA SA

DILZEM 60 mg 60mg PFIZER EUROPE MA EEIG

90mgC08DB01 DILTIAZEMUM COMPR.DILTIAZEM ALKALOID 90 mg 90mg ALKALOID DOO

90mgC08DB01 DILTIAZEMUM COMPR. FILM. ELIB. PREL.DILZEM 90 mg RETARD 90mg PFIZER EUROPE MA EEIG

53 CAPTOPRILUMC09AA01

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului

in utero.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului

12,5mgC09AA01 CAPTOPRILUM COMPR.CAPTOPRIL MCC 12,5 mg 12,5mg MAGISTRA C & C

12.5mgC09AA01 CAPTOPRILUM COMPR.CAPTOPRIL 12,5 mg 12.5mg EGIS PHARMACEUTICALS LTD.

25mgC09AA01 CAPTOPRILUM COMPR.CAPTOPRIL - AC 25 mg 25mg AC HELCOR PHARMA SRL

CAPTOPRIL SINTOFARM 25 mg 25mg SINTOFARM SA

CAPTOPRIL 25 EEL 25mg BIO EEL SRL

CAPTOPRIL 25 mg 25mg EGIS PHARMACEUTICALS LTD.

CAPTOPRIL LPH 25 mg 25mg LABORMED PHARMA SA

CAPTOPRIL MCC 25 mg 25mg MAGISTRA C & C

50 mgC09AA01 CAPTOPRILUM COMPR.CAPTOPRIL 50 mg 50 mg ARENA GROUP SA

50mgC09AA01 CAPTOPRILUM COMPR.CAPTOPRIL - AC 50 mg 50mg AC HELCOR PHARMA SRL

CAPTOPRIL 50 EEL 50mg BIO EEL SRL

CAPTOPRIL 50 mg 50mg EGIS PHARMACEUTICALS LTD.

CAPTOPRIL LPH 50 mg 50mg LABORMED PHARMA SA

CAPTOPRIL MCC 50 mg 50mg MAGISTRA C & C

54 ENALAPRILUMC09AA02

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului

in utero.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului

1.25mg/mlC09AA02 ENALAPRILUM SOL. INJ.ENAP® 1.25mg/ml KRKA D.D.

10mgC09AA02 ENALAPRILUM COMPR.EDNYT® 10 mg 10mg GEDEON RICHTER LTD.

ENAHEXAL® 10 mg 10mg HEXAL AG

ENALA TAD 10 10mg TAD PHARMA GMBH

ENALAP 10mg E.I.P.I.CO. MED S.R.L.

ENALAPRIL 10 mg 10mg MAGISTRA C & C

ENALAPRIL AL 10 10mg ALIUD® PHARMA GMBH & CO.KG

ENALAPRIL FABIOL 10 mg 10mg FABIOL SA

ENALAPRIL LPH 10 mg 10mg LABORMED PHARMA SA

ENALAPRIL SANDOZ 10 mg 10mg SANDOZ SRL

ENALAPRIL TERAPIA 10 mg 10mg TERAPIA SA

ENAM 10 mg 10mg REPREZENTANTA DR. REDDY'S LABORATORIES LTD.

ENAP 10 mg 10mg KRKA D.D. NOVO MESTO

RENITEC 10 mg 10mg MERCK SHARP & DOHME ROMANIA S.R.L.

2.5mgC09AA02 ENALAPRILUM COMPR.EDNYT® 2,5 mg 2.5mg GEDEON RICHTER LTD.

20mgC09AA02 ENALAPRILUM COMPR.EDNYT® 20 mg 20mg GEDEON RICHTER LTD.

ENAHEXAL® 20 mg 20mg HEXAL AG

ENALA TAD 20 20mg TAD PHARMA GMBH

ENALAPRIL 20mg OZONE LABORATORIES LTD.

ENALAPRIL 20 mg 20mg MAGISTRA C & C

ENALAPRIL AL 20 20mg ALIUD® PHARMA GMBH & CO.KG

ENALAPRIL FABIOL 20 mg 20mg FABIOL SA

ENALAPRIL LPH 20 mg 20mg LABORMED PHARMA SA

ENALAPRIL SANDOZ 20 mg 20mg SANDOZ SRL

ENALAPRIL TERAPIA 20 mg 20mg TERAPIA SA

ENAP 20 mg 20mg KRKA D.D. NOVO MESTO

RENITEC 20 mg 20mg MERCK SHARP & DOHME ROMANIA S.R.L.

9 153/

Page 10: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

5mgC09AA02 ENALAPRILUM COMPR.EDNYT® 5 mg 5mg GEDEON RICHTER LTD.

ENAHEXAL® 5 mg 5mg HEXAL AG

ENALA TAD 5 5mg TAD PHARMA GMBH

ENALAPRIL 5 mg 5mg OZONE LABORATORIES LTD.

ENALAPRIL AL 5 5mg ALIUD® PHARMA GMBH & CO.KG

ENALAPRIL LPH® 5 mg 5mg LABORMED PHARMA SA

ENALAPRIL SANDOZ 5 mg 5mg SANDOZ SRL

ENAP 5 mg 5mg KRKA D.D. NOVO MESTO

RENITEC 5 mg 5mg MERCK SHARP & DOHME ROMANIA S.R.L.

55 LISINOPRILUMC09AA03

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului

in utero.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului

10mgC09AA03 LISINOPRILUM COMPR.LISIGAMMA 10 mg 10mg WORWAG PHARMA GMBH & CO. KG

LISINOPRIL 10 MEDO 10mg MEDOCHEMIE ROMANIA SRL

LISINOPRIL ANTIBIOTICE 10 mg 10mg ANTIBIOTICE SA

LISINOPRIL SANDOZ 10 mg 10mg HEXAL AG

LISIREN 10 mg 10mg AC HELCOR SRL

MEDAPRIL 10 10mg MEDOCHEMIE LTD.

RANOLIP 10mg RANBAXY U.K. LIMITED

SINOPRYL® 10 10mg ECZACIBASI PHARMACEUTICALS S.R.L.

TONOLYSIN 10 mg 10mg GEDEON RICHTER LTD.

2.5mgC09AA03 LISINOPRILUM COMPR.TONOLYSIN 2,5 mg 2.5mg GEDEON RICHTER LTD.

20mgC09AA03 LISINOPRILUM COMPR.LISIGAMMA 20 mg 20mg WORWAG PHARMA GMBH & CO. KG

LISINOPRIL 20 MEDO 20mg MEDOCHEMIE ROMANIA SRL

LISINOPRIL ANTIBIOTICE 20 mg 20mg ANTIBIOTICE SA

LISINOPRIL SANDOZ 20 mg 20mg HEXAL AG

LISIREN 20 mg 20mg AC HELCOR SRL

MEDAPRIL 20 20mg MEDOCHEMIE LTD.

RANOLIP 20mg RANBAXY U.K. LIMITED

TONOLYSIN 20 mg 20mg GEDEON RICHTER LTD.

40mgC09AA03 LISINOPRILUM COMPR.LISINOPRIL ANTIBIOTICE 40 mg 40mg ANTIBIOTICE SA

5mgC09AA03 LISINOPRILUM COMPR.LISIGAMMA 5 mg 5mg WORWAG PHARMA GMBH & CO. KG

LISINOPRIL 5 MEDO 5mg MEDOCHEMIE ROMANIA SRL

LISINOPRIL SANDOZ 5 mg 5mg HEXAL AG

MEDAPRIL 5 5mg MEDOCHEMIE LTD.

RANOLIP 5mg RANBAXY U.K. LIMITED

TONOLYSIN 5 mg 5mg GEDEON RICHTER LTD.

56 RAMIPRILUMC09AA05

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului

in utero.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului

1.25mgC09AA05 RAMIPRILUM COMPR. FILM.RAMIRAN 1,25 mg 1.25mg RANBAXY U.K. LIMITED

10 mgC09AA05 RAMIPRILUM COMPR.EMREN 10 mg 10 mg GEDEON RICHTER ROMANIA S.A.

VIVACE 10 mg 10 mg ACTAVIS GROUP HF

10mgC09AA05 RAMIPRILUM COMPR.AMPRIL 10 mg 10mg KRKA D.D. NOVO MESTO

PIRAMIL 10 mg 10mg SANDOZ SRL

RAMIGAMMA 10 mg 10mg WORWAG PHARMA GMBH & CO. KG

RAMIPRIL-AC 10 mg 10mg AC HELCOR PHARMA SRL

TRITACE 10 10mg SANOFI - AVENTIS DEUTSCHLAND GMBH

ZENRA 10 10mg ZENTIVA S.A.

10mgC09AA05 RAMIPRILUM COMPR. FILM.RAMIRAN 10 mg 10mg RANBAXY U.K. LIMITED

2,5 mgC09AA05 RAMIPRILUM COMPR.EMREN 2,5 mg 2,5 mg GEDEON RICHTER ROMANIA S.A.

VIVACE 2,5 mg 2,5 mg ACTAVIS GROUP HF

2.5mgC09AA05 RAMIPRILUM COMPR.AMPRIL 2,5 mg 2.5mg KRKA D.D. NOVO MESTO

PIRAMIL 2,5 mg 2.5mg SANDOZ SRL

RAMIPRIL-AC 2,5 mg 2.5mg AC HELCOR PHARMA SRL

TRITACE® 2,5 2.5mg AVENTIS PHARMA DEUTSCHLAND GMBH

ZENRA 2,5 2.5mg ZENTIVA S.A.

2.5mgC09AA05 RAMIPRILUM COMPR. FILM.RAMIRAN 2,5 mg 2.5mg RANBAXY U.K. LIMITED

5 mgC09AA05 RAMIPRILUM COMPR.EMREN 5 mg 5 mg GEDEON RICHTER ROMANIA S.A.

VIVACE 5 mg 5 mg ACTAVIS GROUP HF

5mgC09AA05 RAMIPRILUM COMPR.AMPRIL 5 mg 5mg KRKA D.D. NOVO MESTO

PIRAMIL 5 mg 5mg SANDOZ SRL

RAMIGAMMA 5 mg 5mg WORWAG PHARMA GMBH & CO. KG

RAMIPRIL-AC 5 mg 5mg AC HELCOR PHARMA SRL

TRITACE® 5 5mg AVENTIS PHARMA DEUTSCHLAND GMBH

ZENRA 5 5mg ZENTIVA S.A.

5mgC09AA05 RAMIPRILUM COMPR. FILM.RAMIRAN 5 mg 5mg RANBAXY U.K. LIMITED

10 153/

Page 11: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

57 QUINAPRILUMC09AA06

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului

in utero.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului

10 mgC09AA06 QUINAPRILUM COMPR. FILM.QUINAPRIL SANDOZ 10 mg 10 mg HEXAL AG

10mgC09AA06 QUINAPRILUM COMPR. FILM.ACCUPRO 10 mg 10mg PFIZER EUROPE MA EEIG

AQUIRIL 10 mg 10mg LABORMED PHARMA SA

QUINARAN 10 mg 10mg RANBAXY UK LIMITED

20 mgC09AA06 QUINAPRILUM COMPR. FILM.QUINAPRIL SANDOZ 20 mg 20 mg HEXAL AG

20mgC09AA06 QUINAPRILUM COMPR. FILM.ACCUPRO® 20 20mg PFIZER EUROPE MA EEIG

QUINARAN 20 mg 20mg RANBAXY UK LIMITED

40 mgC09AA06 QUINAPRILUM COMPR. FILM.QUINAPRIL SANDOZ 40 mg 40 mg HEXAL AG

40mgC09AA06 QUINAPRILUM COMPR. FILM.QUINARAN 40 mg 40mg RANBAXY UK LIMITED

5 mgC09AA06 QUINAPRILUM COMPR. FILM.QUINAPRIL SANDOZ 5 mg 5 mg HEXAL AG

5mgC09AA06 QUINAPRILUM COMPR. FILM.ACCUPRO® 5 5mg PFIZER EUROPE MA EEIG

QUINARAN 5 mg 5mg RANBAXY UK LIMITED

58 FOSINOPRILUMC09AA09

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului

in utero.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului

10mgC09AA09 FOSINOPRILUM COMPR.FOSINOPRIL TERAPIA 10 mg 10mg TERAPIA SA

FOSYPRIL 10 mg 10mg TERAPIA S.A.

MONOPRIL 10 mg 10mg BRISTOL MYERS SQUIBB KFT

20mgC09AA09 FOSINOPRILUM COMPR.FOSINOPRIL TERAPIA 20 mg 20mg TERAPIA SA

FOSINOPRIL TEVA 20 mg 20mg TEVA PHARMACEUTICAL S.R.L.

FOSYPRIL 20 mg 20mg TERAPIA S.A.

MONOPRIL 20 mg 20mg BRISTOL-MYERS SQUIBB KFT

59 COMBINATII (ENALAPRILUM+HYDROCHLOROTHIAZIDUM)C09BA02

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului in

utero.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului

10mg/25mgC09BA02 COMBINATII

(ENALAPRILUM+HYDROCHLOROTHIAZIDUM)

COMPR.

ENALAPRIL HCT SANDOZ 10 mg/25 mg 10mg/25mg HEXAL AG

10mg+12.5mgC09BA02 COMBINATII

(ENALAPRILUM+HYDROCHLOROTHIAZIDUM)

COMPR.

ENAP HL 10mg+12.5mg KRKA D.D. NOVO MESTO

10mg+25mgC09BA02 COMBINATII

(ENALAPRILUM+HYDROCHLOROTHIAZIDUM)

COMPR.

ENAP H 10mg+25mg KRKA D.D. NOVO MESTO

20 mg/12.5mgC09BA02 COMBINATII

(ENALAPRILUM+HYDROCHLOROTHIAZIDUM)

COMPR.

ENAP® HL 20 mg/12,5 mg 20 mg/12.5mg KRKA D.D. NOVO MESTO

20mg/12.5mgC09BA02 COMBINATII

(ENALAPRILUM+HYDROCHLOROTHIAZIDUM)

COMPR.

ENALAPRIL HCT SANDOZ 20 mg/12,5 mg 20mg/12.5mg HEXAL AG

C09BA02 COMBINATII

(ENALAPRILUM+HYDROCHLOROTHIAZIDUM)

COMPR.

VIMAPRIL H VIM SPECTRUM SRL

VIMAPRIL HL VIM SPECTRUM SRL

60 COMBINATII (RAMIPRILUM+HYDROCHLOROTHIAZIDUM)C09BA05

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului in

utero.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului

2.5mg/12.5mgC09BA05 COMBINATII

(RAMIPRILUM+HYDROCHLOROTHIAZIDUM)

COMPR.

HARTIL HCT 2,5 mg/12,5mg 2.5mg/12.5mg EGIS PHARMACEUTICALS PLC

PIRAMIL HCT 2,5 mg/12,5 mg 2.5mg/12.5mg HEXAL AG

RAMIPRIL HCT-MEDOCHEMIE 2.5mg/12.5mg MEDOCHEMIE LTD.

2.5mg+12.5mgC09BA05 COMBINATII

(RAMIPRILUM+HYDROCHLOROTHIAZIDUM)

COMPR.

AMPRIL HL 2.5mg+12.5mg KRKA D.D. NOVO MESTO

5mg/25mgC09BA05 COMBINATII

(RAMIPRILUM+HYDROCHLOROTHIAZIDUM)

COMPR.

HARTIL HCT 5 mg/25mg 5mg/25mg EGIS PHARMACEUTICALS PLC

PIRAMIL HCT 5 mg/25 mg 5mg/25mg HEXAL AG

RAMIPRIL HCT-MEDOCHEMIE 5mg/25mg MEDOCHEMIE LTD.

5mg+25mgC09BA05 COMBINATII

(RAMIPRILUM+HYDROCHLOROTHIAZIDUM)

COMPR.

AMPRIL HD 5mg+25mg KRKA D.D. NOVO MESTO

11 153/

Page 12: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

61 LOSARTANUMC09CA01

50mgC09CA01 LOSARTANUM COMPR. FILM.COZAAR 50mg MERCK SHARP & DOHME ROMANIA S.R.L.

62 SIMVASTATINUM Protocol: CE01EC10AA01

Prescriere limitata: Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului

10 mgC10AA01 SIMVASTATINUM COMPR. FILM.SIMVASTATIN 10 mg 10 mg TERAPIA S.A.

10mgC10AA01 SIMVASTATINUM COMPR. FILM.SIMGAL® 10 mg 10mg IVAX - PHARMACEUTICALS S.R.O.

SIMVA TAD 10 mg 10mg TAD PHARMA GMBH

SIMVACARD® 10 10mg ZENTIVA AS

SIMVAGAMMA 10 mg 10mg WORWAG PHARMA GMBH & CO. KG

SIMVAHEXAL® 10 mg 10mg HEXAL AG

SIMVASTATIN LPH 10 mg 10mg LABORMED PHARMA SA

SIMVOR 10 mg 10mg RANBAXY U.K. LIMITED

SINTENAL 10 mg 10mg AC HELCOR PHARMA SRL

VABADIN 10 mg 10mg MENARINI INTERNATIONAL OPERATIONS LUXEMBURG S.A.

VASILIP 10 mg 10mg KRKA D.D.

ZAREDIL 10 mg 10mg OZONE LABORATORIES LTD.

ZEPLAN® 10 mg 10mg GEDEON RICHTER ROMANIA SA

ZOCOR 10 mg 10mg MERCK SHARP & DOHME ROMANIA S.R.L.

20 mgC10AA01 SIMVASTATINUM COMPR. FILM.SIMVASTATIN 20 mg 20 mg TERAPIA S.A.

20mgC10AA01 SIMVASTATINUM COMPR. FILM.SIMCOR 20 mg 20mg ANTIBIOTICE SA

SIMGAL® 20 mg 20mg IVAX - PHARMACEUTICALS S.R.O.

SIMVA TAD 20 mg 20mg TAD PHARMA GMBH

SIMVACARD® 20 20mg ZENTIVA AS

SIMVAGAMMA 20 mg 20mg WORWAG PHARMA GMBH & CO. KG

SIMVAHEXAL® 20 mg 20mg HEXAL AG

SIMVASTATIN LPH 20 mg 20mg LABORMED PHARMA SA

SIMVOR 20 mg 20mg RANBAXY U.K. LIMITED

SINTENAL 20 mg 20mg AC HELCOR PHARMA SRL

VABADIN 20 mg 20mg MENARINI INTERNATIONAL OPERATIONS LUXEMBURG S.A.

VASILIP 20 mg 20mg KRKA D.D.

ZAREDIL 20 mg 20mg OZONE LABORATORIES LTD.

ZEPLAN® 20 mg 20mg GEDEON RICHTER ROMANIA SA

ZOCOR 20 mg 20mg MERCK SHARP & DOHME ROMANIA S.R.L.

30mgC10AA01 SIMVASTATINUM COMPR. FILM.SIMVAHEXAL® 30 mg 30mg HEXAL AG

40 mgC10AA01 SIMVASTATINUM COMPR. FILM.SIMVASTATIN 40 mg 40 mg TERAPIA S.A.

40mgC10AA01 SIMVASTATINUM COMPR. FILM.SIMCOR 40 mg 40mg ANTIBIOTICE S.A.

SIMGAL® 40 mg 40mg IVAX - PHARMACEUTICALS S.R.O.

SIMVA TAD 40 mg 40mg TAD PHARMA GMBH

SIMVACARD® 40 40mg ZENTIVA AS

SIMVAGAMMA 40 mg 40mg WORWAG PHARMA GMBH & CO. KG

SIMVAHEXAL® 40 mg 40mg HEXAL AG

SIMVASTATIN LPH 40 mg 40mg LABORMED PHARMA S.A.

SIMVOR 40 mg 40mg RANBAXY U.K. LIMITED

SINTENAL 40 mg 40mg AC HELCOR PHARMA SRL

VABADIN 40 mg 40mg MENARINI INTERNATIONAL OPERATIONS LUXEMBURG S.A.

VASILIP® 40 mg 40mg KRKA D.D.

ZAREDIL 40 mg 40mg OZONE LABORATORIES LTD.

ZEPLAN® 40 mg 40mg GEDEON RICHTER ROMANIA SA

ZOCOR FORTE 40mg MERCK SHARP & DOHME ROMANIA S.R.L.

5mgC10AA01 SIMVASTATINUM COMPR. FILM.SIMVOR 5 mg 5mg RANBAXY U.K. LIMITED

80mgC10AA01 SIMVASTATINUM COMPR. FILM.SIMVASTATIN LPH 80 mg 80mg LABORMED PHARMA S.A.

63 LOVASTATINUM Protocol: CE01EC10AA02

Prescriere limitata: Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

20mgC10AA02 LOVASTATINUM COMPR.MEDOSTATIN 20mg MEDOCHEMIE LTD.

64 PRAVASTATINUM Protocol: CE01EC10AA03

Prescriere limitata: Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

10mgC10AA03 PRAVASTATINUM COMPR.PRALIP 10 mg 10mg SANDOZ SRL

PRAVATOR 10 mg 10mg RANBAXY U.K. LIMITED

20mgC10AA03 PRAVASTATINUM COMPR.PRALIP 20 mg 20mg SANDOZ SRL

PRAVATOR 20 mg 20mg RANBAXY U.K. LIMITED

40mgC10AA03 PRAVASTATINUM COMPR.PRALIP 40 mg 40mg SANDOZ SRL

PRAVATOR 40 mg 40mg RANBAXY U.K. LIMITED

65 FENOFIBRATUM Protocol: CE01EC10AB05

Prescriere limitata: Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.

12 153/

Page 13: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

Riscul de toxicitate musculară severă creste dacă fenofibratum este utilizat simultan cu inhibitori de HMG CoA reductaza sau alţi fibraţi. Terapia combinata trebuie folosită cu

precautie la pacienţii cu dislipidemie mixta severă combinată cu risc cardiovascular înalt, in absenta antecedentelor de afectiune musculară. Pacienţii vor fi monitorizaţi regulat

pentru semne cronice de toxicitate musculară

NOTA:

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgC10AB05 FENOFIBRATUM CAPS.LIPANTHYL® 100 100mg LAB. FOURNIER SA

160mgC10AB05 FENOFIBRATUM CAPS.LIPOFIB 160 mg 160mg TERAPIA S.A.

160mgC10AB05 FENOFIBRATUM COMPR. FILM. ELIB. MODIF.LIPANTHYL® SUPRA 160 mg 160mg LAB. FOURNIER SA

200mgC10AB05 FENOFIBRATUM CAPS.LIPOFIB 200 mg 200mg TERAPIA S.A.

200mgC10AB05 FENOFIBRATUM CAPS. PULB. MICRONIZATAFENOFIBRAT LPH 200 mg 200mg LABORMED PHARMA SA

LIPANTHYL 200 M 200mg LAB. FOURNIER SA

LIPIVIM 200mg VIM SPECTRUM SRL

66 MICONAZOLUMD01AC02

20mg/gD01AC02 MICONAZOLUM CREMAMICONAL ECOBI 20mg/g FARMACEUTICI ECOBI S.A.S

2%D01AC02 MICONAZOLUM CREMAMEDACTER 2% FARAN LABORATORIES S.A.

MICONAZOL NITRAT 2% 2% SLAVIA PHARM SRL

2%D01AC02 MICONAZOLUM GELDERMOZOL 2% PHARCO IMPEX 93 S.R.L.

67 BIFONAZOLUMD01AC10

0,01g/mlD01AC10 BIFONAZOLUM SOL. CUT.MYCOSPOR 0,01g/ml BAYER HEALTHCARE AG

100gD01AC10 BIFONAZOLUM CREMAMYCO - FLUSEMIDON 100g ANFARM HELLAS S.A. PHARMACEUTICALS

10mg/gD01AC10 BIFONAZOLUM CREMABIAZOL 10 mg/g 10mg/g GEDEON RICHTER ROMANIA SA

1%D01AC10 BIFONAZOLUM CREMAMYCOSPOR 1% BAYER HEALTHCARE AG

68 ACICLOVIRUMD06BB03

50mg/gD06BB03 ACICLOVIRUM CREMAACICLOVIR HYPERION 50mg/g HYPERION S.A.

ACIKLOVIR CREMA 50mg/g A & G MED TRADING S.R.L.

5%D06BB03 ACICLOVIRUM CREMAACICLOVIR 5% OZONE LABORATORIES LTD.

ACICLOVIR 5% 5% GEDEON RICHTER ROMANIA SA

CLOVIRAL® 5% 5% ANTIBIOTICE SA

ZOVIRAX 5% THE WELLCOME FOUNDATION LTD.

69 HYDROCORTISONUM Protocol: D001LD07AA02

1,00%D07AA02 HYDROCORTISONUM UNGUENTHIDROCORTIZON 1% 1% ANTIBIOTICE SA

70 BETAMETHASONUM Protocol: D001LD07AC01

0,5mg/gD07AC01 BETAMETHASONUM CREMABELODERM CREMA 0,5mg/g A & G MED TRADING S.R.L.

0,5mg/gD07AC01 BETAMETHASONUM UNGUENTBELODERM UNGUENT 0,5mg/g A & G MED TRADING S.R.L.

0.1%D07AC01 BETAMETHASONUM CREMABETADERM 0.1% E.I.P.I.CO. MED S.R.L.

0.1%D07AC01 BETAMETHASONUM UNGUENTBETADERM 0.1% E.I.P.I.CO. MED S.R.L.

71 MICONAZOLUMG01AF04

1.2gG01AF04 MICONAZOLUM CAPS. MOI VAG.MICONAL ECOBI 1.2g FARMACEUTICI ECOBI S.A.S

20mg/gG01AF04 MICONAZOLUM CREMA VAG.MICONAL ECOBI 20mg/g FARMACEUTICI ECOBI S.A.S

2mg/mlG01AF04 MICONAZOLUM SOL. VAGINALAMICONAL ECOBI 2mg/ml FARMACEUTICI ECOBI S.A.S

50mgG01AF04 MICONAZOLUM OVULEMICONAL ECOBI 50mg FARMACEUTICI ECOBI S.A.S

2%G01AF04 MICONAZOLUM CREMA VAG.MEDACTER 2% FARAN LABORATORIES S.A.

MYCOHEAL 2% DAR AL DAWA PHARMA S.R.L.

72 ERGOMETRINUMG02AB03

0.2mg/mlG02AB03 ERGOMETRINUM SOL. INJ.MALEAT DE ERGOMETRINA 0,2 mg/ml 0.2mg/ml ZENTIVA S.A.

73 TESTOSTERONUM *G03BA03

1000mg/4mlG03BA03 TESTOSTERONUM SOL. INJ.NEBIDO 1000 mg/4 ml 1000mg/4ml SCHERING AG

40mgG03BA03 TESTOSTERONUM CAPS. MOIUNDESTOR® TESTOCAPS® 40mg ORGANON NV

Deficit androgenic la barbati de cauza primara testiculara sau secundara hipotalamo-hipofizara (confirmat prin nivel plasmatic al testosteronului la cel putin 2

determinari in doua dimineti diferite mai mic sau egal cu limita inferioara a valorilor reactivului utilizat).

Prescriere limitata:

Micropenis, inducerea pubertatii sau intarzierea constitutionala a cresterii sau a pubertatii la baieti sub 18 ani.Prescriere limitata:

50mgG03BA03 TESTOSTERONUM GELANDROGEL 50 mg 50mg LAB. BESINS INTERNATIONAL

74 ESTRADIOLUM *G03CA03

13 153/

Page 14: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

Prescriere limitata: Utilizat in simptomele caracteristice post-menopauzei, in cazul in care terapia estrogenica in doze reduse a demonstrat intoleranta la administrarea orala cu estrogeni.

Aceasta limitare este valabila doar pentru formele farmaceutice Sistem terapeutic transdermic si plasture transdermic.

Estradiol trebuie folosit împreuna cu un progestativ oral la femeile nehisterectomizate.NOTA:

0.06%G03CA03 ESTRADIOLUM GELOESTROGEL® 0.06% LAB. BESINS INTERNATIONAL

0.1%G03CA03 ESTRADIOLUM GELESTREVA® 0.1% LAB. THERAMEX

1mgG03CA03 ESTRADIOLUM COMPR. FILM.ESTROFEM 1 mg 1mg NOVO NORDISK A/S

25µgG03CA03 ESTRADIOLUM COMPR. VAG.VAGIFEM 25µg NOVO NORDISK A/S

25mgG03CA03 ESTRADIOLUM IMPLANTRISELLE 25 mg 25mg ORGANON NV

50µg/24oreG03CA03 ESTRADIOLUM PLASTURE TRANSDERM.CLIMARA 50µg/24ore SCHERING AG

75 DOXAZOSINUMG04CAN1

1mgG04CAN1 DOXAZOSINUM COMPR.DOXAZOSIN 1 MEDOCHEMIE 1mg MEDOCHEMIE ROMANIA SRL

DOXAZOSIN AL 1 1mg ALIUD® PHARMA GMBH & CO.KG

KAMIREN 1mg KRKA D.D. NOVO MESTO

MAGUROL 1mg MEDOCHEMIE LTD.

2mgG04CAN1 DOXAZOSINUM COMPR.DOXAZOSIN 2 MEDOCHEMIE 2mg MEDOCHEMIE ROMANIA SRL

DOXAZOSIN AL 2 2mg ALIUD® PHARMA GMBH & CO.KG

DOXAZOSIN SANDOZ 2 mg 2mg HEXAL AG

KAMIREN 2mg KRKA D.D. NOVO MESTO

MAGUROL 2mg MEDOCHEMIE LTD.

4mgG04CAN1 DOXAZOSINUM COMPR.DOXAZOSIN 4 MEDOCHEMIE 4mg MEDOCHEMIE ROMANIA SRL

DOXAZOSIN AL 4 4mg ALIUD® PHARMA GMBH & CO.KG

KAMIREN 4mg KRKA D.D. NOVO MESTO

MAGUROL 4mg MEDOCHEMIE LTD.

4mgG04CAN1 DOXAZOSINUM COMPR. ELIB. MODIF.CARDURA XL 4 mg 4mg PFIZER H.C.P. CORPORATION

4mgG04CAN1 DOXAZOSINUM COMPR. FILM. ELIB. PREL.KAMIREN XL 4 mg 4mg KRKA D.D. NOVO MESTO

1mgG04CAN1 DOXAZOSINUM COMPR.DOXAZOSIN 1 MEDOCHEMIE 1mg MEDOCHEMIE ROMANIA SRL

DOXAZOSIN AL 1 1mg ALIUD® PHARMA GMBH & CO.KG

KAMIREN 1mg KRKA D.D. NOVO MESTO

MAGUROL 1mg MEDOCHEMIE LTD.

2mgG04CAN1 DOXAZOSINUM COMPR.DOXAZOSIN 2 MEDOCHEMIE 2mg MEDOCHEMIE ROMANIA SRL

DOXAZOSIN AL 2 2mg ALIUD® PHARMA GMBH & CO.KG

DOXAZOSIN SANDOZ 2 mg 2mg HEXAL AG

KAMIREN 2mg KRKA D.D. NOVO MESTO

MAGUROL 2mg MEDOCHEMIE LTD.

4mgG04CAN1 DOXAZOSINUM COMPR.DOXAZOSIN 4 MEDOCHEMIE 4mg MEDOCHEMIE ROMANIA SRL

DOXAZOSIN AL 4 4mg ALIUD® PHARMA GMBH & CO.KG

DOXAZOSIN SANDOZ 4 mg 4mg HEXAL AG

KAMIREN 4mg KRKA D.D. NOVO MESTO

MAGUROL 4mg MEDOCHEMIE LTD.

4mgG04CAN1 DOXAZOSINUM COMPR. ELIB. MODIF.CARDURA XL 4 mg 4mg PFIZER H.C.P. CORPORATION

4mgG04CAN1 DOXAZOSINUM COMPR. FILM. ELIB. PREL.KAMIREN XL 4 mg 4mg KRKA D.D. NOVO MESTO

76 METHYLPREDNISOLONUM *H02AB04

125mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 125 mg 125mg HEMOFARM S.R.L.

125mg/2mlH02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV.PT.SOL.INJSOLU - MEDROL ACT-O-VIAL 125mg/2ml PFIZER EUROPE MA EEIG

20mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 20 mg 20mg HEMOFARM S.R.L.

250mg/4mlH02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV.PT.SOL.INJSOLU - MEDROL ACT-O-VIAL 250mg/4ml PFIZER EUROPE MA EEIG

40mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 40 mg 40mg HEMOFARM S.R.L.

40mg/1mlH02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV.PT.SOL.INJSOLU - MEDROL ACT-O-VIAL 40mg/1ml PFIZER EUROPE MA EEIG

500mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 500 mg 500mg HEMOFARM S.R.L.

500mg/7.8mlH02AB04 METHYLPREDNISOLONUM LIOF. + SOLV. PT. SOL. INJ.SOLU - MEDROL 500 mg/7,8 ml 500mg/7.8ml PFIZER EUROPE MA EEIG

77 PREDNISONUMH02AB07

5mgH02AB07 PREDNISONUM COMPR.N - PREDNISON 5mg MEDUMAN SA

PREDNISON 5 mg 5mg SINTOFARM SA

PREDNISON ARENA 5 mg 5mg ARENA GROUP SA

PREDNISON GEDEON RICHTER 5 mg 5mg GEDEON RICHTER ROMANIA SA

PREDNISON MAGISTRA 5 mg 5mg MAGISTRA C & C

78 HYDROCORTISONUM *H02AB09

14 153/

Page 15: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

100mgH02AB09 HYDROCORTISONUM LIOF. + SOLV. PT. SOL. INJ.HYDROCORTISONE 100 mg 100mg HEMOFARM S.R.L.

HYDROCORTISONE SUCCINAT SODIC 100mg E.I.P.I.CO. MED S.R.L.

25mg/5mlH02AB09 HYDROCORTISONUM SOL. INJ. I.V.HIDROCORTIZON HEMISUCCINAT 25mg/5ml ZENTIVA S.A.

500mgH02AB09 HYDROCORTISONUM LIOF. PT. SOL. INJ. + SOLV.HYDROCORTISONE 500 mg 500mg HEMOFARM S.R.L.

79 DOXYCYCLINUMJ01AA02

100mgJ01AA02 DOXYCYCLINUM CAPS.DOXICICLINA 100mg EUROPHARM SA

DOXICICLINA 100 mg 100mg ANTIBIOTICE SA

DOXICICLINA SANDOZ 100 mg 100mg SANDOZ SRL

100mgJ01AA02 DOXYCYCLINUM COMPR. DISP.UNIDOX SOLUTAB 100mg ASTELLAS PHARMA EUROPE B.V.

100mgJ01AA02 DOXYCYCLINUM CAPS.DOXICICLINA 100mg ARENA GROUP SA

DOXICICLINA 100 mg 100mg ANTIBIOTICE SA

DOXICICLINA SANDOZ 100 mg 100mg SANDOZ SRL

100mgJ01AA02 DOXYCYCLINUM COMPR. DISP.UNIDOX SOLUTAB 100mg ASTELLAS PHARMA EUROPE B.V.

100mgJ01AA02 DOXYCYCLINUM CAPS.DOXICICLINA 100mg ARENA GROUP SA

DOXICICLINA 100 mg 100mg ANTIBIOTICE SA

DOXICICLINA SANDOZ 100 mg 100mg SANDOZ SRL

100mgJ01AA02 DOXYCYCLINUM COMPR. DISP.UNIDOX SOLUTAB 100mg ASTELLAS PHARMA EUROPE B.V.

80 AMOXICILLINUMJ01CA04

1000mgJ01CA04 AMOXICILLINUM COMPR. FILM.OSPAMOX 1000 mg 1000mg SANDOZ GMBH

125mg/5mlJ01CA04 AMOXICILLINUM PULB. PT. SUSP. ORALAAMOXICILINA 125 mg/5 ml 125mg/5ml OZONE LABORATORIES LTD.

AMOXICILINA SANDOZ 125 mg/5 ml PULBERE PENTRU

SUSPENSIE ORALA

125mg/5ml SANDOZ S.R.L.

JULPHAMOX 125mg/5ml GULF PHARMACEUTICAL INDUSTRIES S.R.L.

OSPAMOX® 125 mg/5 ml 125mg/5ml SANDOZ GMBH

125mg/5mlJ01CA04 AMOXICILLINUM PULB. SUSP.MOXILEN 125mg/5ml MEDOCHEMIE LTD.

250mgJ01CA04 AMOXICILLINUM CAPS.AMOXICILINA 250mg EUROPHARM SA

AMOXICILINA SANDOZ 250 mg CAPSULE 250mg SANDOZ SRL

AMOXICILINA 250 mg 250mg OZONE LABORATORIES LTD.

AMOXICILINA ANTIBIOTICE 250 mg 250mg ANTIBIOTICE SA

AMOXICILINA ARENA 250 mg 250mg ARENA GROUP SA

AMOXICILINA MEDICO UNO 250 mg 250mg MEDICO UNO PHARMACEUTICAL S.R.L.

OSPAMOX 250 mg 250mg SANDOZ GMBH

250mg/5mlJ01CA04 AMOXICILLINUM PULB. PT. SUSP. ORALA

AMOXICILINA SANDOZ 250 mg/ 5 ml PULBERE PENTRU

SUSPENSIE ORALA

250mg/5ml SANDOZ S.R.L.

AMOXICILINA 250 mg/5 ml 250mg/5ml OZONE LABORATORIES LTD.

E - MOX 250mg/5ml E.I.P.I.CO. MED S.R.L.

JULPHAMOX 250mg/5ml GULF PHARMACEUTICAL INDUSTRIES S.R.L.

OSPAMOX 250 mg/5 ml 250mg/5ml SANDOZ GMBH

250mg/5mlJ01CA04 AMOXICILLINUM PULB. SUSP.MOXILEN FORTE 250mg/5ml MEDOCHEMIE LTD.

500mgJ01CA04 AMOXICILLINUM CAPS.AMOXICILINA ANTIBIOTICE 500 mg 500mg ANTIBIOTICE SA

AMOXICILINA ARENA 500 mg 500mg ARENA GROUP SA

AMOXICILINA FORTE 500 mg 500mg OZONE LABORATORIES LTD.

AMOXICILINA SANDOZ 500 mg CAPSULE 500mg SANDOZ SRL

E - MOX 500mg E.I.P.I.CO. MED S.R.L.

EPHAMOX 500mg EUROPHARM SA

MOXILEN 500mg MEDOCHEMIE LTD.

500mgJ01CA04 AMOXICILLINUM COMPR. FILM.OSPAMOX 500 mg 500mg SANDOZ GMBH

1000mgJ01CA04 AMOXICILLINUM COMPR. PT. DISPERSIE ORALADUOMOX 1000 mg 1000mg ASTELLAS PHARMA EUROPE BV

250mgJ01CA04 AMOXICILLINUM COMPR. PT. DISPERSIE ORALADUOMOX 250 mg 250mg ASTELLAS PHARMA EUROPE BV

500mgJ01CA04 AMOXICILLINUM COMPR. PT. DISPERSIE ORALADUOMOX 500 mg 500mg ASTELLAS PHARMA EUROPE BV

750mgJ01CA04 AMOXICILLINUM COMPR. PT. DISPERSIE ORALADUOMOX 750 mg 750mg ASTELLAS PHARMA EUROPE BV

81 PHENOXYMETHYLPENICILLINUMJ01CE02

1000000uiJ01CE02 PHENOXYMETHYLPENICILLINUM COMPR.PENICILINA V 1 000 000 U.I. 1000000ui EUROPHARM SA

1000000uiJ01CE02 PHENOXYMETHYLPENICILLINUM COMPR. FILM.OSPEN® 1000 1000000ui SANDOZ GMBH

1500000uiJ01CE02 PHENOXYMETHYLPENICILLINUM COMPR. FILM.OSPEN® 1500 1500000ui SANDOZ GMBH

400000ui/5mlJ01CE02 PHENOXYMETHYLPENICILLINUM SIROPOSPEN 400 400000ui/5ml SANDOZ GMBH

500000uiJ01CE02 PHENOXYMETHYLPENICILLINUM COMPR. FILM.OSPEN® 500 500000ui SANDOZ GMBH

15 153/

Page 16: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

82 BENZATHINI BENZYLPENICILLINUMJ01CE08

1200000uiJ01CE08 BENZATHINI BENZYLPENICILLINUM PULB. PT. SUSP. INJ.MOLDAMIN® 1200000ui ANTIBIOTICE SA

600000uiJ01CE08 BENZATHINI BENZYLPENICILLINUM PULB. PT. SUSP. INJ.MOLDAMIN® 600000ui ANTIBIOTICE SA

83 OXACILLINUMJ01CF04

250mgJ01CF04 OXACILLINUM CAPS.OXACILINA 250mg FARMACOM SA

OXACILINA 250 mg 250mg ANTIBIOTICE SA

OXACILINA ARENA 250 mg 250mg ARENA GROUP SA

OXACILINA FARMEX 250 mg 250mg FARMEX COMPANY SRL

OXACILINA SANDOZ 250 mg 250mg SANDOZ SRL

500mgJ01CF04 OXACILLINUM CAPS.OXACILINA 500 mg 500mg ANTIBIOTICE SA

OXACILINA ARENA 500 mg 500mg ARENA GROUP SA

OXACILINA FORTE 500 mg 500mg OZONE LABORATORIES LTD.

OXACILINA SANDOZ 500 mg 500mg SANDOZ SRL

OXALIN 500 mg 500mg EUROPHARM SA

1gJ01CF04 OXACILLINUM PULB. PT. SOL. INJ./PERF.I.M./I.V.OXACILINA ANTIBIOTICE 1 g 1g ANTIBIOTICE SA

84 AMOXICILLINUM + ACIDUM CLAVULANICUMJ01CR02

Prescriere limitata: Tratamentul de scurta durata a infectiilor bacteriene atunci cand este suspectata rezistenta la amoxicilina.

Infectii la care este dovedita rezistenta la amoxicilina.

A fost raportată hepatotoxicitate la acest medicament.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

1000mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM COMPR. FILM.AMOKSIKLAV 2 x 1000 mg 1000mg LEK PHARMACEUTICALS D.D.

MEDOCLAV 1000 mg 1000mg MEDOCHEMIE LTD.

1062.5mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM COMPR. FILM. ELIB. PREL.AUGMENTIN™ SR 1062.5mg BEECHAM GROUP PLC

125mg+31.25/5m

l

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM PULB. PT. SUSP. ORALA

MEDOCLAV 156,25 mg/5 ml 125mg+31.25/5ml MEDOCHEMIE LTD.

156.25mg/5mlJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM PULB. PT. SUSP. ORALAAMOKSIKLAV 156,25mg/5ml 156.25mg/5ml LEK PHARMACEUTICALS D.D.

BIOCLAVID 156.25mg/5ml 156.25mg/5ml SANDOZ GMBH

250/62,5mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM COMPR. DISP.FORCID SOLUTAB 250/62,5 250/62,5mg ASTELLAS PHARMA EUROPE BV

250mg+125mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM COMPR. FILM.MEDOCLAV 375 mg 250mg+125mg MEDOCHEMIE LTD.

250mg+62.5mg/5

ml

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM PULB. PT. SUSP. ORALA

MEDOCLAV FORTE 312,5mg/5ml 250mg+62.5mg/5

ml

MEDOCHEMIE LTD.

312.5mg/5mlJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM PULB. PT. SUSP. ORALABIOCLAVID 312.5mg/5ml 312.5mg/5ml SANDOZ GMBH

312.5mg/5mlJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM PULB. PT.SUSP. ORALAAMOKSIKLAV 312.5mg/5ml 312.5mg/5ml LEK PHARMACEUTICALS D.D.

ENHANCIN 312,5 mg/5 ml 312.5mg/5ml RANBAXY UK LIMITED

400mg+57mg/5m

l

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM PULB. PT. SUSP. ORALA

AUGMENTIN BIS 400mg+57mg/5ml SMITHKLINE BEECHAM PLC

500/125mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM COMPR. DISP.FORCID SOLUTAB 500/125 500/125mg ASTELLAS PHARMA EUROPE BV

500mg+125mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM COMPR. FILM.AUGMENTIN 625 mg 500mg+125mg BEECHAM GROUP PLC

MEDOCLAV 625 mg 500mg+125mg MEDOCHEMIE LTD.

625mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM COMPR. FILM.AMOKSIKLAV 2 x 625 mg 625mg LEK PHARMACEUTICALS D.D.

BIOCLAVID 625 mg 625mg SANDOZ GMBH

642.90mg/5mlJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM PULB. PT. SUSP. ORALAAUGMENTIN® ES 642.90mg/5ml SMITHKLINE BEECHAM PLC

875mg+125mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM COMPR. DISP.FORCID SOLUTAB 875/125 875mg+125mg ASTELLAS PHARMA EUROPE BV

875mg+125mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM COMPR. FILM.AUGMENTIN 1 g 875mg+125mg BEECHAM GROUP PLC

85 CEFALEXINUMJ01DB01

1000mgJ01DB01 CEFALEXINUM COMPR. FILM.OSPEXIN 1000 mg 1000mg SANDOZ GMBH

125mg/5mlJ01DB01 CEFALEXINUM GRAN. PT. SUSP. ORALA

CEFALEXIN SANDOZ 125 mg/5 ml GRANULE PENTRU

SUSPENSIE ORALA

125mg/5ml SANDOZ SRL

KEFLEX® 125 mg/5 ml 125mg/5ml ACTAVIS GROUP HF

OSPEXIN® 125 mg/5 ml 125mg/5ml SANDOZ GMBH

125mg/5mlJ01DB01 CEFALEXINUM PULB. PT. SUSP. ORALACEFALEXIN 125 mg/5 ml 125mg/5ml OZONE LABORATORIES LTD.

250mgJ01DB01 CEFALEXINUM CAPS.CEFALEXIN 250 mg 250mg OZONE LABORATORIES LTD.

CEFALEXIN SANDOZ 250 mg CAPSULE 250mg SANDOZ SRL

CEFALEXINA 250 mg 250mg ANTIBIOTICE SA

CEFALEXINA ARENA 250 mg 250mg ARENA GROUP SA

CEFALEXINA MEDICO UNO 250 mg 250mg MEDICO UNO PHARMACEUTICAL S.R.L.

16 153/

Page 17: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

OSPEXIN® 250 mg 250mg SANDOZ GMBH

SPORIDEX 250 mg 250mg TERAPIA S.A.

250mg/5mlJ01DB01 CEFALEXINUM GRAN. PT. SUSP. ORALA

CEFALEXIN SANDOZ 250 mg/5 ml GRANULE PENTRU

SUSPENSIE ORALA

250mg/5ml SANDOZ SRL

KEFLEX® 250 mg/5 ml 250mg/5ml ACTAVIS GROUP HF

OSPEXIN® 250 mg/5 ml 250mg/5ml SANDOZ GMBH

250mg/5mlJ01DB01 CEFALEXINUM PULB. PT. SUSP. ORALACEFALEXIN 250 mg/5 ml 250mg/5ml OZONE LABORATORIES LTD.

500mgJ01DB01 CEFALEXINUM CAPS.CEFALEXIN 500 mg 500mg OZONE LABORATORIES LTD.

CEFALEXINA 500 mg 500mg ANTIBIOTICE SA

CEFALEXINA ARENA 500 mg 500mg ARENA GROUP SA

SPORIDEX 500 mg 500mg TERAPIA S.A.

500mgJ01DB01 CEFALEXINUM COMPR. FILM.CEFALEXIN SANDOZ 500 mg COMPRIMATE FILMATE 500mg SANDOZ SRL

OSPEXIN 500 mg 500mg SANDOZ GMBH

86 CEFADROXILUMJ01DB05

1000mgJ01DB05 CEFADROXILUM COMPR. FILM.CEXYL 1000 mg 1000mg SANDOZ S.R.L.

125mg/5mlJ01DB05 CEFADROXILUM GRAN. PT. SUSP. ORALACEXYL 125 mg/5 ml 125mg/5ml SANDOZ S.R.L.

250mgJ01DB05 CEFADROXILUM CAPS.CEXYL 250 mg 250mg SANDOZ S.R.L.

250mg/5mlJ01DB05 CEFADROXILUM GRAN. SUSP. ORALACEXYL 250 mg/5 ml 250mg/5ml SANDOZ S.R.L.

500mgJ01DB05 CEFADROXILUM CAPS.CEFADROXIL 500mg OZONE LABORATORIES LTD.

CEFADROXIL TERAPIA 500mg TERAPIA S.A.

CEFORAN® 500 mg 500mg ANTIBIOTICE SA

CEXYL 500 mg 500mg SANDOZ S.R.L.

500mg/5mlJ01DB05 CEFADROXILUM GRAN. SUSP. ORALACEXYL 500 mg/5 ml 500mg/5ml SANDOZ S.R.L.

87 CEFUROXIMUMJ01DC02

125mgJ01DC02 CEFUROXIMUM COMPR. ACOPERITEAXYCEF® 125 125mg SANDOZ SRL

125mgJ01DC02 CEFUROXIMUM COMPR. FILM.ZINNAT® 125 mg 125mg GLAXOWELLCOME UK LTD.

125mg/5mlJ01DC02 CEFUROXIMUM GRAN. PT. SUSP. ORALACEROXIM 125mg/5ml 125mg/5ml RANBAXY UK LIMITED

ZINNAT 125mg/5ml GLAXO WELLCOME UK LTD.

125mg/5mlJ01DC02 CEFUROXIMUM PULB. PT. SUSP. ORALAAXYCEF® 125 mg/5 ml 125mg/5ml SANDOZ SRL

250mgJ01DC02 CEFUROXIMUM COMPR.CEROXIM 250 mg 250mg RANBAXY U.K. LIMITED

250mgJ01DC02 CEFUROXIMUM COMPR. ACOPERITEAXYCEF® 250 250mg SANDOZ SRL

250mgJ01DC02 CEFUROXIMUM COMPR. FILM.ZINNAT® 250 mg 250mg GLAXOWELLCOME UK LTD.

250mg/5mlJ01DC02 CEFUROXIMUM GRAN. PT. SUSP. ORALACEROXIM 250mg/5ml 250mg/5ml RANBAXY UK LIMITED

500mgJ01DC02 CEFUROXIMUM COMPR.CEROXIM 500 mg 500mg RANBAXY U.K. LIMITED

500mgJ01DC02 CEFUROXIMUM COMPR. ACOPERITEAXYCEF® 500 500mg SANDOZ SRL

500mgJ01DC02 CEFUROXIMUM COMPR. FILM.ZINNAT® 500 mg 500mg GLAXOWELLCOME UK LTD.

88 CEFACLORUMJ01DC04Reactii asemanatoare bolii serului au fost raportate la utilizarea acestui medicament, in special de catre copii.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

125mg/5mlJ01DC04 CEFACLORUM GRAN. PT. SUSP. ORALACECLODYNE 125 mg/5 ml 125mg/5ml SANDOZ SRL

CECLOR® 125 mg/5 ml 125mg/5ml ACTAVIS GROUP HF

CEFACLOR 125 mg/5ml 125mg/5ml OZONE LABORATORIES LTD.

VERCEF 125 mg/5 ml 125mg/5ml TERAPIA S.A.

125mg/5mlJ01DC04 CEFACLORUM PULB. PT. SUSP. ORALACEFAKLOR 125 mg/5 ml 125mg/5ml HEMOFARM S.R.L.

CLORACEF® 125 125mg/5ml DAR AL DAWA PHARMA S.R.L

250mgJ01DC04 CEFACLORUM CAPS.CECLODYNE 250 mg 250mg SANDOZ SRL

CEFACLOR 250 mg 250mg OZONE LABORATORIES LTD.

CLORACEF® 250 250mg DAR AL DAWA PHARMA S.R.L

MEDOCLOR 250 250mg MEDOCHEMIE LTD.

250mg/5mlJ01DC04 CEFACLORUM GRAN. PT. SUSP. ORALACECLODYNE 250 mg/ 5 ml 250mg/5ml SANDOZ SRL

CECLOR® 250 mg/5 ml 250mg/5ml ACTAVIS GROUP HF

CEFACLOR 250 mg/5ml 250mg/5ml OZONE LABORATORIES LTD.

250mg/5mlJ01DC04 CEFACLORUM PULB. PT. SUSP. ORALACEC HEXAL FORTE 250mg/5ml 250mg/5ml HEXAL AG

CEFAKLOR 250 mg/5 ml 250mg/5ml HEMOFARM S.R.L.

CLORACEF® 250 250mg/5ml DAR AL DAWA PHARMA S.R.L

375mgJ01DC04 CEFACLORUM COMPR. ELIB. PREL.CECLOR® MR 375mg ACTAVIS GROUP HF

17 153/

Page 18: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

CECLOZONE MR 375 mg 375mg OZONE LABORATORIES LTD.

375mgJ01DC04 CEFACLORUM COMPR. FILM. ELIB. MODIF.CECLODYNE® MR 375 mg 375mg SANDOZ SRL

500mgJ01DC04 CEFACLORUM CAPS.CECLODYNE FORTE 500 mg 500mg SANDOZ SRL

CEFACLOR 500 mg 500mg OZONE LABORATORIES LTD.

CLORACEF® FORTE 500 500mg DAR AL DAWA PHARMA S.R.L

MEDOCLOR 500 500mg MEDOCHEMIE LTD.

500mgJ01DC04 CEFACLORUM COMPR. ELIB. PREL.CECLOR® MR 500mg ACTAVIS GROUP HF

500mgJ01DC04 CEFACLORUM COMPR. FILM. ELIB. MODIF.CECLODYNE® MR 500 mg 500mg SANDOZ SRL

750mgJ01DC04 CEFACLORUM COMPR. ELIB. PREL.CECLOR® MR 750mg ACTAVIS GROUP HF

CECLOZONE MR 750 mg 750mg OZONE LABORATORIES LTD.

750mgJ01DC04 CEFACLORUM COMPR. FILM. ELIB. MODIF.CECLODYNE® MR 750 mg 750mg SANDOZ SRL

89 CEFIXIMUMJ01DD08

100mg/5mlJ01DD08 CEFIXIMUM GRAN. PT. SUSP. ORALASUPRAX 100mg/5ml GEDEON RICHTER LTD.

200mgJ01DD08 CEFIXIMUM CAPS.EFICEF® 200 mg 200mg ANTIBIOTICE SA

200mgJ01DD08 CEFIXIMUM COMPR. FILM.SUPRAX 200mg GEDEON RICHTER LTD.

90 SULFAMETHOXAZOLUM + TRIMETHOPRIMUMJ01EE01Exista un risc crescut de reactie adversa severa la administrarea acestui medicament la persoane in varsta.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

200mg/40mg

/5ml

J01EE01 SULFAMETHOXAZOLUM +

TRIMETHOPRIMUM

SUSP. ORALA

EPITRIM 200mg/40mg /5ml E.I.P.I.CO. MED S.R.L.

25mg/5mg/mlJ01EE01 SULFAMETHOXAZOLUM +

TRIMETHOPRIMUM

SIROP

SUMETROLIM 25mg/5mg/ml EGIS PHARMACEUTICALS P.L.C.

400mg/80mgJ01EE01 SULFAMETHOXAZOLUM +

TRIMETHOPRIMUM

COMPR.

BISEPTRIM 400mg/80mg EUROPHARM SA

CO - TRIM ELL 400mg/80mg ARENA GROUP S.A.

SUMETROLIM 400mg/80mg EGIS PHARMACEUTICALS P.L.C.

TAGREMIN 400mg/80mg ZENTIVA S.A.

91 ERYTHROMYCINUMJ01FA01

200mgJ01FA01 ERYTHROMYCINUM COMPR.ERITROMAGIS 200 mg 200mg ARENA GROUP SA

ERITROMICINA 200 mg 200mg ANTIBIOTICE SA

ERITROMICINA EUROPHARM 200 mg 200mg EUROPHARM SA

ERITROMICINA SANDOZ 200 mg COMPRIMATE 200mg SANDOZ S.R.L.

200mg/5mlJ01FA01 ERYTHROMYCINUM PULB. PT. SUSP. ORALAERITRO 200 200mg/5ml LEK PHARMATECH SRL

92 CLARITHROMYCINUMJ01FA09

125mg/5mlJ01FA09 CLARITHROMYCINUM GRAN. PT. SUSP. ORALAFROMILID® 125 mg/5 ml 125mg/5ml KRKA D.D.

KLABAX 125 mg/5 ml 125mg/5ml TERAPIA S.A.

KLACID® 125mg/5ml ABBOTT SPA

LEKOKLAR 125 mg/5 ml 125mg/5ml SANDOZ S.R.L.

250mgJ01FA09 CLARITHROMYCINUM COMPR. FILM.CLAR 250 250mg MEDICAROM GROUP S.R.L.

CLARITROMICINA 250 mg 250mg OZONE LABORATORIES LTD.

FROMILID 250 250mg KRKA D.D. NOVO MESTO

KLABAX 250 mg 250mg TERAPIA S.A.

KLACID® 250mg ABBOTT SPA

KLERIMED® 250 250mg MEDOCHEMIE LTD.

LEKOKLAR® 250 mg 250mg LEK PHARMACEUTICALS D.D.

250mg/5mlJ01FA09 CLARITHROMYCINUM GRAN. PT. SUSP. ORALAKLABAX 250 mg/5 ml 250mg/5ml TERAPIA S.A.

LEKOKLAR 250 mg/5 ml 250mg/5ml SANDOZ SRL

500mgJ01FA09 CLARITHROMYCINUM COMPR. FILM.CLAR 500 500mg MEDICAROM GROUP S.R.L.

CLARITROMICINA 500 mg 500mg OZONE LABORATORIES LTD.

FROMILID 500 500mg KRKA D.D. NOVO MESTO

KLABAX 500 mg 500mg TERAPIA S.A.

KLERIMED® 500 500mg MEDOCHEMIE LTD.

LEKOKLAR® 500 mg 500mg LEK PHARMACEUTICALS D.D.

500mgJ01FA09 CLARITHROMYCINUM COMPR. FILM. ELIB. MODIF.KLABAX MR 500 mg 500mg TERAPIA S.A.

LEKOKLAR XL 500 mg 500mg LEK PHARMACEUTICALS D.D.

500mgJ01FA09 CLARITHROMYCINUM COMPR. FILM. ELIB. PREL.FROMILID® UNO 500mg KRKA D.D.

KLACID SR 500mg ABBOTT LABORATORIES LTD.

93 OFLOXACINUMJ01MA01

200mgJ01MA01 OFLOXACINUM COMPR. FILM.OFLOXACIN 200 mg 200mg ANTIBIOTICE SA

OFLOXIN 200 200mg ZENTIVA AS

ZANOCIN 200mg RANBAXY UK LIMITED

18 153/

Page 19: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

400mgJ01MA01 OFLOXACINUM COMPR. FILM. ELIB. PREL.ZANOCIN® OD 400 400mg RANBAXY U.K. LIMITED

94 CIPROFLOXACINUMJ01MA02

250mgJ01MA02 CIPROFLOXACINUM CAPS.EUCIPRIN 250mg EUROPHARM SA

250mgJ01MA02 CIPROFLOXACINUM COMPR. FILM.CIFRAN 250mg RANBAXY UK LIMITED

CIPHIN 250 250mg ZENTIVA A.S.

CIPRINOL 250 mg 250mg KRKA D.D. NOVO MESTO

CIPROCIN 250 mg 250mg E.I.P.I.CO. MED S.R.L.

CIPROFLOXACINA ALKALOID 250 mg 250mg ALKALOID D.O.O.

CIPROLEN® 250 mg 250mg AC HELCOR SRL

CIPROLET 250 mg 250mg DR. REDDY'S LABORATORIES

CIPROZONE 250 mg 250mg OZONE LABORATORIES LTD.

CUMINOL 250 mg 250mg GEDEON RICHTER ROMANIA

500mgJ01MA02 CIPROFLOXACINUM COMPR. FILM.CIFRAN 500mg RANBAXY UK LIMITED

CIPHIN 500 500mg ZENTIVA A.S.

CIPRINOL 500 mg 500mg KRKA D.D. NOVO MESTO

CIPRO QUIN® 500mg ANTIBIOTICE SA

CIPROBAY® 500 500mg BAYER HEALTHCARE AG

CIPROCIN 500 mg 500mg E.I.P.I.CO. MED S.R.L.

CIPRODAR 500mg DAR AL DAWA PHARMA S.R.L

CIPROFLOXACINA ALKALOID 500 mg 500mg ALKALOID D.O.O.

CIPROLEN® 500 mg 500mg AC HELCOR SRL

CIPROLET 500 mg 500mg DR. REDDY'S LABORATORIES

CIPROZONE FORTE 500 mg 500mg OZONE LABORATORIES LTD.

CUMINOL 500 mg 500mg GEDEON RICHTER ROMANIA

SIFLOKS® 500mg ECZACIBASI ILAC SANAYI VE TICARET AS

750mgJ01MA02 CIPROFLOXACINUM COMPR. FILM.CIPRINOL 750 mg 750mg KRKA D.D. NOVO MESTO

95 PEFLOXACINUMJ01MA03

400mgJ01MA03 PEFLOXACINUM COMPR. FILM.PEFLOXACIN LAROPHARM 400mg LAROPHARM S.R.L.

96 NORFLOXACINUMJ01MA06

Prescriere limitata: Enterocolita bacteriana.

Infectii de tract urinar.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

400mgJ01MA06 NORFLOXACINUM COMPR. FILM.EPINOR 400mg E.I.P.I.CO. MED S.R.L.

H - NORFLOXACIN 400 mg 400mg AC HELCOR SRL

NOLICIN 400 mg 400mg KRKA D.D. NOVO MESTO

NORFLOX - 400 400mg LEK PHARMATECH SRL

NORFLOXACIN 400 mg 400mg OZONE LABORATORIES LTD.

NORFLOXACIN OZONE 400 mg 400mg OZONE LABORATORIES LTD.

NORFLOXACINA LPH 400 mg 400mg LABORMED PHARMA SA

97 ACIDUM NALIDIXICUMJ01MB02

500mgJ01MB02 ACIDUM NALIDIXICUM CAPS.NALIXID 500 mg 500mg ZENTIVA SA

98 METRONIDAZOLUMJ01XD01

Prescriere limitata: Tratamentul infectiilor cu anaerobi.

Tratamentul infectiilor cu protozoare sensibile la metronidazol.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

250mgJ01XD01 METRONIDAZOLUM COMPR.METRONIDAZOL 250 mg (J01XD01) 250mg ARENA GROUP SA

250mgJ01XD01 METRONIDAZOLUM COMPR. FILM.FLAGYL 250mg LABORATOIRE AVENTIS

4%J01XD01 METRONIDAZOLUM SUSP. ORALAFLAGYL 4 % (J01XD01) 4% LABORATOIRE AVENTIS

99 TINIDAZOLUMJ01XD02

Prescriere limitata: Tratamentul infectiilor cu anaerobi.

Tratamentul infectiilor cu protozoare sensibile la tinidazol.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

500mgJ01XD02 TINIDAZOLUM COMPR. FILM.FASIGYN (J01XD02) 500mg PFIZER EUROPE MA EEIG

TINIZOL® 500 mg (J01XD02) 500mg ZENTIVA S.A.

TIPROGYN 500 500mg AC HELCOR SRL

100 KETOCONAZOLUMJ02AB02

Prescriere limitata: Candidoza genitala simptomatica recurenta dupa tratamentul local a cel putin doua episoade.

Tratamentul candidozelor muco-cutanate cronice si candidozelor orofaringiene care nu pot fi tratate cu antifungice locale, la pacientii care prezinta rezistenta sau

intoleranta la fluconazol si intraconazol

Micoze sistemice la care alte forme de terapie antifungica nu au avut efect.

A fost raportată hepatotoxicitate la ketoconazol.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

200mgJ02AB02 KETOCONAZOLUM COMPR.KEFUNGIN 200mg ANTIBIOTICE SA

KETOCONAZOL 200 mg 200mg MAGISTRA C & C

KETOSTIN 200 mg 200mg AC HELCOR SRL

NIZORAL 200mg JANSSEN PHARMACEUTICA NV

NIZORAL 200 mg 200mg TERAPIA SA

101 FLUCONAZOLUMJ02AC01

19 153/

Page 20: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

Prescriere limitata: Candidoze genitale.

Candidoze ale mucoaselor orofaringiene, esofargiene, bronhopulmonare non-invazive.

Infectii cu candida ale pielii.

Candidoze sistemice.

Profilaxia candidozelor la pacientii cu risc aflati in tratament cu antibiotic.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 100 mg 100mg KRKA D.D.

FLUCONAZOLE TEVA 100 mg 100mg TEVA PHARMACEUTICALS SRL

FLUCORIC 100 mg 100mg TERAPIA S.A.

FLUCOVIM 100 100mg VIM SPECTRUM SRL

FUNGOLON 100 mg 100mg BALKANPHARMA RAZGRAD AD

150mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 150 mg 150mg KRKA D.D.

DIFLUCAN 150 mg 150mg PFIZER EUROPE MA EEIG

FLUCONAZOL 150 mg 150mg OZONE LABORATORIES LTD.

FLUCONAZOL MEDICO UNO 150 mg 150mg MEDICO UNO PHARMACEUTICAL SRL

FLUCONAZOL MEDOCHEMIE 150 mg 150mg MEDOCHEMIE ROMANIA SRL

FLUCONAZOL SANDOZ® 150 150mg SANDOZ SRL

FLUCONAZOL TERAPIA 150 mg 150mg TERAPIA SA

FLUCONAZOLE TEVA 150 mg 150mg TEVA PHARMACEUTICALS SRL

FLUCORIC 150 mg 150mg TERAPIA S.A.

FLUCOVIM 150 150mg VIM SPECTRUM SRL

MYCOMAX 150 150mg ZENTIVA AS

MYCOSYST® 150 mg 150mg GEDEON RICHTER PLC.

200mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 200 mg 200mg KRKA D.D.

FLUCONAZOLE TEVA 200 mg 200mg TEVA PHARMACEUTICALS SRL

50mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 50 mg 50mg KRKA D.D.

DIFLUCAN 50 mg 50mg PFIZER EUROPE MA EEIG

FLUCONAZOL 50 mg 50mg SLAVIA PHARM SRL

FLUCONAZOL MEDOCHEMIE 50 mg 50mg MEDOCHEMIE ROMANIA SRL

FLUCONAZOL SANDOZ® 50 50mg SANDOZ SRL

FLUCONAZOL TERAPIA 50 mg 50mg TERAPIA S.A.

FLUCONAZOLE TEVA 50 mg 50mg TEVA PHARMACEUTICALS SRL

FLUCORIC 50 mg 50mg TERAPIA S.A.

FLUCOVIM 50 50mg VIM SPECTRUM SRL

FUNGOLON 50 mg 50mg BALKANPHARMA RAZGRAD AD

50mg/5mlJ02AC01 FLUCONAZOLUM PULB. PT. SUSP. ORALADIFLUCAN® 50 mg/5 ml 50mg/5ml PFIZER EUROPE MA EEIG

102 ACICLOVIRUMJ05AB01

Prescriere limitata: Herpes genital.

Tratamentul episodic sau supresiv al herpesului genital recurent.

Herpes cutanat initial moderat/sever.

Tratamentul episodic sau supresiv al herpesului cutanat recurent (forme moderate/severe).

Herpes zoster.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

200mgJ05AB01 ACICLOVIRUM CAPS.ACICLOVIR 200 mg 200mg SLAVIA PHARM SRL

EUVIROX 200 mg 200mg EUROPHARM SA

200mgJ05AB01 ACICLOVIRUM COMPR.ACICLOVIR 200 mg 200mg TERAPIA SA

CLOVIRAL 200 mg 200mg ANTIBIOTICE SA

ZOVIRAX 200mg GLAXO WELLCOME FOUNDATION LTD.

200mgJ05AB01 ACICLOVIRUM COMPR. DISP.ACICLOVIR 200 mg 200mg OZONE LABORATORIES LTD.

LOVIR 200 mg 200mg RANBAXY UK LIMITED

250mgJ05AB01 ACICLOVIRUM PULB. PT. SOL. INJ./PERF.VIROLEX 250mg KRKA D.D. NOVO MESTO

400mgJ05AB01 ACICLOVIRUM CAPS.ACICLOVIR 400 mg 400mg ARENA GROUP S.A.

400mgJ05AB01 ACICLOVIRUM COMPR.ACICLOVIR 400 mg 400mg EGIS PHARMACEUTICALS P.L.C.

400mgJ05AB01 ACICLOVIRUM COMPR. FILM.ACIKLOVIR 400mg A & G MED TRADING S.R.L.

103 AMINOGLUTETHIMIDUML02BG01

250mgL02BG01 AMINOGLUTETHIMIDUM COMPR.ROGLUTEN® 250 mg 250mg ACTAVIS S.R.L.

104 INDOMETACINUMM01AB01A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale

50mgM01AB01 INDOMETACINUM SUPOZ.INDOMETACIN 50 mg 50mg MAGISTRA C & C

105 DICLOFENACUMM01AB05A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgM01AB05 DICLOFENACUM COMPR. FILM. ELIB. PREL.DICLOTARD® 100 mg 100mg TERAPIA SA

REFEN® RETARD 100mg HEMOFARM S.R.L.

VOLTAREN® RETARD 100mg NOVARTIS PHARMA GMBH

100mgM01AB05 DICLOFENACUM SUPOZ.CLAFEN 100 mg 100mg ANTIBIOTICE SA

DICLOFENAC 100 mg 100mg SINTOFARM SA

20 153/

Page 21: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

DICLOFENAC SODIC 100 mg 100mg MAGISTRA C & C

DICLOGESIC 100 SUPOZITOARE 100mg DAR AL DAWA PHARMA SRL

EPIFENAC 100mg E.I.P.I.CO. MED S.R.L.

VOLTAREN® 100mg NOVARTIS PHARMA GMBH

120mgM01AB05 DICLOFENACUM SUPOZ.TRATUL 120 120mg GEROT PHARMAZEUTIKA GMBH

150mgM01AB05 DICLOFENACUM CAPS. ELIB. PREL.DICLOREUM 150 mg 150mg ALFA WASSERMANN SPA

25mgM01AB05 DICLOFENACUM COMPR. FILM. GASTROREZ.RHEUMAVEK 25mg FARAN LABORATORIES S.A.

VOLTAREN® 25 25mg NOVARTIS PHARMA GMBH

25mgM01AB05 DICLOFENACUM COMPR. GASTROREZ.EPIFENAC 25mg E.I.P.I.CO. MED S.R.L.

25mgM01AB05 DICLOFENACUM DRAJ. GASTROREZ.DICLOFENAC 25 mg 25mg ARENA GROUP SA

25mg/mlM01AB05 DICLOFENACUM SOL. INJ.RHEUMAVEK 25mg/ml FARAN LABORATORIES S.A.

VOLTAREN® 25mg/ml NOVARTIS PHARMA GMBH

30mg/mlM01AB05 DICLOFENACUM SOL. INJ.TRATUL® 30mg/ml GEROT PHARMAZEUTIKA GMBH

50mgM01AB05 DICLOFENACUM CAPS. GASTROREZ.TRATUL 50 50mg GEROT PHARMAZEUTIKA GMBH

50mgM01AB05 DICLOFENACUM COMPR. FILM. GASTROREZ.CLAFEN 50 mg 50mg ANTIBIOTICE SA

DICLOFENAC 50 mg 50mg AC HELCOR PHARMA SRL

VOLTAREN® 50 50mg NOVARTIS PHARMA GMBH

50mgM01AB05 DICLOFENACUM DRAJ.VOLTAREN RAPID® 50mg NOVARTIS PHARMA GMBH

50mgM01AB05 DICLOFENACUM DRAJ. GASTROREZ.DICLOFENAC 50 mg 50mg ARENA GROUP SA

50mgM01AB05 DICLOFENACUM SUPOZ.VOLTAREN® 50mg NOVARTIS PHARMA GMBH

60mgM01AB05 DICLOFENACUM SUPOZ.TRATUL 60 60mg GEROT PHARMAZEUTIKA GMBH

75mgM01AB05 DICLOFENACUM COMPR. ELIB. MODIF.DICLAC® 75 ID 75mg HEXAL AG

75mgM01AB05 DICLOFENACUM SOL. INJ.DICLAC 75mg HEXAL AG

VURDON 75mg HELP S.A. PHARMACEUTICALS

75mg/3mlM01AB05 DICLOFENACUM SOL. INJ.ALMIRAL 75mg/3ml MEDOCHEMIE LTD.

DICLOFENAC 75 mg 75mg/3ml TERAPIA SA

DICLOFENAC AL I.M. 75mg/3ml ALIUD PHARMA GMBH & CO.KG

106 KETOROLACUM TROMETHAMINM01AB15

10mgM01AB15 KETOROLACUM TROMETHAMIN COMPR. FILM.KETANOV 10 mg 10mg TERAPIA S.A.

KETOROL 10mg DR. REDDY'S LABORATORIES

30mg/mlM01AB15 KETOROLACUM TROMETHAMIN SOL. INJ.KETANOV 30mg/ml TERAPIA S.A.

KETOROL 30mg/ml DR. REDDY'S LABORATORIES

107 ACECLOFENACUMM01AB16

Prescriere limitata: Tratamentul simptomatic al puseelor de poliartrita reumatoida, osteoartrita, spondilita anchilozanta, artroza sau afectiunilor musculo-scheletale acute.

A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgM01AB16 ACECLOFENACUM COMPR. FILM.AFLAMIL 100mg GEDEON RICHTER PLC.

108 TENOXICAMUMM01AC02A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

20mgM01AC02 TENOXICAMUM CAPS.TENOXICAM LPH 20 mg 20mg LABORMED PHARMA SA

20mgM01AC02 TENOXICAMUM COMPR.TENOXICAM 20 mg 20mg ARENA GROUP SA

20mgM01AC02 TENOXICAMUM COMPR. FILM.NEO - ENDUSIX® 20mg ANFARM HELLAS S.A. PHARMACEUTICALS

TILCOTIL 20mg ROCHE ROMANIA S.R.L.

20mgM01AC02 TENOXICAMUM LIOF. + SOLV. PT. SOL. INJ.NEO - ENDUSIX® 20mg ANFARM HELLAS S.A. PHARMACEUTICALS

20mgM01AC02 TENOXICAMUM LIOF. SI SOLV.PT.SOL.INJTILCOTIL 20mg ROCHE ROMANIA S.R.L.

109 MELOXICAMUMM01AC06A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

15mgM01AC06 MELOXICAMUM COMPR.CELOMIX 15mg ACTAVIS GROUP HF.

MELARTRIN 15 mg 15mg TERAPIA SA

MELOX 15 mg 15mg MEDOCHEMIE LTD

MELOXICAM 15 mg 15mg VIM SPECTRUM SRL

MELOXICAM LPH 15 mg 15mg LABORMED PHARMA SA

MELOXICAM MCC 15 mg 15mg MAGISTRA C & C SRL

MELOXICAM SANDOZ 15 mg 15mg HEXAL AG

MOVALIS® 15 mg 15mg BOEHRINGER INGELHEIM INT. GMBH

21 153/

Page 22: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

RECOXA 15 15mg ZENTIVA AS

15mgM01AC06 MELOXICAMUM SUPOZ.MELOXICAM 15 mg 15mg MAGISTRA C & C

MOVALIS® 15 mg 15mg BOEHRINGER INGELHEIM INT. GMBH

15mg/1.5mlM01AC06 MELOXICAMUM SOL. INJ.MOVALIS® 15mg/1.5ml BOEHRINGER INGELHEIM INT. GMBH

7.5 mgM01AC06 MELOXICAMUM COMPR.MELOX 7,5 mg 7.5 mg MEDOCHEMIE LTD

7.5mgM01AC06 MELOXICAMUM COMPR.MELOXICAM 7,5 mg 7.5mg VIM SPECTRUM SRL

MELOXICAM LPH 7,5 mg 7.5mg LABORMED PHARMA SA

MELOXICAM MCC 7,5 mg 7.5mg MAGISTRA C & C SRL

MELOXICAM SANDOZ 7,5 mg 7.5mg HEXAL AG

MOVALIS® 7,5 mg 7.5mg BOEHRINGER INGELHEIM INT. GMBH

7.5mgM01AC06 MELOXICAMUM SUPOZ.MELOXICAM 7,5 mg 7.5mg MAGISTRA C & C

110 KETOPROFENUMM01AE03A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100 mgM01AE03 KETOPROFENUM COMPR. FILM.RUBIFEN 100 mg 100 mg ANTIBIOTICE SA

100mgM01AE03 KETOPROFENUM CAPS. ELIB. PREL.KETOPROFEN SR 100 mg 100mg TERAPIA SA

100mgM01AE03 KETOPROFENUM COMPR. FILM.KETONAL FORTE 100 mg 100mg LEK PHARMACEUTICALS D.D.

KETOPROXIN 100 mg 100mg AC HELCOR PHARMA SRL

PROFENID® 100 mg 100mg LAB. AVENTIS

100mgM01AE03 KETOPROFENUM LIOF. + SOLV. PT. SOL. INJ.PROFENID® 100 mg 100mg LAB. AVENTIS

100mgM01AE03 KETOPROFENUM SUPOZ.KETOMAG 100mg MAGISTRA C & C

KETONAL 100 mg 100mg LEK PHARMACEUTICALS D.D.

RUBIFEN® 100 mg 100mg ANTIBIOTICE SA

100mg/2mlM01AE03 KETOPROFENUM SOL. INJ.KETONAL 100 mg/ 2 ml 100mg/2ml LEK PHARMACEUTICALS D.D.

100mg/2mlM01AE03 KETOPROFENUM SOL. INJ./CONC. SOL. PERF.KETOPROFEN 100mg/2ml 100mg/2ml TERAPIA SA

150mgM01AE03 KETOPROFENUM CAPS. ELIB. PREL.KETONAL® DUO 150 mg 150mg SANDOZ S.R.L.

150mgM01AE03 KETOPROFENUM COMPR. ELIB. PREL.KETONAL RETARD 150mg LEK PHARMACEUTICALS D.D.

200mgM01AE03 KETOPROFENUM CAPS. ELIB. PREL.KETALGON 200 mg 200mg NOVIA FARM SOLUTIONS SRL

KETONAL UNO 200mg SANDOZ S.R.L.

KETOPROFEN SR 200 mg 200mg TERAPIA SA

200mgM01AE03 KETOPROFENUM COMPR. FILM. ELIB. PREL.PROFENID® LP 200 mg 200mg LAB. AVENTIS

50mgM01AE03 KETOPROFENUM COMPR. FILM.KETOPROXIN 50 mg 50mg AC HELCOR PHARMA SRL

111 TETRAZEPAMUMM03BX07

50mgM03BX07 TETRAZEPAMUM COMPR. FILM.MYOLASTAN® 50 mg 50mg SANOFI-SYNTHELABO FRANCE

112 ALLOPURINOLUM *M04AA01

Doza trebuie ajustata in concordanta cu functia renala.NOTA:

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgM04AA01 ALLOPURINOLUM COMPR.MILURIT 100 mg 100mg EGIS PHARMACEUTICALS LTD.

300mgM04AA01 ALLOPURINOLUM COMPR.MILURIT 300 mg 300mg EGIS PHARMACEUTICALS LTD.

113 COLCHICINUMM04AC01

1mgM04AC01 COLCHICINUM COMPR.COLCHICINA 1mg BIOFARM SA

114 PENTAZOCINUMN02AD01

Prescriere limitata: Durere severa, care nu raspunde la analgezice non-opioide.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCIului.

30mg/mlN02AD01 PENTAZOCINUM SOL. INJ.FORTRAL 30mg/ml KRKA D.D. NOVO MESTO

FORTWIN® 30mg/ml TERAPIA S.A.

50mgN02AD01 PENTAZOCINUM COMPR.FORTRAL 50 mg 50mg KRKA D.D. NOVO MESTO

115 TRAMADOLUMN02AX02

Prescriere limitata: Durere severa, care nu raspunde la analgezice non-opioide.

Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice (mai putin formele injectabile) si concentratiilor corespunzatoare DCI-ului.

100mgN02AX02 TRAMADOLUM COMPR. ELIB. MODIF.TRAMADOLOR® 100 ID 100mg HEXAL AG

100mgN02AX02 TRAMADOLUM COMPR. ELIB. PREL.TRALGIT SR 100 100mg ZENTIVA AS

TRAMADOL® RETARD 100mg KRKA D.D.

100mgN02AX02 TRAMADOLUM COMPR. FILM. ELIB. PREL.TRAMAL RETARD 100 mg 100mg GRUNENTHAL GMBH

22 153/

Page 23: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

100mgN02AX02 TRAMADOLUM SOL. INJ.MABRON 100mg MEDOCHEMIE LTD.

TRADOLAN 100mg LANNACHER HEILMITTEL GMBH

Tratamentul de scurta durata al durerii acute.Prescriere limitata:

100mgN02AX02 TRAMADOLUM SUPOZ.TRADOLAN 100mg LANNACHER HEILMITTEL GMBH

TRAMADOL 100mg KRKA D.D.

TRAMAG 100 100mg MAGISTRA C & C

TRAMAL® 100mg GRUNENTHAL GMBH

100mg/2mlN02AX02 TRAMADOLUM SOL. INJ.TRALGIT 100 100mg/2ml ZENTIVA A.S.

Tratamentul de scurta durata al durerii acute.Prescriere limitata:

100mg/mlN02AX02 TRAMADOLUM PIC. ORALE, SOL.TRALGIT 100mg/ml ZENTIVA A.S.

100mg/mlN02AX02 TRAMADOLUM SOL. ORALATRADOLAN 100mg/ml LANNACHER HEILMITTEL GMBH

150mgN02AX02 TRAMADOLUM COMPR. ELIB. PREL.TRALGIT SR 150 150mg ZENTIVA AS

150mgN02AX02 TRAMADOLUM COMPR. FILM. ELIB. PREL.TRAMADOL RETARD 150 mg 150mg KRKA D.D. NOVO MESTO

TRAMAL RETARD 150 mg 150mg GRUNENTHAL GMBH

200mgN02AX02 TRAMADOLUM COMPR. ELIB. PREL.TRALGIT SR 200 200mg ZENTIVA AS

200mgN02AX02 TRAMADOLUM COMPR. FILM. ELIB. PREL.TRAMADOL RETARD 200 mg 200mg KRKA D.D. NOVO MESTO

TRAMAL RETARD 200 mg 200mg GRUNENTHAL GMBH

50mgN02AX02 TRAMADOLUM CAPS.K-ALMA® 50mg ANTIBIOTICE SA

MABRON 50 mg 50mg MEDOCHEMIE LTD.

TRALGIT 50 50mg ZENTIVA A.S.

TRAMACALM 50mg AC HELCOR SRL

TRAMADOL 50mg KRKA D.D.

TRAMADOL LPH 50 mg 50mg LABORMED PHARMA SA

TRAMADOL AL 50 50mg ALIUD® PHARMA GMBH & CO.KG

TRAMADOL ARENA 50mg ARENA GROUP S.A.

TRAMAL® 50mg GRUNENTHAL GMBH

URGENDOL 50mg MEDICAROM GROUP SRL

50mgN02AX02 TRAMADOLUM COMPR.TRAMADOL 50 mg 50mg OZONE LABORATORIES LTD.

TRAMADOL EEL 50mg BIO EEL SRL

TRAMAG 50 50mg MAGISTRA C & C

50mgN02AX02 TRAMADOLUM COMPR. FILM.TRADOLAN 50 mg 50mg LANNACHER HEILMITTEL GMBH

50mgN02AX02 TRAMADOLUM SOL. INJ.TRADOLAN 50 mg 50mg LANNACHER HEILMITTEL GMBH

Tratamentul de scurta durata al durerii acute.Prescriere limitata:

50mg/mlN02AX02 TRAMADOLUM SOL. INJ.TRALGIT 50 50mg/ml ZENTIVA A.S.

TRAMADOL 50mg/ml KRKA D.D.

TRAMADOL® AL 100 Fiole 50mg/ml ALIUD® PHARMA GMBH & CO.KG

TRAMAL® 100 50mg/ml GRUNENTHAL GMBH

TRAMAL® 50 50mg/ml GRUNENTHAL GMBH

URGENDOL 50mg/ml MEDICAROM GROUP SRL

Tratamentul de scurta durata al durerii acute.Prescriere limitata:

N02AX02 TRAMADOLUM PIC. ORALE, SOL.TRAMADOL AL PICATURI ALIUD PHARMA GMBH & CO.KG

100mg/mlN02AX02 TRAMADOLUM PICATURI ORALE-SOL.TRAMAL® 100mg/ml GRUNENTHAL GMBH

116 SUMATRIPTANUM *N02CC01

Prescriere limitata: Atacurile de migrena la pacientii care primesc sau au primit medicatie profilactica si la care crizele migrenoase nu au raspuns la tratamentul oral cu ergotamina sau

alte medicamente antimigrenoase, sau la care aceste medicamente sunt contraindicate.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgN02CC01 SUMATRIPTANUM COMPR.SUMIGRA 100 mg 100mg SANDOZ S.R.L.

100mgN02CC01 SUMATRIPTANUM COMPR. FILM.IMIGRAN® 100 100mg GLAXO WELLCOME UK LTD.

SUMACTA 100 mg 100mg ACTAVIS GROUP PTC EHF.

SUMATRIPTAN 100mg DR. REDDY'S LABORATORIES

50mgN02CC01 SUMATRIPTANUM COMPR.SUMIGRA 50 mg 50mg SANDOZ S.R.L.

50mgN02CC01 SUMATRIPTANUM COMPR. FILM.IMIGRAN® 50 50mg GLAXO WELLCOME UK LTD.

SUMACTA 50 mg 50mg ACTAVIS GROUP PTC EHF.

SUMATRIPTAN 50mg DR. REDDY'S LABORATORIES

117 CARBAMAZEPINUM Protocol: N025GN03AF01

100mg/5mlN03AF01 CARBAMAZEPINUM SUSP. ORALATIMONIL SIROP 100mg/5ml DESITIN ARZNEIMITTEL GMBH

150mgN03AF01 CARBAMAZEPINUM COMPR. RET.TIMONIL 150 RETARD 150mg DESITIN

200mgN03AF01 CARBAMAZEPINUM COMPR.CARBAMAZEPIN 200mg SLAVIA PHARM SRL

CARBAMAZEPIN EEL 200mg BIO EEL SRL

CARBAMAZEPINA 200mg OZONE LABORATORIES LTD.

23 153/

Page 24: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

CARBAMAZEPINA ARENA 200 mg 200mg ARENA GROUP SA

CARBAMAZEPINA LPH 200 mg 200mg LABORMED PHARMA SA

CARBAVIM 200mg VIM SPECTRUM SRL

CARBEPSIL 200 200mg AC HELCOR SRL

FINLEPSIN 200mg AWD PHARMA GMBH & CO.KG

NEUROTOP 200mg GEROT PHARMAZEUTIKA GMBH

TAVER 200mg MEDOCHEMIE LTD.

TEGRETOL® 200 200mg NOVARTIS PHARMA GMBH

200mgN03AF01 CARBAMAZEPINUM COMPR. FILM. ELIB. PREL.TEGRETOL CR 200 200mg NOVARTIS PHARMA GMBH

300mgN03AF01 CARBAMAZEPINUM COMPR. ELIB. PREL.NEUROTOP® RETARD 300 mg 300mg GEROT PHARMAZEUTIKA GMBH

300mgN03AF01 CARBAMAZEPINUM COMPR. RET.TIMONIL 300 RETARD 300mg DESITIN

400mgN03AF01 CARBAMAZEPINUM COMPR.CARBEPSIL 400 400mg AC HELCOR SRL

TEGRETOL® 400 400mg NOVARTIS PHARMA GMBH

400mgN03AF01 CARBAMAZEPINUM COMPR. FILM. ELIB. PREL.TEGRETOL CR 400 400mg NOVARTIS PHARMA GMBH

400mgN03AF01 CARBAMAZEPINUM COMPR. RET.FINLEPSIN 400 RETARD 400mg AWD PHARMA GMBH & CO.KG

600mgN03AF01 CARBAMAZEPINUM COMPR. ELIB. PREL.NEUROTOP® RETARD 600 mg 600mg GEROT PHARMAZEUTIKA GMBH

600mgN03AF01 CARBAMAZEPINUM COMPR. RET.TIMONIL 600 RETARD 600mg DESITIN

200mgN03AF01 CARBAMAZEPINUM COMPR.FILM.ELIB.PRELFINLEPSIN 200 RETARD 200mg AWD PHARMA GMBH & CO.KG

118 GABAPENTINUM Protocol: N025GN03AX12

100mgN03AX12 GABAPENTINUM CAPS.GABAGAMMA 100 mg 100mg WORWAG PHARMA GMBH & CO. KG

GABALEPT 100 mg 100mg PLIVA LJUBLJANA D.O.O.

300mgN03AX12 GABAPENTINUM CAPS.GABAGAMMA 300 mg 300mg WORWAG PHARMA GMBH & CO. KG

GABALEPT 300 mg 300mg PLIVA LJUBLJANA D.O.O.

GABARAN 300 mg 300mg RANBAXY UK LTD.

400mgN03AX12 GABAPENTINUM CAPS.GABAGAMMA 400 mg 400mg WORWAG PHARMA GMBH & CO. KG

GABALEPT 400 mg 400mg PLIVA LJUBLJANA D.O.O.

GABARAN 400 mg 400mg RANBAXY UK LTD.

600mgN03AX12 GABAPENTINUM COMPR. FILM.GABARAN 600 mg 600mg RANBAXY UK LTD.

800mgN03AX12 GABAPENTINUM COMPR. FILM.GABARAN 800 mg 800mg RANBAXY UK LTD.

119 HALOPERIDOLUMN05AD01

50mg/mlN05AD01 HALOPERIDOLUM SOL. INJ.HALOPERIDOL DECANOAT 50mg/ml GEDEON RICHTER LTD.

5mgN05AD01 HALOPERIDOLUM COMPR.HALDOL 5mg JANSSEN PHARMACEUTICA NV

5mg/mlN05AD01 HALOPERIDOLUM SOL. INJ.HALOPERIDOL 5 mg/ml 5mg/ml GEDEON RICHTER LTD.

2mg/mlN05AD01 HALOPERIDOLUM PIC. ORALE-SOL.HALOPERIDOL 2 mg/ml 2mg/ml GEDEON RICHTER ROMANIA SA

2mg/mlN05AD01 HALOPERIDOLUM PICATURI ORALE-SOL.HALOPERIDOL 2mg/ml TERAPIA SA

120 DIAZEPAMUMN05BA01

Diazepamum este utilizat ca agent anxiolitic, anticonvulsivant si relaxant muscular de tip central. In tratamentul anxietatii se utilizeaza ca sedativ in anxietatea acuta de tip sever

cat si in tratamentul agitatiei asociata cu delirium tremens.

NOTA:

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

10mgN05BA01 DIAZEPAMUM COMPR.DIAZEPAM 10mg TERAPIA SA

DIAZEPAM 10 mg 10mg GEDEON RICHTER ROMANIA SA

10mg/2.5mlN05BA01 DIAZEPAMUM SOL. RECTALADIAZEPAM DESITIN® SOLUTIE RECTALA 10 mg 10mg/2.5ml DESITIN

10mg/2mlN05BA01 DIAZEPAMUM SOL. INJ.DIAZEPAM 10 mg 10mg/2ml TERAPIA SA

5mg/2.5mlN05BA01 DIAZEPAMUM SOL. RECTALADIAZEPAM DESITIN® SOLUTIE RECTALA 5 mg 5mg/2.5ml DESITIN

121 MEDAZEPAMUM *N05BA03

10 mgN05BA03 MEDAZEPAMUM COMPR.MEDAZEPAM 10 mg ARENA GROUP SA

10mgN05BA03 MEDAZEPAMUM CAPS.ANSILAN 10 mg 10mg LEK PHARMACEUTICALS D.D.

10mgN05BA03 MEDAZEPAMUM COMPR.MEDAZEPAM 10 mg 10mg LABORMED PHARMA SA

RUDOTEL 10mg AWD PHARMA GMBH & CO.KG

122 LORAZEPAMUM *N05BA06

1 mgN05BA06 LORAZEPAMUM COMPR.ANXIAR® 1 mg 1 mg GEDEON RICHTER ROMANIA SA

123 BROMAZEPAMUM *N05BA08

1.5mgN05BA08 BROMAZEPAMUM COMPR.BROMAZEPAM LPH 1,5 mg 1.5mg LABORMED PHARMA SA

24 153/

Page 25: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

CALMEPAM® 1.5mg GLAXOSMITHKLINE (GSK) SRL

3mgN05BA08 BROMAZEPAMUM COMPR.BROMAZEPAM LPH 3 mg 3mg LABORMED PHARMA SA

CALMEPAM® 3mg GLAXOSMITHKLINE (GSK) SRL

LEXOTAN 3mg ROCHE ROMANIA S.R.L.

LEXOTANIL 3mg TERAPIA S.A.

124 ALPRAZOLAMUM *N05BA12

Prescriere limitata: Tulburari de panica, in cazul esecului la tratamente similare.

Pentru tratamentul de scurta durata al anxietatii moderate sau severe si al anxietatii asociate cu depresia.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

0,25mgN05BA12 ALPRAZOLAMUM COMPR.XANAX 0,25 mg 0,25mg PFIZER EUROPE MA EEIG

0,5mgN05BA12 ALPRAZOLAMUM COMPR.XANAX 0,5 mg 0,5mg PFIZER EUROPE MA EEIG

0.25mgN05BA12 ALPRAZOLAMUM COMPR.ALPRAZOLAM LPH® 0,25 mg 0.25mg LABORMED PHARMA SA

FRONTIN 0,25 mg 0.25mg EGIS PHARMACEUTICALS PLC

PRAZOLEX® 0,25 mg 0.25mg GEDEON RICHTER ROMANIA SA

0.5mgN05BA12 ALPRAZOLAMUM COMPR.ALPRAZOLAM LPH® 0,5 mg 0.5mg LABORMED PHARMA SA

FRONTIN 0,5 mg 0.5mg EGIS PHARMACEUTICALS PLC

PRAZOLEX® 0,5 mg 0.5mg GEDEON RICHTER ROMANIA SA

0.5mgN05BA12 ALPRAZOLAMUM COMPR. ELIB. PREL.NEUROL® SR 0,5 0.5mg ZENTIVA AS

1mgN05BA12 ALPRAZOLAMUM COMPR.ALPRAZOLAM LPH® 1 mg 1mg LABORMED PHARMA SA

FRONTIN 1mg EGIS PHARMACEUTICALS PLC

PRAZOLEX® 1 mg 1mg GEDEON RICHTER ROMANIA SA

XANAX 1 mg 1mg PFIZER EUROPE MA EEIG

1mgN05BA12 ALPRAZOLAMUM COMPR. ELIB. PREL.NEUROL® SR 1 1mg ZENTIVA AS

2mgN05BA12 ALPRAZOLAMUM COMPR.XANAX 2 mg 2mg PFIZER EUROPE MA EEIG

2mgN05BA12 ALPRAZOLAMUM COMPR. ELIB. PREL.NEUROL® SR 2 2mg ZENTIVA AS

125 NITRAZEPAMUMN05CD02

Cod restrictie 3007: Tratamentul de scurta durata al insomniei.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

2.5mgN05CD02 NITRAZEPAMUM COMPR.NITRAZEPAM LPH® 2,5 mg 2.5mg LABORMED PHARMA SA

5mgN05CD02 NITRAZEPAMUM COMPR.NITRAZEPAM 5 mg 5mg GEDEON RICHTER ROMANIA SA

NITRAZEPAM LPH® 5 mg 5mg LABORMED PHARMA SA

5mgN05CD02 NITRAZEPAMUM COMPR.NITRAZEPAM 5 mg 5mg GEDEON RICHTER ROMANIA SA

NITRAZEPAM LPH® 5 mg 5mg LABORMED PHARMA SA

126 ZOPICLONUM *N05CF01

Cod restrictie 3007: Pentru tratamentul de scurta durata al insomniei.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

7.5mgN05CF01 ZOPICLONUM COMPR. FILM.ALS-ZOPICLON 7,5 mg 7.5mg ALSIFCOM INTERMED SRL

IMOVANE 7,5 mg 7.5mg SANOFI AVENTIS

127 ZOLPIDEMUM *N05CF02

Cod restrictie 3007: Pentru tratamentul de scurta durata al insomniei.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

10mgN05CF02 ZOLPIDEMUM COMPR. FILM.HYPNOGEN 10 mg 10mg ZENTIVA AS

LADINOX 10mg GEDEON RICHTER ROMANIA S.A.

SANVAL® 10 mg 10mg LEK PHARMACEUTICALS D.D.

ZOLPIDEM 10 mg 10mg LABORMED PHARMA SA

ZOLPIDEM ANTIBIOTICE 10 mg 10mg ANTIBIOTICE S.A.

128 CLOMIPRAMINUM *N06AA04

Prescriere limitata: Tratamentul simptomatic al depresiei in special atunci cand este necesara sedarea.

Tratamentul starilor fobice si obsesiv-compulsive.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

10mgN06AA04 CLOMIPRAMINUM DRAJ.ANAFRANIL® 10 mg 10mg NOVARTIS PHARMA GMBH

25mgN06AA04 CLOMIPRAMINUM DRAJ.ANAFRANIL® 25 mg 25mg NOVARTIS PHARMA GMBH

129 AMITRIPTYLINUM *N06AA09

25mgN06AA09 AMITRIPTYLINUM CAPS. RET.AMITRIPTILIN 25 R. DESITIN 25mg DESITIN

25mgN06AA09 AMITRIPTYLINUM COMPR. FILM.AMITRIPTILINA ARENA 25 mg 25mg ARENA GROUP S.A.

50mgN06AA09 AMITRIPTYLINUM CAPS. RET.AMITRIPTILIN 50 R. DESITIN 50mg DESITIN

130 DOXEPINUM *N06AA12

25mgN06AA12 DOXEPINUM DRAJ.DOXEPIN 25 mg 25mg TERAPIA SA

131 FLUOXETINUM *N06AB03

25 153/

Page 26: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

Prescriere limitata: Tratamentul depresiilor cu sau fara anxietate in special cand componenta de sedare nu este necesara.

Tratamentul bulimiei nervoase.

Tratamentul tulburarilor obsesiv compulsive.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

20mgN06AB03 FLUOXETINUM CAPS.FLUOXETINE 20 mg 20mg DR. REDDY'S LABORATORIES

FLUOXIN 20mg VIM SPECTRUM SRL

FLURAN 20mg RANBAXY U.K. LIMITED

MAGRILAN 20 mg 20mg MEDOCHEMIE LTD.

20mgN06AB03 FLUOXETINUM COMPR. DISP.PROZAC 20 mg 20mg ELI LILLY SA

132 CITALOPRAMUM ** Protocol: N008FN06AB04

10mgN06AB04 CITALOPRAMUM COMPR. FILM.CITALORAN 10 mg 10mg RANBAXY UK LIMITED

LINISAN 10 mg 10mg GEDEON RICHTER ROMANIA S.A.

20mgN06AB04 CITALOPRAMUM COMPR. FILM.CITALORAN 20mg 20mg RANBAXY UK LIMITED

LINISAN 20 mg 20mg GEDEON RICHTER ROMANIA S.A.

40mgN06AB04 CITALOPRAMUM COMPR. FILM.CITALORAN 40 mg 40mg RANBAXY UK LIMITED

LINISAN 40 mg 40mg GEDEON RICHTER ROMANIA S.A.

133 PAROXETINUM *N06AB05

Prescriere limitata: Tratamentul tulburarilor depresive majore.

Tratamentul tulburarilor obsesiv-compulsive.

Tratamentul atacurilor de panica.

Tratamentul anxietatii.

Tratamentul fobiei sociale.

Tratamentul bolii de stres posttraumatic.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

20mgN06AB05 PAROXETINUM COMPR.ARKETIS 20mg MEDOCHEMIE LTD.

20mgN06AB05 PAROXETINUM COMPR. FILM.ALS-PAROXETIN 20 mg 20mg ALSIFCOM INTERMED SRL

PALUXETIL 20 mg 20mg HEXAL AG

PAXETEN 20 mg 20mg ACTAVIS GROUP HF.

REXETIN 20mg GEDEON RICHTER PLC.

SEROXAT 20 mg 20mg SMITHKLINE BEECHAM PLC

40mgN06AB05 PAROXETINUM COMPR. FILM.PALUXETIL 40 mg 40mg HEXAL AG

134 SERTRALINUM *N06AB06

Prescriere limitata: Tratamentul tulburarilor depresive inclusiv cu componenta anxioasa.

Tratamentul tulburari obsesiv-compulsive.

Tratamentul atacurilor de panica.

Tratamentul fobiei sociale.

Tratamentul bolii de stres posttraumatic.

Eficienta tratamentului in boala de stres posttraumatic a fost demonstrata doar pentru sexul feminin.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgN06AB06 SERTRALINUM COMPR. FILM.ALS-SERTRALINA 100 mg 100mg ALSIFCOM INTERMED SRL

ASENTRA® 100mg KRKA D.D.

SERLIFT 100 mg 100mg TERAPIA S.A.

SERTRALIN SANDOZ 100 mg 100mg HEXAL AG

SERTRALINA 100 mg 100mg ARENA GROUP S.A.

SERTRALINA DR. REDDY'S 100 mg 100mg DR. REDDY'S LABORATORIES

STIMULOTON® 100 mg 100mg EGIS PHARMACEUTICALS LTD.

20mg/mlN06AB06 SERTRALINUM SOL. ORALAZOLOFT® 20mg/ml PFIZER EUROPE MA EEIG

50mgN06AB06 SERTRALINUM COMPR. FILM.ALS-SERTRALINA 50 mg 50mg ALSIFCOM INTERMED SRL

ASENTRA® 50mg KRKA D.D.

SERLIFT 50 mg 50mg TERAPIA S.A.

SERTRALIN 50 mg 50mg OZONE LABORATORIES LTD.

SERTRALIN SANDOZ 50 mg 50mg HEXAL AG

SERTRALINA 50 mg 50mg ARENA GROUP SA

SERTRALINA DR. REDDY'S 50 mg 50mg DR. REDDY'S LABORATORIES

STIMULOTON® 50 mg 50mg EGIS PHARMACEUTICALS LTD.

ZOLOFT 50 mg 50mg PFIZER EUROPE MA EEIG

135 FLUVOXAMINUM *N06AB08

Prescriere limitata: Tratamentul tulburarilor depresive majore.

Tratamentul tulburarilor obsesiv-compulsive.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgN06AB08 FLUVOXAMINUM COMPR. FILM.FEVARIN® 100 100mg SOLVAY PHARMACEUTICALS BV

FLUVOXAMINE TEVA 100 mg 100mg TEVA PHARMACEUTICALS SRL

50mgN06AB08 FLUVOXAMINUM COMPR. FILM.FEVARIN® 50 50mg SOLVAY PHARMACEUTICALS BV

FLUVOXAMINE TEVA 50 mg 50mg TEVA PHARMACEUTICALS SRL

136 MIANSERINUM *N06AX03

10mgN06AX03 MIANSERINUM COMPR. FILM.MIANSERIN 10 10mg REMEDICA LTD.

10mgN06AX03 MIANSERINUM DRAJ.MIANSERIN 10 mg 10mg TERAPIA SA

26 153/

Page 27: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

30mgN06AX03 MIANSERINUM COMPR. FILM.MIANSERIN 30 30mg REMEDICA LTD.

30mgN06AX03 MIANSERINUM DRAJ.MIANSERIN 30 mg 30mg TERAPIA SA

137 MIRTAZAPINUM *N06AX11

Prescriere limitata: Tratamentul episoadelor depresive majore.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

15mgN06AX11 MIRTAZAPINUM COMPR. DISP.REMERON® SOLTAB 15 mg 15mg ORGANON NV

15mgN06AX11 MIRTAZAPINUM COMPR. FILM.ESPRITAL® 15 15mg ZENTIVA AS

MIRZATEN® 15 mg 15mg KRKA D.D.

30mgN06AX11 MIRTAZAPINUM COMPR. DISP.REMERON® SOLTAB 30 mg 30mg ORGANON NV

30mgN06AX11 MIRTAZAPINUM COMPR. FILM.ESPRITAL® 30 30mg ZENTIVA AS

MIRTAZAPINE-TEVA 30 mg 30mg TEVA PHARMACEUTICALS SRL

MIRZATEN® 30 mg 30mg KRKA D.D.

PHARMATAZ 30 mg 30mg ACTAVIS GROUP HF.

45mgN06AX11 MIRTAZAPINUM COMPR. DISP.REMERON® SOLTAB 45 mg 45mg ORGANON NV

45mgN06AX11 MIRTAZAPINUM COMPR. FILM.ESPRITAL® 45 45mg ZENTIVA AS

MIRZATEN® 45 mg 45mg KRKA D.D.

138 VENLAFAXINUM ** Protocol: N013FN06AX16

150mgN06AX16 VENLAFAXINUM CAPS. ELIB. PREL.EFECTIN ER 150 mg 150mg WYETH LEDERLE PHARMA GMBH

VELAXIN 150 mg 150mg EGIS PHARMACEUTICALS P.L.C.

37.5mgN06AX16 VENLAFAXINUM COMPR.VELAXIN 37,5 mg 37.5mg EGIS PHARMACEUTICALS PLC

VENLAFAXINA LPH 37,5 mg 37.5mg LABORMED PHARMA SA

75mgN06AX16 VENLAFAXINUM CAPS. ELIB. PREL.EFECTIN ER 75 mg 75mg WYETH LEDERLE PHARMA GMBH

VELAXIN 75 mg 75mg EGIS PHARMACEUTICALS P.L.C.

75mgN06AX16 VENLAFAXINUM COMPR.VELAXIN 75 mg 75mg EGIS PHARMACEUTICALS PLC

VENLAFAXINA LPH 75 mg 75mg LABORMED PHARMA SA

139 NEOSTIGMINI BROMIDUMN07AA01

0.5mg/mlN07AA01 NEOSTIGMINI BROMIDUM SOL. INJ.MIOSTIN 0,5 mg/ml 0.5mg/ml ZENTIVA S.A.

15mgN07AA01 NEOSTIGMINI BROMIDUM COMPR.NEOSTIGMINA LPH 15 mg 15mg LABORMED PHARMA SA

140 METRONIDAZOLUMP01AB01

Prescriere limitata: Tratamentul infectiilor cu anaerobi.

Tratamentul infectiilor cu protozoare sensibile la metronidazol.

250mgP01AB01 METRONIDAZOLUM COMPR.METRONIDAZOL 250 mg (P01AB01) 250mg ZENTIVA SA

METRONIDAZOL 250 mg (P01AB1) 250mg ARENA GROUP SA

250mgP01AB01 METRONIDAZOLUM COMPR. FILM.FLAGYL 250mg LABORATOIRE AVENTIS

4%P01AB01 METRONIDAZOLUM SUSP. ORALAFLAGYL 4% (P01AB01) 4% LABORATOIRE AVENTIS

141 TINIDAZOLUMP01AB02

Prescriere limitata: Tratamentul infectiilor cu anaerobi.

Tratamentul infectiilor cu protozoare sensibile la metronidazol.

500mgP01AB02 TINIDAZOLUM COMPR. FILM.FASIGYN (P01AB02) 500mg PFIZER EUROPE MA EEIG

TINIZOL® 500 mg (P01AB02) 500mg ZENTIVA S.A.

TIPROGYN 500 500mg AC HELCOR SRL

500mgP01AB02 TINIDAZOLUM COMPR. FILM.FASIGYN (P01AB02) 500mg PFIZER EUROPE MA EEIG

TINIZOL® 500 mg (J01XD02) 500mg ZENTIVA S.A.

TIPROGYN 500 500mg AC HELCOR SRL

142 ALBENDAZOLUMP02CA03

0.4g/10mlP02CA03 ALBENDAZOLUM SUSP. ORALAZENTEL 0,4 g/10 ml 0.4g/10ml GLAXOSMITHKLINE EXPORT LTD.

200mgP02CA03 ALBENDAZOLUM COMPR. FILM.DUADOR 200 mg 200mg GEDEON RICHTER ROMANIA SA

ZENTEL 200 mg 200mg GLAXOSMITHKLINE EXPORT LTD.

400mgP02CA03 ALBENDAZOLUM COMPR.ESKAZOLE 400mg GLAXO SMITHKLINE EXPORT LTD.

400mgP02CA03 ALBENDAZOLUM SUSP. ORALAALBENDAZOL BIOFARM 400 mg 400mg BIOFARM S.A.

200mgP02CA03 ALBENDAZOLUM COMPR.FILMALBENDAZOL 200mg OZONE LABORATORIES LTD.

143 LEVAMISOLUMP02CE01

150mgP02CE01 LEVAMISOLUM COMPR.DECARIS 150 mg 150mg GEDEON RICHTER ROMANIA SA

50mgP02CE01 LEVAMISOLUM COMPR.DECARIS 50 mg 50mg GEDEON RICHTER ROMANIA SA

27 153/

Page 28: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

144 SALBUTAMOLUMR03AC02

100µg/dozaR03AC02 SALBUTAMOLUM SUSP. INHAL. PRESURIZATAASTHALIN INHALER 100µg/doza CIPLA (UK) LIMITED

ECOSAL Easi-Breath 100µg/doza IVAX - PHARMACEUTICALS S.R.O.

VENTOLIN 100 INHALER CFC-FREE 100µg/doza GLAXOWELLCOME UK LTD.

5mg/mlR03AC02 SALBUTAMOLUM SOL. INHAL.VENTOLIN® 5mg/ml GLAXOWELLCOME UK LTD.

145 BECLOMETASONUM *R03BA01

100µg/dozaR03BA01 BECLOMETASONUM AEROSOL SOL. INHAL.ECOBEC 100 µg CFC FREE 100µg/doza IVAX - PHARMACEUTICALS S.R.O.

ECOBEC EASI - BREATHE 100 µg CFC FREE 100µg/doza IVAX - PHARMACEUTICALS S.R.O.

100µg/dozaR03BA01 BECLOMETASONUM SPRAY NAZ.,SUSP.RINOCLENIL 100 100µg/doza CHIESI FARMACEUTICI S.P.A.

250µg/dozaR03BA01 BECLOMETASONUM AEROSOL SOL. INHAL.ECOBEC 250 µg CFC FREE 250µg/doza IVAX - PHARMACEUTICALS S.R.O.

ECOBEC EASI - BREATHE 250 µg CFC FREE 250µg/doza IVAX - PHARMACEUTICALS S.R.O.

250µg/dozaR03BA01 BECLOMETASONUM SOL. DE INHALAT PRESURIZATABECLOFORTE® CFC-Free 250µg/doza GLAXO WELLCOME UK LTD.

250µg/dozaR03BA01 BECLOMETASONUM SOL. INHALAT PRESURIZATACLENIL® JET 250 µg 250µg/doza CHIESI FARMACEUTICI SPA

50µg/dozaR03BA01 BECLOMETASONUM SOL. DE INHALAT PRESURIZATABECOTIDE® CFC-Free 50µg/doza GLAXO WELLCOME UK LTD.

146 BUDESONIDUM *R03BA02

200 µg/dozaR03BA02 BUDESONIDUM PULB. INHAL.FRENOLYN 200 200 µg/doza MEDOCHEMIE ROMANIA SRL

200µg/dozaR03BA02 BUDESONIDUM PULB. INHAL.PULMICORT TURBUHALER 200 µg/doza 200µg/doza ASTRAZENECA AB

400 µg/dozaR03BA02 BUDESONIDUM PULB. INHAL.FRENOLYN 400 400 µg/doza MEDOCHEMIE ROMANIA SRL

147 IPRATROPII BROMIDUM *R03BB01

20µg/dozaR03BB01 IPRATROPII BROMIDUM AEROSOLIPRAVENT 20 - INHALER 20µg/doza CIPLA (UK) LIMITED

148 SALBUTAMOLUMR03CC02

0.04%R03CC02 SALBUTAMOLUM SOL. ORALASALBUTAMOL T 0.04% TIS FARMACEUTIC SA

0.5mg/mlR03CC02 SALBUTAMOLUM SOL. INJ.VENTOLIN® 0.5mg/ml GLAXO WELLCOME UK LTD.

2mg/5mlR03CC02 SALBUTAMOLUM SIROPSALBUTAMOL EIPICO 2mg/5ml 2mg/5ml E.I.P.I.CO. MED S.R.L.

VENTOLIN® 2mg/5ml GLAXOWELLCOME UK LTD.

2mg/5mlR03CC02 SALBUTAMOLUM SOL. ORALASALBUTAMOL 2mg/5ml TERAPIA S.A.

149 THEOPHYLLINUMR03DA04Datorita efectelor variabile ale alimentelor asupra absorbtiei teofilinei, pacientii care folosesc un anumit preparat nu trebuie sa il schimbe cu un altul fara o monitorizare adecvata.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgR03DA04 THEOPHYLLINUM CAPS. ELIB. PREL.TEOFILINA SR 100 mg 100mg TERAPIA SA

THEO SR 100 100mg GLAXOSMITHKLINE (GSK) SRL

200mgR03DA04 THEOPHYLLINUM CAPS. ELIB. PREL.TEOFILINA SR 200 mg 200mg TERAPIA SA

TEOTARD® 200 200mg KRKA D.D.

THEO SR 200 200mg GLAXOSMITHKLINE (GSK) SRL

300mgR03DA04 THEOPHYLLINUM CAPS. ELIB. PREL.TEOFILINA SR 300 mg 300mg TERAPIA SA

THEO SR 300 300mg GLAXOSMITHKLINE (GSK) SRL

350mgR03DA04 THEOPHYLLINUM CAPS. ELIB. PREL.TEOTARD® 350 350mg KRKA D.D.

50mgR03DA04 THEOPHYLLINUM CAPS. ELIB. PREL.TEOFILINA SR 50 mg 50mg TERAPIA SA

150 CODEINUMR05DA04

15mgR05DA04 CODEINUM COMPR.CODEINA FOSFAT 15mg SLAVIA PHARM SRL

CODEINA FOSFAT 15 mg 15mg OZONE LABORATORIES LTD.

CODEINA FOSFAT LPH 15 mg 15mg LABORMED PHARMA SA

CODEINA FOSFORICA 15mg BIO EEL SRL

CODEINA FOSFORICA 15 mg 15mg MAGISTRA C & C

FARMACOD 15mg FARMACOM SA

FOSFAT DE CODEINA 15 mg 15mg SINTOFARM SA

151 CHLORPHENAMINUMR06AB04

4mgR06AB04 CHLORPHENAMINUM COMPR.CLORFENIRAMIN 4mg LABORMED PHARMA SA

152 CETIRIZINUMR06AE07

10 mgR06AE07 CETIRIZINUM COMPR. FILM.CELERG 10 mg AC HELCOR PHARMA SRL

10mgR06AE07 CETIRIZINUM COMPR. FILM.LETIZEN® 10 mg 10mg KRKA D.D.

1mg/mlR06AE07 CETIRIZINUM SOL. ORALALETIZEN 1mg/ml KRKA D.D.

10mg/mlR06AE07 CETIRIZINUM PICATURI ORALE-SOL.ZYRTEC® 10mg/ml U.C.B. GMBH

28 153/

Page 29: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

153 KETOTIFENUMR06AX17

1mgR06AX17 KETOTIFENUM CAPS.KETOF 1 mg 1mg HEXAL AG

1mgR06AX17 KETOTIFENUM COMPR.H - KETOTIFEN 1mg AC HELCOR SRL

KETOTIFEN 1mg MAGISTRA C & C

KETOTIFEN LPH® 1 mg 1mg LABORMED PHARMA SA

1mg/5mlR06AX17 KETOTIFENUM SIROPFRENASMA 1mg/5ml FARAN LABORATORIES S.A.

KETOF 1 mg/5 ml 1mg/5ml HEXAL AG

154 CIPROFLOXACINUMS01AX13

0.3%S01AX13 CIPROFLOXACINUM UNG. OFT.CIPLOX 0.3% CIPLA (UK) LIMITED

155 DICLOFENACUMS01BC03

0.1%S01BC03 DICLOFENACUM PICATURI OFT.-SOL.DICLOGESIC 0,1% PICATURI OFTALMICE, SOLUTIE 0.1% DAR AL DAWA PHARMA S.R.L.

UNICLOPHEN® 0,1% 0.1% UNIMED PHARMA LTD.

VOLTAREN OPHTHA CD 0.1% NOVARTIS PHARMA GMBH

1mg/mlS01BC03 DICLOFENACUM PIC. OFT.-SOL.DICLOFENAC RPH 1mg/ml ROMPHARM COMPANY SRL

1mg/mlS01BC03 DICLOFENACUM PIC.OFT.-SOL.VURDON 1mg/ml HELP S.A. PHARMACEUTICALS

156 COMBINATII (BETHAMETASONUM+ANTIINFECTIOASE)S01CA05

0,2g+0,5gS01CA05 COMBINATII

(BETHAMETASONUM+ANTIINFECTIOASE)

UNG. OFT.

BETABIOPTAL 0,2g+0,5g FARMILA FARMACEUTICI

0,2g+0,5gS01CA05 COMBINATII

(BETHAMETASONUM+ANTIINFECTIOASE)

PICATURI OFT.SUSP.

BETABIOPTAL 0,2g+0,5g FARMILA FARMACEUTICI MILANO SPA

29 153/

Page 30: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

SUBLISTA B - MEDICAMENTE CU NIVEL DE COMPENSARE 50% DIN PREŢUL DE REFERINŢĂ

157 PANTOPRAZOLUMA02BC02

20mgA02BC02 PANTOPRAZOLUM COMPR. FILM. GASTROREZ.CONTROLOC 20 mg 20mg ALTANA PHARMA AG

Mentinerea rezultatelor terapiei refluxului gastro-esofagianPrescriere limitata:

Boala de reflux gastro-esofagianPrescriere limitata:

Profilaxia ulcerului gastro-duodenal asociat tratamentului cu antiinflamatoare nesteroidiene pe termen lung la pacientii la pacientii cu factori de risc gastrointestinal.Prescriere limitata:

Se aplica pentru toate denumirile comerciale si formele farmaceutice corespunzatoare concentratiei de 20 mg.

40mgA02BC02 PANTOPRAZOLUM COMPR. FILM. GASTROREZ.CONTROLOC 40mg 40mg ALTANA PHARMA AG

Boala de reflux gastro-esofagian.Prescriere limitata:

Sindromul Zollinger-EllisonPrescriere limitata:

Tratamentul ulcerului gastric si duodenal.Prescriere limitata:

Se aplica pentru toate denumirile comerciale si formele farmaceutice corespunzatoare concentratiiei de 40mg.

40mgA02BC02 PANTOPRAZOLUM LIOF. PT. SOL. INJ.

CONTROLOC 40mg LIOFILIZAT PENTRU SOLUTIE

INJECTABILA

40mg ALTANA PHARMA AG

158 ESOMEPRAZOLUMA02BC05

40mgA02BC05 ESOMEPRAZOLUM COMPR. FILM. GASTROREZ.NEXIUM 40 mg 40mg ASTRAZENECA AB

Terapia refluxului gastro-esofagian.Prescriere limitata:

Sindromul Zollinger-Ellison.Prescriere limitata:

Se aplica pentru toate denumirile comerciale si formele farmaceutice corespunzatoare concentratiei de 40 mg.

40mgA02BC05 ESOMEPRAZOLUM LIOF. PT. SOL. INJ./PERF.NEXIUM® 40mg ASTRAZENECA AB

20mgA02BC05 ESOMEPRAZOLUM COMPR. FILM. GASTROREZ.NEXIUM 20 mg 20mg ASTRAZENECA AB

Tratamentul ulcerului gastric si duodenal.Prescriere limitata:

Mentinerea rezultatelor terapiei refluxului gastro-esofagian.Prescriere limitata:

Profilaxia ulcerului gastro-duodenal asociat tratamentului cu antiinflamatoare nesteroidiene pe termen lung la pacientii cu factori de risc gastrointestinali.Prescriere limitata:

Se aplica pentru toate denumirile comerciale si formele farmaceutice corespunzatoare concentratiei de 20 mg.

159 SUCRALFATUMA02BX02

1gA02BX02 SUCRALFATUM COMPR.GASTROFAIT 1g E.I.P.I.CO. MED S.R.L.

SUCRALAN® 1g LANNACHER HEILMITTEL GMBH

VENTER 1g KRKA D.D.

160 BISMUTHI SUBCITRASA02BX05

120mgA02BX05 BISMUTHI SUBCITRAS COMPR. FILM.DE - NOL 120mg ASTELLAS PHARMA EUROPE B.V.

161 OTILONIUM BROMIDUMA03AB06

40mgA03AB06 OTILONIUM BROMIDUM COMPR. FILM.SPASMOMEN® 40mg A. MENARINI IND. FARM. RIUNITE SRL

162 MACROGOLUM *(2)A06AD15

A06AD15 MACROGOLUM PULB. PT. SOL. ORALAFORTRANS® BEAUFOUR IPSEN INT.

163 RIFAXIMINUMA07AA11

200mgA07AA11 RIFAXIMINUM COMPR. FILM.NORMIX 200 mg 200mg ALFA WASSERMANN SPA

164 BUDESONIDUM **A07EA06

Prescriere limitata: Inducerea remisiunii formelor usoare/moderate de boala Crohn cu afectare ileala sau / si de colon ascendent.

3mgA07EA06 BUDESONIDUM CAPS. GASTROREZ.BUDENOFALK 3mg DR. FALK PHARMA GMBH

165 RACECADOTRILUMA07XA04

100mgA07XA04 RACECADOTRILUM CAPS.HIDRASEC 100 mg 100mg LAB. FOURNIER SA

10mgA07XA04 RACECADOTRILUM PULB. PT. SOL. ORALAHIDRASEC 10 mg 10mg LAB. FOURNIER SA

30mgA07XA04 RACECADOTRILUM PULB. PT. SOL. ORALAHIDRASEC 30 mg 30mg LAB. FOURNIER SA

166 SIBUTRAMINUM **** Protocol: A003EA08AA10

10mgA08AA10 SIBUTRAMINUM CAPS.LINDAXA 10 10mg ZENTIVA A.S.

REDUCTIL 10mg 10mg ABBOTT GMBH&CO.KG

15mgA08AA10 SIBUTRAMINUM CAPS.LINDAXA 15 15mg ZENTIVA A.S.

REDUCTIL 15 mg 15mg ABBOTT GMBH&CO.KG

167 ORLISTATUM **** Protocol: A001EA08AB01

120mgA08AB01 ORLISTATUM CAPS.XENICAL 120mg 120mg ROCHE REGISTRATION LTD.

168 RIMONABANTUM **** Protocol: A031EA08AX01

20mgA08AX01 RIMONABANTUM COMPR. FILM.ACOMPLIA 20mg 20mg SANOFI AVENTIS

169 ALFACALCIDOLUMA11CC03

0.25µgA11CC03 ALFACALCIDOLUM CAPS. MOIALPHA D3 0,25 µg 0.25µg TEVA PHARMACEUTICALS SRL

0.50µgA11CC03 ALFACALCIDOLUM CAPS. MOIALPHA D3 0.50 µg 0.50µg TEVA PHARMACEUTICALS S.R.L.

30 153/

Page 31: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

170 ACIDUM TIOCTICUM (ALFA-LIPOICUM) **# Protocol: A021EA16AX01

12mg/mlA16AX01 ACIDUM TIOCTICUM (ALFA-LIPOICUM) SOL. PERF.THIOGAMMA® TURBO-SE 12mg/ml WORWAG PHARMA GMBH & CO. KG

THIOGAMMA® TURBO-SET 12mg/ml WORWAG PHARMA GMBH & CO. KG

30mg/mlA16AX01 ACIDUM TIOCTICUM (ALFA-LIPOICUM) CONC. PT. SOL. PERF.THIOGAMMA® 600 INJEKT 30mg/ml WORWAG PHARMA GMBH & CO. KG

600mgA16AX01 ACIDUM TIOCTICUM (ALFA-LIPOICUM) COMPR. FILM.THIOGAMMA® 600 oral 600mg WORWAG PHARMA GMBH & CO. KG

171 DALTEPARINUM **# Protocol: B008DB01AB04

10000ui/mlB01AB04 DALTEPARINUM SOL. INJ.FRAGMIN 10000 UI/ml 10000ui/ml PFIZER EUROPE MA EEIG

15000ui/0.6mlB01AB04 DALTEPARINUM SOL. INJ.FRAGMIN15000 UI/0,6 ml 15000ui/0.6ml PFIZER EUROPE MA EEIG

2500ui/0.2mlB01AB04 DALTEPARINUM SOL. INJ.FRAGMIN 2500 UI/0,2 ml 2500ui/0.2ml PFIZER EUROPE MA EEIG

5000ui/0.2mlB01AB04 DALTEPARINUM SOL. INJ.FRAGMIN 5000 UI/0,2 ml 5000ui/0.2ml PFIZER EUROPE MA EEIG

7500ui/0.3mlB01AB04 DALTEPARINUM SOL. INJ.FRAGMIN 7500 UI/0,3 ml 7500ui/0.3ml PFIZER EUROPE MA EEIG

172 ENOXAPARINUM **# Protocol: B008DB01AB05

2000ui

anti-Xa/0.2ml

B01AB05 ENOXAPARINUM SOL. INJ.

CLEXANE 2000ui anti-Xa/0.2ml 2000ui

anti-Xa/0.2ml

LAB. AVENTIS

4000ui

anti-Xa/0,4ml

B01AB05 ENOXAPARINUM SOL. INJ.

CLEXANE 4000ui anti-Xa/0.4ml 4000ui

anti-Xa/0,4ml

LAB. AVENTIS

6000ui

anti-Xa/0.6ml

B01AB05 ENOXAPARINUM SOL. INJ.

CLEXANE 6000ui anti-Xa/0.6ml 6000ui

anti-Xa/0.6ml

LAB. AVENTIS

8000ui

anti-Xa/0.8ml

B01AB05 ENOXAPARINUM SOL. INJ.

CLEXANE 8000ui anti-Xa/0.8ml 8000ui

anti-Xa/0.8ml

LAB. AVENTIS

2000ui

anti-Xa/0.2ml

B01AB05 ENOXAPARINUM SOL. INJ.

CLEXANE 2000ui anti-Xa/0.2ml 2000ui

anti-Xa/0.2ml

LAB. AVENTIS

4000ui

anti-Xa/0,4ml

B01AB05 ENOXAPARINUM SOL. INJ.

CLEXANE 4000ui anti-Xa/0.4ml 4000ui

anti-Xa/0,4ml

LAB. AVENTIS

6000ui

anti-Xa/0.6ml

B01AB05 ENOXAPARINUM SOL. INJ.

CLEXANE 6000ui anti-Xa/0.6ml 6000ui

anti-Xa/0.6ml

LAB. AVENTIS

173 NADROPARINUM **# Protocol: B008DB01AB06

11400

uiAXa/0.6ml

B01AB06 NADROPARINUM SOL. INJ.

FRAXODI 11400 UI anti-factor Xa/0,6ml 11400 uiAXa/0.6ml GLAXO GROUP LTD.

15200

uiAXa/0.8ml

B01AB06 NADROPARINUM SOL. INJ.

FRAXODI 15200 UI anti-factor Xa/0,8ml 15200 uiAXa/0.8ml GLAXO GROUP LTD.

2850 ui

AFXa/0.3ml

B01AB06 NADROPARINUM SOL. INJ.

FRAXIPARINE® 2850 UI anti-factor Xa/0,3 ml 2850 ui

AFXa/0.3ml

GLAXO GROUP LTD.

3800 ui

AFXa/0.4ml

B01AB06 NADROPARINUM SOL. INJ.

FRAXIPARINE® 3800 UI anti-factor Xa/0,4 ml 3800 ui

AFXa/0.4ml

GLAXO GROUP LTD.

5700 ui

AFXa/0.6ml

B01AB06 NADROPARINUM SOL. INJ.

FRAXIPARINE® 5700 UI anti-factor Xa/0,6 ml 5700 ui

AFXa/0.6ml

GLAXO GROUP LTD.

7600 ui

AXa/0.8ml

B01AB06 NADROPARINUM SOL. INJ.

FRAXIPARINE® 7600 UI anti-factor Xa/0,8 ml 7600 ui AXa/0.8ml GLAXO GROUP LTD.

174 REVIPARINUM **# Protocol: B008DB01AB08

1432ui/0.25mlB01AB08 REVIPARINUM SOL. INJ.CLIVARIN® 1432UI/0,25 ml 1432ui/0.25ml ABBOTT GMBH&CO.KG

3436ui/0.6mlB01AB08 REVIPARINUM SOL. INJ.CLIVARIN® 3436 UI/0,6 ml 3436ui/0.6ml ABBOTT GMBH&CO.KG

175 TINZAPARINUM **# Protocol: B008DB01AB10

10000u ANTIF.

Xa/ml

B01AB10 TINZAPARINUM SOL. INJ.

31 153/

Page 32: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

INNOHEP 10000u ANTIF.

Xa/ml

LEO PHARMACEUTICAL PRODUCTS

20000u ANTIF.

Xa/ml

B01AB10 TINZAPARINUM SOL. INJ.

INNOHEP 20000u ANTIF.

Xa/ml

LEO PHARMACEUTICAL PRODUCTS

176 SULODEXIDUM ** Protocol: B014IB01AB11

250ULSB01AB11 SULODEXIDUM CAPS. MOIVESSEL DUE F 250ULS ALFA WASSERMANN SPA

600ULS/2mlB01AB11 SULODEXIDUM SOL. INJ.VESSEL DUE F 600ULS/2ml ALFA WASSERMANN SPA

177 CLOPIDOGRELUM ** Protocol: B009I;B010IB01AC04

75mgB01AC04 CLOPIDOGRELUM COMPR. FILM.PLAVIX 75mg 75mg SANOFI PHARMA - BRISTOL MYERS SQUIBB

Preventia recurentei accidentului vascular ischiemic sau a accidentului ischemic tranzitor la pacientii cu istoric de episoade ischiemice cererbrovasculare conform

protocolului de prescriere.

Cod restrictie 1719:

Preventia recurentei infarctului de miocard sau a anginei instabile la pacienţii cu istoric de evenimente ischiemice cardiace simptomatice conform protocolului de

prescriere.

Cod restrictie 1722:

Tratamentul antiagregant al ateromatozei extensive (carotidiene, coronariene si perfierice).Cod restrictie 3008:

178 COMBINATII (DIPYRIDAMOLUM+ACIDUM

ACETYLSALICYLICUM) **

Protocol: B010IB01AC30

B01AC30 COMBINATII (DIPYRIDAMOLUM+ACIDUM

ACETYLSALICYLICUM)

CAPS. ELIB. MODIF.

AGGRENOX BOEHRINGER INGELHEIM INTERNATIONAL GMBH

179 FONDAPARINUX SODIUM **# Protocol: B008DB01AX05

10mg/0.8mlB01AX05 FONDAPARINUX SODIUM SOL. INJ. IN SERINGA PREUMPLUTAARIXTRA 10mg/0.8ml 10mg/0.8ml GLAXO GROUP LTD.

2.5mg/0.5mlB01AX05 FONDAPARINUX SODIUM SOL. INJ. IN SERINGA PREUMPLUTAARIXTRA 2.5mg/0.5ml 2.5mg/0.5ml GLAXO GROUP LTD.

5mg/0.4mlB01AX05 FONDAPARINUX SODIUM SOL. INJ. IN SERINGA PREUMPLUTAARIXTRA 5mg/0.4ml 5mg/0.4ml GLAXO GROUP LTD.

7.5mg/0.6mlB01AX05 FONDAPARINUX SODIUM SOL. INJ. IN SERINGA PREUMPLUTAARIXTRA 7.5mg/0.6ml 7.5mg/0.6ml GLAXO GROUP LTD.

180 COMPLEX DE HIDROXID DE FER (III) SUCROZAB03AC02

20mg/mlB03AC02 COMPLEX DE HIDROXID DE FER (III)

SUCROZA

SOL. INJ./PERF.

VENOFER® 20mg/ml VIFOR FRANCE S.A.

Anemie feriprivă, la pacienţii care au prezentat o reacţie de hipersensibilitate documentată la fier polimaltozat şi la care este indicată administrarea continuă

intravenoasă.

Cod restrictie 2070:

181 TRIFLUSALUMB01AC18

300mgB01AC18 TRIFLUSALUM CAPS.AFLEN® 300mg ZENTIVA S.A.

182 MEXILETINUMC01BB02

200mgC01BB02 MEXILETINUM CAPS.MEXITIL® 200 mg 200mg BOEHRINGER INGELHEIM INT. GMBH

183 IVABRADINUM ** Protocol: C003IC01EB17

5mgC01EB17 IVABRADINUM COMPR. FILM.CORLENTOR 5mg 5mg LES LAB. SERVIER

7.5mgC01EB17 IVABRADINUM COMPR. FILM.CORLENTOR 7,5mg 7.5mg LES LAB. SERVIER

184 MOXONIDINUMC02AC05

Prescriere limitata: Hipertensiune arteriala esentiala la pacienţii care primesc tratament antihipertensiv concomitent.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

0.2mgC02AC05 MOXONIDINUM COMPR. FILM.MOXOGAMMA 0,2 mg 0.2mg WORWAG PHARMA GMBH

PHYSIOTENS 0,2 0.2mg SOLVAY PHARMACEUTICALS GMBH

0.3mgC02AC05 MOXONIDINUM COMPR. FILM.MOXOGAMMA 0,3 mg 0.3mg WORWAG PHARMA GMBH

0.4mgC02AC05 MOXONIDINUM COMPR. FILM.MOXOGAMMA 0,4 mg 0.4mg WORWAG PHARMA GMBH

PHYSIOTENS 0,4 0.4mg SOLVAY PHARMACEUTICALS GMBH

185 RILMENIDINUMC02AC06

1mgC02AC06 RILMENIDINUM COMPR.TENAXUM 1mg LES LABORATOIRES SERVIER INDUSTRIE

186 PRAZOSINUMC02CA01

1mgC02CA01 PRAZOSINUM COMPR.MINIPRESS® 1 mg 1mg PFIZER EUROPE MA EEIG

2mgC02CA01 PRAZOSINUM COMPR.MINIPRESS® 2 mg 2mg PFIZER EUROPE MA EEIG

187 EPLERENONUM *#C03DA04

Prescriere limitata: Insuficienţă cardiacă cu o fracţie de ejecţie a ventriculului stâng de 40% sau mai puţin, apărută la 3-14 zile de la un infarct miocardic acut. Tratmentul cu eplerenone

trebuie început la maximum 14 zile de la data aparitiei infarctului miocardic acut. Data infarctului miocardic acut şi data iniţierii tratamentului cu eplerenone trebuie

documentate în fişa pacientului.

Electroliţii serici trebuie să fie verificaţi periodic.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

25mgC03DA04 EPLERENONUM COMPR. FILM.INSPRA 25 mg 25mg PFIZER EUROPE MA EEIG

50mgC03DA04 EPLERENONUM COMPR. FILM.

32 153/

Page 33: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

INSPRA 50 mg 50mg PFIZER EUROPE MA EEIG

188 NICERGOLINUMC04AE02

10mgC04AE02 NICERGOLINUM COMPR. FILM.NICERGOLINA LPH 10 mg 10mg LABORMED PHARMA SA

10mgC04AE02 NICERGOLINUM DRAJ.NICERIUM® 10 10mg HEXAL AG

SINERGOLIN 10 10mg SINTOFARM SA

15mgC04AE02 NICERGOLINUM CAPS. ELIB. MODIF.NICERIUM® 15 15mg HEXAL AG

30mgC04AE02 NICERGOLINUM CAPS. ELIB. MODIF.NICERIUM® 30 UNO 30mg HEXAL AG

30mgC04AE02 NICERGOLINUM COMPR. FILM.NICERGOLINA LPH 30 mg 30mg LABORMED PHARMA SA

SERMION 30mg PFIZER EUROPE MA EEIG

30mgC04AE02 NICERGOLINUM DRAJ.SINERGOLIN 30 30mg SINTOFARM SA

5mgC04AE02 NICERGOLINUM COMPR. FILM.NICERGOLINA LPH 5 mg 5mg LABORMED PHARMA SA

189 VINCAMINUMC04AX07

10mgC04AX07 VINCAMINUM DRAJ.VINCAMINA 10mg BIOFARM SA

20mgC04AX07 VINCAMINUM COMPR.VINCAMIL 20mg FARMACEUTICI ECOBI S.A.S

30mgC04AX07 VINCAMINUM CAPS. ELIB. PREL.OXYBRAL SR 30 mg 30mg GLAXOSMITHKLINE (GSK) SRL

190 GINKGO BILOBA ** Protocol: C001IC04AXN1

120mgC04AXN1 GINKGO BILOBA COMPR. FILM.GINGIUM 120m 120mg HEXAL AG

40mgC04AXN1 GINKGO BILOBA COMPR. FILM.GINGIUM 40mg 40mg HEXAL AG

TEBOKAN 40mg DR. WILLMAR SCHWABE GMBH & CO KG

80mgC04AXN1 GINKGO BILOBA CAPS.BILOBIL FORTE 80mg KRKA D.D. NOVO MESTO

80mgC04AXN1 GINKGO BILOBA COMPR. FILM.GINGIUM 80mg 80mg HEXAL AG

191 DIOSMINUM (COMBINATII) ** Protocol: B016IC05CA53

500mgC05CA53 DIOSMINUM (COMBINATII) COMPR. FILM.DETRALEX® 500mg LES LAB. SERVIER IND.

192 NEBIVOLOLUMC07AB12

5mgC07AB12 NEBIVOLOLUM COMPR.NEBILET® 5mg BERLIN CHEMIE AG MENARINI GROUP

193 COMBINATII (BISOPROLOLUM+HYDROCHLOROTHIAZIDUM)C07BB07

C07BB07 COMBINATII

(BISOPROLOLUM+HYDROCHLOROTHIAZIDU

M)

COMPR. FILM.

LODOZ 10 mg MERCK KGAA

LODOZ 2,5 mg MERCK KGAA

LODOZ 5 mg MERCK KGAA

194 COMBINATII (METOPROLOLUM+FELODIPINUM)C07EBN1

50mg+5mgC07EBN1 COMBINATII

(METOPROLOLUM+FELODIPINUM)

COMPR. ELIB. PREL.

LOGIMAX® 50mg+5mg ASTRAZENECA AB

195 LACIDIPINUMC08CA09

4mgC08CA09 LACIDIPINUM COMPR. FILM.LACIPIL 4 mg 4mg GLAXO OPERATIONS UK LTD.

196 LERCANIDIPINUMC08CA13

10mgC08CA13 LERCANIDIPINUM COMPR. FILM.LERIDIP 10mg BERLIN CHEMIE AG MENARINI GROUP

20mgC08CA13 LERCANIDIPINUM COMPR. FILM.LERIDIP 20 20mg BERLIN CHEMIE AG MENARINI GROUP

197 PERINDOPRILUMC09AA04

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului

in utero.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

10 mgC09AA04 PERINDOPRILUM COMPR. FILM.PRESTARIUM 10 mg 10 mg LES LAB. SERVIER IND.

4mgC09AA04 PERINDOPRILUM COMPR.PRESTARIUM® 4 mg 4mg LES LAB. SERVIER IND.

5mgC09AA04 PERINDOPRILUM COMPR. FILM.PRESTARIUM 5 mg 5mg LES LAB. SERVIER IND.

8mgC09AA04 PERINDOPRILUM COMPR.PRESTARIUM® 8 mg 8mg LES LAB. SERVIER IND.

198 BENAZEPRILUMC09AA07

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului

in utero.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

10mgC09AA07 BENAZEPRILUM COMPR. FILM.BENAZEPRIL STADA 10 mg 10mg STADA ARZNEIMITTEL AG

CIBACEN® 10 mg 10mg NOVARTIS PHARMA GMBH

33 153/

Page 34: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

20mgC09AA07 BENAZEPRILUM COMPR. FILM.BENAZEPRIL STADA 20 mg 20mg STADA ARZNEIMITTEL AG

CIBACEN® 20 mg 20mg NOVARTIS PHARMA GMBH

5mgC09AA07 BENAZEPRILUM COMPR. FILM.BENAZEPRIL STADA 5 mg 5mg STADA ARZNEIMITTEL AG

CIBACEN® 5 mg 5mg NOVARTIS PHARMA GMBH

199 TRANDOLAPRILUMC09AA10

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului

in utero.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

0.5mgC09AA10 TRANDOLAPRILUM CAPS.GOPTEN® 0,5 mg 0.5mg ABBOTT GMBH&CO.KG

2mgC09AA10 TRANDOLAPRILUM CAPS.GOPTEN® 2 mg 2mg ABBOTT GMBH&CO.KG

4mgC09AA10 TRANDOLAPRILUM CAPS.GOPTEN® 4 mg 4mg ABBOTT GMBH&CO.KG

200 ZOFENOPRILUMC09AA15

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului

in utero.

30mgC09AA15 ZOFENOPRILUM COMPR. FILM.ZOMEN® 30 mg 30mg BERLIN CHEMIE AG

7.5mgC09AA15 ZOFENOPRILUM COMPR. FILM.ZOMEN® 7,5 mg 7.5mg BERLIN CHEMIE AG

201 COMBINATII (PERINDOPRILUM+INDAPAMIDUM)C09BA04

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului

in utero.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

2mg+0.625mgC09BA04 COMBINATII

(PERINDOPRILUM+INDAPAMIDUM)

COMPR.

NOLIPREL® 2mg+0.625mg LES LAB. SERVIER IND.

4mg+1.25mgC09BA04 COMBINATII

(PERINDOPRILUM+INDAPAMIDUM)

COMPR.

NOLIPREL FORTE® 4mg+1.25mg LES LAB. SERVIER IND.

PRESTARIUM PLUS 4mg+1.25mg LES LAB. SERVIER IND.

202 COMBINATII (QUINAPRILUM+HYDROCHLOROTHIAZIDUM)C09BA06

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului

in utero.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

10mg/12.5mgC09BA06 COMBINATII

(QUINAPRILUM+HYDROCHLOROTHIAZIDUM)

COMPR. FILM.

ACCUZIDE 10mg/12.5mg PFIZER EUROPE MA EEIG

20mg/12.5mgC09BA06 COMBINATII

(QUINAPRILUM+HYDROCHLOROTHIAZIDUM)

COMPR. FILM.

ACUZIDE FORTE 20mg/12.5mg PFIZER EUROPE MA EEIG

203 COMBINATII (FOSINOPRILUM+HYDROCHLOROTHIAZIDUM)C09BA09

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului

in utero.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

20mg/12.5mgC09BA09 COMBINATII

(FOSINOPRILUM+HYDROCHLOROTHIAZIDU

M)

COMPR.

FOSINOZIDE 20 mg/12,5 mg 20mg/12.5mg BRISTOL MYERS SQUIBB KFT

204 COMBINATII (NITRENDIPINUM+ENALAPRILUM)C09BB02

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului

in utero.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

10mg+20mgC09BB02 COMBINATII

(NITRENDIPINUM+ENALAPRILUM)

COMPR.

ENEAS 10mg+20mg VITA CIENTIFICA SL

205 COMBINATII (VERAPAMILUM+TRANDOLAPRILUM)C09BB10

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului

in utero.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

180mg/2mgC09BB10 COMBINATII

(VERAPAMILUM+TRANDOLAPRILUM)

COMPR.FILM.ELIB.MODIF.

TARKA 180mg/2mg ABBOTT GMBH&CO.KG

206 VALSARTANUMC09CA03

Prescriere limitata: Tratamentul hipertensiunii arteriale la pacientii cu intoleranta la inhibitorii enzimei de conversie ai angiotensinei.

Tratamentul hipertensiunii arteriale la pacientii ale caror valori tensionale nu pot fi controlate adecvat cu celelalte clase de medicamente antihipertensive.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

160mgC09CA03 VALSARTANUM COMPR. FILM.DIOVAN 160 mg 160mg NOVARTIS PHARMA GMBH

80mgC09CA03 VALSARTANUM COMPR. FILM.DIOVAN 80 mg 80mg NOVARTIS PHARMA GMBH

207 IRBESARTANUMC09CA04

Prescriere limitata: Tratamentul hipertensiunii arteriale la pacientii cu intoleranta la inhibitorii enzimei de conversie ai angiotensinei.

Tratamentul hipertensiunii arteriale la pacientii ale caror valori tensionale nu pot fi controlate adecvat cu celelalte clase de medicamente antihipertensive.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

34 153/

Page 35: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

150mgC09CA04 IRBESARTANUM COMPR. FILM.APROVEL 150mg 150mg SANOFI PHARMA - BRISTOL MYERS SQUIBB

300mgC09CA04 IRBESARTANUM COMPR. FILM.APROVEL 300mg 300mg SANOFI PHARMA - BRISTOL MYERS SQUIBB

208 CANDESARTANUM CILEXETILC09CA06

Prescriere limitata: Tratamentul hipertensiunii arteriale la pacientii cu intoleranta la inhibitorii enzimei de conversie ai angiotensinei.

Tratamentul hipertensiunii arteriale la pacientii ale caror valori tensionale nu pot fi controlate adecvat cu celelalte clase de medicamente antihipertensive.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

16mgC09CA06 CANDESARTANUM CILEXETIL COMPR.ATACAND 16mg ASTRAZENECA AB

8mgC09CA06 CANDESARTANUM CILEXETIL COMPR.ATACAND 8mg ASTRAZENECA AB

209 TELMISARTANUMC09CA07

Prescriere limitata: Tratamentul hipertensiunii arteriale la pacientii cu intoleranta la inhibitorii enzimei de conversie ai angiotensinei.

Tratamentul hipertensiunii arteriale la pacientii ale caror valori tensionale nu pot fi controlate adecvat cu celelalte clase de medicamente antihipertensive.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

40mgC09CA07 TELMISARTANUM COMPR.MICARDIS 40 mg 40mg BOEHRINGER INGELHEIM INT. GMBH

PRITOR 40 mg 40mg BAYER HEALTHCARE AG

80mgC09CA07 TELMISARTANUM COMPR.MICARDIS 80 mg 80mg BOEHRINGER INGELHEIM INT. GMBH

PRITOR 80 mg 80mg BAYER HEALTHCARE AG

210 COMBINATII (LOSARTANUM+HYDROCHLOROTHIAZIDUM)C09DA01

Prescriere limitata: Tratamentul hipertensiunii arteriale la pacientii cu intoleranta la inhibitorii enzimei de conversie ai angiotensinei.

Tratamentul hipertensiunii arteriale la pacientii ale caror valori tensionale nu pot fi controlate adecvat cu celelalte clase de medicamente antihipertensive.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

50mg+12.5mgC09DA01 COMBINATII

(LOSARTANUM+HYDROCHLOROTHIAZIDUM)

COMPR. FILM.

HYZAAR® 50 mg/12,5 mg 50mg+12.5mg MERCK SHARP & DOHME ROMANIA S.R.L.

211 COMBINATII (VALSARTANUM+HYDROCHLOROTHIAZIDUM)C09DA03

Prescriere limitata: Tratamentul hipertensiunii arteriale la pacientii cu intoleranta la inhibitorii enzimei de conversie ai angiotensinei.

Tratamentul hipertensiunii arteriale la pacientii ale caror valori tensionale nu pot fi controlate adecvat cu celelalte clase de medicamente antihipertensive.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

80mg/12.5mgC09DA03 COMBINATII

(VALSARTANUM+HYDROCHLOROTHIAZIDUM

)

COMPR. FILM.

CO-DIOVAN 80 mg/12,5 mg 80mg/12.5mg NOVARTIS PHARMA GMBH

212 COMBINATII (IRBERSARTANUM+HYDROCHLOROTHIAZIDUM)C09DA04

Prescriere limitata: Tratamentul hipertensiunii arteriale la pacientii cu intoleranta la inhibitorii enzimei de conversie ai angiotensinei.

Tratamentul hipertensiunii arteriale la pacientii ale caror valori tensionale nu pot fi controlate adecvat cu celelalte clase de medicamente antihipertensive.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

150mg/12.5mgC09DA04 COMBINATII

(IRBERSARTANUM+HYDROCHLOROTHIAZID

UM)

COMPR.

COAPROVEL 150mg/12.5mg 150mg/12.5mg SANOFI PHARMA - BRISTOL MYERS SQUIBB SNC

300mg/12.5mgC09DA04 COMBINATII

(IRBERSARTANUM+HYDROCHLOROTHIAZID

UM)

COMPR.

COAPROVEL 300mg/12.5mg 300mg/12.5mg SANOFI PHARMA - BRISTOL MYERS SQUIBB SNC

213 COMBINATII (TELMISARTANUM+HYDROCHLOROTHIAZIDUM)C09DA07

Prescriere limitata: Tratamentul hipertensiunii arteriale la pacientii cu intoleranta la inhibitorii enzimei de conversie ai angiotensinei.

Tratamentul hipertensiunii arteriale la pacientii ale caror valori tensionale nu pot fi controlate adecvat cu celelalte clase de medicamente antihipertensive.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

80/12.5mgC09DA07 COMBINATII

(TELMISARTANUM+HYDROCHLOROTHIAZID

UM)

COMPR.

MICARDISPLUS 80/12.5mg 80/12.5mg BOEHRINGER INGELHEIM INT. GMBH

80mg/12.5mgC09DA07 COMBINATII

(TELMISARTANUM+HYDROCHLOROTHIAZID

UM)

COMPR.

PRITOR PLUS 80mg/12,5mg 80mg/12.5mg BAYER HEALTHCARE AG

214 COMBINATII ( VALSARTANUM+AMLODIPINUM)C09DB01

Prescriere limitata: Tratamentul hipertensiunii arteriale la pacientii cu intoleranta la inhibitorii enzimei de conversie ai angiotensinei.

Tratamentul hipertensiunii arteriale la pacientii ale caror valori tensionale nu pot fi controlate adecvat cu celelalte clase de medicamente antihipertensive.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

10mg/160mgC09DB01 COMBINATII (

VALSARTANUM+AMLODIPINUM)

COMPR. FILM.

EXFORGE 10mg/160mg 10mg/160mg NOVARTIS EUROPHARM LTD.

5mg/160mgC09DB01 COMBINATII (

VALSARTANUM+AMLODIPINUM)

COMPR. FILM.

EXFORGE 5mg/160mg 5mg/160mg NOVARTIS EUROPHARM LTD.

5mg/80mgC09DB01 COMBINATII (

VALSARTANUM+AMLODIPINUM)

COMPR. FILM.

EXFORGE 5mg/80mg 5mg/80mg NOVARTIS EUROPHARM LTD.

215 FLUVASTATINUM Protocol: CE01EC10AA04

Prescriere limitata: Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

35 153/

Page 36: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

20mgC10AA04 FLUVASTATINUM CAPS.LESCOL® 20 20mg NOVARTIS PHARMA GMBH

40mgC10AA04 FLUVASTATINUM CAPS.LESCOL® 40 40mg NOVARTIS PHARMA GMBH

80mgC10AA04 FLUVASTATINUM COMPR. ELIB. PREL.LESCOL® XL 80mg NOVARTIS PHARMA GMBH

216 ATORVASTATINUM Protocol: CE01EC10AA05

Prescriere limitata: Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

10mgC10AA05 ATORVASTATINUM COMPR. FILM.SORTIS 10 mg 10mg PFIZER EUROPE MA EEIG

20mgC10AA05 ATORVASTATINUM COMPR. FILM.SORTIS 20 mg 20mg PFIZER EUROPE MA EEIG

40mgC10AA05 ATORVASTATINUM COMPR. FILM.SORTIS 40 mg 40mg PFIZER EUROPE MA EEIG

80mgC10AA05 ATORVASTATINUM COMPR. FILM.SORTIS 80 mg 80mg PFIZER EUROPE MA EEIG

217 ROSUVASTATINUM Protocol: CE01EC10AA07

Prescriere limitata: Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

10mgC10AA07 ROSUVASTATINUM COMPR. FILM.CRESTOR 10 mg 10mg ASTRAZENECA UK LTD.

20mgC10AA07 ROSUVASTATINUM COMPR. FILM.CRESTOR 20 mg 20mg ASTRAZENECA UK LTD.

40mgC10AA07 ROSUVASTATINUM COMPR. FILM.CRESTOR 40 mg 40mg ASTRAZENECA UK LTD.

5mgC10AA07 ROSUVASTATINUM COMPR. FILM.CRESTOR 5 mg 5mg ASTRAZENECA UK LTD.

218 BEZAFIBRATUM Protocol: CE01EC10AB02

Prescriere limitata: Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

200mgC10AB02 BEZAFIBRATUM DRAJ.REGADRIN® B 200mg BERLIN CHEMIE AG MENARINI GROUP

219 CIPROFIBRATUM Protocol: CE01EC10AB08

Prescriere limitata: Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgC10AB08 CIPROFIBRATUM CAPS.LIPANOR® 100 mg 100mg SANOFI-AVENTIS FRANCE

220 ACID OMEGA-3-ESTERI ETILICI 90 ** Protocol: C004IC10AX06

1000mgC10AX06 ACID OMEGA-3-ESTERI ETILICI 90 CAPS. MOIOMACOR® 1000mg PRONOVA BIOCARE AS

221 EZETIMIBUMC10AX09

Prescriere limitata: Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.

Cod restrictie 2649: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol

nu este controlat adecvat cu o statină şi care au:(a) boală coronariana. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului

peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine concomitent cu dieta si exercitii fizice. Doza, durata

tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu

ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul

inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155 mg/dl dupa cel putin 3 luni de tratament cu o doza zilnica optima de statine

concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul

medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul

initierii tratamentului cu ezetimib.

Cod restrictie 2650: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol

nu este controlat adecvat cu o statină şi care au:(b) diabet zaharat. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste

pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii fizice. Doza, durata

tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu

ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul

inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155 mg/dl dupa cel ptuin 3 luni de tratament cu o doza zilnica optima de statine

concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul

medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul

initierii tratamentului cu ezetimib

Cod restrictie 2651: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol

nu este controlat adecvat cu o statină şi care au:(c) boala vasculara periferica. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al

colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii fizice.

Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii

tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2)

Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155 mg/dl dupa cel ptuin 3 luni de tratament cu o doza zilnica optima de statine

concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul

medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul

initierii tratamentului cu ezetimib.

36 153/

Page 37: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

Cod restrictie 2652: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol

nu este controlat adecvat cu o statină şi care au:(d) hipercolesterolemie familiala heterozigota. Controlul inadecvat sub tratament cu o statina este definit astfel: (1)

nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii

fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul

initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib;

SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155mg/dl dupa cel ptuin 3 luni de tratament cu o doza zilnica optima de statine

concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul

medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul

initierii tratamentului cu ezetimib

Cod restrictie 2653: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol

nu este controlat adecvat cu o statină şi care au:(e) boala cerebrovasculara simptomatica. Controlul inadecvat sub tratament cu o statina este definit astfel: (1)

nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii

fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul

initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib;

SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155mg/dl dupa cel putin 3 luni de tratament cu o doza zilnica optima de statine

concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul

medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul

initierii tratamentului cu ezetimib.

Cod restrictie 2667: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol

nu este controlat adecvat cu o statină şi care au:(f) istoric familial de boala coronariana. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel

al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii fizice.

Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii

tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2)

Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155mg/dl dupa cel putin 3 luni de tratament cu o doza zilnica optima de statine

concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul

medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul

initierii tratamentului cu ezetimib.

Cod restrictie 2668: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol

nu este controlat adecvat cu o statină şi care au:(g) HTA. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul

initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu

statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb.

Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al

colesterolului cu nivele ale acestuia mai mari decat 155mg/dl dupa cel putin 3 luni de tratament cu o doza zilnica optima de statine concomitent cu dieta

si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la

momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul initierii tratamentului cu

ezetimib.

Cod restrictie 1989: Pacienti care indeplinesc criteriile de eligibilitate pentru prescrierea de hipolipemiante (in concordanta cu criteriile stabilite in Protocoalele de prescriere in vederea

decontarii) atunci cand tratamentul cu un inhibitor de HMG CoA reductaza (statine) este contraindicat

Cod restrictie 2669: Pacienti care indeplinesc criteriile de eligibilitate pentru prescrierea de hipolipemiante (in concordanta cu criteriile stabilite in Protocoalele de prescriere in vederea

decontarii) atunci cand tratamentul cu un inhibitor de HMG CoA reductaza (statin) trebuie intrerupt sau redus la mai putin de 20 mg/zi datorita aparitiei efectelor

secundare urmatoare: (i) Mialgie severa (simptome mulsculare fara cresterea CK) care survine pe perioada tratamentului cu statine; sau (ii) Miozita (cresterea

importanta a CK, cu sau fara simptomatologie musculara) demonstrata prin valori de doua ori mai mari decat limita superioara a normalului la o singura

determinare sau o tendinta de crestere la determinari consecutive, neexplicate de alte cauze; sau (iii) Persistenta unor valori crescute ale transaminazelor,

neexplicata de alte cauze (mai mult de trei ori decat valoarea limita maxima a normalului) in timpul tratamentului cu o statina

Cod restrictie 1991: Homozygous sitosterolaemia;

Cod restrictie 2438: Pacienti cu hipercolesterolemie familiala (homozigota) care sunt eligibili pentru tratamentul cu hipolipemiante (in concordanta cu Protocolul de prescriere in

vederea decontarii), in combinatie cu un inhibitor de HMG CoA reductase (statin).

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

10mgC10AX09 EZETIMIBUM COMPR.EZETROL® 10mg MERCK SHARP & DOHME ROMANIA SRL

222 COMBINATII (EZETIMIBUM + SIMVASTATINUM)C10BA02

Cod restrictie 2654: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol

nu este controlat adecvat cu o statină şi care au:(a) boală coronariana. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului

peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii fizice. Doza, durata

tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu

ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul

inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155mg/dl dupa cel putin 3 luni de tratament cu o doza zilnica optima de statine

concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul

medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul

initierii tratamentului cu ezetimib.

Cod restrictie 2655: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol

nu este controlat adecvat cu o statină şi care au:(b) diabet zaharat. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste

pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii fizice. Doza, durata

tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu

ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul

inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155mg/dl dupa cel ptuin 3 luni de tratament cu o doza zilnica optima de statine

concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul

medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul

initierii tratamentului cu ezetimib

Cod restrictie 2656: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol

nu este controlat adecvat cu o statină şi care au:(c) boala vasculara periferica. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al

colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii fizice.

Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii

tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2)

Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155mg/dl dupa cel ptuin 3 luni de tratament cu o doza zilnica optima de statine

concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul

medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul

initierii tratamentului cu ezetimib.

37 153/

Page 38: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

Cod restrictie 2657: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol

nu este controlat adecvat cu o statină şi care au:(d) hipercolesterolemie familiala heterozigota. Controlul inadecvat sub tratament cu o statina este definit astfel: (1)

nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii

fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul

initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib;

SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155mg/dl dupa cel ptuin 3 luni de tratament cu o doza zilnica optima de statine

concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul

medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul

initierii tratamentului cu ezetimib

Cod restrictie 2658: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol

nu este controlat adecvat cu o statină şi care au:(e) boala cerebrovasculara simptomatica. Controlul inadecvat sub tratament cu o statina este definit astfel: (1)

nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii

fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul

initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib;

SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155mg/dl dupa cel ptuin 3 luni de tratament cu o doza zilnica optima de statine

concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul

medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul

initierii tratamentului cu ezetimib.

Cod restrictie 2678: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol

nu este controlat adecvat cu o statină şi care au:(f) istoric familial de boala coronariana. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel

al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii fizice.

Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii

tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2)

Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155mg/dl dupa cel ptuin 3 luni de tratament cu o doza zilnica optima de statine

concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul

medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul

initierii tratamentului cu ezetimib.

Cod restrictie 2679:Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol

nu este controlat adecvat cu o statină şi care au:(g) HTA. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul

initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu

statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb.

Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al

colesterolului cu nivele ale acestuia mai mari decat 155mg/dl dupa cel putin 3 luni de tratament cu o doza zilnica optima de statine concomitent cu dieta

si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la

momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu

ezetimib.

Cod restrictie 2431: Pacientii cu hipercolesterolemie familiala (heterozigota) care sunt eligibili pentru tratament cu hipo-lipemiante (in concordanta cu criteriile stabilite prin Protocolul

de prescriere in vederea decontarii).

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

10mg/10mgC10BA02 COMBINATII (EZETIMIBUM +

SIMVASTATINUM)

COMPR.

INEGY® 10 mg/10 mg 10mg/10mg MERCK SHARP & DOHME ROMANIA S.R.L.

10mg/20mgC10BA02 COMBINATII (EZETIMIBUM +

SIMVASTATINUM)

COMPR.

INEGY® 10 mg/20 mg 10mg/20mg MERCK SHARP & DOHME ROMANIA S.R.L.

10mg/40mgC10BA02 COMBINATII (EZETIMIBUM +

SIMVASTATINUM)

COMPR.

INEGY® 10 mg/40 mg 10mg/40mg MERCK SHARP & DOHME ROMANIA S.R.L.

10mg/80mgC10BA02 COMBINATII (EZETIMIBUM +

SIMVASTATINUM)

COMPR.

INEGY® 10 mg/80 mg 10mg/80mg MERCK SHARP & DOHME ROMANIA S.R.L.

223 COMBINATII (ATORVASTATINUM + AMLODIPINUM) Protocol: CE01EC10BX03

Prescriere limitata: Pentru utilizarea la pacientii cu hipertensiune arteriala si/sau angina pectorala care indeplinesc criteriile sabilite de Protocolul de prescriere a medicamentelor

hipolipemiante in vederea decontarii, si:(a) care primesc in mod curent tratament cu un blocant de canale de calciu.

Pentru utilizarea la pacientii cu hipertensiune arteriala si/sau angina pectorala care indeplinesc criteriile sabilite de Protocolul de prescriere a medicamentelor

hipolipemiante in vederea decontarii, si:(b) al caror nivel al tensiunii arteriale si/sau angina pectorala sunt insuficient controlate cu alte clase de antihipertensive

si/sau medicamente anti-angina si la care terapia adjuvanta cu blocanti ai canalelor de calciu ar fi adecvata;

Pentru utilizarea la pacientii cu hipertensiune arteriala si/sau angina pectorala care indeplinesc criteriile sabilite de Protocolul de prescriere a medicamentelor

hipolipemiante in vederea decontarii, si (c) care nu tolereaza efectele secundare ale altor clase de antihipertensive si/sau medicamente anti-angina si la care

inlocuirea terapiei cu un blocant de canale de calciu ar fi indicata.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

10mg/10mgC10BX03 COMBINATII (ATORVASTATINUM +

AMLODIPINUM)

COMPR. FILM.

CADUET 10mg/10mg 10mg/10mg PFIZER EUROPE MA EEIG

5mg/10mgC10BX03 COMBINATII (ATORVASTATINUM +

AMLODIPINUM)

COMPR. FILM.

CADUET 5mg/10mg 5mg/10mg PFIZER EUROPE MA EEIG

224 NATAMYCINUMD01AA02

20mg/gD01AA02 NATAMYCINUM CREMAPIMAFUCIN 20mg/g ASTELLAS EUROPE B.V.

226 TERBINAFINUMD01BA02

Prescriere limitata: Tratamentul de prima intentie al onicomicozelor proximale sau extinse la care tratamentul topic a esuat.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

250mgD01BA02 TERBINAFINUM COMPR.LAMISIL® 250mg NOVARTIS PHARMA GMBH

TERBINARAN 250mg RANBAXY UK LIMITED

TERBISIL® 250 mg 250mg GEDEON RICHTER LTD.

227 CALCIPOTRIOLUM *D05AX02

50µg/gD05AX02 CALCIPOTRIOLUM CREMA

38 153/

Page 39: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

DAIVONEX 50µg/g LEO PHARMACEUTICAL PRODUCTS

50µg/gD05AX02 CALCIPOTRIOLUM UNGUENTDAIVONEX UNGUENT 50µg/g LEO PHARMACEUTICAL PRODUCTS

50µg/mlD05AX02 CALCIPOTRIOLUM SOL. CUT.DAIVONEX SOLUTIE CUTANATA PENTRU SCALP 50µg/ml LEO PHARMACEUTICAL PRODUCTS

0.005%D05AX02 CALCIPOTRIOLUM UNGUENTSOREL® unguent 0,005% 0.005% LEK PHARMACEUTICALS D.D.

228 COMBINATII (CALCIPOTRIOLUM+BETAMETHASONUM) *D05AX52

D05AX52 COMBINATII

(CALCIPOTRIOLUM+BETAMETHASONUM)

UNGUENT

DAIVOBET® UNGUENT LEO PHARMACEUTICAL PRODUCTS

230 ACIDUM FUSIDICUMD06AX01

2,00%D06AX01 ACIDUM FUSIDICUM CREMAFUCIDIN® 2% LEO PHARMACEUTICAL PRODUCTS

2,00%D06AX01 ACIDUM FUSIDICUM UNGUENTFUCIDIN® 2% LEO PHARMACEUTICAL PRODUCTS

231 COMBINATII (NEOMYCINUM+BACITRACINUM)D06AXN1

D06AXN1 COMBINATII (NEOMYCINUM+BACITRACINUM) PULB. CUT.BANEOCIN® SANDOZ GMBH

D06AXN1 COMBINATII (NEOMYCINUM+BACITRACINUM) UNGUENTBANEOCIN® SANDOZ GMBH

NEOBACIN DAR AL DAWA PHARMA SRL

232 SULFADIAZINUMD06BA01

1,00%D06BA01 SULFADIAZINUM CREMADERMAZIN® 1% 1% LEK PHARMACEUTICALS D.D.

233 PODOPHYLLOTOXINUM *D06BB04

1,5 mg/gD06BB04 PODOPHYLLOTOXINUM CREMAWARTEC 1,5 mg/g 1,5 mg/g STIEFEL LABORATORIES (UK) LTD.

5mg/mlD06BB04 PODOPHYLLOTOXINUM SOL. CUT.CONDYLINE 5mg/ml ASTELLAS PHARMA EUROPE B.V.

Pentru tratamentul verucilor.Prescriere limitata:

235 HYDROCORTISONUM BUTYRATUM Protocol: D001LD07AB02

0.1%D07AB02 HYDROCORTISONUM BUTYRATUM CREMALOCOID® crema 0,1% 0.1% ASTELLAS PHARMA EUROPE BV

LOCOID® LIPOCREAM 0,1% 0.1% ASTELLAS PHARMA EUROPE B.V.

0.1%D07AB02 HYDROCORTISONUM BUTYRATUM EMULSIE CUT.LOCOID CRELO® 0,1% 0.1% ASTELLAS PHARMA EUROPE BV

0.1%D07AB02 HYDROCORTISONUM BUTYRATUM SOL. CUT.LOCOID® 0.1% ASTELLAS PHARMA EUROPE B.V.

236 MOMETASONUM Protocol: D001LD07AC13

1mg/gD07AC13 MOMETASONUM CREMAELOCOM 1mg/g SCHERING PLOUGH EUROPE

1mg/gD07AC13 MOMETASONUM SOL. CUT.ELOCOM 1mg/g SCHERING PLOUGH EUROPE

1mg/gD07AC13 MOMETASONUM UNGUENTELOCOM 1mg/g SCHERING PLOUGH EUROPE

237 METHYLPREDNISOLONUM ACEPONAT Protocol: D001LD07AC14

0.1%D07AC14 METHYLPREDNISOLONUM ACEPONAT EMULSIE CUT.ADVANTAN® MILK 0.1% INTENDIS GMBH

1mg/gD07AC14 METHYLPREDNISOLONUM ACEPONAT CREMAADVANTAN 1mg/g INTENDIS GmbH

1mg/gD07AC14 METHYLPREDNISOLONUM ACEPONAT UNGUENTADVANTAN 1mg/g INTENDIS GmbH

238 FLUTICASONUM Protocol: D001LD07AC17

0.05%D07AC17 FLUTICASONUM CREMACUTIVATE 0.05% GLAXO WELLCOME UK LIMITED

0.005%D07AC17 FLUTICASONUM UNGUENTCUTIVATE 0.005% GLAXO WELLCOME UK LIMITED

239 CLOBETASOLUM * Protocol: D001LD07AD01

0.05%D07AD01 CLOBETASOLUM CREMADERMOVATE 0.05% GLAXOWELLCOME UK LTD.

0.05%D07AD01 CLOBETASOLUM SOL. CUT.DERMOVATE® 0.05% GLAXO WELLCOME UK LTD.

0.05%D07AD01 CLOBETASOLUM UNGUENTDERMIONE 0.05% OZONE LABORATORIES LTD.

DERMOVATE 0.05% GLAXOWELLCOME UK LTD.

240 COMBINATII (HYDROCORTISONUM+ANTIINFECTIOASE) Protocol: D001LD07CA01

D07CA01 COMBINATII

(HYDROCORTISONUM+ANTIINFECTIOASE)

CREMA

FUCIDIN® H LEO PHARMACEUTICAL PRODUCTS

PIMAFUCORT ASTELLAS PHARMA EUROPE B.V.

D07CA01 COMBINATII

(HYDROCORTISONUM+ANTIINFECTIOASE)

UNGUENT

PIMAFUCORT ASTELLAS PHARMA EUROPE B.V.

241 COMBINATII (BETAMETHASONUM+ANTIINFECTIOASE) Protocol: D001LD07CC01

D07CC01 COMBINATII

(BETAMETHASONUM+ANTIINFECTIOASE)

CREMA

FUCICORT® LEO PHARMACEUTICAL PRODUCTS

39 153/

Page 40: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

242 COMBINATII (MOMETASONUM + AC. SALICILICUM) Protocol: D001LD07XC03

D07XC03 COMBINATII (MOMETASONUM + AC.

SALICILICUM)

UNGUENT

ELOSALIC SCHERING PLOUGH EUROPE

243 COMBINATII (ISOTRETINOINUM + ERITROMICINUM)D10AD54

0,05%/0,2%D10AD54 COMBINATII (ISOTRETINOINUM +

ERITROMICINUM)

GEL

ISOTREXIN GEL 0,05%/0,2% STIEFEL LABORATORIES (UK) LTD.

244 ACIDUM AZELAICUMD10AX03

200mg/gD10AX03 ACIDUM AZELAICUM CREMASKINOREN 200mg/g INTENDIS GmbH

15%D10AX03 ACIDUM AZELAICUM GELSKINOREN® 15% 15% INTENDIS GMBH

245 ISOTRETINOINUM **D10BA01

Cod restrictie 1354: Acnee chistica severa care nu raspunde la alte tipuri de tratamente.

Acest medicament poate cauza defecte la nastere. Isotretinoin a fost incriminat pentru cauzarea frecventa a altor efecte toxice cu potential sever.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

10mgD10BA01 ISOTRETINOINUM CAPS. MOIROACCUTANE 10 mg 10mg ROCHE ROMANIA SRL

SOTRET 10 mg 10mg RANBAXY U.K. LIMITED

20mgD10BA01 ISOTRETINOINUM CAPS. MOISOTRET 20 mg 20mg RANBAXY U.K. LIMITED

246 NATAMYCINUMG01AA02

100mgG01AA02 NATAMYCINUM OVULEPIMAFUCIN® 100mg ASTELLAS PHARMA EUROPE B.V.

247 COMBINATIIG01AA51

10g/400000UIG01AA51 COMBINATII CREMA VAG.MACMIROR COMPLEX 10g/400000UI POLICHEM SA

500mg/200000UIG01AA51 COMBINATII CAPS. MOI VAG.MACMIROR COMPLEX 500mg/200000UI POLICHEM SA

G01AA51 COMBINATII CAPS. MOI VAG.POLYGYNAX LAB. INNOTECH INT.

248 FENTICONAZOLUMG01AF12

600mgG01AF12 FENTICONAZOLUM CAPS. MOI VAG.LOMEXIN 600 mg 600mg RECORDATI SPA

249 BUTOCONAZOLUMG01AF15

G01AF15 BUTOCONAZOLUM CREMA VAG.GYNOFORT 2% GEDEON RICHTER LTD.

251 NIFURATELUMG01AX05

200mgG01AX05 NIFURATELUM DRAJ.MACMIROR 200mg POLICHEM SA

252 CABERGOLINUM * Protocol: G001CG02CB03

0.5mgG02CB03 CABERGOLINUM COMPR.DOSTINEX 0.5mg PFIZER EUROPE MA EEG

Prevenirea aparitiei lactatiei in lauzie.Prescriere limitata:

Hiperprolactinemia patologica pentru care nu este indicata interventia chirurgicalaCod restrictie 2659:

Hiperprolactinemia patologica pentru care a fost utilizat tratament chirurgical dar cu rezultate incompleteCod restrictie 2660:

253 LYNESTRENOLUM *G03AC02

0.5mgG03AC02 LYNESTRENOLUM COMPR.EXLUTON® 0.5mg ORGANON NV

254 LEVONORGESTRELUM ***# Protocol: G005NG03AC03

52mgG03AC03 LEVONORGESTRELUM DISPOZITIV INTRAUTERINMIRENA 20 µg/24 h 52mg SCHERING OY (SCHERING AG)

255 ESTRIOLUM *G03CA04

0.1%G03CA04 ESTRIOLUM CREMA VAG.OVESTIN 0.1% ORGANON NV

0.5mgG03CA04 ESTRIOLUM OVULEOVESTIN 0.5mg ORGANON NV

256 PROMESTRIENUM *G03CA09

10mgG03CA09 PROMESTRIENUM CAPS. MOI VAG.COLPOTROPHINE® 10mg LAB. THERAMEX

1%G03CA09 PROMESTRIENUM CREMA VAG.COLPOTROPHINE® 1% LAB. THERAMEX

257 PROGESTERONUM *G03DA04

100mgG03DA04 PROGESTERONUM CAPS. MOIUTROGESTAN® 100 mg 100mg LAB. BESINS INTERNATIONAL

1%G03DA04 PROGESTERONUM GELMASTOPROFEN 1% 1% ANTIBIOTICE SA

PROGESTOGEL 1% LAB. BESINS INTERNATIONAL

258 DYDROGESTERONUM *G03DB01

10mgG03DB01 DYDROGESTERONUM COMPR. FILM.DUPHASTON® 10mg SOLVAY PHARMACEUTICALS BV

259 LYNESTRENOLUM *G03DC03

5mgG03DC03 LYNESTRENOLUM COMPR.ORGAMETRIL 5mg ORGANON NV

260 TIBOLONUM ** Protocol: G007NG03DC05

40 153/

Page 41: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

2,5mgG03DC05 TIBOLONUM COMPR.LADYBON 2,5mg ZENTIVA A.S.

2.5mgG03DC05 TIBOLONUM COMPR.LIVIAL® 2,5 mg 2.5mg ORGANON NV

261 COMBINATII ** Protocol: G002NG03FA01

1mg/0,5mgG03FA01 COMBINATII COMPR. FILM.ACTIVELLE 1mg/0,5mg 1mg/0,5mg NOVO NORDISK A/S

262 COMBINATII ** Protocol: G002NG03FA14

G03FA14 COMBINATII COMPR. FILM.FEMOSTON® conti 1/5 SOLVAY PHARMACEUTICALS BV

263 ESTRADIOLUMVALERAT+DIENOGEST ** Protocol: G002NG03FA15

G03FA15 ESTRADIOLUMVALERAT+DIENOGEST DRAJ.KLIMODIEN SCHERING AG

264 COMBINATII ** Protocol: G002NG03FA17

G03FA17 COMBINATII COMPR. FILM.ANGELIQ SCHERING AG

265 COMBINATII ** Protocol: G002NG03FB01

G03FB01 COMBINATII DRAJ.CYCLO PROGINOVA® SCHERING AG

266 COMBINATII ** Protocol: G002NG03FB05

G03FB05 COMBINATII COMPR. FILM.NOVOFEM NOVO NORDISK A/S

267 COMBINATII ** Protocol: G002NG03FB08

G03FB08 COMBINATII COMPR. FILM.FEMOSTON 2/10 SOLVAY PHARMACEUTICALS BV

G03FB08 COMBINATII COMPR. FILM.FEMOSTON 2/10 SOLVAY PHARMACEUTICALS BV

268 FOLITROPINUM ALFA ****# Protocol: G003NG03GA05

Prescriere limitata: Infertilitate anovulatorie.

Cu excepţia cazurilor de hipopituitarism sau amenoree primara, pacienta trebuie sa fi fost tratata anterior cu citrat de clomifen si/sau gonadorelin, iar tratamentul sa fi ramas fără

efect (sarcina nu a fost obţinuta). Femeile care au urmat tratament pentru inducerea ovulaţiei cu alte clase de medicamente si nu au obţinut o sarcina necesita evaluare

laparoscopică pentru a exclude alte cauze care împiedica apariţia unei sarcini.

NOTA:

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

150UIG03GA05 FOLITROPINUM ALFA PULB. + SOLV. PT. SOL. INJ.GONAL - f 150 UI 150UI SERONO EUROPE LTD.

75UIG03GA05 FOLITROPINUM ALFA PULB. + SOLV. PT. SOL. INJ.GONAL - f 75 UI 75UI SERONO EUROPE LTD.

Infertilitate anovulatoriePrescriere limitata:

269 FOLLITROPINUM BETA ****# Protocol: G008NG03GA06

Prescriere limitata: Infertilitate anovulatorie.

Cu excepţia cazurilor de hipopituitarism sau amenoree primara, pacienta trebuie sa fi fost tratata anterior cu citrat de clomifen si/sau gonadorelin, iar tratamentul sa fi ramas fără

efect (sarcina nu a fost obţinuta). Femeile care au urmat tratament pentru inducerea ovulaţiei cu alte clase de medicamente si nu au obţinut o sarcina necesita evaluare

laparoscopică pentru a exclude alte cauze care împiedica apariţia unei sarcini.

NOTA:

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100UI/0.5mlG03GA06 FOLLITROPINUM BETA SOL. INJ.PUREGON 100UI/0,5ml 100UI/0.5ml N. V. ORGANON

300UI/0.36mlG03GA06 FOLLITROPINUM BETA SOL. INJ.PUREGON 300UI/0,36 ml 300UI/0.36ml N. V. ORGANON

50UI/0.5mlG03GA06 FOLLITROPINUM BETA SOL. INJ.PUREGON 50UI/0,5ml 50UI/0.5ml N. V. ORGANON

600UI/0.72mlG03GA06 FOLLITROPINUM BETA SOL. INJ.PUREGON 600UI/0,72 ml 600UI/0.72ml N. V. ORGANON

100UI/mlG03GA06 FOLLITROPINUM BETA PULB+SOLV. PT. SOL. INJ.PUREGON 100UI 100UI/ml ORGANON NV

50UI/mlG03GA06 FOLLITROPINUM BETA PULB+SOLV. PT. SOL. INJPUREGON 50UI 50UI/ml ORGANON NV

271 CLOMIFENUMG03GB02

50mgG03GB02 CLOMIFENUM COMPR.CLOSTILBEGYT 50mg EGIS PHARMACEUTICALS PLC

OVA - MIT 50mg REMEDICA LTD.

Infertilitate anovulatoriePrescriere limitata:

272 RALOXIFENUMG03XC01

60mgG03XC01 RALOXIFENUM COMPR. FILM.EVISTA 60mg 60mg ELI LILLY NEDERLAND BV

Monoterapie cu medicamente antiresorbtive pentru tratamentul si profilaxia osteoporozei sexoidoprive la femei pana la varsta de 60 ani.Cod restrictie 3006:

NOTA: Agentii antiresorbtivi utilizati in tratamentul osteoporozei instalate sunt: ALENDRONATE SODIUM, RISEDRONAT SODIUM, RALOXIFEN HYDROCHLORIDE, IBANDRONATE,

ZOLENDRONATE SI STRONTIUM RANELATE (agent antiresorbtiv si formator osos)..

273 OXYBUTYNINUMG04BD04

5mgG04BD04 OXYBUTYNINUM COMPR.DRIPTANE® 5 mg 5mg LAB. FOURNIER SA

Hipereactivitate a detrusoruluiPrescriere limitata:

274 TOLTERODINUM **# Protocol: G010NG04BD07

4mgG04BD07 TOLTERODINUM CAPS. ELIB. PREL.DETRUSITOL SR 4 mg 4mg PFIZER EUROPE MA EEIG

275 SOLIFENACINUM SUCCINATE **# Protocol: G009NG04BD08

10mgG04BD08 SOLIFENACINUM SUCCINATE COMPR. FILM.VESICARE 10 mg 10mg ASTELLAS PHARMA EUROPE B.V.

41 153/

Page 42: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

5mgG04BD08 SOLIFENACINUM SUCCINATE COMPR. FILM.VESICARE 5 mg 5mg ASTELLAS PHARMA EUROPE B.V.

276 TROSPIUMG04BD09

15mgG04BD09 TROSPIUM COMPR. FILM.INKONTAN 15 mg 15mg PHARMAZEUTISCHE FABRIK MONTAVIT GES.M.B.H.

30mgG04BD09 TROSPIUM COMPR. FILM.INKONTAN 30 mg 30mg PHARMAZEUTISCHE FABRIK MONTAVIT GES.M.B.H.

277 ALFUZOSINUMG04CA01

10mgG04CA01 ALFUZOSINUM COMPR. ELIB. PREL.ALFURAN MR 10 mg 10mg TERAPIA S.A.

XATRAL SR 10 mg 10mg SANOFI-SYNTHELABO FRANCE

5mgG04CA01 ALFUZOSINUM COMPR. FILM. ELIB. PREL.XATRAL® LP 5 mg 5mg SANOFI-SYNTHELABO FRANCE

278 TAMSULOSINUMG04CA02

Prescriere limitata: Tratamentul hiperplaziei benigne de prostata.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului

0,4mgG04CA02 TAMSULOSINUM CAPS. ELIB. MODIF.TAMSOL 0,4 mg 0,4mg GEDEON RICHTER ROMANIA

TAMSULOSIN ACTAVIS 0,4mg ACTAVIS GROUP HF.

0.4mgG04CA02 TAMSULOSINUM CAPS. ELIB. MODIF.FOKUSIN 0.4mg ZENTIVA AS

0.4mgG04CA02 TAMSULOSINUM CAPS. ELIB. PREL.CONTIFLO MR 0.4mg RANBAXY UK LTD.

TANYZ 0.4mg KRKA D.D. NOVO MESTO

0.4mgG04CA02 TAMSULOSINUM COMPR. FILM. ELIB. PREL.OMNIC TOCAS® 0,4 0.4mg ASTELLAS PHARMA EUROPE B.V.

279 FINASTERIDUM *G04CB01

Prescriere limitata: Tratamentul hiperplaziei benigne de prostata.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului

5mgG04CB01 FINASTERIDUM COMPR. FILM.MOSTRAFIN 5mg PLIVA LJUBLIJANA D.O.O.

PROSCAR 5 mg 5mg MERCK SHARP & DOHME ROMANIA S.R.L.

TAREDOX 5 mg 5mg DR. REDDY'S LABORATORIES

5mgG04CB01 FINASTERIDUM COMPR. FILM.MOSTRAFIN 5mg PLIVA LJUBLIJANA D.O.O.

PROSCAR 5 mg 5mg MERCK SHARP & DOHME ROMANIA S.R.L.

TAREDOX 5 mg 5mg DR. REDDY'S LABORATORIES

5 mgG04CB01 FINASTERIDUM COMPR. FILM.FINASTERID SANDOZ 5 mg 5 mg HEXAL AG

280 DUTASTERIDUM *G04CB02

Prescriere limitata: Tratamentul hiperplaziei benigne de prostata.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului

0.5mgG04CB02 DUTASTERIDUM CAPS. MOIAVODART® 0.5mg GLAXO GROUP LTD.

281 TETRACOSACTIDUMH01AA02

1mg/mlH01AA02 TETRACOSACTIDUM SUSP. INJ.SYNACHTEN DEPOT 1mg/ml NOVARTIS PHARMA GMBH

282 SOMATROPINUM ***# Protocol: H009EH01AC01

10mg/1.5mlH01AC01 SOMATROPINUM SOL. INJ.NORDITROPIN SIMPLEX x 10mg/1,5ml 10mg/1.5ml NOVO NORDISK A/S

10mg/2mlH01AC01 SOMATROPINUM SOL. INJ.NUTROPINAq 10 mg/2 ml 10mg/2ml IPSEN LIMITED

3,3mg/mlH01AC01 SOMATROPINUM SOL. INJ.OMNITROPE 3,3mg/ml 3,3mg/ml SANDOZ GMBH

4mg (12ui)H01AC01 SOMATROPINUM LIOF. + SOLV. PT. SOL. INJ.ZOMACTON 4mg (12ui) FERING GMBH

5.3mg/ml (16ui)H01AC01 SOMATROPINUM PULB. + SOLV. PT. SOL. INJ.GENOTROPIN® 16 ui (5,3 mg) 5.3mg/ml (16ui) PFIZER EUROPE MA EEIG

5mg/1.5mlH01AC01 SOMATROPINUM SOL. INJ.NORDITROPIN SIMPLEXx 5 mg/1,5 ml 5mg/1.5ml NOVO NORDISK A/S

283 GANIRELIXUM ***# Protocol: G004NH01CC01

0.25mg/0.5mlH01CC01 GANIRELIXUM SOL. INJ.ORGALUTRAN 0.25mg/0.5ml 0.25mg/0.5ml N. V. ORGANON

284 CETRORELIXUM ***# Protocol: H004EH01CC02

0.25mgH01CC02 CETRORELIXUM LIOF. + SOLV. PT. SOL. INJ.CETROTIDE 0,25 mg 0.25mg SERONO EUROPE LTD.

3mgH01CC02 CETRORELIXUM LIOF. + SOLV. PT. SOL. INJ.CETROTIDE 3 mg 3mg SERONO EUROPE LTD.

285 FLUDROCORTISONUMH02AA02

0.1mgH02AA02 FLUDROCORTISONUM COMPR.ASTONIN H 0.1mg MERCK KGAA

286 BETAMETHASONUMH02AB01

7mg/mlH02AB01 BETAMETHASONUM SUSP. INJ. I.M.DIPROPHOS® 7mg/ml SCHERING PLOUGH EUROPE

287 PREDNISOLONUMH02AB06

250mgH02AB06 PREDNISOLONUM LIOF. + SOLV. PT. SOL. INJ.SOLU - DECORTIN H 250 250mg MERCK KGAA

50mgH02AB06 PREDNISOLONUM LIOF. + SOLV. PT. SOL. INJ.

42 153/

Page 43: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

SOLU - DECORTIN H 50 50mg MERCK KGAA

288 THIAMAZOLUMH03BB02

10mgH03BB02 THIAMAZOLUM COMPR. FILM.THYROZOL® 10 mg 10mg MERCK KGAA

20mgH03BB02 THIAMAZOLUM COMPR. FILM.THYROZOL® 20 mg 20mg MERCK KGAA

5mgH03BB02 THIAMAZOLUM COMPR. FILM.THYROZOL® 5 mg 5mg MERCK KGAA

289 CALCITONINUM (SOMON)H05BA01

100UIH05BA01 CALCITONINUM (SOMON) SOL. INJ.TONOCALCIN 100 UI 100UI ALFA WASSERMANN SPA

100ui/dozaH05BA01 CALCITONINUM (SOMON) SPRAY NAZ.,SOL.NYLEX 100 UI/doza 100UI/doza PHARMACEUTICAL IND. PROEL EPAM. G.CORONIS SA

100UI/mlH05BA01 CALCITONINUM (SOMON) SOL. INJ.NYLEX® 100UI/ml PROEL E.P. CORONIS SA

200UI/dozaH05BA01 CALCITONINUM (SOMON) SPRAY NAZAL - SOL.MIACALCIC® NASAL 200 200ui/doza NOVARTIS PHARMA GMBH

NYLEX® 200UI/doza PROEL E.P. CORONIS SA

50ui/mlH05BA01 CALCITONINUM (SOMON) SOL. INJ.MIACALCIC® 50ui/ml NOVARTIS PHARMA GMBH

290 AMPICILLINUM + SULBACTAMJ01CR01

1g+500mgJ01CR01 AMPICILLINUM + SULBACTAM PULB. PT. SOL. INJ.AMPIPLUS® 1,5 g 1g+500mg ANTIBIOTICE SA

291 SULTAMICILLINUMJ01CR04

250mg/5mlJ01CR04 SULTAMICILLINUM PULB. PT. SUSP. ORALAUNASYN 250mg/5ml PFIZER EUROPE MA EEIG

375mgJ01CR04 SULTAMICILLINUM COMPR. FILM.UNASYN 375mg PFIZER EUROPE MA EEIG

292 CEFPROZILUMJ01DC10

125mg/5mlJ01DC10 CEFPROZILUM PULB. PT. SUSP. ORALACEFZIL 125 mg/5 ml 125mg/5ml BRISTOL-MYERS SQUIBB KFT.

250mgJ01DC10 CEFPROZILUM COMPR. FILM.CEFZIL 250 mg 250mg BRISTOL-MYERS SQUIBB KFT.

250mg/5mlJ01DC10 CEFPROZILUM PULB. PT. SUSP. ORALACEFZIL 250 mg/5 ml 250mg/5ml BRISTOL-MYERS SQUIBB KFT.

500mgJ01DC10 CEFPROZILUM COMPR. FILM.CEFZIL 500 mg 500mg BRISTOL-MYERS SQUIBB KFT.

293 CEFTIBUTENUMJ01DD14

36mg/mlJ01DD14 CEFTIBUTENUM PULB. PT. SUSP. ORALACEDAX 36mg/ml SCHERING PLOUGH EUROPE

400mgJ01DD14 CEFTIBUTENUM CAPS.CEDAX 400mg SCHERING PLOUGH EUROPE

294 SPIRAMYCINUMJ01FA02

1.5 M uiJ01FA02 SPIRAMYCINUM COMPR. FILM.ROVAMYCINE® 1,5 Mil. UI 1.5 M ui LAB. AVENTIS

3M uiJ01FA02 SPIRAMYCINUM COMPR. FILM.ROVAMYCINE® 3 Mil. UI 3M ui LAB. AVENTIS

295 AZITHROMYCINUMJ01FA10

100mg/5mlJ01FA10 AZITHROMYCINUM PULB. PT. SUSP. ORALAAZITROMICINA SANDOZ 100 mg/5 ml 100mg/5ml SANDOZ SRL

125mgJ01FA10 AZITHROMYCINUM COMPR. FILM.SUMAMED 125 mg 125mg PLIVA LJUBLJANA D.O.O.

200 mg/5 mlJ01FA10 AZITHROMYCINUM PULB. PT. SUSP. ORALAAZITROMICINA SANDOZ 200 mg/5 ml 200 mg/5 ml SANDOZ SRL

200mg/5mlJ01FA10 AZITHROMYCINUM PULB. + SOLV. SUSP. ORALAAZITROX 200 mg/5 ml 200mg/5ml ECZACIBASI PHARMACEUTICALS S.R.L.

200mg/5mlJ01FA10 AZITHROMYCINUM PULB. PT. SUSP. ORALASUMAMED FORTE 200mg/5ml PLIVA LJUBLIJANA D.O.O.

250mgJ01FA10 AZITHROMYCINUM CAPS.AZATRIL 250 mg 250mg BALKANPHARMA RAZGRAD AD

250mgJ01FA10 AZITHROMYCINUM COMPR. FILM.AZITROMICINA SANDOZ 250 mg COMPRIMATE FILMATE 250mg SANDOZ S.R.L.

AZITROX® 250 250mg ZENTIVA AS

500mgJ01FA10 AZITHROMYCINUM COMPR. FILM.AZITROMICINA SANDOZ 500 mg COMPRIMATE FILMATE 500mg SANDOZ S.R.L.

AZITROX® 500 500mg ZENTIVA AS

AZRO® 500 mg 500mg ECZACIBASI PHARMACEUTICALS S.R.L.

SUMAMED 500 mg 500mg PLIVA LJUBLJANA D.O.O.

ZITROCIN 500 mg 500mg OZONE LABORATORIES LTD.

2gJ01FA10 AZITHROMYCINUM GRAN. ELIB. PREL. PT. SUSP. ORALAZMAX 2 g 2g PFIZER EUROPE MA EEIG

296 CLINDAMYCINUMJ01FF01

Prescriere limitata: Infectii cu coci Gram pozitivi care nu pot fi tratate eficient cu peniciline.

Infectii severe cu germeni anaerobi.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

150mgJ01FF01 CLINDAMYCINUM CAPS.DALACIN C 150 mg 150mg PFIZER EUROPE MA EEIG

300mgJ01FF01 CLINDAMYCINUM CAPS.DALACIN C 300 mg 300mg PFIZER EUROPE MA EEIG

43 153/

Page 44: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

297 LEVOFLOXACINUMJ01MA12

500mgJ01MA12 LEVOFLOXACINUM COMPR. FILM.TAVANIC® 500mg AVENTIS PHARMA DEUTSCHLAND GMBH

298 MOXIFLOXACINUMJ01MA14

400mgJ01MA14 MOXIFLOXACINUM COMPR. FILM.AVELOX® 400 mg 400mg BAYER HEALTHCARE AG

299 ITRACONAZOLUM *J02AC02

100mgJ02AC02 ITRACONAZOLUM CAPS.ITRACONAZOL 100 mg 100mg TERAPIA S.A.

OMICRAL 100 mg 100mg MEDICO UNO PHARMACEUTICAL S.R.L.

ORUNGAL 100mg JANSSEN PHARMACEUTICA NV

300 VALACYCLOVIRUM *J05AB11

500mgJ05AB11 VALACYCLOVIRUM COMPR. FILM.VALTREX 500 mg 500mg THE WELLCOME FOUNDATION LTD.

Tratamentul pacientilor cu herpes zoster in decurs de 72 de ore de la debutul rash-uluiPrescriere limitata:

Herpes zoster oftalmic.Prescriere limitata:

Herpes genital initial moderat/sever.Prescriere limitata:

Tratamentul episodic sau supresiv al herpesului genital recurent (forme moderate/severe).Prescriere limitata:

301 BRIVUDINUM *#J05ABN1

Prescriere limitata: Tratamentul pacientilor cu herpes zoster in decurs de 72 de ore de la debutul rash-ului.

125mgJ05ABN1 BRIVUDINUM COMPR.BRIVAL® 125mg BERLIN CHEMIE AG MENARINI GROUP

302 CYCLOPHOSPHAMIDUM *L01AA01

50mgL01AA01 CYCLOPHOSPHAMIDUM DRAJ.ENDOXAN® 50 mg 50mg BAXTER ONCOLOGY GMBH

305 TRIPTORELINUM ***# Protocol: L013EL02AE04

Prescriere limitata: Tratamentul de scurta durata (pana la 6 luni) al endometriozei confirmate histologic.

Tratamentul pubertatii precoce.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului

0.1mgL02AE04 TRIPTORELINUM LIOF. + SOLV. PT. SOL. INJ.DIPHERELINE 0,1 mg 0.1mg BEAUFOUR IPSEN PHARMA

11.25mgL02AE04 TRIPTORELINUM LIOF.+ SOLV. PT. SUSP. INJ. I.M. ELIB. PREL.DIPHERELINE® 11,25 mg 11.25mg BEAUFOUR IPSEN PHARMA

3.75mgL02AE04 TRIPTORELINUM LIOF.+ SOLV. PT. SUSP. INJ. I.M. ELIB. PREL.DIPHERELINE® 3,75 mg 3.75mg BEAUFOUR IPSEN PHARMA

306 AZATHIOPRINUM *L04AX01

50mgL04AX01 AZATHIOPRINUM COMPR. FILM.IMURAN® 50mg THE WELLCOME FOUNDATION LTD.

307 PIROXICAMUMM01AC01A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

20mgM01AC01 PIROXICAMUM COMPR.FLAMEXIN 20mg CHIESI FARMACEUTICI SPA

N - PIROXICAM MEDUMAN 20 mg 20mg MEDUMAN S.A.

PIROXICAM 20 mg 20mg ARENA GROUP SA

PIROXICAM LPH 20 mg 20mg LABORMED PHARMA SA

PIROXSAL 20mg SLAVIA PHARM SRL

20mgM01AC01 PIROXICAMUM COMPR. EFF.FLAMEXIN 20mg CHIESI FARMACEUTICI S.P.A.

20mgM01AC01 PIROXICAMUM SUPOZ.PIROXICAM 20 mg 20mg SINTOFARM SA

20mg/mlM01AC01 PIROXICAMUM SOL. INJ.FELDENE® 20 mg/ml 20mg/ml PFIZER EUROPE MA EEIG

HOTEMIN 20mg/ml EGIS PHARMACEUTICALS PLC

20mg/plicM01AC01 PIROXICAMUM PULB. PT. SOL. ORALAFLAMEXIN® 20mg/plic CHIESI FARMACEUTICI SPA

40mgM01AC01 PIROXICAMUM SUPOZ.PIROXICAM 40 mg 40mg ANTIBIOTICE SA

308 LORNOXICAMUMM01AC05A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

4mgM01AC05 LORNOXICAMUM COMPR. FILM.XEFO® 4 mg 4mg NYCOMED AUSTRIA GMBH

8mgM01AC05 LORNOXICAMUM COMPR. FILM.XEFO® 8 mg 8mg NYCOMED AUSTRIA GMBH

8mg/2mlM01AC05 LORNOXICAMUM PULB. + SOLV. PT. SOL. INJ.XEFO 8 mg/ 2 ml 8mg/2ml NYCOMED AUSTRIA GMBH

309 DEXKETOPROFENUMM01AE17A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

25mgM01AE17 DEXKETOPROFENUM COMPR. FILM.TADOR 25mg BERLIN CHEMIE AG MENARINI GROUP

50mg/2mlM01AE17 DEXKETOPROFENUM SOL. INJ./CONC. PT. SOL. PERF.TADOR INJECT 50mg/2ml MENARINI INTERNATIONAL OPERATIONS S.A.

310 CELECOXIBUMM01AH01

Prescriere limitata: Tratamentul simptomatic antiinflamator la pacientii cu intoleranta la AINS neselective.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgM01AH01 CELECOXIBUM CAPS.

44 153/

Page 45: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

CELEBREX 100 mg 100mg PFIZER EUROPE MA EEIG

200mgM01AH01 CELECOXIBUM CAPS.CELEBREX 200 mg 200mg PFIZER EUROPE MA EEIG

311 ETORICOXIBUMM01AH05

Prescriere limitata: Tratamentul simptomatic antiinflamator la pacientii cu intoleranta la AINS neselective.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

120mgM01AH05 ETORICOXIBUM COMPR. FILM.ARCOXIA® 120 mg 120mg MERCK SHARP & DOHME ROMANIA S.R.L.

60mgM01AH05 ETORICOXIBUM COMPR. FILM.ARCOXIA® 60 mg 60mg MERCK SHARP & DOHME ROMANIA S.R.L.

90mgM01AH05 ETORICOXIBUM COMPR. FILM.ARCOXIA® 90 mg 90mg MERCK SHARP & DOHME ROMANIA S.R.L.

312 GLUCOSAMINUMM01AX05

150mg/plicM01AX05 GLUCOSAMINUM PULB. PT. SOL. ORALADONA® 150mg/plic ROTTAPHARM SPA

313 NIMESULIDUMM01AX17A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgM01AX17 NIMESULIDUM COMPR.APONIL 100mg MEDOCHEMIE LTD

AULIN® 100 mg 100mg CSC PHARMACEUTICALS HANDELS GMBH

COXTRAL 100mg ZENTIVA AS

LEMESIL 100mg ANFARM HELLAS S.A. PHARMACEUTICALS

NIMESULID LPH 100 mg 100mg LABORMED PHARMA SA

NIMESULID 100 mg 100mg MAGISTRA C & C

NIMESULID ARENA 100 mg 100mg ARENA GROUP S.A.

NIMESULID SLAVIA 100mg SLAVIA PHARM SRL

NISE 100 mg 100mg DR. REDDY'S LABORATORIES

100mgM01AX17 NIMESULIDUM PULB. PT. SUSP. ORALASULIDAMOR 100mg FARMACEUTICI DAMOR SPA

100mg/plicM01AX17 NIMESULIDUM GRAN. PT. SUSP. ORALAAULIN® 100mg/plic CSC PHARMACEUTICALS HANDELS GMBH

NIMESIL 100mg/plic LAB. GUIDOTTI SPA

314 BACLOFENUMM03BX01

10mgM03BX01 BACLOFENUM COMPR.LIORESAL® 10mg NOVARTIS PHARMA GMBH

25mgM03BX01 BACLOFENUM COMPR.LIORESAL® 25mg NOVARTIS PHARMA GMBH

315 ACIDUM ALENDRONICUM *M05BA04

Cod restrictie 3001: Tratamentul osteoporozei la pacienti cu scor T</= -2,5 masurat DEXA (coloana vertebrala sau sold).

Cod restrictie 3002 : Tratamentul osteoporozei la pacienti cu scor T</= -2 masurat DEXA (coloana vertebrala sau sold) si istoric de fracturi pe structuri osoase fragile.

Cod restrictie 3003 : Tratamentul osteoporozei la paciente in postmenopauza care au suferit fracturi vertebrale osteoporotice in antecedente.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

10mgM05BA04 ACIDUM ALENDRONICUM COMPR.FOSAMAX 10 mg 10mg MERCK SHARP & DOHME S.R.L.

70mgM05BA04 ACIDUM ALENDRONICUM COMPR.FOSAMAX 70 mg 70mg MERCK SHARP & DOHME S.R.L.

316 ACIDUM IBANDRONICUM *M05BA06

Cod restrictie 3001: Tratamentul osteoporozei la pacienti cu scor T</= -2,5 masurat DEXA (coloana vertebrala sau sold).

Cod restrictie 3002 : Tratamentul osteoporozei la pacienti cu scor T</= -2 masurat DEXA (coloana vertebrala sau sold) si istoric de fracturi pe structuri osoase fragile.

Cod restrictie 3003 : Tratamentul osteoporozei la paciente in postmenopauza care au suferit fracturi vertebrale osteoporotice in antecedente.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

150mgM05BA06 ACIDUM IBANDRONICUM COMPR. FILM.BONVIVA 150mg 150mg ROCHE REGISTRATION LTD.

317 ACIDUM RISEDRONICUM *M05BA07

Cod restrictie 3001: Tratamentul osteoporozei la pacienti cu scor T</= -2,5 masurat DEXA (coloana vertebrala sau sold).

Cod restrictie 3002 : Tratamentul osteoporozei la pacienti cu scor T</= -2 masurat DEXA (coloana vertebrala sau sold) si istoric de fracturi pe structuri osoase fragile.

Cod restrictie 3003 : Tratamentul osteoporozei la paciente in postmenopauza care au suferit fracturi vertebrale osteoporotice in antecedente.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

35mgM05BA07 ACIDUM RISEDRONICUM COMPR. FILM.ACTONEL® SAPTAMANAL 35mg AVENTIS PHARMA AB

318 STRONTIUM RANELATUM *M05BX03

2gM05BX03 STRONTIUM RANELATUM GRAN. PT. SUSP. ORALAOSSEOR 2 g 2g LES LAB. SERVIER

319 COMBINATII (ACIDUM

ALENDRONICUM+COLECALCIFEROLUM) *

M05BB03

Cod restrictie 3001: Tratamentul osteoporozei la pacienti cu scor T</= -2,5 masurat DEXA (coloana vertebrala sau sold).

Cod restrictie 3002 : Tratamentul osteoporozei la pacienti cu scor T</= -2 masurat DEXA (coloana vertebrala sau sold) si istoric de fracturi pe structuri osoase fragile.

Cod restrictie 3003 : Tratamentul osteoporozei la paciente in postmenopauza care au suferit fracturi vertebrale osteoporotice in antecedente.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

70mg/2800UIM05BB03 COMBINATII (ACIDUM

ALENDRONICUM+COLECALCIFEROLUM)

COMPR.

FOSAVANCE 70mg/2800UI 70mg/2800UI MERCK SHARP & DOHME LTD.

320 OXYCODONUM *#N02AA05

Prescriere limitata: Durere severa, invalidanta, care nu raspunde la analgezice non-opioide.

Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni.

Risc inalt de aparitie a dependentei.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

10 mgN02AA05 OXYCODONUM COMPR. FILM. ELIB. MODIF.

45 153/

Page 46: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

OXYCONTIN® 10 mg 10 mg MUNDIPHARMA GMBH

20 mgN02AA05 OXYCODONUM COMPR. FILM. ELIB. MODIF.OXYCONTIN® 20 mg 20 mg MUNDIPHARMA GMBH

40 mgN02AA05 OXYCODONUM COMPR. FILM. ELIB. MODIF.OXYCONTIN® 40 mg 40 mg MUNDIPHARMA GMBH

80mgN02AA05 OXYCODONUM COMPR. FILM. ELIB. MODIF.OXYCONTIN® 80 mg 80mg MUNDIPHARMA GMBH

321 DIHYDROCODEINUM *N02AA08

120mgN02AA08 DIHYDROCODEINUM COMPR. ELIB. PREL.DHC CONTINUS 120 mg 120mg MUNDIPHARMA GMBH

60mgN02AA08 DIHYDROCODEINUM COMPR. ELIB. PREL.DHC CONTINUS 60 mg 60mg MUNDIPHARMA GMBH

90mgN02AA08 DIHYDROCODEINUM COMPR. ELIB. PREL.DHC CONTINUS 90 mg 90mg MUNDIPHARMA GMBH

322 COMBINATII (TRAMADOLUM+PARACETAMOLUM)N02AX52

Prescriere limitata: Durere severa, care nu raspunde la analgezice non-opioide.

Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

37,5mg+325mgN02AX52 COMBINATII

(TRAMADOLUM+PARACETAMOLUM)

COMPR. FILM.

ZALDIAR® 37,5mg+325mg GRUNENTHAL GMBH

323 CLONAZEPAMUMN03AE01

0.5mgN03AE01 CLONAZEPAMUM COMPR.RIVOTRIL 0.5mg ROCHE ROMANIA S.R.L.

2mgN03AE01 CLONAZEPAMUM COMPR.RIVOTRIL® 2mg ROCHE ROMANIA S.R.L.

324 PREGABALINUM **# Protocol: N025G;N032GN03AX16

150mgN03AX16 PREGABALINUM CAPS.LYRICA 150 mg 150mg PFIZER LTD.

300mgN03AX16 PREGABALINUM CAPS.LYRICA 300 mg 300mg PFIZER LTD.

75mgN03AX16 PREGABALINUM CAPS.LYRICA 75 mg 75mg PFIZER LTD.

326 PRAMIPEXOLUM *N04BC05

Prescriere limitata: Tratamentul simptomatic al sindromului idiopatic al picioarelor nelinistite, forme moderate/severe.

La acest medicament au fost raportate episoade de instalare brusca a somnului fara avertizare in timpul activitatii.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

0.18mgN04BC05 PRAMIPEXOLUM COMPR.MIRAPEXIN 0,18 mg 0.18mg BOEHRINGER INGELHEIM INTERNATIONAL GMBH

0.7mgN04BC05 PRAMIPEXOLUM COMPR.MIRAPEXIN 0,7 mg 0.7mg BOEHRINGER INGELHEIM INTERNATIONAL GMBH

327 PIRIBEDILUM **N04BXN1

50mgN04BXN1 PIRIBEDILUM DRAJ. ELIB. PREL.PRONORAN® 50 mg LP 50mg LES LAB. SERVIER IND.

328 TIAPRIDUMN05AL03

100mgN05AL03 TIAPRIDUM COMPR.TIAPRIDAL® 100 mg 100mg SANOFI-SYNTHELABO FRANCE

100mg/2mlN05AL03 TIAPRIDUM SOL. INJ.TIAPRIDAL 100 mg/2 ml 100mg/2ml SANOFI-AVENTIS FRANCE

329 BUSPIRONUMN05BE01

Prescriere limitata: Pentru tratamentul de scurta durata al anxietatii.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

10mgN05BE01 BUSPIRONUM COMPR.SPITOMIN 10 mg 10mg EGIS PHARMACEUTICALS PLC

STRESSIGAL 10mg ANFARM HELLAS S.A. PHARMACEUTICALS

5mgN05BE01 BUSPIRONUM COMPR.SPITOMIN 5 mg 5mg EGIS PHARMACEUTICALS PLC

330 MAPROTILINUM *N06AA21

10mgN06AA21 MAPROTILINUM COMPR. FILM.LUDIOMIL® 10 mg 10mg NOVARTIS PHARMA GMBH

25mgN06AA21 MAPROTILINUM COMPR. FILM.LUDIOMIL® 25 mg 25mg NOVARTIS PHARMA GMBH

331 ESCITALOPRAMUM ** Protocol: N009FN06AB10

10mgN06AB10 ESCITALOPRAMUM COMPR. FILM.CIPRALEX 10 mg 10mg H. LUNDBECK A/S

5mgN06AB10 ESCITALOPRAMUM COMPR. FILM.CIPRALEX 5 mg 5mg H. LUNDBECK A/S

332 TRAZODONUM ** Protocol: N010FN06AX05

150mgN06AX05 TRAZODONUM COMPR. ELIB. PREL.TRITTICO AC 150 mg 150mg ANGELINI FRANCESCO SPA

333 TIANEPTINUM ** Protocol: N011FN06AX14

12.5mgN06AX14 TIANEPTINUM DRAJ.COAXIL® 12.5mg LES LAB. SERVIER IND.

334 MILNACIPRANUM ** Protocol: N002FN06AX17

25mgN06AX17 MILNACIPRANUM CAPS.IXEL 25mg PIERRE FABRE MEDICAMENT

50mgN06AX17 MILNACIPRANUM CAPS.IXEL 50mg PIERRE FABRE MEDICAMENT

46 153/

Page 47: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

335 DULOXETINUM ** Protocol: N014FN06AX21

30mgN06AX21 DULOXETINUM CAPS. GASTROREZ.CYMBALTA 30mg 30mg ELI LILLY NEDERLAND BV

100mg/50mlN06AX21 DULOXETINUM SOL. PERF.CYMBALTA 60mg 60mg ELI LILLY NEDERLAND BV

336 BUPROPIONUM **#N06AXN1

150mgN06AXN1 BUPROPIONUM COMPR. FILM. ELIB. PREL.WELLBUTRIN SR 150 mg 150mg GLAXO WELLCOME UK LTD.

337 PRAMIRACETAMUM **#N06BX16

600mgN06BX16 PRAMIRACETAMUM COMPR. FILM.PRAMISTAR 600mg F.I.R.M.A. S.p.a. (MENARINI GROUP)

338 VINPOCETINUMN06BX18

10mgN06BX18 VINPOCETINUM COMPR.CAVINTON® FORTE 10mg GEDEON RICHTER LTD.

5mgN06BX18 VINPOCETINUM CAPS.VIMPOCETIN 5 mg 5mg VIM SPECTRUM SRL

5mgN06BX18 VINPOCETINUM COMPR.CAVINTON® 5mg GEDEON RICHTER LTD.

339 BETAHISTINUMN07CA01

16mgN07CA01 BETAHISTINUM COMPR.BETASERC® 16 mg 16mg SOLVAY PHARMACEUTICALS BV

24mgN07CA01 BETAHISTINUM COMPR.BETASERC® 24 mg 24mg SOLVAY PHARMACEUTICALS BV

80mgN07CA01 BETAHISTINUM COMPR.URUTAL 8 mg 80mg A & G MED TRADING S.R.L.

8mgN07CA01 BETAHISTINUM COMPR.BETASERC® 8 mg 8mg SOLVAY PHARMACEUTICALS BV

MICROSER 8mg PRODOTTI FORMENTI

VESTIBO 8 mg 8mg ACTAVIS GROUP HF.

340 COMBINATII (CINNARIZINUM+DIMENHIDRATUM)N07CA52

N07CA52 COMBINATII

(CINNARIZINUM+DIMENHIDRATUM)

COMPR.

ARLEVERT HENNIG ARZNEIMITTEL GMBH & CO.KG

341 HIDROLIZAT DE PROTEINA DIN CREIER DE PORCINA ** Protocol: N026FN07XN01

215.2mg/mlN07XN01 HIDROLIZAT DE PROTEINA DIN CREIER DE

PORCINA

SOL. INJ./PERF.

CEREBROLYSIN® 215.2mg/ml EBEWE PHARMA GMBH NFG. KG

342 HYDROXYCHLOROQUINUMP01BA02

200mgP01BA02 HYDROXYCHLOROQUINUM COMPR. FILM.PLAQUENIL® 200mg SANOFI-SYNTHELABO LTD.

343 FENOTEROLUMR03AC04

100µg/dozaR03AC04 FENOTEROLUM SOL. DE INHALAT PRESURIZATABEROTEC N - 100 µg 100µg/doza BOEHRINGER INGELHEIM INT. GMBH

344 BUDESONIDUM *R01AD05

Prescriere limitata: Profilaxia si tratamentul rinitei alergice.

32µg/dozaR01AD05 BUDESONIDUM SPRAY NAZAL SUSP.RHINOCORT® AQUA 32µg/doza ASTRAZENECA AB

50µg/dozaR01AD05 BUDESONIDUM SPRAY NAZ.,SUSP.TAFEN NASAL 50µg/doza LEK PHARMACEUTICALS D.D.

345 FLUTICASONUM *R01AD08

50µg/dozaR01AD08 FLUTICASONUM SPRAY NAZAL SUSP.FLIXONASE® 50µg/doza GLAXOWELLCOME UK LTD.

Profilaxia si tratamentul rinitei alergicePrescriere limitata:

346 MOMETASONUM *R01AD09

50µg/dozaR01AD09 MOMETASONUM SPRAY NAZAL SUSP.NASONEX 50µg/doza SCHERING PLOUGH EUROPE

Profilaxia si tratamentul rinitei alergice.Prescriere limitata:

Tratamentul polipozelor nazale a adultului.Prescriere limitata:

347 COMBINATII (FENOTEROLUM + IPRATROPIUM) *R03AK03

0,020mg+0,050m

g

R03AK03 COMBINATII (FENOTEROLUM +

IPRATROPIUM)

AEROSOL SOL. INHAL.

BERODUAL® N 0,020mg+0,050mg BOEHRINGER INGELHEIM INT. GMBH

348 COMBINATII (SALMETEROLUM+FLUTICASONUM) *R03AK06

Prescriere limitata: Tratament simptomatic al bolii pulmonare cronice obstructive (BPOC) la pacientii cu FEV1 mai mica decat 50% fata de normal si cu istoric de exacerbari repetate si

simptome importante in timpul tratamentului bronhodilatator cu agonisti ai receptorilor beta-2 adrenergici.

Tratamentul astmului bronsic care nu este controlat adecvat cu corticosteroizi inhalatori si beta-2-agonisti inhalatori de scurta durata.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

25mg/125mgR03AK06 COMBINATII

(SALMETEROLUM+FLUTICASONUM)

AEROSOL SUSP. INHAL.

SERETIDE® 25/125 µg INHALER CFC FREE 25mg/125mg GLAXOWELLCOME UK LTD.

25mg/250mgR03AK06 COMBINATII

(SALMETEROLUM+FLUTICASONUM)

AEROSOL SUSP. INHAL.

SERETIDE® 25/250 µg INHALER CFC FREE 25mg/250mg GLAXOWELLCOME UK LTD.

25mg/50mgR03AK06 COMBINATII

(SALMETEROLUM+FLUTICASONUM)

AEROSOL SUSP. INHAL.

SERETIDE® 25/50 µg INHALER CFC FREE 25mg/50mg GLAXOWELLCOME UK LTD.

47 153/

Page 48: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

50mg/100mgR03AK06 COMBINATII

(SALMETEROLUM+FLUTICASONUM)

PULB. INHAL.

SERETIDE DISKUS 50/100 50mg/100mg GLAXO WELLCOME UK LIMITED

50mg/250mgR03AK06 COMBINATII

(SALMETEROLUM+FLUTICASONUM)

PULB. INHAL.

SERETIDE DISKUS 50/250 50mg/250mg GLAXOWELLCOME UK LTD.

50mg/500mgR03AK06 COMBINATII

(SALMETEROLUM+FLUTICASONUM)

PULB. INHAL.

SERETIDE DISKUS 50/500 50mg/500mg GLAXOWELLCOME UK LTD.

349 COMBINATII (BUDESONIDUM+FORMOTEROLUM) *R03AK07

Prescriere limitata: Tratament simptomatic al bolii pulmonare cronice obstructive (BPCO) la pacientii cu FEV1 mai mica decat 50% fata de normal si cu istoric de exacerbari repetate si

simptome importante in timpul tratamentului bronhodilatator cu agonisti ai receptorilor beta-2 adrenergici.

Tratamentul astmului bronsic care nu este controlat adecvat cu corticosteroizi inhalatori si beta-2-agonisti inhalatori de scurta durata.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

160/4.5µgR03AK07 COMBINATII

(BUDESONIDUM+FORMOTEROLUM)

PULB. INHAL.

SYMBIOCORT® TURBUHALER® 160/4,5 µg 160/4.5µg ASTRAZENECA AB

320/9µgR03AK07 COMBINATII

(BUDESONIDUM+FORMOTEROLUM)

PULB. INHAL.

SYMBIOCORT® TURBUHALER® 320/9 µg 320/9µg ASTRAZENECA AB

80/4.5µgR03AK07 COMBINATII

(BUDESONIDUM+FORMOTEROLUM)

PULB. INHAL.

SYMBIOCORT® TURBUHALER® 80/4,5 µg 80/4.5µg ASTRAZENECA AB

350 FLUTICASONUM *R03BA05

Prescriere limitata: Tratamentul de control al astmului bronsic persistent.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

0.5mg/2mlR03BA05 FLUTICASONUM SUSP. INHAL.FLIXOTIDE® NEBULES® 0,5 mg/2 ml 0.5mg/2ml GLAXO WELLCOME UK LTD.

125µg/dozaR03BA05 FLUTICASONUM SUSP. INHAL. PRESURIZATAFLIXOTIDE 125 INHALER CFC - Free 125µg/doza GLAXO WELLCOME UK LTD.

2mg/2mlR03BA05 FLUTICASONUM SUSP. INHAL.FLIXOTIDE® NEBULES® 2 mg/2 ml 2mg/2ml GLAXO WELLCOME UK LTD.

50µg/dozaR03BA05 FLUTICASONUM SUSP. INHAL. PRESURIZATAFLIXOTIDE® 50 INHALER CFC - Free 50µg/doza GLAXO WELLCOME UK LTD.

352 CICLESONIDUM *R03BA08

Prescriere limitata: Tratamentul de fond al astmului bronsic persistent.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

160µg/dozaR03BA08 CICLESONIDUM SOL. DE INHALAT PRESURIZATAALVESCO 160 INHALER 160µg/doza ALTANA PHARMA AG

80µg/dozaR03BA08 CICLESONIDUM SOL. DE INHALAT PRESURIZATAALVESCO 80 INHALER 80µg/doza ALTANA PHARMA AG

353 TIOTROPIUM *R03BB04

18µgR03BB04 TIOTROPIUM CAPS. CU PULB.INHAL.SPIRIVA® 18 µg 18µg BOEHRINGER INGELHEIM PHARMA GMBH&CO.KG

Pentru tratamentul de intretinere pe termen lung al bronhospasmului si dispneei associate bolii pulmonare obstructive cronicePrescriere limitata:

354 AMINOPHYLLINUMR03DA05

100mgR03DA05 AMINOPHYLLINUM CAPS.MIOFILIN 100 mg 100mg ZENTIVA SA

100mgR03DA05 AMINOPHYLLINUM COMPR.AMINOFILINA EEL 100mg BIO EEL SRL

200mgR03DA05 AMINOPHYLLINUM COMPR.AMINOFILINA 200 mg 200mg ARENA GROUP SA

24mg/mlR03DA05 AMINOPHYLLINUM SOL. INJ.MIOFILIN 24mg/ml ZENTIVA S.A.

355 MONTELUKASTUM *R03DC03

10mgR03DC03 MONTELUKASTUM COMPR. FILM.SINGULAIR® 10mg MERCK SHARP & DOHME ROMANIA S.R.L.

Tratamentul combinat al astmului bronsic persistent la pacientii cu simptomatologie necontrolata corespunzator cu corticosteroizi inhalatori si beta-2-agonisti cu

durata scurta de actiune.

Prescriere limitata:

4mgR03DC03 MONTELUKASTUM COMPR. MAST.SINGULAIR 4mg MERCK SHARP & DOHME S.R.L.

Tratamentul combinat al astmului bronsic persistent la pacientii cu simptomatologie necontrolata corespunzator cu corticosteroizi inhalatori si beta-2-agonisti cu

durata scurta de actiune.

Prescriere limitata:

Tratament astmului bronsic persistent la copii cu varste cuprinse intre 2 si 5 ani la care nu se poate administra terapie cu corticosteroizi inhalatori.Cod restrictie 2617:

4mg/plicR03DC03 MONTELUKASTUM GRANULESINGULAIR® 4mg/plic MERCK SHARP & DOHME ROMANIA S.R.L.

Tratamentul combinat al astmului bronsic persistent la pacientii cu simptomatologie necontrolata corespunzator cu corticosteroizi inhalatori si beta-2-agonisti cu

durata scurta de actiune.

Prescriere limitata:

Tratament astmului bronsic persistent la copii cu varste cuprinse intre 2 si 5 ani la care nu se poate administra terapie cu corticosteroizi inhalatori.Cod restrictie 2617:

5mgR03DC03 MONTELUKASTUM COMPR. MAST.SINGULAIR® 5mg MERCK SHARP & DOHME ROMANIA S.R.L.

Tratamentul combinat al astmului bronsic persistent la pacientii cu simptomatologie necontrolata corespunzator cu corticosteroizi inhalatori si beta-2-agonisti cu

durata scurta de actiune.

Prescriere limitata:

Tratament astmului bronsic persistent la copii cu varste cuprinse intre 6 si 14 ani la care nu se poate administra terapie cu corticosteroizi inhalatori.Cod restrictie 2617:

356 FENSPIRIDUMR03DX03

0.2%R03DX03 FENSPIRIDUM SIROPEURESPAL® 0.2% LES LAB. SERVIER IND.

80mgR03DX03 FENSPIRIDUM COMPR. FILM.

48 153/

Page 49: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

EURESPAL 80 mg 80mg LES LAB. SERVIER IND.

357 ERDOSTEINUMR05CB15

175mg/5mlR05CB15 ERDOSTEINUM PULB. PT. SUSP. ORALAERDOMED® 175 175mg/5ml CSC PHARMACEUTICALS HANDELS GMBH

300mgR05CB15 ERDOSTEINUM CAPS.ERDOMED 300mg MEDICOM INTERNATIONAL SRO

358 DEXTROMETHORPHANUMR05DA09

0.1%R05DA09 DEXTROMETHORPHANUM SIROPHUMEX 0.1% LAB. URGO SA

TUSSIN SIROP 0.1% GLOBAL PHARMACEUTICALS S.R.L.

0.13%R05DA09 DEXTROMETHORPHANUM SIROPHUMEX 0.13% LAB. URGO SA

10mgR05DA09 DEXTROMETHORPHANUM COMPR.TUSSIN 10mg EUROPHARM SA

15mg/5mlR05DA09 DEXTROMETHORPHANUM SIROPROFEDEX 15mg/5ml BIOFARM SA

20mgR05DA09 DEXTROMETHORPHANUM COMPR.TUSSIN FORTE 20mg EUROPHARM SA

3.75mg/5mlR05DA09 DEXTROMETHORPHANUM SOL. ORALAROBITUSSIN JUNIOR 3.75mg/5ml WYETH WHITEHALL EXPORT GMBH

7.5mg/5mlR05DA09 DEXTROMETHORPHANUM SOL. ORALAROBITUSSIN ANTITUSSICUM 7.5mg/5ml WYETH WHITEHALL EXPORT GMBH

359 LEVOCETIRIZINUMR06AE09

5mgR06AE09 LEVOCETIRIZINUM COMPR. FILM.XYZAL® 5mg U.C.B. GMBH

5mg/mlR06AE09 LEVOCETIRIZINUM PIC. ORALE, SOL.XYZAL 5mg/ml U.C.B. GMBH

360 FEXOFENADINUMR06AX26

120mgR06AX26 FEXOFENADINUM COMPR. FILM.ALTIVA 120 mg 120mg RANBAXY UK LTD.

TELFAST® 120 mg 120mg AVENTIS PHARMA DEUTSCHLAND GMBH

180mgR06AX26 FEXOFENADINUM COMPR. FILM.ALTIVA 180 mg 180mg RANBAXY UK LTD.

TELFAST® 180 mg 180mg AVENTIS PHARMA DEUTSCHLAND GMBH

30mgR06AX26 FEXOFENADINUM COMPR. FILM.TELFAST® 30 mg 30mg AVENTIS PHARMA DEUTSCHLAND GMBH

361 DESLORATADINUMR06AX27

0.5mg/mlR06AX27 DESLORATADINUM SIROPAERIUS 0.5mg/ml 0.5mg/ml SP EUROPE

5mgR06AX27 DESLORATADINUM COMPR. FILM.AERIUS 5mg 5mg SP EUROPE

362 GENTAMICINUMS01AA11

0.3%S01AA11 GENTAMICINUM PICATURI OFT.-SOL.OPHTAGRAM® 0,3% 0.3% LAB. CHAUVIN

0.3%S01AA11 GENTAMICINUM SOL. OFT.GENTICOL 0.3% S.I.F.I. SPA

0.3%S01AA11 GENTAMICINUM UNG. OFT.GENTICOL 0.3% S.I.F.I. SPA

OPHTAGRAM® 0,3% 0.3% LAB. CHAUVIN

0.3%S01AA11 GENTAMICINUM PIC. OFT., SOLGENTAMICIN SULPHATE 0.3% E.I.P.I.CO. MED S.R.L.

363 TOBRAMYCINUMS01AA12

0.3%S01AA12 TOBRAMYCINUM UNG. OFT.TOBREX® 0.3% ALCON COUVREUR NV

0.3%S01AA12 TOBRAMYCINUM PIC. OFT., SOL.TOBISOL 0.3% E.I.P.I.CO. MED S.R.L.

3mg/mlS01AA12 TOBRAMYCINUM PIC. OFT.,SOL.TOBREX 3mg/ml ALCON COUVREUR NV

364 NETILMICINUMS01AA23

0.3%S01AA23 NETILMICINUM PICATURI OFT.-SOL.NETTACIN® 0.3% S.I.F.I. SPA

3mg/gS01AA23 NETILMICINUM UNG. OFT.NETTAVISC 3mg/g 3mg/g S.I.F.I. SPA

0.3%S01AA23 NETILMICINUM PIC. OFT., SOLNETTACIN® 0.3% S.I.F.I. SPA

365 OFLOXACINUMS01AX11

0.3%S01AX11 OFLOXACINUM PICATURI OFT.-SOL.FLOXAL® 0.3% DR. GERHARD MANN CHEM-PHARM. FABRIK GMBH

0.3%S01AX11 OFLOXACINUM UNG. OFT.FLOXAL® 0.3% DR. GERHARD MANN CHEM-PHARM. FABRIK GMBH

366 DEXAMETHASONUMS01BA01

0.1%S01BA01 DEXAMETHASONUM PICATURI OFT.-SUSP.MAXIDEX® 0.1% ALCON COUVREUR NV

367 BETAMETHASONUMS01BA06

0.1%S01BA06 BETAMETHASONUM SOL. OFT.OPHTAMESONE 0.1% DAR AL DAWA PHARMA S.R.L

368 COMBINATII (NETILMICINUM + DEXAMETHASONUM)S01CA01

49 153/

Page 50: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

S01CA01 COMBINATII (NETILMICINUM +

DEXAMETHASONUM)

PIC. OFT.,SOL.

NETILDEX S.I.F.I. SPA

S01CA01 COMBINATII (NETILMICINUM +

DEXAMETHASONUM)

PIC. OFT.SOL. UNIDOZA

NETILDEX S.I.F.I. SPA

369 COMBINATII (TOBRAMYCINUM + DEXAMETHASONUM)S01CA01

1mg+3mgS01CA01 COMBINATII (TOBRAMYCINUM +

DEXAMETHASONUM)

UNG. OFT.

TOBRADEX® 1mg+3mg ALCON COUVREUR NV

1mg+3mgS01CA01 COMBINATII (TOBRAMYCINUM +

DEXAMETHASONUM)

PICATURI OFT.-SUSP.

TOBRADEX® 1mg+3mg ALCON COUVREUR NV

370 COMBINATII (CHLORAMPHENICOLUM + DEXAMETHASONUM)S01CA01

5mg/ml+1mg/mlS01CA01 COMBINATII (CHLORAMPHENICOLUM +

DEXAMETHASONUM)

PICATURI OFT.-SOL.

SPERSADEX COMP 5mg/ml+1mg/ml NOVARTIS PHARMA GMBH

371 OLOPATADINUMS01GX09

1mg/mlS01GX09 OLOPATADINUM PIC. OFT., SOL.OPATANOL 1mg/ml 1mg/ml ALCON LABORATORIES LTD.

372 RETINOLUMS01XA02

10mg/gS01XA02 RETINOLUM GEL OFT.OCULOTECT 10mg/g NOVARTIS PHARMA GMBH

1219 CARBIMAZOLUMH03BB01

5mgH03BB01 CARBIMAZOLUM COMPR. FILM.CARBIMAZOLE 5 5mg REMEDICA LTD.

50 153/

Page 51: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

SUBLISTA C1-G1 INSUFICIENTA CARDIACA CRONICA (CLASA III SAU IV NYHA).

373 ACENOCUMAROLUMB01AA07

2mgB01AA07 ACENOCUMAROLUM COMPR.TROMBOSTOP 2 mg 2mg TERAPIA SA

4mgB01AA07 ACENOCUMAROLUM COMPR.SINTROM® 4mg NOVARTIS PHARMA GMBH

374 DIGOXINUMC01AA05

0.05mg/mlC01AA05 DIGOXINUM SOL. ORALALANOXIN SOLUTIE ORALA 0.05mg/ml THE WELLCOME FOUNDATION LTD.

0.25mgC01AA05 DIGOXINUM COMPR.DIGOXIN 0,25 mg 0.25mg ZENTIVA S.A.

0.5mg/mlC01AA05 DIGOXINUM SOL. INJ.DIGOXIN 0,5 mg/2 ml 0.5mg/ml ZENTIVA S.A.

375 HYDROCHLOROTHIAZIDUMC03AA03

25mgC03AA03 HYDROCHLOROTHIAZIDUM COMPR.NEFRIX 25 mg 25mg ZENTIVA SA

376 FUROSEMIDUMC03CA01Electroliţii serici trebuie să fie verificaţi periodic.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

10mg/mlC03CA01 FUROSEMIDUM SOL. INJ.FUROSEMID 20 mg/2 ml 10mg/ml ZENTIVA SA

40mgC03CA01 FUROSEMIDUM COMPR.FUROSEMID ARENA 40 mg 40mg ARENA GROUP S.A.

FUROSEMID EEL 40mg BIO EEL SRL

FUROSEMID LPH 40 mg 40mg LABORMED PHARMA SA

FUROSEMID MCC 40 mg 40mg MAGISTRA C & C SRL

FUROSEMID SLAVIA 40mg SLAVIA PHARM SRL

FUROSEMID ZENTIVA 40mg ZENTIVA SA

377 SPIRONOLACTONUMC03DA01

Electroliţii serici trebuie să fie verificaţi periodic.

Femeile la varsta fertila la care s-a initiat tratament cu spironolactona trebuie sa ia masuri adecvate de contraceptie.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgC03DA01 SPIRONOLACTONUM CAPS.VEROSPIRON 100mg GEDEON RICHTER LTD.

25mgC03DA01 SPIRONOLACTONUM COMPR.SPIRONOLACTONA 25 mg 25mg BIO EEL SRL

25mgC03DA01 SPIRONOLACTONUM COMPR. FILM.ALSPIRON 25 mg 25mg AC HELCOR PHARMA SRL

SPIRONOLACTONA 25 mg 25mg TERAPIA SA

50mgC03DA01 SPIRONOLACTONUM CAPS.VEROSPIRON 50mg GEDEON RICHTER LTD.

50mgC03DA01 SPIRONOLACTONUM COMPR. FILM.ALSPIRON 50 mg 50mg AC HELCOR PHARMA SRL

378 METOPROLOLUMC07AB02

100mgC07AB02 METOPROLOLUM COMPR.BETAPROL 100 mg 100mg AC HELCOR PHARMA SRL

BLOXAN 100mg KRKA D.D. NOVO MESTO

EGILOK 100 mg 100mg EGIS PHARMACEUTICALS P.L.C.

METOPRO TAD 100 100mg TAD PHARMA GMBH

METOPROLOL 100 mg 100mg OZONE LABORATORIES LTD.

METOPROLOL AL 100 100mg ALIUD® PHARMA GMBH & CO.KG

METOPROLOL LPH 100 mg 100mg LABORMED PHARMA SA

METOPROLOL MEDICO UNO 100 mg 100mg MEDICO UNO PHARMACEUTICAL S.R.L.

METOPROLOL TERAPIA 100 mg 100mg TERAPIA SA

VASOCARDIN® 100 100mg SLOVAKOFARMA

100mgC07AB02 METOPROLOLUM COMPR. ELIB. PREL.METOPROLOL RETARD 100 mg 100mg TERAPIA S.A.

100mgC07AB02 METOPROLOLUM COMPR. FILM. ELIB. PREL.BETALOC® ZOC 100 mg 100mg ASTRAZENECA AB

190mgC07AB02 METOPROLOLUM COMPR.FILM.ELIB.MOD.METOSUCCINAT SANDOZ 190 mg 190mg HEXAL AG

1mg/mlC07AB02 METOPROLOLUM SOL. INJ.BETALOC 1mg/ml ASTRAZENECA AB

200mgC07AB02 METOPROLOLUM COMPR. ELIB. PREL.VASOCARDIN® SR 200 200mg ZENTIVA AS

25mgC07AB02 METOPROLOLUM COMPR.EGILOK 25 mg 25mg EGIS PHARMACEUTICALS P.L.C.

METOPROLOL 25 mg 25mg ARENA GROUP S.A.

METOPROLOL LPH 25 mg 25mg LABORMED PHARMA SA

METOPROLOL MEDICO UNO 25 mg 25mg MEDICO UNO PHARMACEUTICAL S.R.L.

47.5mgC07AB02 METOPROLOLUM COMPR.FILM.ELIB.MOD.METOSUCCINAT SANDOZ 47,5 mg 47.5mg HEXAL AG

50mgC07AB02 METOPROLOLUM COMPR.BETAPROL 50 mg 50mg AC HELCOR PHARMA SRL

EGILOK 50 mg 50mg EGIS PHARMACEUTICALS P.L.C.

METOPRO TAD 50 50mg TAD PHARMA GMBH

METOPROLOL 50 mg 50mg OZONE LABORATORIES LTD.

METOPROLOL AL 50 50mg ALIUD PHARMA GMBH & CO.KG

METOPROLOL LPH 50 mg 50mg LABORMED PHARMA SA

METOPROLOL MEDICO UNO 50 mg 50mg MEDICO UNO PHARMACEUTICAL S.R.L.

METOPROLOL TERAPIA 50 mg 50mg TERAPIA SA

51 153/

Page 52: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

50mgC07AB02 METOPROLOLUM COMPR. FILM. ELIB. PREL.BETALOC® ZOC 50 mg 50mg ASTRAZENECA AB

95mgC07AB02 METOPROLOLUM COMPR.FILM.ELIB.MOD.METOSUCCINAT SANDOZ 95 mg 95mg HEXAL AG

379 BISOPROLOLUMC07AB07

2.5mgC07AB07 BISOPROLOLUM COMPR. FILM.CONCOR COR 2,5 mg 2.5mg MERCK KGAA

380 NEBIVOLOLUM **C07AB12

5mgC07AB12 NEBIVOLOLUM COMPR.NEBILET® 5mg BERLIN CHEMIE AG MENARINI GROUP

381 CARVEDILOLUMC07AG02

12,5 mgC07AG02 CARVEDILOLUM COMPR.CARVEDILOL SANDOZ 12,5 mg HEXAL AG

12.5mgC07AG02 CARVEDILOLUM COMPR.ATRAM 12,5 12.5mg ZENTIVA AS

CARVEDILOL 12,5 mg 12.5mg VIM SPECTRUM SRL

CARVEDILOL HELCOR 12,5 mg 12.5mg AC HELCOR PHARMA SRL

CARVEDILOL LPH 12,5 mg 12.5mg LABORMED PHARMA SA

CARVEDILOL TEVA 12,5 mg 12.5mg TEVA PHARMACEUTICAL S.R.L.

CORYOL® 12.5mg KRKA D.D.

DILATREND® 12,5 mg 12.5mg ROCHE ROMANIA S.R.L.

TALLITON® 12,5 mg 12.5mg EGIS PHARMACEUTICALS LTD.

12.5mgC07AG02 CARVEDILOLUM COMPR. FILM.CARVEDIGAMMA 12,5 mg 12.5mg WORWAG PHARMA GMBH & CO. KG

25mgC07AG02 CARVEDILOLUM COMPR.ATRAM 25 25mg ZENTIVA AS

CARVEDILOL HELCOR 25 mg 25mg AC HELCOR PHARMA SRL

CARVEDILOL LPH 25 mg 25mg LABORMED PHARMA SA

CARVEDILOL SANDOZ 25mg HEXAL AG

CARVEDILOL TEVA 25 mg 25mg TEVA PHARMACEUTICAL S.R.L.

CORYOL® 25mg KRKA D.D.

DILATREND® 25 mg 25mg ROCHE ROMANIA S.R.L.

TALLITON® 25 mg 25mg EGIS PHARMACEUTICALS LTD.

25mgC07AG02 CARVEDILOLUM COMPR. FILM.CARVEDIGAMMA 25 mg 25mg WORWAG PHARMA GMBH & CO. KG

3.125mgC07AG02 CARVEDILOLUM COMPR.CORYOL® 3,125 mg 3.125mg KRKA D.D.

6.25mgC07AG02 CARVEDILOLUM COMPR.ATRAM 6,25 6.25mg ZENTIVA AS

CARVEDILOL 6,25 mg 6.25mg VIM SPECTRUM SRL

CARVEDILOL LPH 6,25 mg 6.25mg LABORMED PHARMA SA

CARVEDILOL SANDOZ 6.25mg HEXAL AG

CARVEDILOL TEVA 6,25 mg 6.25mg TEVA PHARMACEUTICAL S.R.L.

CORYOL® 6.25mg KRKA D.D.

DILATREND® 6,25 mg 6.25mg ROCHE ROMANIA S.R.L.

TALLITON 6,25 mg 6.25mg EGIS PHARMACEUTICALS LTD.

6.25mgC07AG02 CARVEDILOLUM COMPR. FILM.CARVEDIGAMMA 6,25 mg 6.25mg WORWAG PHARMA GMBH & CO. KG

382 CAPTOPRILUMC09AA01

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului in

utero.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

12,5mgC09AA01 CAPTOPRILUM COMPR.CAPTOPRIL MCC 12,5 mg 12,5mg MAGISTRA C & C

12.5mgC09AA01 CAPTOPRILUM COMPR.CAPTOPRIL 12,5 mg 12.5mg EGIS PHARMACEUTICALS LTD.

25mgC09AA01 CAPTOPRILUM COMPR.CAPTOPRIL - AC 25 mg 25mg AC HELCOR PHARMA SRL

CAPTOPRIL SINTOFARM 25 mg 25mg SINTOFARM SA

CAPTOPRIL 25 EEL 25mg BIO EEL SRL

CAPTOPRIL 25 mg 25mg EGIS PHARMACEUTICALS LTD.

CAPTOPRIL LPH 25 mg 25mg LABORMED PHARMA SA

CAPTOPRIL MCC 25 mg 25mg MAGISTRA C & C

50 mgC09AA01 CAPTOPRILUM COMPR.CAPTOPRIL 50 mg 50 mg ARENA GROUP SA

50mgC09AA01 CAPTOPRILUM COMPR.CAPTOPRIL - AC 50 mg 50mg AC HELCOR PHARMA SRL

CAPTOPRIL 50 EEL 50mg BIO EEL SRL

CAPTOPRIL 50 mg 50mg EGIS PHARMACEUTICALS LTD.

CAPTOPRIL LPH 50 mg 50mg LABORMED PHARMA SA

CAPTOPRIL MCC 50 mg 50mg MAGISTRA C & C

383 ENALAPRILUMC09AA02

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului in

utero.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

1.25mg/mlC09AA02 ENALAPRILUM SOL. INJ.ENAP® 1.25mg/ml KRKA D.D.

10mgC09AA02 ENALAPRILUM COMPR.EDNYT® 10 mg 10mg GEDEON RICHTER LTD.

ENAHEXAL® 10 mg 10mg HEXAL AG

ENALA TAD 10 10mg TAD PHARMA GMBH

ENALAP 10mg E.I.P.I.CO. MED S.R.L.

ENALAPRIL 10 mg 10mg MAGISTRA C & C

52 153/

Page 53: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

ENALAPRIL AL 10 10mg ALIUD® PHARMA GMBH & CO.KG

ENALAPRIL FABIOL 10 mg 10mg FABIOL SA

ENALAPRIL LPH 10 mg 10mg LABORMED PHARMA SA

ENALAPRIL SANDOZ 10 mg 10mg SANDOZ SRL

ENALAPRIL TERAPIA 10 mg 10mg TERAPIA SA

ENAM 10 mg 10mg REPREZENTANTA DR. REDDY'S LABORATORIES LTD.

ENAP 10 mg 10mg KRKA D.D. NOVO MESTO

RENITEC 10 mg 10mg MERCK SHARP & DOHME ROMANIA S.R.L.

2.5mgC09AA02 ENALAPRILUM COMPR.EDNYT® 2,5 mg 2.5mg GEDEON RICHTER LTD.

20mgC09AA02 ENALAPRILUM COMPR.EDNYT® 20 mg 20mg GEDEON RICHTER LTD.

ENAHEXAL® 20 mg 20mg HEXAL AG

ENALA TAD 20 20mg TAD PHARMA GMBH

ENALAPRIL 20mg OZONE LABORATORIES LTD.

ENALAPRIL 20 mg 20mg MAGISTRA C & C

ENALAPRIL AL 20 20mg ALIUD® PHARMA GMBH & CO.KG

ENALAPRIL FABIOL 20 mg 20mg FABIOL SA

ENALAPRIL LPH 20 mg 20mg LABORMED PHARMA SA

ENALAPRIL SANDOZ 20 mg 20mg SANDOZ SRL

ENALAPRIL TERAPIA 20 mg 20mg TERAPIA SA

ENAP 20 mg 20mg KRKA D.D. NOVO MESTO

RENITEC 20 mg 20mg MERCK SHARP & DOHME ROMANIA S.R.L.

5mgC09AA02 ENALAPRILUM COMPR.EDNYT® 5 mg 5mg GEDEON RICHTER LTD.

ENAHEXAL® 5 mg 5mg HEXAL AG

ENALA TAD 5 5mg TAD PHARMA GMBH

ENALAPRIL 5 mg 5mg OZONE LABORATORIES LTD.

ENALAPRIL AL 5 5mg ALIUD® PHARMA GMBH & CO.KG

ENALAPRIL LPH® 5 mg 5mg LABORMED PHARMA SA

ENALAPRIL SANDOZ 5 mg 5mg SANDOZ SRL

ENAP 5 mg 5mg KRKA D.D. NOVO MESTO

RENITEC 5 mg 5mg MERCK SHARP & DOHME ROMANIA S.R.L.

384 LISINOPRILUMC09AA03

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului in

utero.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

10mgC09AA03 LISINOPRILUM COMPR.LISIGAMMA 10 mg 10mg WORWAG PHARMA GMBH & CO. KG

LISINOPRIL 10 MEDO 10mg MEDOCHEMIE ROMANIA SRL

LISINOPRIL ANTIBIOTICE 10 mg 10mg ANTIBIOTICE SA

LISINOPRIL SANDOZ 10 mg 10mg HEXAL AG

LISIREN 10 mg 10mg AC HELCOR SRL

MEDAPRIL 10 10mg MEDOCHEMIE LTD.

RANOLIP 10mg RANBAXY U.K. LIMITED

SINOPRYL® 10 10mg ECZACIBASI PHARMACEUTICALS S.R.L.

TONOLYSIN 10 mg 10mg GEDEON RICHTER LTD.

2.5mgC09AA03 LISINOPRILUM COMPR.TONOLYSIN 2,5 mg 2.5mg GEDEON RICHTER LTD.

20mgC09AA03 LISINOPRILUM COMPR.LISIGAMMA 20 mg 20mg WORWAG PHARMA GMBH & CO. KG

LISINOPRIL 20 MEDO 20mg MEDOCHEMIE ROMANIA SRL

LISINOPRIL ANTIBIOTICE 20 mg 20mg ANTIBIOTICE SA

LISINOPRIL SANDOZ 20 mg 20mg HEXAL AG

LISIREN 20 mg 20mg AC HELCOR SRL

MEDAPRIL 20 20mg MEDOCHEMIE LTD.

RANOLIP 20mg RANBAXY U.K. LIMITED

TONOLYSIN 20 mg 20mg GEDEON RICHTER LTD.

40mgC09AA03 LISINOPRILUM COMPR.LISINOPRIL ANTIBIOTICE 40 mg 40mg ANTIBIOTICE SA

5mgC09AA03 LISINOPRILUM COMPR.LISIGAMMA 5 mg 5mg WORWAG PHARMA GMBH & CO. KG

LISINOPRIL 5 MEDO 5mg MEDOCHEMIE ROMANIA SRL

LISINOPRIL SANDOZ 5 mg 5mg HEXAL AG

MEDAPRIL 5 5mg MEDOCHEMIE LTD.

RANOLIP 5mg RANBAXY U.K. LIMITED

TONOLYSIN 5 mg 5mg GEDEON RICHTER LTD.

385 RAMIPRILUMC09AA05

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului in

utero.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

1.25mgC09AA05 RAMIPRILUM COMPR. FILM.RAMIRAN 1,25 mg 1.25mg RANBAXY U.K. LIMITED

10 mgC09AA05 RAMIPRILUM COMPR.EMREN 10 mg 10 mg GEDEON RICHTER ROMANIA S.A.

VIVACE 10 mg 10 mg ACTAVIS GROUP HF

10mgC09AA05 RAMIPRILUM COMPR.AMPRIL 10 mg 10mg KRKA D.D. NOVO MESTO

PIRAMIL 10 mg 10mg SANDOZ SRL

RAMIGAMMA 10 mg 10mg WORWAG PHARMA GMBH & CO. KG

RAMIPRIL-AC 10 mg 10mg AC HELCOR PHARMA SRL

TRITACE 10 10mg SANOFI - AVENTIS DEUTSCHLAND GMBH

ZENRA 10 10mg ZENTIVA S.A.

10mgC09AA05 RAMIPRILUM COMPR. FILM.RAMIRAN 10 mg 10mg RANBAXY U.K. LIMITED

2,5 mgC09AA05 RAMIPRILUM COMPR.

53 153/

Page 54: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

EMREN 2,5 mg 2,5 mg GEDEON RICHTER ROMANIA S.A.

VIVACE 2,5 mg 2,5 mg ACTAVIS GROUP HF

2.5mgC09AA05 RAMIPRILUM COMPR.AMPRIL 2,5 mg 2.5mg KRKA D.D. NOVO MESTO

PIRAMIL 2,5 mg 2.5mg SANDOZ SRL

RAMIPRIL-AC 2,5 mg 2.5mg AC HELCOR PHARMA SRL

TRITACE® 2,5 2.5mg AVENTIS PHARMA DEUTSCHLAND GMBH

ZENRA 2,5 2.5mg ZENTIVA S.A.

2.5mgC09AA05 RAMIPRILUM COMPR. FILM.RAMIRAN 2,5 mg 2.5mg RANBAXY U.K. LIMITED

5 mgC09AA05 RAMIPRILUM COMPR.EMREN 5 mg 5 mg GEDEON RICHTER ROMANIA S.A.

VIVACE 5 mg 5 mg ACTAVIS GROUP HF

5mgC09AA05 RAMIPRILUM COMPR.AMPRIL 5 mg 5mg KRKA D.D. NOVO MESTO

PIRAMIL 5 mg 5mg SANDOZ SRL

RAMIGAMMA 5 mg 5mg WORWAG PHARMA GMBH & CO. KG

RAMIPRIL-AC 5 mg 5mg AC HELCOR PHARMA SRL

TRITACE® 5 5mg AVENTIS PHARMA DEUTSCHLAND GMBH

ZENRA 5 5mg ZENTIVA S.A.

5mgC09AA05 RAMIPRILUM COMPR. FILM.RAMIRAN 5 mg 5mg RANBAXY U.K. LIMITED

386 VALSARTANUM ** Protocol: C005IC09CA03

160mgC09CA03 VALSARTANUM COMPR. FILM.DIOVAN 160 mg 160mg NOVARTIS PHARMA GMBH

80mgC09CA03 VALSARTANUM COMPR. FILM.DIOVAN 80 mg 80mg NOVARTIS PHARMA GMBH

387 CANDESARTANUM CILEXETIL ** Protocol: C005IC09CA06

16mgC09CA06 CANDESARTANUM CILEXETIL COMPR.ATACAND 16mg ASTRAZENECA AB

8mgC09CA06 CANDESARTANUM CILEXETIL COMPR.ATACAND 8mg ASTRAZENECA AB

Protocol: BB01ISUBLISTA C1-G2 BOLNAVI CU PROTEZE VALVULARE SI VASCULARE.

388 ACENOCUMAROLUM *B01AA07

2mgB01AA07 ACENOCUMAROLUM COMPR.TROMBOSTOP 2 mg 2mg TERAPIA SA

4mgB01AA07 ACENOCUMAROLUM COMPR.SINTROM® 4mg NOVARTIS PHARMA GMBH

SUBLISTA C1-G3 BOLNAVI CU PROCEDURI INTERVENTIONALE PERCUTANE, NUMAI DUPA IMPLANTAREA UNEI PROTEZE

ENDOVASCULARE (STENT).

389 CLOPIDOGRELUM ***B01AC04

75mgB01AC04 CLOPIDOGRELUM COMPR. FILM.PLAVIX 75mg 75mg SANOFI PHARMA - BRISTOL MYERS SQUIBB

54 153/

Page 55: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

Protocol: LB01B;LB02BSUBLISTA C1-G4 HEPATITELE CRONICE DE ETIOLOGIE VIRALA B, C SI D.

390 EPOETINUM ALFA ** Protocol: B013KB03XA01

10000ui/mlB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 10000 UI 10000ui/ml JOHNSON & JOHNSON D.O.O.

1000UI/0.5mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 1000 UI/0,5 ml 1000UI/0.5ml RENAMED FARMA S.R.L.

EPREX® 1000 UI 1000ui/0.5ml JOHNSON & JOHNSON D.O.O.

2000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPOPHAR 2000 U.I. 2000UI GULF PHARMACEUTICAL IND. S.R.L.

2000ui/0.5mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 2000 UI/0,5 ml 2000UI/0.5ml RENAMED FARMA S.R.L.

EPREX® 2000 UI 2000ui/0.5ml JOHNSON & JOHNSON D.O.O.

2000UI/1mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 2000 UI/1 ml 2000UI/1ml RENAMED FARMA S.R.L.

3000ui/0.3mlB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 3000 UI 3000ui/0.3ml JOHNSON & JOHNSON D.O.O.

40 000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 40 000 UI 40 000UI JOHNSON & JOHNSON D.O.O.

4000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPOPHAR 4000 U.I. 4000UI GULF PHARMACEUTICAL IND. S.R.L.

4000ui/0.4mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 4000 UI/0,4 ml 4000UI/0.4ml RENAMED FARMA S.R.L.

EPREX® 4000 UI 4000ui/0.4ml JOHNSON & JOHNSON D.O.O.

4000UI/1mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 4000 UI/1 ml 4000UI/1ml RENAMED FARMA S.R.L.

391 EPOETINUM BETA ** Protocol: B013KB03XA01

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 10000 UI 10000UI/0,6ml ROCHE REGISTRATION L

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 1000 UI 1000UI/0,3ml ROCHE REGISTRATION L

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 2000 UI 2000UI/0,3ml ROCHE REGISTRATION L

30000 UI/0,6mlB03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 30000UI/0,6ml 30000 UI/0,6ml ROCHE REGISTRATION LTD.

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 4000 UI 4000UI/0,3ml ROCHE REGISTRATION L

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 5000 UI 5000UI/0,3ml ROCHE REGISTRATION L

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 500 UI 500UI/0,3ml ROCHE REGISTRATION L

392 RIBAVIRINUM **** Protocol: J002NJ05AB04

200mgJ05AB04 RIBAVIRINUM CAPS.REBETOL 200 mg 200mg SP EUROPE

200mgJ05AB04 RIBAVIRINUM COMPR. FILM.COPEGUS® 200mg ROCHE ROMANIA SRL

393 LAMIVUDINUM **** Protocol: J005NJ05AF05

100mgJ05AF05 LAMIVUDINUM COMPR. FILM.ZEFFIX 100 mg 100mg GLAXO GROUP LTD.

10mg/mlJ05AF05 LAMIVUDINUM SOL. ORALAEPIVIR 10mg/ml 10mg/ml GLAXO GROUP LTD.

150mgJ05AF05 LAMIVUDINUM COMPR. FILM.EPIVIR 150mg 150mg GLAXO GROUP LTD.

5mg/mlJ05AF05 LAMIVUDINUM SOL. ORALAZEFFIX 5 mg/ml 5mg/ml GLAXO GROUP LTD.

395 ENTECAVIRUM **** Protocol: J008NJ05AF10

0,5mgJ05AF10 ENTECAVIRUM COMPR. FILM.BARACLUDE 0,5mg 0,5mg BRISTOL-MYERS SQUIBB PHARMA EEIG

1mgJ05AF10 ENTECAVIRUM COMPR. FILM.BARACLUDE 1mg 1mg BRISTOL-MYERS SQUIBB PHARMA EEIG

396 FILGRASTIMUM (G-CSF) ** Protocol: B013KL03AA02

30MU/0.5mlL03AA02 FILGRASTIMUM (G-CSF) SOL. INJ.NEUPOGEN® 30MU/0.5ml AMGEN EUROPE B.V.

48MU/0.5mlL03AA02 FILGRASTIMUM (G-CSF) SOL. INJ.NEUPOGEN® 48MU/0.5ml AMGEN EUROPE B.V.

397 INTERFERONUM ALFA 2a **** Protocol: J007NL03AB04

Tratamentul cu interferon alfa a fost asociat cu depresie şi suicid la unii pacienţi. Pacienţii cu istoric de ideaţie suicidară sau boală depresivă trebuie avertizaţi de riscuri. Trebuie

monitorizat statusul psihiatric în timpul tratamentului.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

18Mui/0.6mlL03AB04 INTERFERONUM ALFA 2a SOL. INJ.ROFERON A 18Mui/0.6ml ROCHE ROMANIA S.R.L.

3Mui/0.5mlL03AB04 INTERFERONUM ALFA 2a SOL. INJ.ROFERON A 3Mui/0.5ml ROCHE ROMANIA S.R.L.

4.5Mui/0.5mlL03AB04 INTERFERONUM ALFA 2a SOL. INJ.ROFERON A 4.5Mui/0.5ml ROCHE ROMANIA S.R.L.

9Mui/0.5mlL03AB04 INTERFERONUM ALFA 2a SOL. INJ.ROFERON A 9Mui/0.5ml ROCHE ROMANIA S.R.L.

3Mui/0.5mlL03AB04 INTERFERONUM ALFA 2a SOL. INJ.ROFERON A 3Mui/0.5ml ROCHE ROMANIA S.R.L.

4.5Mui/0.5mlL03AB04 INTERFERONUM ALFA 2a SOL. INJ.

55 153/

Page 56: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

ROFERON A 4.5Mui/0.5ml ROCHE ROMANIA S.R.L.

9Mui/0.5mlL03AB04 INTERFERONUM ALFA 2a SOL. INJ.ROFERON A 9Mui/0.5ml ROCHE ROMANIA S.R.L.

398 INTERFERONUM ALFA 2b **** Protocol: J006NL03AB05

Tratamentul cu interferon alfa a fost asociat cu depresie şi suicid la unii pacienţi. Pacienţii cu istoric de ideaţie suicidară sau boală depresivă trebuie avertizaţi de riscuri. Trebuie

monitorizat statusul psihiatric în timpul tratamentului.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

18 milioane U.I.L03AB05 INTERFERONUM ALFA 2b SOL. INJ. PEN MULTIDOZAINTRON A 18 milioane U.I. 18 milioane U.I. SP EUROPE

30 milioane U.I.L03AB05 INTERFERONUM ALFA 2b SOL. INJ. PEN MULTIDOZAINTRON A 30 milioane U.I. 30 milioane U.I. SP EUROPE

INTRON A 60 milioane U.I. 60 milioane U.I. SP EUROPE

60 milioane U.I.L03AB05 INTERFERONUM ALFA 2b SOL. INJ. PEN MULTIDOZAINTRON A 30 milioane U.I. 30 milioane U.I. SP EUROPE

INTRON A 60 milioane U.I. 60 milioane U.I. SP EUROPE

399 PEGINTERFERON alfa-2b **** Protocol: J003NL03AB10

Tratamentul cu interferon alfa a fost asociat cu depresie şi suicid la unii pacienţi. Pacienţii cu istoric de ideaţie suicidară sau boală depresivă trebuie avertizaţi de riscuri. Trebuie

monitorizat statusul psihiatric în timpul tratamentului.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100µgL03AB10 PEGINTERFERON alfa-2b PULB. + SOLV. PT. SOL. INJ.PEGINTRON 100 µg 100µg SP EUROPE

120µgL03AB10 PEGINTERFERON alfa-2b PULB. + SOLV. PT. SOL. INJ.PEGINTRON 120 µg 120µg SP EUROPE

150µgL03AB10 PEGINTERFERON alfa-2b PULB. + SOLV. PT. SOL. INJ.PEGINTRON 150 µg 150µg SP EUROPE

50µgL03AB10 PEGINTERFERON alfa-2b PULB. + SOLV. PT. SOL. INJ.PEGINTRON 50 µg 50µg SP EUROPE

400 PEGINTERFERON alfa-2a **** Protocol: J004NL03AB11

Tratamentul cu interferon alfa a fost asociat cu depresie şi suicid la unii pacienţi. Pacienţii cu istoric de ideaţie suicidară sau boală depresivă trebuie avertizaţi de riscuri. Trebuie

monitorizat statusul psihiatric în timpul tratamentului.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

135µg/mlL03AB11 PEGINTERFERON alfa-2a SOL. INJ.PEGASYS 135 µg/ml 135µg/ml ROCHE REGISTRATION LTD.

180µg/0.5mlL03AB11 PEGINTERFERON alfa-2a SOL. INJ. IN SERINGA PREUMPLUTAPEGASYS 180 µg/0,5ml 180µg/0.5ml ROCHE REGISTRATION LTD.

401 AMANTADINUM **N04BB01

100mgN04BB01 AMANTADINUM CAPS.VIREGYT®- K 100mg EGIS PHARMACEUTICALS LTD.

SUBLISTA C1-G5 HEPATITA AUTOIMUNA.

402 METHYLPREDNISOLONUMH02AB04

125mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 125 mg 125mg HEMOFARM S.R.L.

125mg/2mlH02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV.PT.SOL.INJSOLU - MEDROL ACT-O-VIAL 125mg/2ml PFIZER EUROPE MA EEIG

16mgH02AB04 METHYLPREDNISOLONUM COMPR.MEDROL A 16 16mg PFIZER EUROPE MA EEIG

20mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 20 mg 20mg HEMOFARM S.R.L.

250mg/4mlH02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV.PT.SOL.INJSOLU - MEDROL ACT-O-VIAL 250mg/4ml PFIZER EUROPE MA EEIG

32mgH02AB04 METHYLPREDNISOLONUM COMPR.MEDROL 32 32mg PFIZER EUROPE MA EEIG

40mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 40 mg 40mg HEMOFARM S.R.L.

40mg/1mlH02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV.PT.SOL.INJSOLU - MEDROL ACT-O-VIAL 40mg/1ml PFIZER EUROPE MA EEIG

4mgH02AB04 METHYLPREDNISOLONUM COMPR.MEDROL 4 mg 4mg PFIZER EUROPE MA EEIG

500mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 500 mg 500mg HEMOFARM S.R.L.

500mg/7.8mlH02AB04 METHYLPREDNISOLONUM LIOF. + SOLV. PT. SOL. INJ.SOLU - MEDROL 500 mg/7,8 ml 500mg/7.8ml PFIZER EUROPE MA EEIG

403 PREDNISOLONUMH02AB06

250mgH02AB06 PREDNISOLONUM LIOF. + SOLV. PT. SOL. INJ.SOLU - DECORTIN H 250 250mg MERCK KGAA

50mgH02AB06 PREDNISOLONUM LIOF. + SOLV. PT. SOL. INJ.SOLU - DECORTIN H 50 50mg MERCK KGAA

404 AZATHIOPRINUM *L04AX01

50mgL04AX01 AZATHIOPRINUM COMPR. FILM.IMURAN® 50mg THE WELLCOME FOUNDATION LTD.

SUBLISTA C1-G06 CIROZA BILIARA PRIMARA, COLANGITA SCLEROZANTA PRIMITIVA, HEPATITA CRONICA SI CIROZE DE

ALTE ETIOLOGII CU COLESTAZA.

405 ACIDUM URSODEOXYCHOLICUMA05AA02

300mgA05AA02 ACIDUM URSODEOXYCHOLICUM CAPS.URSOFALK (R) 250mg DR. FALK PHARMA GMBH

URSOFALK® 250mg DR. FALK PHARMA GMBH

URSOSAN 250mg PRO. MED. CS PRAHA AS

56 153/

Page 57: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

SUBLISTA C1-G7 CIROZA HEPATICA.

406 LACTULOSUM *A06AD11

66.7%A06AD11 LACTULOSUM LICHID ORALDUPHALAC® 66.7% SOLVAY PHARMACEUTICALS BV

A06AD11 LACTULOSUMLACTULOSE AL SIROP 66.7% ALIUD PHARMA GMBH & CO.KG

A06AD11 LACTULOSUMLAEVOLAC 670mg/ml 670mg/ml FRESENIUS KABI AUSTRIA GMBH

66.7%A06AD11 LACTULOSUM SIROPLACTULOSE AL SIROP 66.7% ALIUD PHARMA GMBH & CO.KG

670mg/mlA06AD11 LACTULOSUM SOL. ORALALAEVOLAC 670mg/ml 670mg/ml FRESENIUS KABI AUSTRIA GMBH

66.7%A06AD11 LACTULOSUM SIROPLACTULOSE AL SIROP 66.7% ALIUD PHARMA GMBH & CO.KG

670mg/mlA06AD11 LACTULOSUM SOL. ORALALAEVOLAC 670mg/ml 670mg/ml FRESENIUS KABI AUSTRIA GMBH

66.7%A06AD11 LACTULOSUM LICHID ORALDUPHALAC® 66.7% SOLVAY PHARMACEUTICALS BV

65%A06AD11 LACTULOSUM SIROPLACTULOSE 65% E.I.P.I.CO. MED S.R.L.

407 RIFAXIMINUM *A07AA11

200mgA07AA11 RIFAXIMINUM COMPR. FILM.NORMIX 200 mg 200mg ALFA WASSERMANN SPA

408 EPOETINUM ALFA ** Protocol: B013KB03XA01

10000ui/mlB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 10000 UI 10000ui/ml JOHNSON & JOHNSON D.O.O.

1000UI/0.5mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 1000 UI/0,5 ml 1000UI/0.5ml RENAMED FARMA S.R.L.

EPREX® 1000 UI 1000ui/0.5ml JOHNSON & JOHNSON D.O.O.

2000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPOPHAR 2000 U.I. 2000UI GULF PHARMACEUTICAL IND. S.R.L.

2000ui/0.5mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 2000 UI/0,5 ml 2000UI/0.5ml RENAMED FARMA S.R.L.

EPREX® 2000 UI 2000ui/0.5ml JOHNSON & JOHNSON D.O.O.

2000UI/1mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 2000 UI/1 ml 2000UI/1ml RENAMED FARMA S.R.L.

3000ui/0.3mlB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 3000 UI 3000ui/0.3ml JOHNSON & JOHNSON D.O.O.

40 000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 40 000 UI 40 000UI JOHNSON & JOHNSON D.O.O.

4000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPOPHAR 4000 U.I. 4000UI GULF PHARMACEUTICAL IND. S.R.L.

4000ui/0.4mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 4000 UI/0,4 ml 4000UI/0.4ml RENAMED FARMA S.R.L.

EPREX® 4000 UI 4000ui/0.4ml JOHNSON & JOHNSON D.O.O.

4000UI/1mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 4000 UI/1 ml 4000UI/1ml RENAMED FARMA S.R.L.

409 EPOETINUM BETA ** Protocol: B013KB03XA01

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 10000 UI 10000UI/0,6ml ROCHE REGISTRATION L

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 1000 UI 1000UI/0,3ml ROCHE REGISTRATION L

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 2000 UI 2000UI/0,3ml ROCHE REGISTRATION L

30000 UI/0,6mlB03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 30000UI/0,6ml 30000 UI/0,6ml ROCHE REGISTRATION LTD.

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 4000 UI 4000UI/0,3ml ROCHE REGISTRATION L

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 5000 UI 5000UI/0,3ml ROCHE REGISTRATION L

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 500 UI 500UI/0,3ml ROCHE REGISTRATION L

410 FUROSEMIDUMC03CA01Electroliţii serici trebuie să fie verificaţi periodic.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

10mg/mlC03CA01 FUROSEMIDUM SOL. INJ.FUROSEMID 20 mg/2 ml 10mg/ml ZENTIVA SA

40mgC03CA01 FUROSEMIDUM COMPR.FUROSEMID ARENA 40 mg 40mg ARENA GROUP S.A.

FUROSEMID EEL 40mg BIO EEL SRL

FUROSEMID LPH 40 mg 40mg LABORMED PHARMA SA

FUROSEMID MCC 40 mg 40mg MAGISTRA C & C SRL

FUROSEMID SLAVIA 40mg SLAVIA PHARM SRL

FUROSEMID ZENTIVA 40mg ZENTIVA SA

411 SPIRONOLACTONUMC03DA01

Electroliţii serici trebuie să fie verificaţi periodic.

Femeile la varsta fertila la care s-a initiat tratament cu spironolactona trebuie sa ia masuri adecvate de contraceptie.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgC03DA01 SPIRONOLACTONUM CAPS.

57 153/

Page 58: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

VEROSPIRON 100mg GEDEON RICHTER LTD.

25mgC03DA01 SPIRONOLACTONUM COMPR.SPIRONOLACTONA 25 mg 25mg BIO EEL SRL

25mgC03DA01 SPIRONOLACTONUM COMPR. FILM.ALSPIRON 25 mg 25mg AC HELCOR PHARMA SRL

SPIRONOLACTONA 25 mg 25mg TERAPIA SA

50mgC03DA01 SPIRONOLACTONUM CAPS.VEROSPIRON 50mg GEDEON RICHTER LTD.

50mgC03DA01 SPIRONOLACTONUM COMPR. FILM.ALSPIRON 50 mg 50mg AC HELCOR PHARMA SRL

412 PREDNISOLONUMH02AB06

250mgH02AB06 PREDNISOLONUM LIOF. + SOLV. PT. SOL. INJ.SOLU - DECORTIN H 250 250mg MERCK KGAA

50mgH02AB06 PREDNISOLONUM LIOF. + SOLV. PT. SOL. INJ.SOLU - DECORTIN H 50 50mg MERCK KGAA

413 RIBAVIRINUM ****J05AB04

200mgJ05AB04 RIBAVIRINUM CAPS.REBETOL 200 mg 200mg SP EUROPE

200mgJ05AB04 RIBAVIRINUM COMPR. FILM.COPEGUS® 200mg ROCHE ROMANIA SRL

414 LAMIVUDINUM ****J05AF05

100mgJ05AF05 LAMIVUDINUM COMPR. FILM.ZEFFIX 100 mg 100mg GLAXO GROUP LTD.

10mg/mlJ05AF05 LAMIVUDINUM SOL. ORALAEPIVIR 10mg/ml 10mg/ml GLAXO GROUP LTD.

150mgJ05AF05 LAMIVUDINUM COMPR. FILM.EPIVIR 150mg 150mg GLAXO GROUP LTD.

5mg/mlJ05AF05 LAMIVUDINUM SOL. ORALAZEFFIX 5 mg/ml 5mg/ml GLAXO GROUP LTD.

416 ENTECAVIRUM ****J05AF10

0,5mgJ05AF10 ENTECAVIRUM COMPR. FILM.BARACLUDE 0,5mg 0,5mg BRISTOL-MYERS SQUIBB PHARMA EEIG

1mgJ05AF10 ENTECAVIRUM COMPR. FILM.BARACLUDE 1mg 1mg BRISTOL-MYERS SQUIBB PHARMA EEIG

417 FILGRASTIMUM (G-CSF) ** Protocol: B013KL03AA02

30MU/0.5mlL03AA02 FILGRASTIMUM (G-CSF) SOL. INJ.NEUPOGEN® 30MU/0.5ml AMGEN EUROPE B.V.

48MU/0.5mlL03AA02 FILGRASTIMUM (G-CSF) SOL. INJ.NEUPOGEN® 48MU/0.5ml AMGEN EUROPE B.V.

418 INTERFERONUM ALFA 2a ****L03AB04

Tratamentul cu interferon alfa a fost asociat cu depresie şi suicid la unii pacienţi. Pacienţii cu istoric de ideaţie suicidară sau boală depresivă trebuie avertizaţi de riscuri. Trebuie

monitorizat statusul psihiatric în timpul tratamentului.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

18Mui/0.6mlL03AB04 INTERFERONUM ALFA 2a SOL. INJ.ROFERON A 18Mui/0.6ml ROCHE ROMANIA S.R.L.

3Mui/0.5mlL03AB04 INTERFERONUM ALFA 2a SOL. INJ.ROFERON A 3Mui/0.5ml ROCHE ROMANIA S.R.L.

4.5Mui/0.5mlL03AB04 INTERFERONUM ALFA 2a SOL. INJ.ROFERON A 4.5Mui/0.5ml ROCHE ROMANIA S.R.L.

9Mui/0.5mlL03AB04 INTERFERONUM ALFA 2a SOL. INJ.ROFERON A 9Mui/0.5ml ROCHE ROMANIA S.R.L.

3Mui/0.5mlL03AB04 INTERFERONUM ALFA 2a SOL. INJ.ROFERON A 3Mui/0.5ml ROCHE ROMANIA S.R.L.

4.5Mui/0.5mlL03AB04 INTERFERONUM ALFA 2a SOL. INJ.ROFERON A 4.5Mui/0.5ml ROCHE ROMANIA S.R.L.

9Mui/0.5mlL03AB04 INTERFERONUM ALFA 2a SOL. INJ.ROFERON A 9Mui/0.5ml ROCHE ROMANIA S.R.L.

419 INTERFERONUM ALFA 2b ****L03AB05

Tratamentul cu interferon alfa a fost asociat cu depresie şi suicid la unii pacienţi. Pacienţii cu istoric de ideaţie suicidară sau boală depresivă trebuie avertizaţi de riscuri. Trebuie

monitorizat statusul psihiatric în timpul tratamentului.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

18 milioane U.I.L03AB05 INTERFERONUM ALFA 2b SOL. INJ. PEN MULTIDOZAINTRON A 18 milioane U.I. 18 milioane U.I. SP EUROPE

30 milioane U.I.L03AB05 INTERFERONUM ALFA 2b SOL. INJ. PEN MULTIDOZAINTRON A 30 milioane U.I. 30 milioane U.I. SP EUROPE

INTRON A 60 milioane U.I. 60 milioane U.I. SP EUROPE

60 milioane U.I.L03AB05 INTERFERONUM ALFA 2b SOL. INJ. PEN MULTIDOZAINTRON A 30 milioane U.I. 30 milioane U.I. SP EUROPE

INTRON A 60 milioane U.I. 60 milioane U.I. SP EUROPE

420 PEGINTERFERON alfa-2b ****L03AB10

Tratamentul cu interferon alfa a fost asociat cu depresie şi suicid la unii pacienţi. Pacienţii cu istoric de ideaţie suicidară sau boală depresivă trebuie avertizaţi de riscuri. Trebuie

monitorizat statusul psihiatric în timpul tratamentului.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100µgL03AB10 PEGINTERFERON alfa-2b PULB. + SOLV. PT. SOL. INJ.PEGINTRON 100 µg 100µg SP EUROPE

120µgL03AB10 PEGINTERFERON alfa-2b PULB. + SOLV. PT. SOL. INJ.PEGINTRON 120 µg 120µg SP EUROPE

150µgL03AB10 PEGINTERFERON alfa-2b PULB. + SOLV. PT. SOL. INJ.PEGINTRON 150 µg 150µg SP EUROPE

58 153/

Page 59: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

50µgL03AB10 PEGINTERFERON alfa-2b PULB. + SOLV. PT. SOL. INJ.PEGINTRON 50 µg 50µg SP EUROPE

421 PEGINTERFERON alfa-2a ****L03AB11

Tratamentul cu interferon alfa a fost asociat cu depresie şi suicid la unii pacienţi. Pacienţii cu istoric de ideaţie suicidară sau boală depresivă trebuie avertizaţi de riscuri. Trebuie

monitorizat statusul psihiatric în timpul tratamentului.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

135µg/mlL03AB11 PEGINTERFERON alfa-2a SOL. INJ.PEGASYS 135 µg/ml 135µg/ml ROCHE REGISTRATION LTD.

180µg/0.5mlL03AB11 PEGINTERFERON alfa-2a SOL. INJ. IN SERINGA PREUMPLUTAPEGASYS 180 µg/0,5ml 180µg/0.5ml ROCHE REGISTRATION LTD.

422 AMANTADINUM **N04BB01

100mgN04BB01 AMANTADINUM CAPS.VIREGYT®- K 100mg EGIS PHARMACEUTICALS LTD.

59 153/

Page 60: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

Protocol: N030CSUBLISTA C1-G10 LEUCEMII, LIMFOAME, APLAZIE MEDULARA, GAMAPATII MONOCLONALE MALIGNE, MIELOPROLIFERARI

CRONICE SI TUMORI MALIGNE, SINDROAME MIELODISPLAZICE.

423 ONDANSETRONUM ** Protocol: A004CA04AA01

2mg/mlA04AA01 ONDANSETRONUM SOL. INJ.OSETRON 4 mg 2mg/ml DR. REDDY'S LABORATORIES

OSETRON 8 mg 2mg/ml DR. REDDY'S LABORATORIES

2mg/mlA04AA01 ONDANSETRONUM SOL. INJ./PERF.EMESET 4 mg/2 ml 2mg/ml CIPLA (UK) LIMITED

EMESET 8 mg/4 ml 2mg/ml CIPLA (UK) LIMITED

4mgA04AA01 ONDANSETRONUM COMPR. FILM.OSETRON 4 mg 4mg DR. REDDY'S LABORATORIES

SETRONON 4 mg 4mg PLIVA LJUBLJANA D.O.O.

ZOFRAN 4 mg 4mg GLAXO WELLCOME UK LTD.

4mgA04AA01 ONDANSETRONUM COMPR. ORODISPERSABILEONDARAN MD 4mg 4mg RANBAXY UK LTD.

4mg/2mlA04AA01 ONDANSETRONUM SOL. INJ.ZOFRAN 4mg/2ml 4mg/2ml GLAXO WELLCOME UK LIMITED

4mg/2mlA04AA01 ONDANSETRONUM SOL. INJ./PERF.SETRONON 4 mg/2 ml 4mg/2ml PLIVA LJUBLJANA D.O.O.

8mgA04AA01 ONDANSETRONUM COMPR. FILM.OSETRON 8 mg 8mg DR. REDDY'S LABORATORIES (UK) LTD

SETRONON 8 mg 8mg PLIVA LJUBLJANA D.O.O.

8mgA04AA01 ONDANSETRONUM COMPR. ORODISPERSABILEONDARAN MD 8 mg 8mg RANBAXY UK LIMITED

8mg/4mlA04AA01 ONDANSETRONUM SOL. INJ.ZOFRAN 8mg/4ml 8mg/4ml GLAXO WELLCOME UK LIMITED

4mgA04AA01 ONDANSETRONUM COMPR. FILM.OSETRON 4 mg 4mg DR. REDDY'S LABORATORIES

SETRONON 4 mg 4mg PLIVA LJUBLJANA D.O.O.

ZOFRAN 4 mg 4mg GLAXO WELLCOME UK LTD.

4mgA04AA01 ONDANSETRONUM COMPR. ORODISPERSABILEONDARAN MD 4mg 4mg RANBAXY UK LTD.

8mgA04AA01 ONDANSETRONUM COMPR. FILM.OSETRON 8 mg 8mg DR. REDDY'S LABORATORIES (UK) LTD

SETRONON 8 mg 8mg PLIVA LJUBLJANA D.O.O.

8mgA04AA01 ONDANSETRONUM COMPR. ORODISPERSABILEONDARAN MD 8 mg 8mg RANBAXY UK LIMITED

8mg/4 mlA04AA01 ONDANSETRONUM SOL. INJ./PERF.SETRONON 8 mg/4 ml 8mg/4 ml PLIVA LJUBLJANA D.O.O.

424 GRANISETRONUM ** Protocol: A004CA04AA02

1mgA04AA02 GRANISETRONUM COMPR. FILM.KYTRIL® 1 mg 1mg ROCHE ROMANIA S.R.L.

2mgA04AA02 GRANISETRONUM COMPR. FILM.KYTRIL 2mg F. HOFFMANN LA ROCHE LTD.

3mg/3mlA04AA02 GRANISETRONUM SOL. INJ.KYTRIL 3mg/3ml ROCHE ROMANIA SRL

2mgA04AA02 GRANISETRONUM COMPR. FILM.KYTRIL 2mg F. HOFFMANN LA ROCHE LTD.

425 PALONOSETRONUM ** Protocol: A002C;A004CA04AA05

250 µg/5mlA04AA05 PALONOSETRONUM SOL. INJ.ALOXI 250 µg/5ml HELSINN BIREX PHARMACEUTICALS LTD.

426 EPOETINUM ALFA *** Protocol: L022BB03XA01

10000ui/mlB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 10000 UI 10000ui/ml JOHNSON & JOHNSON D.O.O.

1000UI/0.5mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 1000 UI/0,5 ml 1000UI/0.5ml RENAMED FARMA S.R.L.

EPREX® 1000 UI 1000ui/0.5ml JOHNSON & JOHNSON D.O.O.

2000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPOPHAR 2000 U.I. 2000UI GULF PHARMACEUTICAL IND. S.R.L.

2000ui/0.5mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 2000 UI/0,5 ml 2000UI/0.5ml RENAMED FARMA S.R.L.

EPREX® 2000 UI 2000ui/0.5ml JOHNSON & JOHNSON D.O.O.

2000UI/1mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 2000 UI/1 ml 2000UI/1ml RENAMED FARMA S.R.L.

3000ui/0.3mlB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 3000 UI 3000ui/0.3ml JOHNSON & JOHNSON D.O.O.

40 000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 40 000 UI 40 000UI JOHNSON & JOHNSON D.O.O.

4000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPOPHAR 4000 U.I. 4000UI GULF PHARMACEUTICAL IND. S.R.L.

4000ui/0.4mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 4000 UI/0,4 ml 4000UI/0.4ml RENAMED FARMA S.R.L.

EPREX® 4000 UI 4000ui/0.4ml JOHNSON & JOHNSON D.O.O.

4000UI/1mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 4000 UI/1 ml 4000UI/1ml RENAMED FARMA S.R.L.

427 EPOETINUM BETA *** Protocol: L022BB03XA01

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 10000 UI 10000UI/0,6ml ROCHE REGISTRATION L

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 1000 UI 1000UI/0,3ml ROCHE REGISTRATION L

60 153/

Page 61: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 2000 UI 2000UI/0,3ml ROCHE REGISTRATION L

30000 UI/0,6mlB03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 30000UI/0,6ml 30000 UI/0,6ml ROCHE REGISTRATION LTD.

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 4000 UI 4000UI/0,3ml ROCHE REGISTRATION L

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 5000 UI 5000UI/0,3ml ROCHE REGISTRATION L

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 500 UI 500UI/0,3ml ROCHE REGISTRATION L

428 DARBEPOETINUM ALFA *** Protocol: L022BB03XA02

10µg/0.4mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 10µg/0.4ml 10µg/0.4ml AMGEN EUROPE BV

100µg/0.5mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 100µg/0.5ml 100µg/0.5ml AMGEN EUROPE BV

15µg/0.375mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 15µg/0.375ml 15µg/0.375ml AMGEN EUROPE BV

150µg/0.3mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 150µg/0.3ml 150µg/0.3ml AMGEN EUROPE BV

20µg/0.5mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 20µg/0.5ml 20µg/0.5ml AMGEN EUROPE BV

30µg/0.3mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 30µg/0.3ml 30µg/0.3ml AMGEN EUROPE BV

300µg/0.6mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 300µg/0.6ml 300µg/0.6ml AMGEN EUROPE BV

40µg/0.4mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 40µg/0.4ml 40µg/0.4ml AMGEN EUROPE BV

50µg/0.5mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 50µg/0.5ml 50µg/0.5ml AMGEN EUROPE BV

500µg/mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 500µg/ml 500µg/ml AMGEN EUROPE BV

60µg/0.3mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 60µg/0.3ml 60µg/0.3ml AMGEN EUROPE BV

80µg/0.4mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 80µg/0.4ml 80µg/0.4ml AMGEN EUROPE BV

429 CYPROTERONUM **G03HA01

50mgG03HA01 CYPROTERONUM COMPR.ANDROCUR 50mg SCHERING AG

Cancer de prostata in stadiu avansat;Cod restrictie 1014:

G03HA01 CYPROTERONUMANDROCUR 50mg SCHERING AG

430 DEXAMETHASONUMH02AB02

8mgH02AB02 DEXAMETHASONUM SOL. INJ.DEXAMETHASONE SODIUM PHOSPHATE 8mg E.I.P.I.CO. MED S.R.L.

8mg/2mlH02AB02 DEXAMETHASONUM SOL. INJ.DEXAMED 8mg/2ml MEDOCHEMIE LTD.

431 ITRACONAZOLUMJ02AC02

100mgJ02AC02 ITRACONAZOLUM CAPS.ITRACONAZOL 100 mg 100mg TERAPIA S.A.

OMICRAL 100 mg 100mg MEDICO UNO PHARMACEUTICAL S.R.L.

ORUNGAL 100mg JANSSEN PHARMACEUTICA NV

432 VORICONAZOLUM ** Protocol: J012BJ02AC03

200mgJ02AC03 VORICONAZOLUM COMPR. FILM.VFEND 200mg 200mg PFIZER LTD.

200mgJ02AC03 VORICONAZOLUM PULB. PT. SOL. PERF.VFEND 200mg 200mg PFIZER LTD.

40mg/mlJ02AC03 VORICONAZOLUM PULB. PT. SUSP. ORALAVFEND 40 mg/ml 40mg/ml PFIZER LTD.

50mgJ02AC03 VORICONAZOLUM COMPR. FILM.VFEND 50mg 50mg PFIZER LTD.

433 POSACONAZOLUM **J02AC04

40mg/mlJ02AC04 POSACONAZOLUM SUSP. ORALANOXAFIL SP 40mg/ml 40mg/ml SP EUROPE

Profilaxia si infectiilor fungice invazive la pacientii aflati sub chimioterapie de inductie-remisie pentru LAM sau pentru sindroame mielodisplazice si care prezinta risc

inalt de a dezvolta infectii fungice masive;

Prescriere limitata:

Profilaxia si infectiilor fungice invazive la pacientii in procedura de transplant medular si aflati sub terapie imunosupresoare cu doze mari, cu risc mare de a dezvolta

infectii fungice masive.

Prescriere limitata:

434 CASPOFUNGINUM ** Protocol: J010DJ02AX04

50mgJ02AX04 CASPOFUNGINUM PULB. PT. CONC. PT. SOL. PERF.CANCIDAS 50 mg 50mg MERCK SHARP & DOHME LTD

70mgJ02AX04 CASPOFUNGINUM PULB. PT. CONC. PT. SOL. PERF.CANCIDAS 70 mg 70mg MERCK SHARP & DOHME LTD

435 ANAGRELIDUM *** Protocol: L015DL01XX35

0.5mgL01XX35 ANAGRELIDUM CAPS.THROMBOREDUCTIN 0.5mg ORPHA-DEVEL HANDELS UND VERTRIEBS GMBH

436 CICLOSPORINUM *L04AA01

100mgL04AA01 CICLOSPORINUM CAPS. MOIEQUORAL® 100 mg 100mg IVAX - PHARMACEUTICALS S.R.O.

100mg/mlL04AA01 CICLOSPORINUM SOL. ORALA

61 153/

Page 62: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

EQUORAL® 100mg/ml IVAX - PHARMACEUTICALS S.R.O.

SANDIMMUN NEORAL® 100mg/ml NOVARTIS PHARMA GMBH

25mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL® 25 mg 25mg HEXAL AG

EQUORAL® 25 mg 25mg IVAX - PHARMACEUTICALS S.R.O.

SANDIMMUN NEORAL® 25mg NOVARTIS PHARMA GMBH

50mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL 50 mg 50mg HEXAL AG

EQUORAL® 50 mg 50mg IVAX - PHARMACEUTICALS S.R.O.

SANDIMMUN NEORAL® 50mg NOVARTIS PHARMA GMBH

437 MORPHYNUMN02AA01

Prescriere limitata: Durere severa, invalidanta, asociata cu diagnosticul de cancer.

Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide.

Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni.

Risc inalt de aparitie a dependentei.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare acestui DCI

100mgN02AA01 MORPHYNUM COMPR. FILM. ELIB. MODIF.MST CONTINUS® 100 mg 100mg MUNDIPHARMA GMBH

100mgN02AA01 MORPHYNUM COMPR. FILM. ELIB. PREL.VENDAL® RETARD 100 mg 100mg LANNACHER HEILMITTEL GMBH

10mgN02AA01 MORPHYNUM COMPR. FILM.SEVREDOL 10 mg 10mg MUNDIPHARMA GMBH

10mgN02AA01 MORPHYNUM COMPR. FILM. ELIB. MODIF.MST CONTINUS® 10 mg 10mg MUNDIPHARMA GMBH

10mgN02AA01 MORPHYNUM COMPR. FILM. ELIB. PREL.VENDAL® RETARD 10 mg 10mg LANNACHER HEILMITTEL GMBH

200mgN02AA01 MORPHYNUM COMPR. FILM. ELIB. MODIF.MST CONTINUS® 200 mg 200mg MUNDIPHARMA GMBH

20mgN02AA01 MORPHYNUM COMPR. FILM.SEVREDOL 20 mg 20mg MUNDIPHARMA GMBH

20mg/mlN02AA01 MORPHYNUM SOL. INJ.MORFINA 20 mg/ml 20mg/ml ZENTIVA S.A.

30mgN02AA01 MORPHYNUM COMPR. FILM. ELIB. MODIF.MST CONTINUS® 30 mg 30mg MUNDIPHARMA GMBH

30mgN02AA01 MORPHYNUM COMPR. FILM. ELIB. PREL.VENDAL® RETARD 30 mg 30mg LANNACHER HEILMITTEL GMBH

60mgN02AA01 MORPHYNUM COMPR. FILM. ELIB. MODIF.MST CONTINUS® 60 mg 60mg MUNDIPHARMA GMBH

60mgN02AA01 MORPHYNUM COMPR. FILM. ELIB. PREL.VENDAL® RETARD 60 mg 60mg LANNACHER HEILMITTEL GMBH

438 OXYCODONUMN02AA05

Prescriere limitata: Durere severa, invalidanta, asociata cu diagnosticul de cancer.

Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide.

Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni.

Risc inalt de aparitie a dependentei.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare acestui DCI

10 mgN02AA05 OXYCODONUM COMPR. FILM. ELIB. MODIF.OXYCONTIN® 10 mg 10 mg MUNDIPHARMA GMBH

20 mgN02AA05 OXYCODONUM COMPR. FILM. ELIB. MODIF.OXYCONTIN® 20 mg 20 mg MUNDIPHARMA GMBH

40 mgN02AA05 OXYCODONUM COMPR. FILM. ELIB. MODIF.OXYCONTIN® 40 mg 40 mg MUNDIPHARMA GMBH

80mgN02AA05 OXYCODONUM COMPR. FILM. ELIB. MODIF.OXYCONTIN® 80 mg 80mg MUNDIPHARMA GMBH

439 DIHYDROCODEINUMN02AA08

120mgN02AA08 DIHYDROCODEINUM COMPR. ELIB. PREL.DHC CONTINUS 120 mg 120mg MUNDIPHARMA GMBH

60mgN02AA08 DIHYDROCODEINUM COMPR. ELIB. PREL.DHC CONTINUS 60 mg 60mg MUNDIPHARMA GMBH

90mgN02AA08 DIHYDROCODEINUM COMPR. ELIB. PREL.DHC CONTINUS 90 mg 90mg MUNDIPHARMA GMBH

440 PETHIDINUMN02AB02

50mg/mlN02AB02 PETHIDINUM SOL. INJ.MIALGIN® 100 mg/2 ml 50mg/ml ZENTIVA SA

441 FENTANYLUM **N02AB03

Prescriere limitata: Durere severa, invalidanta, asociata cu diagnosticul de cancer.

Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide.

Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare acestui DCI.

100µg/hN02AB03 FENTANYLUM PLASTURE TRANSDERMICFENTANYL SANDOZ 100 µg/h 100µg/h SANDOZ S.R.L.

16.8mg/42.0cmpN02AB03 FENTANYLUM PLASTURE TRANSDERM.DUROGESIC 100 µg/h 16.8mg/42.0cmp JANSSEN PHARMACEUTICA NV

25µg/hN02AB03 FENTANYLUM PLASTURE TRANSDERMICFENTANYL SANDOZ 25 µg/h 25µg/h SANDOZ S.R.L.

4.2mg/10.5cmpN02AB03 FENTANYLUM PLASTURE TRANSDERM.DUROGESIC 25 µg/h 4.2mg/10.5cmp JANSSEN PHARMACEUTICA NV

50µg/hN02AB03 FENTANYLUM PLASTURE TRANSDERMICFENTANYL SANDOZ 50 µg/h 50µg/h SANDOZ S.R.L.

75µg/hN02AB03 FENTANYLUM PLASTURE TRANSDERMIC

62 153/

Page 63: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

FENTANYL SANDOZ 75 µg/h 75µg/h SANDOZ S.R.L.

8.4mg/21.0cmpN02AB03 FENTANYLUM PLASTURE TRANSDERM.DUROGESIC 50 µg/h 8.4mg/21.0cmp JANSSEN PHARMACEUTICA NV

442 TRAMADOLUMN02AX02

Prescriere limitata: Durere severa, care nu raspunde la analgezice non-opioide.

Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice (mai putin formelor injenctabile) si concentratiilor corespunzatoare DCI-ului.

100mgN02AX02 TRAMADOLUM COMPR. ELIB. MODIF.TRAMADOLOR® 100 ID 100mg HEXAL AG

100mgN02AX02 TRAMADOLUM COMPR. ELIB. PREL.TRALGIT SR 100 100mg ZENTIVA AS

TRAMADOL® RETARD 100mg KRKA D.D.

100mgN02AX02 TRAMADOLUM COMPR. FILM. ELIB. PREL.TRAMAL RETARD 100 mg 100mg GRUNENTHAL GMBH

100mgN02AX02 TRAMADOLUM SOL. INJ.MABRON 100mg MEDOCHEMIE LTD.

TRADOLAN 100mg LANNACHER HEILMITTEL GMBH

Tratamentul de scurta durata al durerii acute.Prescriere limitata:

100mgN02AX02 TRAMADOLUM SUPOZ.TRADOLAN 100mg LANNACHER HEILMITTEL GMBH

TRAMADOL 100mg KRKA D.D.

TRAMAG 100 100mg MAGISTRA C & C

TRAMAL® 100mg GRUNENTHAL GMBH

100mg/2mlN02AX02 TRAMADOLUM SOL. INJ.TRALGIT 100 100mg/2ml ZENTIVA A.S.

Tratamentul de scurta durata al durerii acute.Prescriere limitata:

100mg/mlN02AX02 TRAMADOLUM PIC. ORALE, SOL.TRALGIT 100mg/ml ZENTIVA A.S.

100mg/mlN02AX02 TRAMADOLUM SOL. ORALATRADOLAN 100mg/ml LANNACHER HEILMITTEL GMBH

150mgN02AX02 TRAMADOLUM COMPR. ELIB. PREL.TRALGIT SR 150 150mg ZENTIVA AS

150mgN02AX02 TRAMADOLUM COMPR. FILM. ELIB. PREL.TRAMADOL RETARD 150 mg 150mg KRKA D.D. NOVO MESTO

TRAMAL RETARD 150 mg 150mg GRUNENTHAL GMBH

200mgN02AX02 TRAMADOLUM COMPR. ELIB. PREL.TRALGIT SR 200 200mg ZENTIVA AS

200mgN02AX02 TRAMADOLUM COMPR. FILM. ELIB. PREL.TRAMADOL RETARD 200 mg 200mg KRKA D.D. NOVO MESTO

TRAMAL RETARD 200 mg 200mg GRUNENTHAL GMBH

50mgN02AX02 TRAMADOLUM CAPS.K-ALMA® 50mg ANTIBIOTICE SA

MABRON 50 mg 50mg MEDOCHEMIE LTD.

TRALGIT 50 50mg ZENTIVA A.S.

TRAMACALM 50mg AC HELCOR SRL

TRAMADOL 50mg KRKA D.D.

TRAMADOL LPH 50 mg 50mg LABORMED PHARMA SA

TRAMADOL AL 50 50mg ALIUD® PHARMA GMBH & CO.KG

TRAMADOL ARENA 50mg ARENA GROUP S.A.

TRAMAL® 50mg GRUNENTHAL GMBH

URGENDOL 50mg MEDICAROM GROUP SRL

50mgN02AX02 TRAMADOLUM COMPR.TRAMADOL 50 mg 50mg OZONE LABORATORIES LTD.

TRAMADOL EEL 50mg BIO EEL SRL

TRAMAG 50 50mg MAGISTRA C & C

50mgN02AX02 TRAMADOLUM COMPR. FILM.TRADOLAN 50 mg 50mg LANNACHER HEILMITTEL GMBH

50mgN02AX02 TRAMADOLUM SOL. INJ.TRADOLAN 50 mg 50mg LANNACHER HEILMITTEL GMBH

Tratamentul de scurta durata al durerii acute.Prescriere limitata:

50mg/mlN02AX02 TRAMADOLUM SOL. INJ.TRALGIT 50 50mg/ml ZENTIVA A.S.

TRAMADOL 50mg/ml KRKA D.D.

TRAMADOL® AL 100 Fiole 50mg/ml ALIUD® PHARMA GMBH & CO.KG

TRAMAL® 100 50mg/ml GRUNENTHAL GMBH

TRAMAL® 50 50mg/ml GRUNENTHAL GMBH

URGENDOL 50mg/ml MEDICAROM GROUP SRL

Tratamentul de scurta durata al durerii acute.Prescriere limitata:

N02AX02 TRAMADOLUM PIC. ORALE, SOL.TRAMADOL AL PICATURI ALIUD PHARMA GMBH & CO.KG

100mg/mlN02AX02 TRAMADOLUM PICATURI ORALE-SOL.TRAMAL® 100mg/ml GRUNENTHAL GMBH

443 METHADONUMN07BC02Risc inalt de aparitie a dependentei.

2.5mgN07BC02 METHADONUM COMPR.SINTALGON 2,5 mg 2.5mg ZENTIVA S.A.

444 CODEINUMR05DA04

15mgR05DA04 CODEINUM COMPR.CODEINA FOSFAT 15mg SLAVIA PHARM SRL

CODEINA FOSFAT 15 mg 15mg OZONE LABORATORIES LTD.

CODEINA FOSFAT LPH 15 mg 15mg LABORMED PHARMA SA

CODEINA FOSFORICA 15mg BIO EEL SRL

CODEINA FOSFORICA 15 mg 15mg MAGISTRA C & C

63 153/

Page 64: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

FARMACOD 15mg FARMACOM SA

FOSFAT DE CODEINA 15 mg 15mg SINTOFARM SA

445 DEFEROXAMINUM **(3) Protocol: V001DV03AC01

500mgV03AC01 DEFEROXAMINUM LIOF. PT. SOL. INJ./PERF.DESFERAL 500mg NOVARTIS PHARMA GMBH

446 DEFERASIROXUM *** Protocol: V002DV03AC03

125mgV03AC03 DEFERASIROXUM COMPR. DISP.EXJADE 125mg 125mg NOVARTIS EUROPHARM LTD.

250mgV03AC03 DEFERASIROXUM COMPR. DISP.EXJADE 250mg 250mg NOVARTIS EUROPHARM LTD.

500mgV03AC03 DEFERASIROXUM COMPR. DISP.EXJADE 500mg 500mg NOVARTIS EUROPHARM LTD.

64 153/

Page 65: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

Protocol: NG01GSUBLISTA C1-G11 EPILEPSIE.

447 PHENOBARBITALUMN03AA02

100 mgN03AA02 PHENOBARBITALUM COMPR.FENOBARBITAL 100 mg 100 mg ZENTIVA SA

EpilepsiePrescriere limitata:

100mgN03AA02 PHENOBARBITALUM COMPR.FENOBARBITAL 100 mg 100mg SC ARENA GROUP SA

EpilepsiePrescriere limitata:

10%N03AA02 PHENOBARBITALUM SOL. INJ.FENOBARBITAL 200 mg/ 2 ml 10% ZENTIVA S.A

448 PHENYTOINUMN03AB02

100mgN03AB02 PHENYTOINUM COMPR.FENITOIN 100 mg 100mg GEDEON RICHTER ROMANIA SA

50mg/mlN03AB02 PHENYTOINUM SOL. INJ.PHENHYDAN®SOLUTIE INJECTABILA 50mg/ml DESITIN

449 CLONAZEPAMUMN03AE01

0.5mgN03AE01 CLONAZEPAMUM COMPR.RIVOTRIL 0.5mg ROCHE ROMANIA S.R.L.

2mgN03AE01 CLONAZEPAMUM COMPR.RIVOTRIL® 2mg ROCHE ROMANIA S.R.L.

450 CARBAMAZEPINUMN03AF01

100mg/5mlN03AF01 CARBAMAZEPINUM SUSP. ORALATIMONIL SIROP 100mg/5ml DESITIN ARZNEIMITTEL GMBH

150mgN03AF01 CARBAMAZEPINUM COMPR. RET.TIMONIL 150 RETARD 150mg DESITIN

200mgN03AF01 CARBAMAZEPINUM COMPR.CARBAMAZEPIN 200mg SLAVIA PHARM SRL

CARBAMAZEPIN EEL 200mg BIO EEL SRL

CARBAMAZEPINA 200mg OZONE LABORATORIES LTD.

CARBAMAZEPINA ARENA 200 mg 200mg ARENA GROUP SA

CARBAMAZEPINA LPH 200 mg 200mg LABORMED PHARMA SA

CARBAVIM 200mg VIM SPECTRUM SRL

CARBEPSIL 200 200mg AC HELCOR SRL

FINLEPSIN 200mg AWD PHARMA GMBH & CO.KG

NEUROTOP 200mg GEROT PHARMAZEUTIKA GMBH

TAVER 200mg MEDOCHEMIE LTD.

TEGRETOL® 200 200mg NOVARTIS PHARMA GMBH

200mgN03AF01 CARBAMAZEPINUM COMPR. FILM. ELIB. PREL.TEGRETOL CR 200 200mg NOVARTIS PHARMA GMBH

300mgN03AF01 CARBAMAZEPINUM COMPR. ELIB. PREL.NEUROTOP® RETARD 300 mg 300mg GEROT PHARMAZEUTIKA GMBH

300mgN03AF01 CARBAMAZEPINUM COMPR. RET.TIMONIL 300 RETARD 300mg DESITIN

400mgN03AF01 CARBAMAZEPINUM COMPR.CARBEPSIL 400 400mg AC HELCOR SRL

TEGRETOL® 400 400mg NOVARTIS PHARMA GMBH

400mgN03AF01 CARBAMAZEPINUM COMPR. FILM. ELIB. PREL.TEGRETOL CR 400 400mg NOVARTIS PHARMA GMBH

400mgN03AF01 CARBAMAZEPINUM COMPR. RET.FINLEPSIN 400 RETARD 400mg AWD PHARMA GMBH & CO.KG

600mgN03AF01 CARBAMAZEPINUM COMPR. ELIB. PREL.NEUROTOP® RETARD 600 mg 600mg GEROT PHARMAZEUTIKA GMBH

600mgN03AF01 CARBAMAZEPINUM COMPR. RET.TIMONIL 600 RETARD 600mg DESITIN

200mgN03AF01 CARBAMAZEPINUM COMPR.FILM.ELIB.PRELFINLEPSIN 200 RETARD 200mg AWD PHARMA GMBH & CO.KG

451 OXCARBAZEPINUMN03AF02

Cod restrictie 1587: Tratamentul crizelor epileptice partiale si al crizelor primare cu contractii tonico-clonice generalizate, care nu pot fi suficient controlate cu alte medicamente

anti-epileptice

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare acestui DCI.

300mgN03AF02 OXCARBAZEPINUM COMPR. FILM.TRILEPTAL® 300 mg 300mg NOVARTIS PHARMA GMBH

600mgN03AF02 OXCARBAZEPINUM COMPR. FILM.TRILEPTAL® 600 mg 600mg NOVARTIS PHARMA GMBH

452 ACIDUM VALPROICUM + SARURIN03AG01S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare acestui DCI.

1000mgN03AG01 ACIDUM VALPROICUM + SARURI MINICOMPR. ELIB. PREL.ORFIRIL LONG 1000 mg 1000mg DESITIN ARZNEIMITTEL GMBH

150mgN03AG01 ACIDUM VALPROICUM + SARURI CAPS. ELIB. PREL.ORFIRIL LONG 150 mg 150mg DESITIN ARZNEIMITTEL GMBH

150mgN03AG01 ACIDUM VALPROICUM + SARURI CAPS. MOI GASTROREZ.CONVULEX® 150 mg 150mg GEROT PHARMAZEUTIKA GMBH

150mgN03AG01 ACIDUM VALPROICUM + SARURI COMPR. FILM. GASTROREZ.ORFIRIL 150 150mg DESITIN ARZNEIMITTEL GMBH

200mgN03AG01 ACIDUM VALPROICUM + SARURI COMPR. FILM.PETILIN 200mg REMEDICA LTD.

200mgN03AG01 ACIDUM VALPROICUM + SARURI COMPR. FILM. GASTROREZ.DEPAKINE 200 mg 200mg SANOFI-AVENTIS FRANCE

300mgN03AG01 ACIDUM VALPROICUM + SARURI CAPS. ELIB. PREL.

65 153/

Page 66: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

ORFIRIL LONG 300 mg 300mg DESITIN ARZNEIMITTEL GMBH

300mgN03AG01 ACIDUM VALPROICUM + SARURI CAPS. MOI GASTROREZ.CONVULEX® 300 mg 300mg GEROT PHARMAZEUTIKA GMBH

300mgN03AG01 ACIDUM VALPROICUM + SARURI COMPR. FILM. GASTROREZ.ORFIRIL 300 300mg DESITIN ARZNEIMITTEL GMBH

300mg/5mlN03AG01 ACIDUM VALPROICUM + SARURI SIROPORFIRIL SIROP 300mg/5ml DESITIN ARZNEIMITTEL GMBH

400mg/4mlN03AG01 ACIDUM VALPROICUM + SARURI LIOF. + SOLV. PT. SOL.

DEPAKINE® 400 mg/4 ml LIOFILIZAT SI SOLVENT PENTRU

SOLUTIE INJECTABILA i.v.

400mg/4ml SANOFI-AVENTIS FRANCE

500mgN03AG01 ACIDUM VALPROICUM + SARURI CAPS. MOI GASTROREZ.CONVULEX® 500 mg 500mg GEROT PHARMAZEUTIKA GMBH

500mgN03AG01 ACIDUM VALPROICUM + SARURI MINICOMPR. ELIB. PREL.ORFIRIL LONG 500 mg 500mg DESITIN ARZNEIMITTEL GMBH

50mg/mlN03AG01 ACIDUM VALPROICUM + SARURI SIROPCONVULEX® 50mg/ml GEROT PHARMAZEUTIKA GMBH

57.64mg/mlN03AG01 ACIDUM VALPROICUM + SARURI SIROPDEPAKINE 57.64mg/ml SANOFI - AVENTIS FRANCE

600mgN03AG01 ACIDUM VALPROICUM + SARURI COMPR. FILM. GASTROREZ.ORFIRIL 600 600mg DESITIN ARZNEIMITTEL GMBH

300mgN03AG01 ACIDUM VALPROICUM + SARURI COMPR. FILM. ELIB. PREL. DIVIZ.DEPAKINE CHRONO 300 mg 300mg SANOFI-AVENTIS FRANCE

500mgN03AG01 ACIDUM VALPROICUM + SARURI COMPR. FILM. ELIB. PREL. DIVIZ.DEPAKINE® CHRONO 500 mg 500mg SANOFI-AVENTIS FRANCE

453 LAMOTRIGINUM **N03AX09

Cod restrictie 1426: Tratamentul crizelor epileptice insuficient controlate prin administrarea altor medicamente antiepileptice.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare acestui DCI.

0.1mg/mlN03AX09 LAMOTRIGINUM SOL. INJ.EPIMIL 100 mg 100mg IVAX PHARMCEUTICALS S.R.O.

EPIZOL 100 mg 100mg KRKA D.D. NOVO MESTO

LAMICTAL 100 mg 100mg THE WELLCOME FOUNDATION LTD.

LAMOLEP 100 mg 100mg GEDEON RICHTER LTD.

LAMOTIRAN 100 mg 100mg RANBAXY UK LTD.

LAMOTRIX 100 mg 100mg MEDOCHEMIE LTD.

PLEXXO® 100 mg 100mg DESITIN ARZNEIMITTEL GMBH

100mgN03AX09 LAMOTRIGINUM COMPR. DISP.LAMOTRIGIN STADA 100 mg 100mg STADA ARZNEIMITTEL AG

LAMOTRIN 100 mg 100mg ACTAVIS GROUP HF.

200mgN03AX09 LAMOTRIGINUM COMPR.LAMOTIRAN 200 mg 200mg RANBAXY UK LTD.

LAMOTRIX 200 mg 200mg MEDOCHEMIE LTD.

25mgN03AX09 LAMOTRIGINUM COMPR.EPIMIL 25mg 25mg IVAX PHARMCEUTICALS S.R.O.

EPIZOL 25 mg 25mg KRKA D.D. NOVO MESTO

LAMICTAL 25 mg 25mg THE WELLCOME FOUNDATION LTD.

LAMOLEP 25 mg 25mg GEDEON RICHTER LTD.

LAMOTIRAN 25 mg 25mg RANBAXY UK LTD.

LAMOTRIX 25 mg 25mg MEDOCHEMIE LTD.

PLEXXO® 25 mg 25mg DESITIN ARZNEIMITTEL GMBH

25mgN03AX09 LAMOTRIGINUM COMPR. DISP.LAMOTRIGIN STADA 25 mg 25mg STADA ARZNEIMITTEL AG

LAMOTRIN 25 mg 25mg ACTAVIS GROUP HF.

25mgN03AX09 LAMOTRIGINUM COMPR. DISP./MAST.LAMICTAL 25 mg 25mg THE WELLCOME FOUNDATION LTD.

2mgN03AX09 LAMOTRIGINUM COMPR. DISP./MAST.LAMICTAL® 2 mg 2mg THE WELLCOME FOUNDATION LTD.

50mgN03AX09 LAMOTRIGINUM COMPR.EPIMIL 50 mg 50mg IVAX PHARMCEUTICALS S.R.O.

EPIZOL 50 mg 50mg KRKA D.D. NOVO MESTO

LAMICTAL 50 mg 50mg THE WELLCOME FOUNDATION LTD.

LAMOLEP 50 mg 50mg GEDEON RICHTER LTD.

LAMOTIRAN 50 mg 50mg RANBAXY UK LTD.

LAMOTRIX 50 mg 50mg MEDOCHEMIE LTD.

PLEXXO® 50 mg 50mg DESITIN ARZNEIMITTEL GMBH

50mgN03AX09 LAMOTRIGINUM COMPR. DISP.LAMOTRIGIN STADA 50 mg 50mg STADA ARZNEIMITTEL AG

LAMOTRIN 50 mg 50mg ACTAVIS GROUP HF.

5mgN03AX09 LAMOTRIGINUM COMPR. DISP./MAST.LAMICTAL 5 mg 5mg THE WELLCOME FOUNDATION LTD.

454 TOPIRAMATUM **N03AX11

Cod restrictie 2797: Tratamentul crizelor epileptice partiale, crizelor primare cu contractii tonico-clonice generalizate, crizelor din sindromul Lennox-Gastaut, insuficient controlate prin

administrarea altor merdicamente antiepileptice.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare acestui DCI.

100mgN03AX11 TOPIRAMATUM COMPR. FILM.TOPAMAX 100 mg 100mg JOHNSON & JOHNSON D.O.O.

TOPRAN 100 mg 100mg TERAPIA S.A.

200mgN03AX11 TOPIRAMATUM COMPR. FILM.TOPAMAX 200 mg 200mg JOHNSON & JOHNSON D.O.O.

TOPRAN 200 mg 200mg TERAPIA S.A.

25mgN03AX11 TOPIRAMATUM COMPR. FILM.TOPAMAX 25 mg 25mg JOHNSON & JOHNSON D.O.O.

TOPRAN 25 mg 25mg TERAPIA S.A.

50mgN03AX11 TOPIRAMATUM COMPR. FILM.

66 153/

Page 67: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

TOPAMAX 50 mg 50mg JOHNSON & JOHNSON D.O.O.

TOPRAN 50 mg 50mg TERAPIA S.A.

455 GABAPENTINUM ***N03AX12

Cod restrictie 2664: Tratamentul crizelor epileptice partiale insuficient controlate prin administrarea altor medicamente antiepileptice.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare acestui DCI.

100mgN03AX12 GABAPENTINUM CAPS.GABAGAMMA 100 mg 100mg WORWAG PHARMA GMBH & CO. KG

GABALEPT 100 mg 100mg PLIVA LJUBLJANA D.O.O.

300mgN03AX12 GABAPENTINUM CAPS.GABAGAMMA 300 mg 300mg WORWAG PHARMA GMBH & CO. KG

GABALEPT 300 mg 300mg PLIVA LJUBLJANA D.O.O.

GABARAN 300 mg 300mg RANBAXY UK LTD.

400mgN03AX12 GABAPENTINUM CAPS.GABAGAMMA 400 mg 400mg WORWAG PHARMA GMBH & CO. KG

GABALEPT 400 mg 400mg PLIVA LJUBLJANA D.O.O.

GABARAN 400 mg 400mg RANBAXY UK LTD.

600mgN03AX12 GABAPENTINUM COMPR. FILM.GABARAN 600 mg 600mg RANBAXY UK LTD.

800mgN03AX12 GABAPENTINUM COMPR. FILM.GABARAN 800 mg 800mg RANBAXY UK LTD.

456 LEVETIRACETAMUM **N03AX14

Prescriere limitata: Tratamentul crizelor epileptice partiale insuficient controlate prin administrarea altor medicamente antiepileptice.

Tratamentul crizelor epileptice partiale insuficient controlate prin administrarea altor medicamente antiepileptice si unde au existat reactii adverse in antecedente la

alte antiepileptice.

Tratamentul crizelor epileptice partiale insuficient controlate prin administrarea altor medicamente antiepileptice si unde au existat interactiuni medicamentoase cu

alte medicamente compensate adecvate.

Tratamentul crizelor epileptice partiale insuficient controlate prin administrarea altor medicamente antiepileptice si unde transferul la alt medicament compensat

adecvat este posibil sa genereze consecinte clinice adverse.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

1000mgN03AX14 LEVETIRACETAMUM COMPR. FILM.KEPPRA 1000 mg 1000mg UCB PHARMA SA

100mg/mlN03AX14 LEVETIRACETAMUM SOL. ORALAKEPPRA 100 mg/ml 100mg/ml UCB PHARMA SA

500mgN03AX14 LEVETIRACETAMUM COMPR. FILM.KEPPRA 500 mg 500mg UCB PHARMA LTD

1000mgN03AX14 LEVETIRACETAMUM COMPR. FILM.KEPPRA 1000 mg 1000mg UCB PHARMA SA

500mgN03AX14 LEVETIRACETAMUM COMPR. FILM.KEPPRA 500 mg 500mg UCB PHARMA LTD

457 PREGABALINUM ***N03AX16

Prescriere limitata: Tratamentul adjuvant al epilepsiei la adulţii cu convulsii parţiale, cu sau fără generalizare secundară.

150mgN03AX16 PREGABALINUM CAPS.LYRICA 150 mg 150mg PFIZER LTD.

300mgN03AX16 PREGABALINUM CAPS.LYRICA 300 mg 300mg PFIZER LTD.

75mgN03AX16 PREGABALINUM CAPS.LYRICA 75 mg 75mg PFIZER LTD.

67 153/

Page 68: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

SUBLISTA C1-G12 BOALA PARKINSON.

458 TRIHEXYPHENIDYLUMN04AA01

2mgN04AA01 TRIHEXYPHENIDYLUM COMPR.ROMPARKIN® 2 mg 2mg TERAPIA SA

460 COMBINATII (LEVODOPUM + CARBIDOPUM) **N04BA02

100mg+25mgN04BA02 COMBINATII (LEVODOPUM + CARBIDOPUM) CAPS. ELIB. MODIF.MADOPAR HBS 100mg+25mg ROCHE ROMANIA S.R.L.

200mg+50mgN04BA02 COMBINATII (LEVODOPUM + CARBIDOPUM) COMPR.MADOPAR 250 200mg+50mg ROCHE ROMANIA SRL

MADOPAR® 250 200mg+50mg TERAPIA SA

Boala Parkinson in care tulburarile functiei motorii nu sunt suficient controlate cu administrari frecvente ale formulelor conventionale de levodopa combinat cu

inhibitor al decarboxylazei

Cod restrictie 1257:

250mg/25mgN04BA02 COMBINATII (LEVODOPUM + CARBIDOPUM) COMPR.ISICOM 250 mg/25 mg 250mg/25mg DESITIN ARZNEIMITTEL GMBH

250mg+25mgN04BA02 COMBINATII (LEVODOPUM + CARBIDOPUM) COMPR.CARBIDOPA / LEVODOPA TEVA 25/250 250mg+25mg TEVA PHARMACEUTICALS SRL

CREDANIL 25/250 250mg+25mg REMEDICA LTD.

NAKOM 250mg+25mg LEK PHARMACEUTICALS D.D.

ZIMOX 250mg+25mg FARAN LABORATORIES S.A.

461 COMBINATII (LEVODOPUM + BENSERAZIDUM) **N04BA02

Cod restrictie 1257: Boala Parkinson in care tulburarile functiei motorii nu sunt suficient controlate cu administrari frecvente ale formulelor conventionale de levodopa combinat cu

inhibitor al decarboxylazei.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mg+25mgN04BA02 COMBINATII (LEVODOPUM +

BENSERAZIDUM)

CAPS. ELIB. MODIF.

MADOPAR HBS 100mg+25mg ROCHE ROMANIA S.R.L.

200mg+50mgN04BA02 COMBINATII (LEVODOPUM +

BENSERAZIDUM)

COMPR.

MADOPAR 250 200mg+50mg ROCHE ROMANIA SRL

MADOPAR® 250 200mg+50mg TERAPIA SA

250mg/25mgN04BA02 COMBINATII (LEVODOPUM +

BENSERAZIDUM)

COMPR.

ISICOM 250 mg/25 mg 250mg/25mg DESITIN ARZNEIMITTEL GMBH

250mg+25mgN04BA02 COMBINATII (LEVODOPUM +

BENSERAZIDUM)

COMPR.

CARBIDOPA / LEVODOPA TEVA 25/250 250mg+25mg TEVA PHARMACEUTICALS SRL

CREDANIL 25/250 250mg+25mg REMEDICA LTD.

NAKOM 250mg+25mg LEK PHARMACEUTICALS D.D.

ZIMOX 250mg+25mg FARAN LABORATORIES S.A.

462 COMBINATII (LEVODOPUM+CARBIDOPUM+ENTACAPONUM)

***

N04BA03

Cod restrictie 2059: Boala Parkinson la pacienti tratati cu combinatii de inhibitor de decarboxylase-levodopa, care prezinta tulburari ale functiilor motorii induse la sfarsitul perioadei

de actiune a unei doze

Cod restrictie 2060: Boala Parkinson la pacienti stabilizati sub tratamentul cu inhibitor de decarboxylase-levodopa in asociere cu entacapone

100mg/25mg/200

mg

N04BA03 COMBINATII

(LEVODOPUM+CARBIDOPUM+ENTACAPONU

M)

COMPR. FILM.

STALEVO 100 mg/25 mg/200 mg 100mg/25mg/200

mg

ORION CORPORATION

150mg/37.5mg/2

00mg

N04BA03 COMBINATII

(LEVODOPUM+CARBIDOPUM+ENTACAPONU

M)

COMPR. FILM.

STALEVO 150 mg/37,5 mg/200 mg 150mg/37.5mg/20

0mg

ORION CORPORATION

50mg/12.5mg/20

0mg

N04BA03 COMBINATII

(LEVODOPUM+CARBIDOPUM+ENTACAPONU

M)

COMPR. FILM.

STALEVO 50 mg/12,5 mg/200 mg 50mg/12.5mg/200

mg

ORION CORPORATION

463 AMANTADINUM **N04BB01

100mgN04BB01 AMANTADINUM CAPS.VIREGYT®- K 100mg EGIS PHARMACEUTICALS LTD.

464 BROMOCRIPTINUMN04BC01

2.5mgN04BC01 BROMOCRIPTINUM DRAJ.BROCRIPTIN 2.5mg BIOFARM SA

Boala ParkinsonPrescriere limitata:

465 ROPINIROLUM **N04BC04

N04BC04 ROPINIROLUM COMPR. FILM.REQUIP 0,25 mg SMITHKLINE BEECHAM PLC T/A

REQUIP 1 mg SMITHKLINE BEECHAM PLC T/A

REQUIP 2 mg SMITHKLINE BEECHAM PLC T/A

REQUIP 5 mg SMITHKLINE BEECHAM PLC T/A

466 PRAMIPEXOLUM **N04BC05La acest medicament au fost raportate episoade de instalare brusca a somnului fara avertizare in timpul activitatii.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

0.18mgN04BC05 PRAMIPEXOLUM COMPR.MIRAPEXIN 0,18 mg 0.18mg BOEHRINGER INGELHEIM INTERNATIONAL GMBH

0.7mgN04BC05 PRAMIPEXOLUM COMPR.

68 153/

Page 69: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

MIRAPEXIN 0,7 mg 0.7mg BOEHRINGER INGELHEIM INTERNATIONAL GMBH

467 ROTIGOTINUM ***N04BC09

Prescriere limitata: Monoterapie (fără levodopa), pentru tratarea semnelor şi simptomelor bolii Parkinson idiopatice, în stadiu incipient.

Tratament in asociere cu levodopa in perioada de evoluţie şi în stadiile avansate ale bolii Parkinson, când efectul medicamentului levodopa diminuează sau devine

inconstant şi apar fluctuaţii ale efectului terapeutic (fluctuaţii apărute către sfârşitul intervalului dintre doze sau fluctuaţii de tip on-off).

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

2mg/24hN04BC09 ROTIGOTINUM PLASTURE TRANSDERMICNEUPRO 2mg/24h 2mg/24h SCHWARZ PHARMA LTD

4mg/24hN04BC09 ROTIGOTINUM PLASTURE TRANSDERMICNEUPRO 4mg/24h 4mg/24h SCHWARZ PHARMA LTD

6mg/24hN04BC09 ROTIGOTINUM PLASTURE TRANSDERMICNEUPRO 6mg/24h 6mg/24h SCHWARZ PHARMA LTD

8mg/24hN04BC09 ROTIGOTINUM PLASTURE TRANSDERMICNEUPRO 8mg/24h 8mg/24h SCHWARZ PHARMA LTD

468 SELEGILINUMN04BD01

Prescriere limitata: Stadiu tardiv al bolii Parkinson ca tratament complementar la pacientii tratati cu levodopa combinat cu inhibitor al decarboxylazei.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

5mgN04BD01 SELEGILINUM COMPR.ALS-SELEGILINA 5 mg 5mg ALSIFCOM INTERMED SRL

JUMEX 5 mg 5mg CHINOIN PRIVATE CO. LTD.

SELEGOS 5mg MEDOCHEMIE LTD.

469 RASAGILINUM ***N04BD02

Prescriere limitata: Tratamentul bolii Parkinson idiopatică (BP) ca monoterapie (fără levodopa).

Tratament adjuvant (în asociere cu levodopa) la pacienţii cu fluctuaţii de sfârşit de doză.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

1mgN04BD02 RASAGILINUM COMPR.AZILECT 1mg 1mg TEVA PHARMA GMBH

470 ENTACAPONUM ***N04BX02

200mgN04BX02 ENTACAPONUM COMPR. FILM.COMTAN 200mg 200mg NOVARTIS EUROPHARM LTD.

Boala Parkinson la pacienti tratati cu combinatii de inhibitor de decarboxylase-levodopa, care prezinta tulburari ale functiilor motorii induse la sfarsitul perioadei de

actiune a unei doze

Cod restrictie 2067:

471 CLOZAPINUM **N05AH02

Prescriere limitata: Tulburari psihotice aparute in cursul bolii Parkinson in situatia in care terapia standard a esuat.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgN05AH02 CLOZAPINUM COMPR.LEPONEX® 100 mg 100mg NOVARTIS PHARMA GMBH

25mgN05AH02 CLOZAPINUM COMPR.LEPONEX® 25 mg 25mg NOVARTIS PHARMA GMBH

SUBLISTA C1-G13 MIASTENIA GRAVIS.

472 PREDNISONUMH02AB07

5mgH02AB07 PREDNISONUM COMPR.N - PREDNISON 5mg MEDUMAN SA

PREDNISON 5 mg 5mg SINTOFARM SA

PREDNISON ARENA 5 mg 5mg ARENA GROUP SA

PREDNISON GEDEON RICHTER 5 mg 5mg GEDEON RICHTER ROMANIA SA

PREDNISON MAGISTRA 5 mg 5mg MAGISTRA C & C

473 METHOTREXATUM (4)L01BA01

L01BA01 METHOTREXATUM

474 AZATHIOPRINUML04AX01

50mgL04AX01 AZATHIOPRINUM COMPR. FILM.IMURAN® 50mg THE WELLCOME FOUNDATION LTD.

475 NEOSTIGMINI BROMIDUMN07AA01

0.5mg/mlN07AA01 NEOSTIGMINI BROMIDUM SOL. INJ.MIOSTIN 0,5 mg/ml 0.5mg/ml ZENTIVA S.A.

15mgN07AA01 NEOSTIGMINI BROMIDUM COMPR.NEOSTIGMINA LPH 15 mg 15mg LABORMED PHARMA SA

476 PYRIDOSTIGMINI BROMIDUMN07AA02

60mgN07AA02 PYRIDOSTIGMINI BROMIDUM DRAJ.MESTINON 60 mg 60mg ICN POLFA RZESZOW S.A.

69 153/

Page 70: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

SUBLISTA C1-G14 SCLEROZA MULTIPLA.

477 METHYLPREDNISOLONUMH02AB04

125mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 125 mg 125mg HEMOFARM S.R.L.

125mg/2mlH02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV.PT.SOL.INJSOLU - MEDROL ACT-O-VIAL 125mg/2ml PFIZER EUROPE MA EEIG

16mgH02AB04 METHYLPREDNISOLONUM COMPR.MEDROL A 16 16mg PFIZER EUROPE MA EEIG

20mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 20 mg 20mg HEMOFARM S.R.L.

250mg/4mlH02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV.PT.SOL.INJSOLU - MEDROL ACT-O-VIAL 250mg/4ml PFIZER EUROPE MA EEIG

32mgH02AB04 METHYLPREDNISOLONUM COMPR.MEDROL 32 32mg PFIZER EUROPE MA EEIG

40mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 40 mg 40mg HEMOFARM S.R.L.

40mg/1mlH02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV.PT.SOL.INJSOLU - MEDROL ACT-O-VIAL 40mg/1ml PFIZER EUROPE MA EEIG

4mgH02AB04 METHYLPREDNISOLONUM COMPR.MEDROL 4 mg 4mg PFIZER EUROPE MA EEIG

500mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 500 mg 500mg HEMOFARM S.R.L.

500mg/7.8mlH02AB04 METHYLPREDNISOLONUM LIOF. + SOLV. PT. SOL. INJ.SOLU - MEDROL 500 mg/7,8 ml 500mg/7.8ml PFIZER EUROPE MA EEIG

478 PREDNISONUMH02AB07

5mgH02AB07 PREDNISONUM COMPR.N - PREDNISON 5mg MEDUMAN SA

PREDNISON 5 mg 5mg SINTOFARM SA

PREDNISON ARENA 5 mg 5mg ARENA GROUP SA

PREDNISON GEDEON RICHTER 5 mg 5mg GEDEON RICHTER ROMANIA SA

PREDNISON MAGISTRA 5 mg 5mg MAGISTRA C & C

480 MITOXANTRONUM *** Protocol: L001GL01DB07

2 mg/mlL01DB07 MITOXANTRONUM CONC. PT. SOL. PERF.MITOXANTRONE TEVA 2 mg/ml 2 mg/ml TEVA PHARMACEUTICALS SRL

20mg/10mlL01DB07 MITOXANTRONUM SOL. PERF.NOVANTRONE 20mg/10ml WYETH LEDERLE PHARMA GMBH

2mg/mlL01DB07 MITOXANTRONUM CONC. PT. SOL. INJ.ONKOTRONE 2mg/ml BAXTER ONCOLOGY GMBH

481 AZATHIOPRINUML04AX01

50mgL04AX01 AZATHIOPRINUM COMPR. FILM.IMURAN® 50mg THE WELLCOME FOUNDATION LTD.

70 153/

Page 71: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

SUBLISTA C1-G15 BOLI PSIHICE (SCHIZOFRENIE, TULBURARI SCHIZOTIPALE SI DELIRANTE, TULBURARI AFECTIVE

MAJORE, TULBURARI PSIHOTICE ACUTE SI BOLI PSIHICE COPII, AUTISM).

482 ACIDUM VALPROICUM + SARURIN03AG01S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

1000mgN03AG01 ACIDUM VALPROICUM + SARURI MINICOMPR. ELIB. PREL.ORFIRIL LONG 1000 mg 1000mg DESITIN ARZNEIMITTEL GMBH

150mgN03AG01 ACIDUM VALPROICUM + SARURI CAPS. ELIB. PREL.ORFIRIL LONG 150 mg 150mg DESITIN ARZNEIMITTEL GMBH

150mgN03AG01 ACIDUM VALPROICUM + SARURI CAPS. MOI GASTROREZ.CONVULEX® 150 mg 150mg GEROT PHARMAZEUTIKA GMBH

150mgN03AG01 ACIDUM VALPROICUM + SARURI COMPR. FILM. GASTROREZ.ORFIRIL 150 150mg DESITIN ARZNEIMITTEL GMBH

200mgN03AG01 ACIDUM VALPROICUM + SARURI COMPR. FILM.PETILIN 200mg REMEDICA LTD.

200mgN03AG01 ACIDUM VALPROICUM + SARURI COMPR. FILM. GASTROREZ.DEPAKINE 200 mg 200mg SANOFI-AVENTIS FRANCE

300mgN03AG01 ACIDUM VALPROICUM + SARURI CAPS. ELIB. PREL.ORFIRIL LONG 300 mg 300mg DESITIN ARZNEIMITTEL GMBH

300mgN03AG01 ACIDUM VALPROICUM + SARURI CAPS. MOI GASTROREZ.CONVULEX® 300 mg 300mg GEROT PHARMAZEUTIKA GMBH

300mgN03AG01 ACIDUM VALPROICUM + SARURI COMPR. FILM. GASTROREZ.ORFIRIL 300 300mg DESITIN ARZNEIMITTEL GMBH

300mg/5mlN03AG01 ACIDUM VALPROICUM + SARURI SIROPORFIRIL SIROP 300mg/5ml DESITIN ARZNEIMITTEL GMBH

400mg/4mlN03AG01 ACIDUM VALPROICUM + SARURI LIOF. + SOLV. PT. SOL.

DEPAKINE® 400 mg/4 ml LIOFILIZAT SI SOLVENT PENTRU

SOLUTIE INJECTABILA i.v.

400mg/4ml SANOFI-AVENTIS FRANCE

500mgN03AG01 ACIDUM VALPROICUM + SARURI CAPS. MOI GASTROREZ.CONVULEX® 500 mg 500mg GEROT PHARMAZEUTIKA GMBH

500mgN03AG01 ACIDUM VALPROICUM + SARURI MINICOMPR. ELIB. PREL.ORFIRIL LONG 500 mg 500mg DESITIN ARZNEIMITTEL GMBH

50mg/mlN03AG01 ACIDUM VALPROICUM + SARURI SIROPCONVULEX® 50mg/ml GEROT PHARMAZEUTIKA GMBH

57.64mg/mlN03AG01 ACIDUM VALPROICUM + SARURI SIROPDEPAKINE 57.64mg/ml SANOFI - AVENTIS FRANCE

600mgN03AG01 ACIDUM VALPROICUM + SARURI COMPR. FILM. GASTROREZ.ORFIRIL 600 600mg DESITIN ARZNEIMITTEL GMBH

300mgN03AG01 ACIDUM VALPROICUM + SARURI COMPR. FILM. ELIB. PREL. DIVIZ.DEPAKINE CHRONO 300 mg 300mg SANOFI-AVENTIS FRANCE

500mgN03AG01 ACIDUM VALPROICUM + SARURI COMPR. FILM. ELIB. PREL. DIVIZ.DEPAKINE® CHRONO 500 mg 500mg SANOFI-AVENTIS FRANCE

483 LAMOTRIGINUM ** Protocol: N012FN03AX09

100mgN03AX09 LAMOTRIGINUM COMPR.EPIMIL 100 mg 100mg IVAX PHARMCEUTICALS S.R.O.

EPIZOL 100 mg 100mg KRKA D.D. NOVO MESTO

LAMICTAL 100 mg 100mg THE WELLCOME FOUNDATION LTD.

LAMOLEP 100 mg 100mg GEDEON RICHTER LTD.

LAMOTIRAN 100 mg 100mg RANBAXY UK LTD.

LAMOTRIX 100 mg 100mg MEDOCHEMIE LTD.

PLEXXO® 100 mg 100mg DESITIN ARZNEIMITTEL GMBH

100mgN03AX09 LAMOTRIGINUM COMPR. DISP.LAMOTRIGIN STADA 100 mg 100mg STADA ARZNEIMITTEL AG

LAMOTRIN 100 mg 100mg ACTAVIS GROUP HF.

200mgN03AX09 LAMOTRIGINUM COMPR.LAMOTIRAN 200 mg 200mg RANBAXY UK LTD.

LAMOTRIX 200 mg 200mg MEDOCHEMIE LTD.

25mgN03AX09 LAMOTRIGINUM COMPR.EPIMIL 25mg 25mg IVAX PHARMCEUTICALS S.R.O.

EPIZOL 25 mg 25mg KRKA D.D. NOVO MESTO

LAMICTAL 25 mg 25mg THE WELLCOME FOUNDATION LTD.

LAMOLEP 25 mg 25mg GEDEON RICHTER LTD.

LAMOTIRAN 25 mg 25mg RANBAXY UK LTD.

LAMOTRIX 25 mg 25mg MEDOCHEMIE LTD.

PLEXXO® 25 mg 25mg DESITIN ARZNEIMITTEL GMBH

25mgN03AX09 LAMOTRIGINUM COMPR. DISP.LAMOTRIGIN STADA 25 mg 25mg STADA ARZNEIMITTEL AG

LAMOTRIN 25 mg 25mg ACTAVIS GROUP HF.

25mgN03AX09 LAMOTRIGINUM COMPR. DISP./MAST.LAMICTAL 25 mg 25mg THE WELLCOME FOUNDATION LTD.

2mgN03AX09 LAMOTRIGINUM COMPR. DISP./MAST.LAMICTAL® 2 mg 2mg THE WELLCOME FOUNDATION LTD.

50mgN03AX09 LAMOTRIGINUM COMPR.EPIMIL 50 mg 50mg IVAX PHARMCEUTICALS S.R.O.

EPIZOL 50 mg 50mg KRKA D.D. NOVO MESTO

LAMICTAL 50 mg 50mg THE WELLCOME FOUNDATION LTD.

LAMOLEP 50 mg 50mg GEDEON RICHTER LTD.

LAMOTIRAN 50 mg 50mg RANBAXY UK LTD.

LAMOTRIX 50 mg 50mg MEDOCHEMIE LTD.

PLEXXO® 50 mg 50mg DESITIN ARZNEIMITTEL GMBH

50mgN03AX09 LAMOTRIGINUM COMPR. DISP.LAMOTRIGIN STADA 50 mg 50mg STADA ARZNEIMITTEL AG

71 153/

Page 72: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

LAMOTRIN 50 mg 50mg ACTAVIS GROUP HF.

5mgN03AX09 LAMOTRIGINUM COMPR. DISP./MAST.LAMICTAL 5 mg 5mg THE WELLCOME FOUNDATION LTD.

484 TRIHEXYPHENIDYLUMN04AA01

2mgN04AA01 TRIHEXYPHENIDYLUM COMPR.ROMPARKIN® 2 mg 2mg TERAPIA SA

485 HALOPERIDOLUMN05AD01

50mg/mlN05AD01 HALOPERIDOLUM SOL. INJ.HALOPERIDOL DECANOAT 50mg/ml GEDEON RICHTER LTD.

5mgN05AD01 HALOPERIDOLUM COMPR.HALDOL 5mg JANSSEN PHARMACEUTICA NV

5mg/mlN05AD01 HALOPERIDOLUM SOL. INJ.HALOPERIDOL 5 mg/ml 5mg/ml GEDEON RICHTER LTD.

2mg/mlN05AD01 HALOPERIDOLUM PIC. ORALE-SOL.HALOPERIDOL 2 mg/ml 2mg/ml GEDEON RICHTER ROMANIA SA

2mg/mlN05AD01 HALOPERIDOLUM PICATURI ORALE-SOL.HALOPERIDOL 2mg/ml TERAPIA SA

486 SERTINDOL ** Protocol: N017FN05AE03

12mgN05AE03 SERTINDOL COMPR. FILM.SERDOLECT 12 mg 12mg H. LUNDBECK A/S

16mgN05AE03 SERTINDOL COMPR. FILM.SERDOLECT 16 mg 16mg H. LUNDBECK A/S

20mgN05AE03 SERTINDOL COMPR. FILM.SERDOLECT 20 mg 20mg H. LUNDBECK A/S

4mgN05AE03 SERTINDOL COMPR. FILM.SERDOLECT 4 mg 4mg H. LUNDBECK A/S

487 ZIPRASIDONUM ** Protocol: N018FN05AE04

20mg/mlN05AE04 ZIPRASIDONUM LIOF. PT. SOL. INJ. + SOLV.ZELDOX® 20 mg/ml 20mg/ml PFIZER EUROPE MA EEIG

40mgN05AE04 ZIPRASIDONUM CAPS.ZELDOX® 40 mg 40mg PFIZER EUROPE MA EEIG

60mgN05AE04 ZIPRASIDONUM CAPS.ZELDOX® 60 mg 60mg PFIZER EUROPE MA EEIG

80mgN05AE04 ZIPRASIDONUM CAPS.ZELDOX® 80 mg 80mg PFIZER EUROPE MA EEIG

488 FLUPENTIXOLUM ** Protocol: N015FN05AF01

20mg/mlN05AF01 FLUPENTIXOLUM SOL. INJ.FLUANXOL DEPOT 20mg/ml H. LUNDBECK A/S

489 ZUCLOPENTHIXOLUM ** Protocol: N019FN05AF05

10mgN05AF05 ZUCLOPENTHIXOLUM COMPR. FILM.CLOPIXOL® 10 mg 10mg H. LUNDBECK A/S

200mg/mlN05AF05 ZUCLOPENTHIXOLUM SOL. INJ.CLOPIXOL® DEPOT 200mg/ml H. LUNDBECK A/S

25mgN05AF05 ZUCLOPENTHIXOLUM COMPR. FILM.CLOPIXOL® 25 mg 25mg H. LUNDBECK A/S

50mg/mlN05AF05 ZUCLOPENTHIXOLUM SOL. INJ.CLOPIXOL ACUPHASE® 50mg/ml H. LUNDBECK A/S

20mg/mlN05AF05 ZUCLOPENTHIXOLUM PIC. ORALE-SOL.CLOPIXOL 20 mg/ml 20mg/ml H. LUNDBECK A/S

490 CLOZAPINUM ** Protocol: N016FN05AH02

100mgN05AH02 CLOZAPINUM COMPR.LEPONEX® 100 mg 100mg NOVARTIS PHARMA GMBH

25mgN05AH02 CLOZAPINUM COMPR.LEPONEX® 25 mg 25mg NOVARTIS PHARMA GMBH

491 OLANZAPINUM ** Protocol: N003FN05AH03

10mgN05AH03 OLANZAPINUM COMPR. FILM.ZYPREXA 10 mg 10mg ELI LILLY NEDERLAND BV

10mgN05AH03 OLANZAPINUM PULB. PT. SOL. INJ.ZYPREXA 10 mg 10mg ELI LILLY NEDERLAND BV

15mgN05AH03 OLANZAPINUM COMPR. ORODISPERSABILEZYPREXA VELOTAB 15 mg 15mg ELI LILLY NEDERLAND BV

20mgN05AH03 OLANZAPINUM COMPR. ORODISPERSABILEZYPREXA VELOTAB 20 mg 20mg ELI LILLY NEDERLAND BV

5mgN05AH03 OLANZAPINUM COMPR. FILM.ZYPREXA 5 mg 5mg ELI LILLY NEDERLAND BV

492 QUETIAPINUM ** Protocol: N005FN05AH04

100mgN05AH04 QUETIAPINUM COMPR. FILM.SEROQUEL 100mg 100mg ASTRAZENECA UK LTD.

200mgN05AH04 QUETIAPINUM COMPR. FILM.SEROQUEL 200 mg 200mg ASTRAZENECA UK LTD.

200mgN05AH04 QUETIAPINUM COMPR. FILM. ELIB. PREL.SEROQUEL XR 200 mg 200mg ASTRAZENECA UK LTD.

300mgN05AH04 QUETIAPINUM COMPR. FILM.SEROQUEL® 300 mg 300mg ASTRAZENECA UK LTD.

300mgN05AH04 QUETIAPINUM COMPR. FILM. ELIB. PREL.SEROQUEL XR 300 mg 300mg ASTRAZENECA UK LTD.

493 SULPIRIDUMN05AL01

200mgN05AL01 SULPIRIDUM COMPR.EGLONYL® 200 mg 200mg SANOFI-SYNTHELABO FRANCE

72 153/

Page 73: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

50mgN05AL01 SULPIRIDUM CAPS.EGLONYL® 50 mg 50mg SANOFI-SYNTHELABO FRANCE

50mg/mlN05AL01 SULPIRIDUM SOL. INJ.EGLONYL 100 mg/2 ml 50mg/ml SANOFI-AVENTIS FRANCE

494 AMISULPRIDUM ** Protocol: N006FN05AL05

200mgN05AL05 AMISULPRIDUM COMPR. DIVIZ.SOLIAN 200 mg 200mg SANOFI-AVENTIS FRANCE

400mgN05AL05 AMISULPRIDUM COMPR. FILM.SOLIAN® 400 mg 400mg SANOFI-AVENTIS FRANCE

495 RISPERIDONUM ** Protocol: N004FN05AX08

1 mgN05AX08 RISPERIDONUM COMPR. FILM.RISSET 1 mg 1 mg PLIVA LJUBLJANA D.O.O.

1mgN05AX08 RISPERIDONUM COMPR. FILM.RILEPTID 1 mg 1mg EGIS PHARMACEUTICALS P.L.C.

RISPEN 1 1mg ZENTIVA AS

RISPERIDONA 1 mg 1mg ARENA GROUP S.A.

RISPERIDONE TEVA 1 mg 1mg TEVA PHARMACEUTICAL S.R.L.

RISPOLEPT® 1 mg 1mg JANSSEN PHARMACEUTICA NV

TORENDO 1 mg 1mg KRKA D.D. NOVO MESTO

1mgN05AX08 RISPERIDONUM COMPR. ORODISPERSABILERISPOLEPT QUICKLET 1mg JANSSEN PHARMACEUTICA NV

TORENDO Q-TAB 1 mg 1mg KRKA D.D. NOVO MESTO

1mg/mlN05AX08 RISPERIDONUM SOL. ORALARISPOLEPT 1mg/ml JANSSEN PHARMACEUTICA NV

2 mgN05AX08 RISPERIDONUM COMPR. FILM.RISPEN 2 2 mg ZENTIVA AS

RISSET 2 mg 2 mg PLIVA LJUBLJANA D.O.O.

25mgN05AX08 RISPERIDONUM PULB. + SOLV. PT. SOL. INJ.RISPOLEPT CONSTA® 25 mg 25mg JANSSEN PHARMACEUTICA NV

2mgN05AX08 RISPERIDONUM COMPR. FILM.RILEPTID 2 mg 2mg EGIS PHARMACEUTICALS P.L.C.

RISON 2 mg 2mg ACTAVIS GROUP HF.

RISPERIDONA 2 mg 2mg ARENA GROUP S.A.

RISPERIDONE TEVA 2 mg 2mg TEVA PHARMACEUTICALS SRL

RISPOLEPT® 2 mg 2mg JANSSEN PHARMACEUTICA NV

TORENDO 2 mg 2mg KRKA D.D. NOVO MESTO

2mgN05AX08 RISPERIDONUM COMPR. ORODISPERSABILERISPOLEPT QUICKLET 2mg JANSSEN PHARMACEUTICA NV

TORENDO Q-TAB 2 mg 2mg KRKA D.D. NOVO MESTO

37.5mgN05AX08 RISPERIDONUM PULB. + SOLV. PT. SOL. INJ.RISPOLEPT CONSTA® 37,5 mg 37.5mg JANSSEN PHARMACEUTICA NV

3mgN05AX08 RISPERIDONUM COMPR. FILM.RILEPTID 3 mg 3mg EGIS PHARMACEUTICALS P.L.C.

RISON 3 mg 3mg ACTAVIS GROUP HF.

RISPEN 3 3mg ZENTIVA AS

RISPERIDONA 3 mg 3mg ARENA GROUP S.A.

RISPERIDONE TEVA 3 mg 3mg TEVA PHARMACEUTICALS SRL

RISPOLEPT® 3 mg 3mg JANSSEN PHARMACEUTICA NV

RISSET 3 mg 3mg PLIVA LJUBLJANA D.O.O.

TORENDO 3 mg 3mg KRKA D.D. NOVO MESTO

4 mgN05AX08 RISPERIDONUM COMPR. FILM.RISPEN 4 4 mg ZENTIVA AS

4mgN05AX08 RISPERIDONUM COMPR. FILM.RILEPTID 4 mg 4mg EGIS PHARMACEUTICALS P.L.C.

RISON 4 mg 4mg ACTAVIS GROUP HF.

RISPERIDONA 4 mg 4mg ARENA GROUP S.A.

RISPERIDONE TEVA 4 mg 4mg TEVA PHARMACEUTICALS SRL

RISPOLEPT® 4 mg 4mg JANSSEN PHARMACEUTICA NV

RISSET 4 mg 4mg PLIVA LJUBLJANA D.O.O.

TORENDO 4 mg 4mg KRKA D.D. NOVO MESTO

50mgN05AX08 RISPERIDONUM PULB. + SOLV. PT. SOL. INJ.RISPOLEPT CONSTA® 50 mg 50mg JANSSEN PHARMACEUTICA NV

496 ARIPIPRAZOLUM ** Protocol: N007FN05AX12

10mgN05AX12 ARIPIPRAZOLUM COMPR.ABILIFY 10mg 10mg OTSUKA PHARMACEUTICAL EUROPE LTD.

15mgN05AX12 ARIPIPRAZOLUM COMPR.ABILIFY 15mg 15mg OTSUKA PHARMACEUTICAL EUROPE LTD.

498 CITALOPRAMUM ** Protocol: N008FN06AB04

10mgN06AB04 CITALOPRAMUM COMPR. FILM.CITALORAN 10 mg 10mg RANBAXY UK LIMITED

LINISAN 10 mg 10mg GEDEON RICHTER ROMANIA S.A.

20mgN06AB04 CITALOPRAMUM COMPR. FILM.CITALORAN 20mg 20mg RANBAXY UK LIMITED

LINISAN 20 mg 20mg GEDEON RICHTER ROMANIA S.A.

40mgN06AB04 CITALOPRAMUM COMPR. FILM.CITALORAN 40 mg 40mg RANBAXY UK LIMITED

LINISAN 40 mg 40mg GEDEON RICHTER ROMANIA S.A.

499 ESCITALOPRAMUM ** Protocol: N009FN06AB10

10mgN06AB10 ESCITALOPRAMUM COMPR. FILM.CIPRALEX 10 mg 10mg H. LUNDBECK A/S

5mgN06AB10 ESCITALOPRAMUM COMPR. FILM.CIPRALEX 5 mg 5mg H. LUNDBECK A/S

73 153/

Page 74: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

500 TRAZODONUM ** Protocol: N010FN06AX05

150mgN06AX05 TRAZODONUM COMPR. ELIB. PREL.TRITTICO AC 150 mg 150mg ANGELINI FRANCESCO SPA

501 TIANEPTINUM ** Protocol: N011FN06AX14

12.5mgN06AX14 TIANEPTINUM DRAJ.COAXIL® 12.5mg LES LAB. SERVIER IND.

502 VENLAFAXINUM ** Protocol: N013FN06AX16

150mgN06AX16 VENLAFAXINUM CAPS. ELIB. PREL.EFECTIN ER 150 mg 150mg WYETH LEDERLE PHARMA GMBH

VELAXIN 150 mg 150mg EGIS PHARMACEUTICALS P.L.C.

37.5mgN06AX16 VENLAFAXINUM COMPR.VELAXIN 37,5 mg 37.5mg EGIS PHARMACEUTICALS PLC

VENLAFAXINA LPH 37,5 mg 37.5mg LABORMED PHARMA SA

75mgN06AX16 VENLAFAXINUM CAPS. ELIB. PREL.EFECTIN ER 75 mg 75mg WYETH LEDERLE PHARMA GMBH

VELAXIN 75 mg 75mg EGIS PHARMACEUTICALS P.L.C.

75mgN06AX16 VENLAFAXINUM COMPR.VELAXIN 75 mg 75mg EGIS PHARMACEUTICALS PLC

VENLAFAXINA LPH 75 mg 75mg LABORMED PHARMA SA

503 MILNACIPRANUM ** Protocol: N002FN06AX17

25mgN06AX17 MILNACIPRANUM CAPS.IXEL 25mg PIERRE FABRE MEDICAMENT

50mgN06AX17 MILNACIPRANUM CAPS.IXEL 50mg PIERRE FABRE MEDICAMENT

504 DULOXETINUM ** Protocol: N014FN06AX21

30mgN06AX21 DULOXETINUM CAPS. GASTROREZ.CYMBALTA 30mg 30mg ELI LILLY NEDERLAND BV

60mgN06AX21 DULOXETINUM CAPS. GASTROREZ.CYMBALTA 60mg 60mg ELI LILLY NEDERLAND BV

SUBLISTA C1-G16 DEMENTE (DEGENERATIVE, VASCULARE, MIXTE).

505 DONEPEZILUM *** Protocol: N020GN06DA02

10mgN06DA02 DONEPEZILUM COMPR. FILM.ARICEPT® 10 mg 10mg PFIZER EUROPE MA EEIG

10mgN06DA02 DONEPEZILUM COMPR. ORODISPERSABILEARICEPT EVESS 10mg PFIZER EUROPE MA EEIG

5mgN06DA02 DONEPEZILUM COMPR. FILM.ARICEPT® 5 mg 5mg PFIZER EUROPE MA EEIG

5mgN06DA02 DONEPEZILUM COMPR. ORODISPERSABILEARICEPT EVESS 5mg PFIZER EUROPE MA EEIG

506 RIVASTIGMINUM *** Protocol: N021GN06DA03

1.5mgN06DA03 RIVASTIGMINUM CAPS.EXELON 1.5mg 1.5mg NOVARTIS EUROPHARM LTD.

3mgN06DA03 RIVASTIGMINUM CAPS.EXELON 3mg 3mg NOVARTIS EUROPHARM LTD.

4.5mgN06DA03 RIVASTIGMINUM CAPS.EXELON 4.5mg 4.5mg NOVARTIS EUROPHARM LTD.

4.6mg/24hN06DA03 RIVASTIGMINUM PLASTURE TRANSDERMICEXELON 4.6mg/24h 4.6mg/24h NOVARTIS EUROPHARM LTD.

6mgN06DA03 RIVASTIGMINUM CAPS.EXELON 6mg 6mg NOVARTIS EUROPHARM LTD.

9.5mg/24hN06DA03 RIVASTIGMINUM PLASTURE TRANSDERMICEXELON 9.5mg/24h 9.5mg/24h NOVARTIS EUROPHARM LTD.

507 GALANTAMINUM *** Protocol: N022GN06DA04

12mgN06DA04 GALANTAMINUM COMPR. FILM.REMINYL® 12 mg 12mg JANSSEN-PHARMACEUTICA NV

16mgN06DA04 GALANTAMINUM CAPS. ELIB. PREL.REMINYL 16 mg 16mg JANSSEN PHARMACEUTICA NV

24mgN06DA04 GALANTAMINUM CAPS. ELIB. PREL.REMINYL 24 mg 24mg JANSSEN PHARMACEUTICA NV

4mgN06DA04 GALANTAMINUM COMPR. FILM.REMINYL® 4 mg 4mg JANSSEN-PHARMACEUTICA NV

4mg/mlN06DA04 GALANTAMINUM SOL. ORALAREMINYL® 4 mg/ml 4mg/ml JANSSEN-PHARMACEUTICA NV

8mgN06DA04 GALANTAMINUM CAPS. ELIB. PREL.REMINYL 8 mg 8mg JANSSEN PHARMACEUTICA NV

8mgN06DA04 GALANTAMINUM COMPR. FILM.REMINYL® 8 mg 8mg JANSSEN-PHARMACEUTICA NV

508 MEMANTINUM *** Protocol: N001FN06DX01

10mgN06DX01 MEMANTINUM COMPR. FILM.EBIXA® 10 mg 10mg H. LUNDBECK A/S

10mg/gN06DX01 MEMANTINUM PIC. ORALE, SOL.EBIXA® 10 mg/g 10mg/g H. LUNDBECK A/S

74 153/

Page 75: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

Protocol: L045MSUBLISTA C1-G17 COLAGENOZE MAJORE (LUPUS ERITEMATOS SISTEMIC, SCLERODERMIE, POLI/DERMATOMIOZITA,

VASCULITE SISTEMICE).

509 METHYLPREDNISOLONUM (5)H02AB04

16mgH02AB04 METHYLPREDNISOLONUM COMPR.MEDROL A 16 16mg PFIZER EUROPE MA EEIG

32mgH02AB04 METHYLPREDNISOLONUM COMPR.MEDROL 32 32mg PFIZER EUROPE MA EEIG

4mgH02AB04 METHYLPREDNISOLONUM COMPR.MEDROL 4 mg 4mg PFIZER EUROPE MA EEIG

510 CYCLOPHOSPHAMIDUM *L01AA01

1gL01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. INJ./PERF.ENDOXAN® 1 g 1g BAXTER ONCOLOGY GMBH

200mgL01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. PERF./INJ. I.V.ENDOXAN 200 mg 200mg ACTAVIS S.R.L.

500mgL01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. INJ./PERF.ENDOXAN® 500 mg 500mg BAXTER ONCOLOGY GMBH

50mgL01AA01 CYCLOPHOSPHAMIDUM DRAJ.ENDOXAN® 50 mg 50mg BAXTER ONCOLOGY GMBH

511 AZATHIOPRINUM *L04AX01

50mgL04AX01 AZATHIOPRINUM COMPR. FILM.IMURAN® 50mg THE WELLCOME FOUNDATION LTD.

512 HYDROXYCHLOROQUINUMP01BA02

200mgP01BA02 HYDROXYCHLOROQUINUM COMPR. FILM.PLAQUENIL® 200mg SANOFI-SYNTHELABO LTD.

75 153/

Page 76: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

SUBLISTA C1-G18 POLIARTRITA REUMATOIDA, ARTROPATIA PSORIAZICA, SI ARTRITA JUVENILA.

513 SULFASALAZINUMA07EC01

500mgA07EC01 SULFASALAZINUM COMPR. FILM.SALAZIDIN 500mg AC HELCOR SRL

500mgA07EC01 SULFASALAZINUM COMPR. FILM. GASTROREZ.SULFASALAZIN EN 500mg KRKA D.D. NOVO MESTO

514 BETAMETHASONUMH02AB01

7mg/mlH02AB01 BETAMETHASONUM SUSP. INJ. I.M.DIPROPHOS® 7mg/ml SCHERING PLOUGH EUROPE

515 METHYLPREDNISOLONUM (5)H02AB04

16mgH02AB04 METHYLPREDNISOLONUM COMPR.MEDROL A 16 16mg PFIZER EUROPE MA EEIG

32mgH02AB04 METHYLPREDNISOLONUM COMPR.MEDROL 32 32mg PFIZER EUROPE MA EEIG

4mgH02AB04 METHYLPREDNISOLONUM COMPR.MEDROL 4 mg 4mg PFIZER EUROPE MA EEIG

516 METHOTREXATUM (4)L01BA01

L01BA01 METHOTREXATUM

517 CICLOSPORINUM *L04AA01

Prescriere limitata: Terapie de mentinere ulterioara initierii si stabilizarii tratamentului cu ciclosporina, la pacientii cu poliartrita reumatoida severa pentru care agentii antireumatici clasici

cu actiune lenta (inclusiv methotrexat) sunt ineficienti sau inadecvati.

Monitorizarea atentă a pacienţilor este obligatorie.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgL04AA01 CICLOSPORINUM CAPS. MOIEQUORAL® 100 mg 100mg IVAX - PHARMACEUTICALS S.R.O.

100mg/mlL04AA01 CICLOSPORINUM SOL. ORALAEQUORAL® 100mg/ml IVAX - PHARMACEUTICALS S.R.O.

SANDIMMUN NEORAL® 100mg/ml NOVARTIS PHARMA GMBH

25mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL® 25 mg 25mg HEXAL AG

EQUORAL® 25 mg 25mg IVAX - PHARMACEUTICALS S.R.O.

SANDIMMUN NEORAL® 25mg NOVARTIS PHARMA GMBH

50mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL 50 mg 50mg HEXAL AG

EQUORAL® 50 mg 50mg IVAX - PHARMACEUTICALS S.R.O.

SANDIMMUN NEORAL® 50mg NOVARTIS PHARMA GMBH

518 LEFLUNOMIDUM **L04AA13

Cod restrictie 2643: Tratamentul iniţial al poliartritei reumatoide active severe in conditiile in care alte medicamente remisive standard (inclusiv methotrexat) sunt ineficiente şi/sau

Cod restrictie 2681: Tratamentul iniţial al poliartritei reumatoide active severe in conditiile in care alte medicamente remisive standard (inclusiv methotrexat) sunt ineficiente şi/sau

Leflunomide este un medicament care nu trebuie administrat la gravide. Sarcina trebuie evitată timp de doi ani după întreruperea tratamentului.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgL04AA13 LEFLUNOMIDUM COMPR. FILM.ARAVA 100mg 100mg SANOFI- AVENTIS DEUTSCHLAND GMBH

10mgL04AA13 LEFLUNOMIDUM COMPR. FILM.ARAVA 10mg 10mg SANOFI- AVENTIS DEUTSCHLAND GMBH

20mgL04AA13 LEFLUNOMIDUM COMPR. FILM.ARAVA 20mg 20mg SANOFI- AVENTIS DEUTSCHLAND GMBH

519 AZATHIOPRINUM *L04AX01

50mgL04AX01 AZATHIOPRINUM COMPR. FILM.IMURAN® 50mg THE WELLCOME FOUNDATION LTD.

520 DICLOFENACUMM01AB05A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgM01AB05 DICLOFENACUM COMPR. FILM. ELIB. PREL.DICLOTARD® 100 mg 100mg TERAPIA SA

REFEN® RETARD 100mg HEMOFARM S.R.L.

VOLTAREN® RETARD 100mg NOVARTIS PHARMA GMBH

100mgM01AB05 DICLOFENACUM SUPOZ.CLAFEN 100 mg 100mg ANTIBIOTICE SA

DICLOFENAC 100 mg 100mg SINTOFARM SA

DICLOFENAC SODIC 100 mg 100mg MAGISTRA C & C

DICLOGESIC 100 SUPOZITOARE 100mg DAR AL DAWA PHARMA SRL

EPIFENAC 100mg E.I.P.I.CO. MED S.R.L.

VOLTAREN® 100mg NOVARTIS PHARMA GMBH

120mgM01AB05 DICLOFENACUM SUPOZ.TRATUL 120 120mg GEROT PHARMAZEUTIKA GMBH

150mgM01AB05 DICLOFENACUM CAPS. ELIB. PREL.DICLOREUM 150 mg 150mg ALFA WASSERMANN SPA

25mgM01AB05 DICLOFENACUM COMPR. FILM. GASTROREZ.RHEUMAVEK 25mg FARAN LABORATORIES S.A.

VOLTAREN® 25 25mg NOVARTIS PHARMA GMBH

25mgM01AB05 DICLOFENACUM COMPR. GASTROREZ.EPIFENAC 25mg E.I.P.I.CO. MED S.R.L.

25mgM01AB05 DICLOFENACUM DRAJ. GASTROREZ.DICLOFENAC 25 mg 25mg ARENA GROUP SA

25mg/mlM01AB05 DICLOFENACUM SOL. INJ.RHEUMAVEK 25mg/ml FARAN LABORATORIES S.A.

VOLTAREN® 25mg/ml NOVARTIS PHARMA GMBH

30mg/mlM01AB05 DICLOFENACUM SOL. INJ.

76 153/

Page 77: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

TRATUL® 30mg/ml GEROT PHARMAZEUTIKA GMBH

50mgM01AB05 DICLOFENACUM CAPS. GASTROREZ.TRATUL 50 50mg GEROT PHARMAZEUTIKA GMBH

50mgM01AB05 DICLOFENACUM COMPR. FILM. GASTROREZ.CLAFEN 50 mg 50mg ANTIBIOTICE SA

DICLOFENAC 50 mg 50mg TERAPIA SA

VOLTAREN® 50 50mg NOVARTIS PHARMA GMBH

50mgM01AB05 DICLOFENACUM DRAJ.VOLTAREN RAPID® 50mg NOVARTIS PHARMA GMBH

50mgM01AB05 DICLOFENACUM DRAJ. GASTROREZ.DICLOFENAC 50 mg 50mg ARENA GROUP SA

50mgM01AB05 DICLOFENACUM SUPOZ.VOLTAREN® 50mg NOVARTIS PHARMA GMBH

60mgM01AB05 DICLOFENACUM SUPOZ.TRATUL 60 60mg GEROT PHARMAZEUTIKA GMBH

75mgM01AB05 DICLOFENACUM COMPR. ELIB. MODIF.DICLAC® 75 ID 75mg HEXAL AG

75mgM01AB05 DICLOFENACUM SOL. INJ.DICLAC 75mg HEXAL AG

VURDON 75mg HELP S.A. PHARMACEUTICALS

75mg/3mlM01AB05 DICLOFENACUM SOL. INJ.ALMIRAL 75mg/3ml MEDOCHEMIE LTD.

DICLOFENAC 75 mg 75mg/3ml TERAPIA SA

DICLOFENAC AL I.M. 75mg/3ml ALIUD PHARMA GMBH & CO.KG

521 HYDROXYCHLOROQUINUMP01BA02

200mgP01BA02 HYDROXYCHLOROQUINUM COMPR. FILM.PLAQUENIL® 200mg SANOFI-SYNTHELABO LTD.

77 153/

Page 78: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

SUBLISTA C1-G19 SPONDILITA ANKILOZANTA.

522 SULFASALAZINUMA07EC01

500mgA07EC01 SULFASALAZINUM COMPR. FILM.SALAZIDIN 500mg AC HELCOR SRL

500mgA07EC01 SULFASALAZINUM COMPR. FILM. GASTROREZ.SULFASALAZIN EN 500mg KRKA D.D. NOVO MESTO

523 BETAMETHASONUMH02AB01

7mg/mlH02AB01 BETAMETHASONUM SUSP. INJ. I.M.DIPROPHOS® 7mg/ml SCHERING PLOUGH EUROPE

524 DICLOFENACUMM01AB05A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgM01AB05 DICLOFENACUM COMPR. FILM. ELIB. PREL.DICLOTARD® 100 mg 100mg TERAPIA SA

REFEN® RETARD 100mg HEMOFARM S.R.L.

VOLTAREN® RETARD 100mg NOVARTIS PHARMA GMBH

100mgM01AB05 DICLOFENACUM SUPOZ.CLAFEN 100 mg 100mg ANTIBIOTICE SA

DICLOFENAC 100 mg 100mg SINTOFARM SA

DICLOFENAC SODIC 100 mg 100mg MAGISTRA C & C

DICLOGESIC 100 SUPOZITOARE 100mg DAR AL DAWA PHARMA SRL

EPIFENAC 100mg E.I.P.I.CO. MED S.R.L.

VOLTAREN® 100mg NOVARTIS PHARMA GMBH

120mgM01AB05 DICLOFENACUM SUPOZ.TRATUL 120 120mg GEROT PHARMAZEUTIKA GMBH

150mgM01AB05 DICLOFENACUM CAPS. ELIB. PREL.DICLOREUM 150 mg 150mg ALFA WASSERMANN SPA

25mgM01AB05 DICLOFENACUM COMPR. FILM. GASTROREZ.RHEUMAVEK 25mg FARAN LABORATORIES S.A.

VOLTAREN® 25 25mg NOVARTIS PHARMA GMBH

25mgM01AB05 DICLOFENACUM COMPR. GASTROREZ.EPIFENAC 25mg E.I.P.I.CO. MED S.R.L.

25mgM01AB05 DICLOFENACUM DRAJ. GASTROREZ.DICLOFENAC 25 mg 25mg ARENA GROUP SA

25mg/mlM01AB05 DICLOFENACUM SOL. INJ.RHEUMAVEK 25mg/ml FARAN LABORATORIES S.A.

VOLTAREN® 25mg/ml NOVARTIS PHARMA GMBH

30mg/mlM01AB05 DICLOFENACUM SOL. INJ.TRATUL® 30mg/ml GEROT PHARMAZEUTIKA GMBH

50mgM01AB05 DICLOFENACUM CAPS. GASTROREZ.TRATUL 50 50mg GEROT PHARMAZEUTIKA GMBH

50mgM01AB05 DICLOFENACUM COMPR. FILM. GASTROREZ.CLAFEN 50 mg 50mg ANTIBIOTICE SA

DICLOFENAC 50 mg 50mg AC HELCOR PHARMA SRL

VOLTAREN® 50 50mg NOVARTIS PHARMA GMBH

50mgM01AB05 DICLOFENACUM DRAJ.VOLTAREN RAPID® 50mg NOVARTIS PHARMA GMBH

50mgM01AB05 DICLOFENACUM DRAJ. GASTROREZ.DICLOFENAC 50 mg 50mg ARENA GROUP SA

50mgM01AB05 DICLOFENACUM SUPOZ.VOLTAREN® 50mg NOVARTIS PHARMA GMBH

60mgM01AB05 DICLOFENACUM SUPOZ.TRATUL 60 60mg GEROT PHARMAZEUTIKA GMBH

75mgM01AB05 DICLOFENACUM COMPR. ELIB. MODIF.DICLAC® 75 ID 75mg HEXAL AG

75mgM01AB05 DICLOFENACUM SOL. INJ.DICLAC 75mg HEXAL AG

VURDON 75mg HELP S.A. PHARMACEUTICALS

75mg/3mlM01AB05 DICLOFENACUM SOL. INJ.ALMIRAL 75mg/3ml MEDOCHEMIE LTD.

DICLOFENAC 75 mg 75mg/3ml TERAPIA SA

DICLOFENAC AL I.M. 75mg/3ml ALIUD PHARMA GMBH & CO.KG

78 153/

Page 79: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

SUBLISTA C1-G22 BOLI ENDOCRINE (GUSA ENDEMICA, INSUFICIENTA SUPRARENALA CRONICA, DIABETUL INSIPID,

MIXEDEMUL ADULTULUI, TUMORI HIPOFIZARE CU EXPANSIUNE SUPRASELARA SI TUMORI NEUROENDOCRINE).

525 CABERGOLINUM ** Protocol: G001CG02CB03

0.5mgG02CB03 CABERGOLINUM COMPR.DOSTINEX 0.5mg PFIZER EUROPE MA EEG

0.5mgG02CB03 CABERGOLINUM COMPR.DOSTINEX 0.5mg PFIZER EUROPE MA EEG

Prevenirea aparitiei lactatiei in lauzie din motive medicalePrescriere limitata:

Hiperprolactinemia patologica pentru care nu este indicata interventia chirurgicalaCod restrictie 2659:

Hiperprolactinemia patologica pentru care a fost utilizat tratament chirurgical dar cu rezultate incompleteCod restrictie 2660:

526 PEGVISOMANTUM **** Protocol: H012EH01AX01

10mgH01AX01 PEGVISOMANTUM LIOF. + SOLV. PT. SOL. INJ.SOMAVERT 10 mg 10mg PFIZER LTD.

20mgH01AX01 PEGVISOMANTUM LIOF. + SOLV. PT. SOL. INJ.SOMAVERT 20 mg 20mg PFIZER LTD.

527 DESMOPRESSINUMH01BA02

0.2mgH01BA02 DESMOPRESSINUM COMPR.MINIRIN 0,2 mg 0.2mg FERRING AB

Diabet insipid.Cod restrictie 1678:

H01BA02 DESMOPRESSINUMMINIRIN 0,2 mg 0.2mg FERRING AB

528 OCTREOTIDUM **** Protocol: H008EH01CB02

100mgH01CB02 OCTREOTIDUM COMPR.SANDOSTATIN® 0.1mg/ml NOVARTIS PHARMA GMBH

10mgH01CB02 OCTREOTIDUM PULB.+SOLV.PT.SUSP. INJ. (I.M.) CU ELIB.

PRELUNG.SANDOSTATIN LAR 10 mg 10mg NOVARTIS PHARMA GMBH

20mgH01CB02 OCTREOTIDUM PULB. + SOLV. PT. SUSP. INJ. (I.M.) CU ELIB.

PRELUSANDOSTATIN LAR 20 mg 20mg NOVARTIS PHARMA GMBH

30mgH01CB02 OCTREOTIDUM PULB.+SOLV.PT.SUSP. INJ. (I.M.) CU ELIB.

PRELUNG.SANDOSTATIN LAR 30 mg 30mg NOVARTIS PHARMA GMBH

529 LANREOTIDUM **** Protocol: H005E;H006CH01CB03

30mgH01CB03 LANREOTIDUM LIOF. PT. SOL. INJ. + SOLV.SOMATULINE® PR 30 mg 30mg BEAUFOUR IPSEN PHARMA

530 FLUDROCORTISONUMH02AA02

0.1mgH02AA02 FLUDROCORTISONUM COMPR.ASTONIN H 0.1mg MERCK KGAA

531 PREDNISOLONUMH02AB06

250mgH02AB06 PREDNISOLONUM LIOF. + SOLV. PT. SOL. INJ.SOLU - DECORTIN H 250 250mg MERCK KGAA

50mgH02AB06 PREDNISOLONUM LIOF. + SOLV. PT. SOL. INJ.SOLU - DECORTIN H 50 50mg MERCK KGAA

532 PREDNISONUMH02AB07

5mgH02AB07 PREDNISONUM COMPR.N - PREDNISON 5mg MEDUMAN SA

PREDNISON 5 mg 5mg SINTOFARM SA

PREDNISON ARENA 5 mg 5mg ARENA GROUP SA

PREDNISON GEDEON RICHTER 5 mg 5mg GEDEON RICHTER ROMANIA SA

PREDNISON MAGISTRA 5 mg 5mg MAGISTRA C & C

533 HYDROCORTISONUMH02AB09

100mgH02AB09 HYDROCORTISONUM LIOF. + SOLV. PT. SOL. INJ.HYDROCORTISONE 100 mg 100mg HEMOFARM S.R.L.

HYDROCORTISONE SUCCINAT SODIC 100mg E.I.P.I.CO. MED S.R.L.

25mg/5mlH02AB09 HYDROCORTISONUM SOL. INJ. I.V.HIDROCORTIZON HEMISUCCINAT 25mg/5ml ZENTIVA S.A.

500mgH02AB09 HYDROCORTISONUM LIOF. PT. SOL. INJ. + SOLV.HYDROCORTISONE 500 mg 500mg HEMOFARM S.R.L.

534 LEVOTHYROXINUMH03AA01

100µgH03AA01 LEVOTHYROXINUM COMPR.EUTHYROX® 100 100µg MERCK KGAA

L-THYROXIN 100 BERLIN - CHEMIE 100µg BERLIN CHEMIE AG MENARINI GROUP

200µgH03AA01 LEVOTHYROXINUM COMPR.EUTHYROX® 200 200µg MERCK KGAA

25µgH03AA01 LEVOTHYROXINUM COMPR.EUTHYROX® 25 25µg MERCK KGAA

50µgH03AA01 LEVOTHYROXINUM COMPR.EUTHYROX® 50 50µg MERCK KGAA

L-THYROXIN 50 50µg BERLIN CHEMIE AG MENARINI GROUP

535 KALII IODIDUMH03CA01

100µgH03CA01 KALII IODIDUM COMPR.JODID 100 100µg MERCK KGAA

200µgH03CA01 KALII IODIDUM COMPR.JODID 200 200µg MERCK KGAA

536 BROMOCRIPTINUMG02CB01

2.5mgG02CB01 BROMOCRIPTINUM DRAJ.

79 153/

Page 80: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

BROCRIPTIN 2.5mg BIOFARM SA

Hiperprolactinemia patologica pentru care nu este indicata interventia chirurgicalaPrescriere limitata:

Hiperprolactinemia patologica pentru care tratamentul chirurgical utilizat a dus la rezultate incomplete;Prescriere limitata:

SUBLISTA C1-G23 BOALA WILSON.

537 PENICILLAMINUM **(4)M01CC01

M01CC01 PENICILLAMINUM

80 153/

Page 81: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

SUBLISTA C1-G25 BOALA CRONICA DE RINICHI – FAZA PREDIALIZA.

538 PARICALCITOLUM ** Protocol: A005EA11CC07

5 µg/mlA11CC07 PARICALCITOLUM SOL. INJ.ZEMPLAR 5 µg/ml ABBOTT LABORATORIES S.A.

539 COMPLEX DE HIDROXID DE FER (III) SUCROZA ** Protocol: A010NB03AC02

20mg/mlB03AC02 COMPLEX DE HIDROXID DE FER (III)

SUCROZA

SOL. INJ./PERF.

VENOFER® 20mg/ml VIFOR FRANCE S.A.

540 EPOETINUM ALFA ** Protocol: B010NB03XA01

10000ui/mlB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 10000 UI 10000ui/ml JOHNSON & JOHNSON D.O.O.

1000UI/0.5mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 1000 UI/0,5 ml 1000UI/0.5ml RENAMED FARMA S.R.L.

EPREX® 1000 UI 1000ui/0.5ml JOHNSON & JOHNSON D.O.O.

2000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPOPHAR 2000 U.I. 2000UI GULF PHARMACEUTICAL IND. S.R.L.

2000ui/0.5mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 2000 UI/0,5 ml 2000UI/0.5ml RENAMED FARMA S.R.L.

EPREX® 2000 UI 2000ui/0.5ml JOHNSON & JOHNSON D.O.O.

2000UI/1mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 2000 UI/1 ml 2000UI/1ml RENAMED FARMA S.R.L.

3000ui/0.3mlB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 3000 UI 3000ui/0.3ml JOHNSON & JOHNSON D.O.O.

40 000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 40 000 UI 40 000UI JOHNSON & JOHNSON D.O.O.

4000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPOPHAR 4000 U.I. 4000UI GULF PHARMACEUTICAL IND. S.R.L.

4000ui/0.4mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 4000 UI/0,4 ml 4000UI/0.4ml RENAMED FARMA S.R.L.

EPREX® 4000 UI 4000ui/0.4ml JOHNSON & JOHNSON D.O.O.

4000UI/1mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 4000 UI/1 ml 4000UI/1ml RENAMED FARMA S.R.L.

541 EPOETINUM BETA ** Protocol: B009NB03XA01

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 10000 UI 10000UI/0,6ml ROCHE REGISTRATION L

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 1000 UI 1000UI/0,3ml ROCHE REGISTRATION L

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 2000 UI 2000UI/0,3ml ROCHE REGISTRATION L

30000 UI/0,6mlB03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 30000UI/0,6ml 30000 UI/0,6ml ROCHE REGISTRATION LTD.

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 4000 UI 4000UI/0,3ml ROCHE REGISTRATION L

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 5000 UI 5000UI/0,3ml ROCHE REGISTRATION L

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 500 UI 500UI/0,3ml ROCHE REGISTRATION L

542 DARBEPOETINUM ALFA ** Protocol: B011NB03XA02

10µg/0.4mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 10µg/0.4ml 10µg/0.4ml AMGEN EUROPE BV

100µg/0.5mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 100µg/0.5ml 100µg/0.5ml AMGEN EUROPE BV

15µg/0.375mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 15µg/0.375ml 15µg/0.375ml AMGEN EUROPE BV

150µg/0.3mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 150µg/0.3ml 150µg/0.3ml AMGEN EUROPE BV

20µg/0.5mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 20µg/0.5ml 20µg/0.5ml AMGEN EUROPE BV

30µg/0.3mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 30µg/0.3ml 30µg/0.3ml AMGEN EUROPE BV

300µg/0.6mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 300µg/0.6ml 300µg/0.6ml AMGEN EUROPE BV

40µg/0.4mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 40µg/0.4ml 40µg/0.4ml AMGEN EUROPE BV

50µg/0.5mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 50µg/0.5ml 50µg/0.5ml AMGEN EUROPE BV

500µg/mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 500µg/ml 500µg/ml AMGEN EUROPE BV

60µg/0.3mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 60µg/0.3ml 60µg/0.3ml AMGEN EUROPE BV

80µg/0.4mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 80µg/0.4ml 80µg/0.4ml AMGEN EUROPE BV

544 IRBESARTANUM ** Protocol: C008NC09CA04

150mgC09CA04 IRBESARTANUM COMPR. FILM.APROVEL 150mg 150mg SANOFI PHARMA - BRISTOL MYERS SQUIBB

300mgC09CA04 IRBESARTANUM COMPR. FILM.APROVEL 300mg 300mg SANOFI PHARMA - BRISTOL MYERS SQUIBB

545 PREDNISONUM Protocol: H002NH02AB07

5mgH02AB07 PREDNISONUM COMPR.

81 153/

Page 82: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

N - PREDNISON 5mg MEDUMAN SA

PREDNISON 5 mg 5mg SINTOFARM SA

PREDNISON ARENA 5 mg 5mg ARENA GROUP SA

PREDNISON GEDEON RICHTER 5 mg 5mg GEDEON RICHTER ROMANIA SA

PREDNISON MAGISTRA 5 mg 5mg MAGISTRA C & C

546 CYCLOPHOSPHAMIDUM Protocol: L027NL01AA01

50mgL01AA01 CYCLOPHOSPHAMIDUM DRAJ.ENDOXAN® 50 mg 50mg BAXTER ONCOLOGY GMBH

547 CICLOSPORINUM * Protocol: L028NL04AA01Monitorizarea atentă a pacienţilor este obligatorie.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgL04AA01 CICLOSPORINUM CAPS. MOIEQUORAL® 100 mg 100mg IVAX - PHARMACEUTICALS S.R.O.

100mg/mlL04AA01 CICLOSPORINUM SOL. ORALAEQUORAL® 100mg/ml IVAX - PHARMACEUTICALS S.R.O.

SANDIMMUN NEORAL® 100mg/ml NOVARTIS PHARMA GMBH

25mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL® 25 mg 25mg HEXAL AG

EQUORAL® 25 mg 25mg IVAX - PHARMACEUTICALS S.R.O.

SANDIMMUN NEORAL® 25mg NOVARTIS PHARMA GMBH

50mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL 50 mg 50mg HEXAL AG

EQUORAL® 50 mg 50mg IVAX - PHARMACEUTICALS S.R.O.

SANDIMMUN NEORAL® 50mg NOVARTIS PHARMA GMBH

548 AZATHIOPRINUM * Protocol: L029NL04AX01

50mgL04AX01 AZATHIOPRINUM COMPR. FILM.IMURAN® 50mg THE WELLCOME FOUNDATION LTD.

549 AMINOACIZI INCLUSIV COMBINATII CU POLIPEPTIDE ** Protocol: V004NV06DDN1

V06DDN1 AMINOACIZI INCLUSIV COMBINATII CU

POLIPEPTIDE

COMPR. FILM.

KETOSTERIL® FRESENIUS KABI DEUTSCHLAND GMBH

82 153/

Page 83: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

SUBLISTA C1-G26 GLAUCOM.

550 DORZOLAMIDUMS01EC03

20mg/mlS01EC03 DORZOLAMIDUM SOL. OFT.TRUSOPT 20mg/ml MERCK SHARP & DOHME S.R.L.

551 BRINZOLAMIDUMS01EC04

10mg/mlS01EC04 BRINZOLAMIDUM PICATURI OFT.-SUSP.AZOPT 10mg/ml 10mg/ml ALCON LABORATORIES LTD.

552 TIMOLOLUMS01ED01

0.25%S01ED01 TIMOLOLUM PICATURI OFT.-SOL.TIMO-COMOD® 0.25% URSAPHARM ARZNEIMITTEL GMBH&CO.KG

TIMOLOL 0,25% 0.25% E.I.P.I.CO. MED S.R.L.

0.5%S01ED01 TIMOLOLUM PICATURI OFT.-SOL.TIMO-COMOD® 0.5% URSAPHARM ARZNEIMITTEL GMBH&CO.KG

TIMO-GAL® 0.5% TERAPIA SA

TIMOLOL 0,5% 0.5% E.I.P.I.CO. MED S.R.L.

1mg/gS01ED01 TIMOLOLUM GEL OFT.NYOLOL GEL 1mg/g NOVARTIS PHARMA GMBH

2.5mg/mlS01ED01 TIMOLOLUM PIC. OFT.-SOL.TIMOPTIC 2.5mg/ml MERCK SHARP & DOHME ROMANIA S.R.L.

2.5mg/mlS01ED01 TIMOLOLUM PICATURI OFT.-SOL.ARUTIMOL 0,25% 2.5mg/ml CHAUVIN ANKERPHARM GMBH

5mg/mlS01ED01 TIMOLOLUM PIC. OFT.-SOL.TIMOPTIC 5mg/ml MERCK SHARP & DOHME ROMANIA S.R.L.

5mg/mlS01ED01 TIMOLOLUM PICATURI OFT.-SOL.ARUTIMOL 0,5% 5mg/ml CHAUVIN ANKERPHARM GMBH

2.5mg/mlS01ED01 TIMOLOLUM PIC. OFT., SOL.TIMOLOL RPH 0,25% 2.5mg/ml ROMPHARM COMPANY SRL

2.5mg/mlS01ED01 TIMOLOLUM PIC. OFT.,SOL.TIMABAK 2,5 mg/ml 2.5mg/ml LABORATOIRES THEA

5mg/mlS01ED01 TIMOLOLUM PIC. OFT.,SOL.TIMABAK 5 mg/ml 5mg/ml LABORATORIES THEA

TIMOLOL RPH 0,5% 5mg/ml ROMPHARM COMPANY SRL

553 BETAXOLOLUMS01ED02

0.25%S01ED02 BETAXOLOLUM PICATURI OFT.-SUSP.BETOPTIC - S 0.25% ALCON COUVREUR NV

5mg/mlS01ED02 BETAXOLOLUM PIC. OFT.-SOL.BETAX 5mg/ml ROMPHARM SRL

5mg/mlS01ED02 BETAXOLOLUM PIC.OFTALMICE,SOL.BETOPTIC 5mg/ml ALCON COUVREUR NV

5mg/mlS01ED02 BETAXOLOLUM PIC. OFT., SOL.BETAXOLOL 5mg/ml TERAPIA SA

554 CARTEOLOLUMS01ED05

20mg/mlS01ED05 CARTEOLOLUM PICATURI OFT.-SOL.CARTEOL 2% 20mg/ml S.I.F.I. SPA

20mg/mlS01ED05 CARTEOLOLUM PIC. OFTALMICE CU ELIB. PREL.FORTINOL EP 2% 20mg/ml DR. GERHARD MANN CHEM-PHARM. FABRIK GMBH

2%S01ED05 CARTEOLOLUM PICATURI OFT.-SOL.CARTEOL 2% 2% S.I.F.I. SPA

555 COMBINATII (BIMATOPROSTUM + TIMOLOLUM)S01ED51

300µg/ml+5mg/m

l

S01ED51 COMBINATII (BIMATOPROSTUM +

TIMOLOLUM)

PIC. OFT.,SOL.

GANFORT 300µg/ml+5mg/ml ALLERGAN PHARMACEUTICALS IRELAND

556 COMBINATII (DORZOLAMIDUM+TIMOLOLUM)S01ED51

S01ED51 COMBINATII (DORZOLAMIDUM+TIMOLOLUM) PIC. OFT.-SOL.COSOPT FARA

CONCENTRATIE

MERCK SHARP & DOHME

557 COMBINATII (LATANOPROSTUM+TIMOLOLUM)S01ED51

S01ED51 COMBINATII

(LATANOPROSTUM+TIMOLOLUM)

SOL. OFT.

XALCOM (R) FARA

CONCENTRATIE

PFIZER EUROPE MA EEI

558 LATANOPROSTUMS01EE01

5,00%S01EE01 LATANOPROSTUM PICATURI OFT.-SOL.XALATAN® 0.005% PFIZER EUROPE MA EEIG

559 BIMATOPROSTUMS01EE03

0,3mg/mlS01EE03 BIMATOPROSTUM PIC. OFT.,SOL.LUMIGAN 0,3mg/ml 0,3mg/ml ALLERGAN PHARMACEUTICALS IRELAND

561 TRAVOPROSTUMS01EE04

40µg/mlS01EE04 TRAVOPROSTUM PICATURI OFT.SOL.TRAVATAN 40µg/ml 40µg/ml ALCON LABORATORIES LTD.

83 153/

Page 84: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

SUBLISTA C1-G27 PEMFIGUS.

562 DEXAMETHASONUMH02AB02

8mgH02AB02 DEXAMETHASONUM SOL. INJ.DEXAMETHASONE SODIUM PHOSPHATE 8mg E.I.P.I.CO. MED S.R.L.

8mg/2mlH02AB02 DEXAMETHASONUM SOL. INJ.DEXAMED 8mg/2ml MEDOCHEMIE LTD.

563 METHYLPREDNISOLONUMH02AB04

H02AB04 METHYLPREDNISOLONUM

H02AB04 METHYLPREDNISOLONUM COMPR.MEDROL 32 32mg PFIZER EUROPE MA EEI

H02AB04 METHYLPREDNISOLONUM COMPR.MEDROL 4 mg 4mg PFIZER EUROPE MA EEI

H02AB04 METHYLPREDNISOLONUM COMPR.MEDROL A 16 16mg PFIZER EUROPE MA EEI

H02AB04 METHYLPREDNISOLONUM LIOF. + SOLV. PT. SOL. INJ.SOLU - MEDROL 500 mg/7,8 ml 500mg/7.8ml PFIZER EUROPE MA EEI

H02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV.PT.SOL.INJSOLU - MEDROL ACT-O-VIAL 125mg/2ml PFIZER EUROPE MA EEI

H02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV.PT.SOL.INJSOLU - MEDROL ACT-O-VIAL 250mg/4ml PFIZER EUROPE MA EEI

H02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV.PT.SOL.INJSOLU - MEDROL ACT-O-VIAL 40mg/1ml PFIZER EUROPE MA EEI

H02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 125 mg 125mg HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 40 mg 40mg HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 20 mg 20mg HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 500 mg 500mg HEMOFARM S.R.L.

564 PREDNISONUMH02AB07

5mgH02AB07 PREDNISONUM COMPR.N - PREDNISON 5mg MEDUMAN SA

PREDNISON 5 mg 5mg SINTOFARM SA

PREDNISON ARENA 5 mg 5mg ARENA GROUP SA

PREDNISON GEDEON RICHTER 5 mg 5mg GEDEON RICHTER ROMANIA SA

PREDNISON MAGISTRA 5 mg 5mg MAGISTRA C & C

565 DAPSONUM (4)J04BA02

J04BA02 DAPSONUM

566 CYCLOPHOSPHAMIDUML01AA01

1gL01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. INJ./PERF.ENDOXAN® 1 g 1g BAXTER ONCOLOGY GMBH

200mgL01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. PERF./INJ. I.V.ENDOXAN 200 mg 200mg ACTAVIS S.R.L.

500mgL01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. INJ./PERF.ENDOXAN® 500 mg 500mg BAXTER ONCOLOGY GMBH

50mgL01AA01 CYCLOPHOSPHAMIDUM DRAJ.ENDOXAN® 50 mg 50mg BAXTER ONCOLOGY GMBH

568 CICLOSPORINUM *L04AA01Monitorizarea atentă a pacienţilor este obligatorie.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgL04AA01 CICLOSPORINUM CAPS. MOIEQUORAL® 100 mg 100mg IVAX - PHARMACEUTICALS S.R.O.

100mg/mlL04AA01 CICLOSPORINUM SOL. ORALAEQUORAL® 100mg/ml IVAX - PHARMACEUTICALS S.R.O.

SANDIMMUN NEORAL® 100mg/ml NOVARTIS PHARMA GMBH

25mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL® 25 mg 25mg HEXAL AG

EQUORAL® 25 mg 25mg IVAX - PHARMACEUTICALS S.R.O.

SANDIMMUN NEORAL® 25mg NOVARTIS PHARMA GMBH

50mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL 50 mg 50mg HEXAL AG

EQUORAL® 50 mg 50mg IVAX - PHARMACEUTICALS S.R.O.

SANDIMMUN NEORAL® 50mg NOVARTIS PHARMA GMBH

569 AZATHIOPRINUM *L04AX01

50mgL04AX01 AZATHIOPRINUM COMPR. FILM.IMURAN® 50mg THE WELLCOME FOUNDATION LTD.

SUBLISTA C1-G29 BOALA GAUCHER.

570 IMIGLUCERASUM **** Protocol: A008EA16AB02

200UA16AB02 IMIGLUCERASUM PULB. PT.CONC. PT.SOL. PERF.CEREZYME 200U 200U GENZYME EUROPE BV

400UA16AB02 IMIGLUCERASUM PULB. PT.CONC. PT.SOL. PERF.CEREZYME 400U 400U GENZYME EUROPE BV

571 MIGLUSTATUM ****A16AX06

Prescriere limitata: Tratamentul pe cale orală al bolii Gaucher de tip I, uşoară până la moderată.numai la pacienţii care nu pot fi supuşi terapiei de substituţie enzimatică

100mgA16AX06 MIGLUSTATUM CAPS.ZAVESCA 100mg ACTELION REGISTRATION LTD.

84 153/

Page 85: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

SUBLISTA C1-G30 BOLI VENERICE (SIFILIS, GONOREE, INFECTIA CU CHLAMIDIA).

572 DOXYCYCLINUMJ01AA02

100mgJ01AA02 DOXYCYCLINUM CAPS.DOXICICLINA 100mg EUROPHARM SA

DOXICICLINA 100 mg 100mg ANTIBIOTICE SA

DOXICICLINA SANDOZ 100 mg 100mg SANDOZ SRL

100mgJ01AA02 DOXYCYCLINUM COMPR. DISP.UNIDOX SOLUTAB 100mg ASTELLAS PHARMA EUROPE B.V.

100mgJ01AA02 DOXYCYCLINUM CAPS.DOXICICLINA 100mg ARENA GROUP SA

DOXICICLINA 100 mg 100mg ANTIBIOTICE SA

DOXICICLINA SANDOZ 100 mg 100mg SANDOZ SRL

100mgJ01AA02 DOXYCYCLINUM COMPR. DISP.UNIDOX SOLUTAB 100mg ASTELLAS PHARMA EUROPE B.V.

100mgJ01AA02 DOXYCYCLINUM CAPS.DOXICICLINA 100mg ARENA GROUP SA

DOXICICLINA 100 mg 100mg ANTIBIOTICE SA

DOXICICLINA SANDOZ 100 mg 100mg SANDOZ SRL

100mgJ01AA02 DOXYCYCLINUM COMPR. DISP.UNIDOX SOLUTAB 100mg ASTELLAS PHARMA EUROPE B.V.

573 TETRACYCLINUMJ01AA07

250mgJ01AA07 TETRACYCLINUM CAPS.TETRACICLINA 250 mg 250mg ANTIBIOTICE SA

TETRACICLINA SANDOZ 250 mg 250mg SANDOZ SRL

574 PHENOXYMETHYLPENICILLINUMJ01CE02

1000000uiJ01CE02 PHENOXYMETHYLPENICILLINUM COMPR.PENICILINA V 1 000 000 U.I. 1000000ui EUROPHARM SA

1000000uiJ01CE02 PHENOXYMETHYLPENICILLINUM COMPR. FILM.OSPEN® 1000 1000000ui SANDOZ GMBH

1500000uiJ01CE02 PHENOXYMETHYLPENICILLINUM COMPR. FILM.OSPEN® 1500 1500000ui SANDOZ GMBH

400000ui/5mlJ01CE02 PHENOXYMETHYLPENICILLINUM SIROPOSPEN 400 400000ui/5ml SANDOZ GMBH

500000uiJ01CE02 PHENOXYMETHYLPENICILLINUM COMPR. FILM.OSPEN® 500 500000ui SANDOZ GMBH

575 BENZYLPENICILLINUMJ01CE01

1 000 000uiJ01CE01 BENZYLPENICILLINUM PULB. PT. SOL. INJ.PENICILINA G SODICA 1 000 000ui ANTIBIOTICE SA

1000000uiJ01CE01 BENZYLPENICILLINUM PULB. PT. SOL. INJ.PENICILINA G POTASICA 1000000ui ANTIBIOTICE SA

400 000uiJ01CE01 BENZYLPENICILLINUM PULB. PT. SOL. INJ.PENICILINA G SODICA 400 000ui ANTIBIOTICE SA

400000uiJ01CE01 BENZYLPENICILLINUM PULB. PT. SOL. INJ.PENICILINA G POTASICA 400000ui ANTIBIOTICE SA

576 BENZATHINI BENZYLPENICILLINUMJ01CE08

1200000uiJ01CE08 BENZATHINI BENZYLPENICILLINUM PULB. PT. SUSP. INJ.MOLDAMIN® 1200000ui ANTIBIOTICE SA

600000uiJ01CE08 BENZATHINI BENZYLPENICILLINUM PULB. PT. SUSP. INJ.MOLDAMIN® 600000ui ANTIBIOTICE SA

577 CEFIXIMUMJ01DD08

100mg/5mlJ01DD08 CEFIXIMUM GRAN. PT. SUSP. ORALASUPRAX 100mg/5ml GEDEON RICHTER LTD.

200mgJ01DD08 CEFIXIMUM CAPS.EFICEF® 200 mg 200mg ANTIBIOTICE SA

200mgJ01DD08 CEFIXIMUM COMPR. FILM.SUPRAX 200mg GEDEON RICHTER LTD.

578 ERYTHROMYCINUMJ01FA01

200mgJ01FA01 ERYTHROMYCINUM COMPR.ERITROMAGIS 200 mg 200mg ARENA GROUP SA

ERITROMICINA 200 mg 200mg ANTIBIOTICE SA

ERITROMICINA EUROPHARM 200 mg 200mg EUROPHARM SA

ERITROMICINA SANDOZ 200 mg COMPRIMATE 200mg SANDOZ S.R.L.

200mg/5mlJ01FA01 ERYTHROMYCINUM PULB. PT. SUSP. ORALAERITRO 200 200mg/5ml LEK PHARMATECH SRL

579 AZITHROMYCINUMJ01FA10

Prescriere limitata: Infectii genitale necomplicate cu Chlamydia trachomatis.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mg/5mlJ01FA10 AZITHROMYCINUM PULB. PT. SUSP. ORALAAZITROMICINA SANDOZ 100 mg/5 ml 100mg/5ml SANDOZ SRL

125mgJ01FA10 AZITHROMYCINUM COMPR. FILM.SUMAMED 125 mg 125mg PLIVA LJUBLJANA D.O.O.

200 mg/5 mlJ01FA10 AZITHROMYCINUM PULB. PT. SUSP. ORALAAZITROMICINA SANDOZ 200 mg/5 ml 200 mg/5 ml SANDOZ SRL

200mg/5mlJ01FA10 AZITHROMYCINUM PULB. + SOLV. SUSP. ORALAAZITROX 200 mg/5 ml 200mg/5ml ECZACIBASI PHARMACEUTICALS S.R.L.

200mg/5mlJ01FA10 AZITHROMYCINUM PULB. PT. SUSP. ORALASUMAMED FORTE 200mg/5ml PLIVA LJUBLIJANA D.O.O.

250mgJ01FA10 AZITHROMYCINUM CAPS.AZATRIL 250 mg 250mg BALKANPHARMA RAZGRAD AD

85 153/

Page 86: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

250mgJ01FA10 AZITHROMYCINUM COMPR. FILM.AZITROMICINA SANDOZ 250 mg COMPRIMATE FILMATE 250mg SANDOZ S.R.L.

AZITROX® 250 250mg ZENTIVA AS

500mgJ01FA10 AZITHROMYCINUM LIOF. PT. SOL. PERF.SUMAMED® 500mg PLIVA LJUBLJANA D.O.O.

500mgJ01FA10 AZITHROMYCINUM COMPR. FILM.AZITROMICINA SANDOZ 500 mg COMPRIMATE FILMATE 500mg SANDOZ S.R.L.

AZITROX® 500 500mg ZENTIVA AS

AZRO® 500 mg 500mg ECZACIBASI PHARMACEUTICALS S.R.L.

SUMAMED 500 mg 500mg PLIVA LJUBLJANA D.O.O.

ZITROCIN 500 mg 500mg OZONE LABORATORIES LTD.

2gJ01FA10 AZITHROMYCINUM GRAN. ELIB. PREL. PT. SUSP. ORALAZMAX 2 g 2g PFIZER EUROPE MA EEIG

580 CIPROFLOXACINUMJ01MA02

Prescriere limitata: Gonoreea.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

250mgJ01MA02 CIPROFLOXACINUM COMPR. FILM.CIFRAN 250mg RANBAXY UK LIMITED

CIPHIN 250 250mg ZENTIVA A.S.

CIPRINOL 250 mg 250mg KRKA D.D. NOVO MESTO

CIPROCIN 250 mg 250mg E.I.P.I.CO. MED S.R.L.

CIPROFLOXACINA ALKALOID 250 mg 250mg ALKALOID D.O.O.

CIPROLEN® 250 mg 250mg AC HELCOR SRL

CIPROLET 250 mg 250mg DR. REDDY'S LABORATORIES

CIPROZONE 250 mg 250mg OZONE LABORATORIES LTD.

CUMINOL 250 mg 250mg GEDEON RICHTER ROMANIA

100mg/10mlJ01MA02 CIPROFLOXACINUM CONC. PT. SOL. PERF.CIPRINOL® 100mg/10ml KRKA D.D.

CIPROFLOXACINA 100 mg/10 ml 100mg/10ml SICOMED SA

100mg/50mlJ01MA02 CIPROFLOXACINUM SOL. PERF.CIPRINOL 100mg/50ml KRKA D.D. NOVO MESTO

200mg/100mlJ01MA02 CIPROFLOXACINUM SOL. PERF.CIPRINOL 200mg/100ml KRKA D.D. NOVO MESTO

CIPROBAY® 200 200mg/100ml BAYER HEALTHCARE AG

250mgJ01MA02 CIPROFLOXACINUM CAPS.EUCIPRIN 250mg EUROPHARM SA

250mgJ01MA02 CIPROFLOXACINUM COMPR. FILM.CIFRAN 250mg RANBAXY UK LIMITED

CIPHIN 250 250mg ZENTIVA A.S.

CIPRINOL 250 mg 250mg KRKA D.D. NOVO MESTO

CIPROCIN 250 mg 250mg E.I.P.I.CO. MED S.R.L.

CIPROFLOXACINA ALKALOID 250 mg 250mg ALKALOID D.O.O.

CIPROLEN® 250 mg 250mg AC HELCOR SRL

CIPROLET 250 mg 250mg DR. REDDY'S LABORATORIES

CIPROZONE 250 mg 250mg OZONE LABORATORIES LTD.

CUMINOL 250 mg 250mg GEDEON RICHTER ROMANIA

2mg/mlJ01MA02 CIPROFLOXACINUM SOL. PERF.CIPROBAY® 400 2mg/ml BAYER HEALTHCARE AG

UFEXIL 2mg/ml DEMO SA

400mg/200mlJ01MA02 CIPROFLOXACINUM SOL. PERF.CIPRINOL® 400mg/200ml KRKA D.D.

500mgJ01MA02 CIPROFLOXACINUM COMPR. FILM.CIFRAN 500mg RANBAXY UK LIMITED

CIPHIN 500 500mg ZENTIVA A.S.

CIPRINOL 500 mg 500mg KRKA D.D. NOVO MESTO

CIPRO QUIN® 500mg ANTIBIOTICE SA

CIPROBAY® 500 500mg BAYER HEALTHCARE AG

CIPROCIN 500 mg 500mg E.I.P.I.CO. MED S.R.L.

CIPRODAR 500mg DAR AL DAWA PHARMA S.R.L

CIPROFLOXACINA ALKALOID 500 mg 500mg ALKALOID D.O.O.

CIPROLEN® 500 mg 500mg AC HELCOR SRL

CIPROLET 500 mg 500mg DR. REDDY'S LABORATORIES

CIPROZONE FORTE 500 mg 500mg OZONE LABORATORIES LTD.

CUMINOL 500 mg 500mg GEDEON RICHTER ROMANIA

SIFLOKS® 500mg ECZACIBASI ILAC SANAYI VE TICARET AS

750mgJ01MA02 CIPROFLOXACINUM COMPR. FILM.CIPRINOL 750 mg 750mg KRKA D.D. NOVO MESTO

Protocol: L034KSUBLISTA C1-G31A BOALA CRONICA INFLAMATORIE INTESTINALA.

582 INFLIXIMABUM ****L04AA12

100mgL04AA12 INFLIXIMABUM PULB. PT. CONC. PT. SOL. PERF.REMICADE 100 mg 100mg CENTOCOR B.V.

583 ADALIMUMABUM ****L04AA17

40mgL04AA17 ADALIMUMABUM SOL. INJ. IN SERINGA PREUMPLUTAHUMIRA 40 mg 40mg ABBOTT LABORATORIES LTD.

86 153/

Page 87: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

Protocol: L043MSUBLISTA C1-G31B POLIARTRITA REUMATOIDA.

584 RITUXIMABUM ****L01XC02

10mg/mlL01XC02 RITUXIMABUM CONC. PT. SOL. PERF.MABTHERA 100 mg 10mg/ml ROCHE REGISTRATION LTD.

MABTHERA 500 mg 10mg/ml ROCHE REGISTRATION LTD.

585 ETANERCEPTUM ****L04AA11

25mgL04AA11 ETANERCEPTUM PULB. + SOLV. PT. SOL. INJ.ENBREL 25mg 25mg WYETH EUROPA LIMITED

50mgL04AA11 ETANERCEPTUM PULB+SOLV.PT.SOL.INJENBREL 50 mg 50mg WYETH EUROPA LIMITED

25mgL04AA11 ETANERCEPTUM PULB. + SOLV. PT. SOL. INJ.ENBREL 25mg 25mg WYETH EUROPA LIMITED

50mgL04AA11 ETANERCEPTUM PULB+SOLV.PT.SOL.INJENBREL 50 mg 50mg WYETH EUROPA LIMITED

25mgL04AA11 ETANERCEPTUM SOL. INJ. IN SERINGA PREUMPLUTAENBREL 25mg 25mg WYETH EUROPA LIMITED

50mgL04AA11 ETANERCEPTUM SOL. INJ. IN SERINGA PREUMPLUTAENBREL 50mg 50mg WYETH EUROPA LIMITED

586 INFLIXIMABUM ****L04AA12

100mgL04AA12 INFLIXIMABUM PULB. PT. CONC. PT. SOL. PERF.REMICADE 100 mg 100mg CENTOCOR B.V.

587 ADALIMUMABUM ****L04AA17

40mgL04AA17 ADALIMUMABUM SOL. INJ. IN SERINGA PREUMPLUTAHUMIRA 40 mg 40mg ABBOTT LABORATORIES LTD.

Protocol: L040MSUBLISTA C1-G31C ARTROPATIA PSORIAZICA.

589 ETANERCEPTUM ****L04AA11

25mgL04AA11 ETANERCEPTUM PULB. + SOLV. PT. SOL. INJ.ENBREL 25mg 25mg WYETH EUROPA LIMITED

50mgL04AA11 ETANERCEPTUM PULB+SOLV.PT.SOL.INJENBREL 50 mg 50mg WYETH EUROPA LIMITED

25mgL04AA11 ETANERCEPTUM PULB. + SOLV. PT. SOL. INJ.ENBREL 25mg 25mg WYETH EUROPA LIMITED

50mgL04AA11 ETANERCEPTUM PULB+SOLV.PT.SOL.INJENBREL 50 mg 50mg WYETH EUROPA LIMITED

25mgL04AA11 ETANERCEPTUM SOL. INJ. IN SERINGA PREUMPLUTAENBREL 25mg 25mg WYETH EUROPA LIMITED

50mgL04AA11 ETANERCEPTUM SOL. INJ. IN SERINGA PREUMPLUTAENBREL 50mg 50mg WYETH EUROPA LIMITED

590 INFLIXIMABUM ****L04AA12

100mgL04AA12 INFLIXIMABUM PULB. PT. CONC. PT. SOL. PERF.REMICADE 100 mg 100mg CENTOCOR B.V.

591 ADALIMUMABUM ****L04AA17

40mgL04AA17 ADALIMUMABUM SOL. INJ. IN SERINGA PREUMPLUTAHUMIRA 40 mg 40mg ABBOTT LABORATORIES LTD.

Protocol: L041MSUBLISTA C1-G31D SPONDILITA ANKILOZANTA.

592 ETANERCEPTUM ****L04AA11

25mgL04AA11 ETANERCEPTUM PULB. + SOLV. PT. SOL. INJ.ENBREL 25mg 25mg WYETH EUROPA LIMITED

50mgL04AA11 ETANERCEPTUM PULB+SOLV.PT.SOL.INJENBREL 50 mg 50mg WYETH EUROPA LIMITED

25mgL04AA11 ETANERCEPTUM PULB. + SOLV. PT. SOL. INJ.ENBREL 25mg 25mg WYETH EUROPA LIMITED

50mgL04AA11 ETANERCEPTUM PULB+SOLV.PT.SOL.INJENBREL 50 mg 50mg WYETH EUROPA LIMITED

25mgL04AA11 ETANERCEPTUM SOL. INJ. IN SERINGA PREUMPLUTAENBREL 25mg 25mg WYETH EUROPA LIMITED

50mgL04AA11 ETANERCEPTUM SOL. INJ. IN SERINGA PREUMPLUTAENBREL 50mg 50mg WYETH EUROPA LIMITED

593 INFLIXIMABUM ****L04AA12

100mgL04AA12 INFLIXIMABUM PULB. PT. CONC. PT. SOL. PERF.REMICADE 100 mg 100mg CENTOCOR B.V.

594 ADALIMUMABUM ****L04AA17

40mgL04AA17 ADALIMUMABUM SOL. INJ. IN SERINGA PREUMPLUTAHUMIRA 40 mg 40mg ABBOTT LABORATORIES LTD.

87 153/

Page 88: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

Protocol: L039MSUBLISTA C1-G31E ARTRITA JUVENILA.

595 ETANERCEPTUM ****L04AA11

25mgL04AA11 ETANERCEPTUM PULB. + SOLV. PT. SOL. INJ.ENBREL 25mg 25mg WYETH EUROPA LIMITED

50mgL04AA11 ETANERCEPTUM PULB+SOLV.PT.SOL.INJENBREL 50 mg 50mg WYETH EUROPA LIMITED

25mgL04AA11 ETANERCEPTUM PULB. + SOLV. PT. SOL. INJ.ENBREL 25mg 25mg WYETH EUROPA LIMITED

50mgL04AA11 ETANERCEPTUM PULB+SOLV.PT.SOL.INJENBREL 50 mg 50mg WYETH EUROPA LIMITED

25mgL04AA11 ETANERCEPTUM SOL. INJ. IN SERINGA PREUMPLUTAENBREL 25mg 25mg WYETH EUROPA LIMITED

50mgL04AA11 ETANERCEPTUM SOL. INJ. IN SERINGA PREUMPLUTAENBREL 50mg 50mg WYETH EUROPA LIMITED

Protocol: L044LSUBLISTA C1-G31F PSORIAZIS CRONIC SEVER (PLACI).

596 ETANERCEPTUM ****L04AA11

25mgL04AA11 ETANERCEPTUM PULB. + SOLV. PT. SOL. INJ.ENBREL 25mg 25mg WYETH EUROPA LIMITED

50mgL04AA11 ETANERCEPTUM PULB+SOLV.PT.SOL.INJENBREL 50 mg 50mg WYETH EUROPA LIMITED

25mgL04AA11 ETANERCEPTUM PULB. + SOLV. PT. SOL. INJ.ENBREL 25mg 25mg WYETH EUROPA LIMITED

50mgL04AA11 ETANERCEPTUM PULB+SOLV.PT.SOL.INJENBREL 50 mg 50mg WYETH EUROPA LIMITED

25mgL04AA11 ETANERCEPTUM SOL. INJ. IN SERINGA PREUMPLUTAENBREL 25mg 25mg WYETH EUROPA LIMITED

50mgL04AA11 ETANERCEPTUM SOL. INJ. IN SERINGA PREUMPLUTAENBREL 50mg 50mg WYETH EUROPA LIMITED

597 INFLIXIMABUM ****L04AA12

100mgL04AA12 INFLIXIMABUM PULB. PT. CONC. PT. SOL. PERF.REMICADE 100 mg 100mg CENTOCOR B.V.

598 EFALIZUMABUM ****L04AA21

100mg/mlL04AA21 EFALIZUMABUM PULB+SOLV.PT.SOL.INJRAPTIVA 100mg/ml 100mg/ml SERONO EUROPE LTD.

599 ADALIMUMABUM ****L04AA17

40mgL04AA17 ADALIMUMABUM SOL. INJ. IN SERINGA PREUMPLUTAHUMIRA 40 mg 40mg ABBOTT LABORATORIES LTD.

88 153/

Page 89: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

SUBLISTA C2-P1: PROGRAMUL NATIONAL DE BOLI TRANSMISIBILE. A ) SUBPROGRAMUL DE TRATAMENT SI

MONITORIZARE A PERSOANELOR CU INFECTIE HIV /SIDA SI TRATAMENTUL POSTEXPUNERE

600 SAQUINAVIRUMJ05AE01

Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

200mgJ05AE01 SAQUINAVIRUM CAPS.INVIRASE 200mg 200mg ROCHE REGISTRATION LTD.

500mgJ05AE01 SAQUINAVIRUM COMPR. FILM.INVIRASE 500 mg 500mg ROCHE REGISTRATION LTD.

601 INDINAVIRUMJ05AE02

Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

200mgJ05AE02 INDINAVIRUM CAPS.CRIXIVAN 200mg 200mg MERCK SHARP & DOHME LTD.

400mgJ05AE02 INDINAVIRUM CAPS.CRIXIVAN 400mg 400mg MERCK SHARP & DOHME LTD.

602 RITONAVIRUM **J05AE03

Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgJ05AE03 RITONAVIRUM CAPS. MOINORVIR 100 mg 100mg ABBOTT LABORATORIES LTD.

603 NELFINAVIRUMJ05AE04

Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

250mgJ05AE04 NELFINAVIRUM COMPR. FILM.VIRACEPT 250 mg 250mg ROCHE REGISTRATION LTD.

50mg/gJ05AE04 NELFINAVIRUM PULB. PT. SOL. ORALAVIRACEPT 50 mg/g 50mg/g ROCHE REGISTRATION LTD.

605 LOPINAVIRUM+RITONAVIRUM **J05AE06

Prescriere limitata: Tratamentul combinat al infectiei HIV cu doua sau mai multe antiretrovirale la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

133.3mg/33.3mgJ05AE06 LOPINAVIRUM+RITONAVIRUM CAPS. MOIKALETRA 133,3mg/33,3mg 133.3mg/33.3mg ABBOTT LABORATORIES LTD.

200mg/50mgJ05AE06 LOPINAVIRUM+RITONAVIRUM COMPR. FILM.KALETRA 200mg/50mg 200mg/50mg ABBOTT LABORATORIES LTD.

80mg/ml+20mg/

ml

J05AE06 LOPINAVIRUM+RITONAVIRUM SOL. ORALA

KALETRA 80mg/ml+20mg/ml 80mg/ml+20mg/ml ABBOTT LABORATORIES LTD.

606 FOSAMPRENAVIRUM **J05AE07

700mgJ05AE07 FOSAMPRENAVIRUM COMPR. FILM.TELZIR 700mg 700mg GLAXO GROUP LTD.

607 ATAZANAVIRUMJ05AE08

Prescriere limitata: Tratamentul combinat al infectiei HIV cu doua sau mai multe antiretrovirale la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

150mgJ05AE08 ATAZANAVIRUM CAPS.REYATAZ 150 mg 150mg BRISTOL-MYERS SQUIBB PHARMA EEIG

200mgJ05AE08 ATAZANAVIRUM CAPS.REYATAZ 200 mg 200mg BRISTOL-MYERS SQUIBB PHARMA EEIG

608 TIPRANAVIRUM **J05AE09

Prescriere limitata: Tratmentul combinat al infectiei HIV concomitent cu 200 mg ritonavir de doua ori pe zi la adulti experimentati cu evidenta replicarii virale (incarcare virala > 10.000

copii per mL) si/ sau celule CD4 < 500 pe mm cub. Pacientii trebuie sa fi avut esec terapeutic sau rezistenta la 3 regimuri ARV diferite care au inclus: cel putin 1

inhibitor de non-nucleozid revers trasncriptaza si cel putin 1 inhibitor de nucleozid revers trasncriptaza si cel putin 2 inhibitori de proteaza

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

250mgJ05AE09 TIPRANAVIRUM CAPS. MOIAPTIVUS 250mg 250mg BOEHRINGER INGELHEIM INTERNATIONAL GMBH

609 DARUNAVIRUM **J05AE10

Prescriere limitata: Tratmentul combinat al infectiei HIV concomitent cu 200 mg ritonavir de doua ori pe zi la adulti experimentati cu evidenta replicarii virale (incarcare virala > 10.000

copii per mL) si/ sau celule CD4 < 500 pe mm cub. Pacientii trebuie sa fi avut esec terapeutic sau rezistenta la 3 regimuri ARV diferite care au inclus: cel putin 1

inhibitor de non-nucleozid revers trasncriptaza si cel putin 1 inhibitor de nucleozid revers trasncriptaza si cel putin 2 inhibitori de proteaza

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

300mgJ05AE10 DARUNAVIRUM COMPR. FILM.PREZISTA 300mg 300mg JANSSEN-CILAG INTERNATIONAL NV

610 ZIDOVUDINUMJ05AF01

Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgJ05AF01 ZIDOVUDINUM CAPS.RETROVIR® 100mg THE WELLCOME FOUNDATION LTD.

1%J05AF01 ZIDOVUDINUM SOL. ORALARETROVIR® 1% THE WELLCOME FOUNDATION LTD.

611 DIDANOSINUMJ05AF02

Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

125mgJ05AF02 DIDANOSINUM CAPS. GASTROREZ.VIDEX EC 125 mg 125mg BRISTOL MYERS SQUIBB KFT

200mgJ05AF02 DIDANOSINUM CAPS. GASTROREZ.VIDEX EC 200 mg 200mg BRISTOL MYERS SQUIBB KFT

89 153/

Page 90: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

250mgJ05AF02 DIDANOSINUM CAPS. GASTROREZ.VIDEX EC 250 mg 250mg BRISTOL MYERS SQUIBB KFT

400mgJ05AF02 DIDANOSINUM CAPS. GASTROREZ.VIDEX EC 400 mg 400mg BRISTOL MYERS SQUIBB KFT

612 STAVUDINUMJ05AF04

Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

15mgJ05AF04 STAVUDINUM CAPS.ZERIT 15 mg 15mg BRISTOL-MYERS SQUIBB PHARMA EEIG

20mgJ05AF04 STAVUDINUM CAPS.ZERIT 20 mg 20mg BRISTOL-MYERS SQUIBB PHARMA EEIG

30mgJ05AF04 STAVUDINUM CAPS.ZERIT 30 mg 30mg BRISTOL-MYERS SQUIBB PHARMA EEIG

40mgJ05AF04 STAVUDINUM CAPS.ZERIT 40 mg 40mg BRISTOL-MYERS SQUIBB PHARMA EEIG

613 LAMIVUDINUMJ05AF05

100mgJ05AF05 LAMIVUDINUM COMPR. FILM.ZEFFIX 100 mg 100mg GLAXO GROUP LTD.

10mg/mlJ05AF05 LAMIVUDINUM SOL. ORALAEPIVIR 10mg/ml 10mg/ml GLAXO GROUP LTD.

150mgJ05AF05 LAMIVUDINUM COMPR. FILM.EPIVIR 150mg 150mg GLAXO GROUP LTD.

5mg/mlJ05AF05 LAMIVUDINUM SOL. ORALAZEFFIX 5 mg/ml 5mg/ml GLAXO GROUP LTD.

614 ABACAVIRUMJ05AF06

Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

20mg/mlJ05AF06 ABACAVIRUM SOL. ORALAZIAGEN 20 mg/ml 20mg/ml GLAXO GROUP LTD.

300mgJ05AF06 ABACAVIRUM COMPR. FILM.ZIAGEN 300 mg 300mg GLAXO GROUP LTD.

615 TENOFOVIRUM DISOPROXIL FUMARATEJ05AF07

Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

245mgJ05AF07 TENOFOVIRUM DISOPROXIL FUMARATE COMPR. FILM.VIREAD 245mg 245mg GILEAD SCIENCE INTERNATIONAL LIMITED

616 EMTRICITABINUMJ05AF09

Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

200mgJ05AF09 EMTRICITABINUM CAPS.EMTRIVA 200mg 200mg GILEAD SCIENCE INTERNATIONAL LIMITED

617 NEVIRAPINUMJ05AG01

Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

200mgJ05AG01 NEVIRAPINUM COMPR.VIRAMUNE 200mg 200mg BOEHRINGER INGELHEIM INT. GMBH

50mg/5mlJ05AG01 NEVIRAPINUM SUSP. ORALAVIRAMUNE 50mg/ml 50mg/5ml BOEHRINGER INGELHEIM INT. GMBH

618 EFAVIRENZUMJ05AG03

Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgJ05AG03 EFAVIRENZUM CAPS.STOCRIN 100 mg 100mg MERCK SHARP & DOHME LTD.

50mgJ05AG03 EFAVIRENZUM CAPS.STOCRIN 50 mg 50mg MERCK SHARP & DOHME LTD.

50mgJ05AG03 EFAVIRENZUM COMPR. FILM.STOCRIN 50 mg 50mg MERCK SHARP & DOHME LTD.

600mgJ05AG03 EFAVIRENZUM COMPR. FILM.STOCRIN 600 mg 600mg MERCK SHARP & DOHME LTD.

619 ZIDOVUDINUM+LAMIVUDINUM **J05AR01

Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

150mg/300mgJ05AR01 ZIDOVUDINUM+LAMIVUDINUM COMPR. FILM.COMBIVIR 150mg/300mg 150mg/300mg GLAXO GROUP LTD.

620 ABACAVIRUM+LAMIVUDINUM **J05AR02

Prescriere limitata: Tratamentul infectiei HIV la pacientii in varsta de peste 12 ani si cu greutate corporala > de 40 kg. cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii

per mL.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

600mg/300mgJ05AR02 ABACAVIRUM+LAMIVUDINUM COMPR. FILM.KIVEXA 600mg/300mg 600mg/300mg GLAXO GROUP LTD.

621 ABACAVIRUM+LAMIVUDINUM+ZIDOVUDINUM **J05AR04

Prescriere limitata: Tratamentul infectiei HIV la pacientii in varsta de peste 12 ani si cu greutate corporala > de 40 kg. cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii

per mL.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

300mg/150mg/30

0mg

J05AR04 ABACAVIRUM+LAMIVUDINUM+ZIDOVUDINUM COMPR. FILM.

90 153/

Page 91: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

TRIZIVIR 300mg/150mg/300mg 300mg/150mg/300

mg

GLAXO GROUP LTD.

622 ENFUVIRTIDUM **J05AX07

Prescriere limitata: Tratmentul combinat al infectiei HIV la pacienti experimentati cu esec la tratament caracterizat prin:evidenta replicarii virale in timpul terapiei antiretrovirale continue

sau intolerantei la medicamentele ARV anterior administrate. Pacientii au avut esec terapeutic sau rezistenta la 3 regimuri ARV diferite care au inclus: cel putin 1

inhibitor de non-nucleozid revers trasncriptaza si cel putin 1 inhibitor de nucleozid revers trasncriptaza si cel putin 2 inhibitori de proteaza.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

90mg/mlJ05AX07 ENFUVIRTIDUM PULB. + SOLV. PT. SOL. INJ.FUZEON 90mg/ml 90mg/ml ROCHE REGISTRATION LTD.

623 RIFAXIMINUMA07AA11

200mgA07AA11 RIFAXIMINUM COMPR. FILM.NORMIX 200 mg 200mg ALFA WASSERMANN SPA

624 MICONAZOLUMD01AC02

20mg/gD01AC02 MICONAZOLUM CREMAMICONAL ECOBI 20mg/g FARMACEUTICI ECOBI S.A.S

2%D01AC02 MICONAZOLUM CREMAMEDACTER 2% FARAN LABORATORIES S.A.

MICONAZOL NITRAT 2% 2% SLAVIA PHARM SRL

2%D01AC02 MICONAZOLUM GELDERMOZOL 2% PHARCO IMPEX 93 S.R.L.

625 ACICLOVIRUMD06BB03

50mg/gD06BB03 ACICLOVIRUM CREMAACICLOVIR HYPERION 50mg/g HYPERION S.A.

ACIKLOVIR CREMA 50mg/g A & G MED TRADING S.R.L.

5%D06BB03 ACICLOVIRUM CREMAACICLOVIR 5% OZONE LABORATORIES LTD.

ACICLOVIR 5% 5% GEDEON RICHTER ROMANIA SA

CLOVIRAL® 5% 5% ANTIBIOTICE SA

ZOVIRAX 5% THE WELLCOME FOUNDATION LTD.

626 MICONAZOLUMG01AF04

1.2gG01AF04 MICONAZOLUM CAPS. MOI VAG.MICONAL ECOBI 1.2g FARMACEUTICI ECOBI S.A.S

200mgG01AF04 MICONAZOLUM SUPOZ. VAG.MYCOHEAL 200 200mg DAR AL DAWA PHARMA S.R.L

20mg/gG01AF04 MICONAZOLUM CREMA VAG.MICONAL ECOBI 20mg/g FARMACEUTICI ECOBI S.A.S

2mg/mlG01AF04 MICONAZOLUM SOL. VAGINALAMICONAL ECOBI 2mg/ml FARMACEUTICI ECOBI S.A.S

50mgG01AF04 MICONAZOLUM OVULEMICONAL ECOBI 50mg FARMACEUTICI ECOBI S.A.S

2%G01AF04 MICONAZOLUM CREMA VAG.MEDACTER 2% FARAN LABORATORIES S.A.

MYCOHEAL 2% DAR AL DAWA PHARMA S.R.L.

627 OXACILLINUMJ01CF04

250mgJ01CF04 OXACILLINUM CAPS.OXACILINA 250mg FARMACOM SA

OXACILINA 250 mg 250mg ANTIBIOTICE SA

OXACILINA ARENA 250 mg 250mg ARENA GROUP SA

OXACILINA FARMEX 250 mg 250mg FARMEX COMPANY SRL

OXACILINA SANDOZ 250 mg 250mg SANDOZ SRL

500mgJ01CF04 OXACILLINUM CAPS.OXACILINA 500 mg 500mg ANTIBIOTICE SA

OXACILINA ARENA 500 mg 500mg ARENA GROUP SA

OXACILINA FORTE 500 mg 500mg OZONE LABORATORIES LTD.

OXACILINA SANDOZ 500 mg 500mg SANDOZ SRL

OXALIN 500 mg 500mg EUROPHARM SA

500mgJ01CF04 OXACILLINUM PULB. PT. SOL. INJ./PERF. I.M./I.V.OXACILINA ANTIBIOTICE 500 mg 500mg ANTIBIOTICE SA

1gJ01CF04 OXACILLINUM PULB. PT. SOL. INJ./PERF.I.M./I.V.OXACILINA ANTIBIOTICE 1 g 1g ANTIBIOTICE SA

250mgJ01CF04 OXACILLINUM PULB. PT. SOL. INJ./PERF.I.M./I.V.OXACILINA ANTIBIOTICE 250 mg 250mg ANTIBIOTICE SA

628 AMPICILLINUM + SULBACTAMJ01CR01

1g+500mgJ01CR01 AMPICILLINUM + SULBACTAM PULB. PT. SOL. INJ.AMPIPLUS® 1,5 g 1g+500mg ANTIBIOTICE SA

629 AMOXICILLINUM + ACIDUM CLAVULANICUMJ01CR02

Prescriere limitata: Tratamentul de scurta durata la infectiilor bacteriene atunci cand este suspectata rezistenta la amoxicilina.

Infectii la care este dovedita rezistenta la amoxicilina.

A fost raportată hepatotoxicitate la acest medicament.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

1.2gJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM PULB. PT. SOL. INJ./PERF.AMOXIPLUS 1,2 g 1.2g ANTIBIOTICE SA

1000mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM COMPR. FILM.MEDOCLAV 1000 mg 1000mg MEDOCHEMIE LTD.

1000mg+200mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM PULB. PT. SOL. INJ./PERF.AUGMENTIN INTRAVENOS 1.2g 1000mg+200mg BEECHAM GROUP PLC

1062.5mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM COMPR. FILM. ELIB. PREL.AUGMENTIN™ SR 1062.5mg BEECHAM GROUP PLC

125mg+31.25/5m

l

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM PULB. PT. SUSP. ORALA

91 153/

Page 92: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

MEDOCLAV 156,25 mg/5 ml 125mg+31.25/5ml MEDOCHEMIE LTD.

156.25mg/5mlJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM PULB. PT. SUSP. ORALAAMOKSIKLAV 156,25mg/5ml 156.25mg/5ml LEK PHARMACEUTICALS D.D.

BIOCLAVID 156.25mg/5ml 156.25mg/5ml SANDOZ GMBH

2000mg+200mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM PULB. PT. SOL. PERF.AUGMENTIN INTRAVENOS 2,2g 2000mg+200mg BEECHAM GROUP PLC

250/62,5mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM COMPR. DISP.FORCID SOLUTAB 250/62,5 250/62,5mg ASTELLAS PHARMA EUROPE BV

250mg+125mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM COMPR. FILM.MEDOCLAV 375 mg 250mg+125mg MEDOCHEMIE LTD.

250mg+62.5mg/5

ml

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM PULB. PT. SUSP. ORALA

MEDOCLAV FORTE 312,5mg/5ml 250mg+62.5mg/5

ml

MEDOCHEMIE LTD.

312.5mg/5mlJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM PULB. PT. SUSP. ORALABIOCLAVID 312.5mg/5ml 312.5mg/5ml SANDOZ GMBH

312.5mg/5mlJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM PULB. PT.SUSP. ORALAAMOKSIKLAV 312.5mg/5ml 312.5mg/5ml LEK PHARMACEUTICALS D.D.

ENHANCIN 312,5 mg/5 ml 312.5mg/5ml RANBAXY UK LIMITED

400mg+57mg/5m

l

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM PULB. PT. SUSP. ORALA

AUGMENTIN BIS 400mg+57mg/5ml SMITHKLINE BEECHAM PLC

500/125mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM COMPR. DISP.FORCID SOLUTAB 500/125 500/125mg ASTELLAS PHARMA EUROPE BV

500mg+125mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM COMPR. FILM.AUGMENTIN 625 mg 500mg+125mg BEECHAM GROUP PLC

MEDOCLAV 625 mg 500mg+125mg MEDOCHEMIE LTD.

600mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM PULB. PT. SOL. INJ./PERF.AMOXIPLUS 600 mg 600mg ANTIBIOTICE SA

625mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM COMPR. FILM.AMOKSIKLAV 2 x 625 mg 625mg LEK PHARMACEUTICALS D.D.

BIOCLAVID 625 mg 625mg SANDOZ GMBH

ENHANCIN 625 mg 625mg RANBAXY UK LIMITED

642.90mg/5mlJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM PULB. PT. SUSP. ORALAAUGMENTIN® ES 642.90mg/5ml SMITHKLINE BEECHAM PLC

875mg+125mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM COMPR. DISP.FORCID SOLUTAB 875/125 875mg+125mg ASTELLAS PHARMA EUROPE BV

875mg+125mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM COMPR. FILM.AUGMENTIN 1 g 875mg+125mg BEECHAM GROUP PLC

630 PIPERACILLINUM + TAZOBACTAMUMJ01CR05

J01CR05 PIPERACILLINUM + TAZOBACTAMUM LIOF. PT. SOL. INJ.TAZOCIN 2,25 WYETH LEDERLE PHARMA GMBH

TAZOCIN 4,5 WYETH LEDERLE PHARMA GMBH

631 COMBINATII (CEFOPERAZONUM+SULBACTAM)J01CR50

1g+1gJ01CR50 COMBINATII

(CEFOPERAZONUM+SULBACTAM)

PULB. PT. SOL. INJ.

SULPERAZON® 2 g 1g+1g PFIZER EUROPE MA EEIG

632 CEFTRIAXONUMJ01DD04

0.5gJ01DD04 CEFTRIAXONUM PULB. PT. SOL. INJ.NOVOSEF 0,5 g i.v. 0.5g ECZACIBASI PHARMACEUTICALS S.R.L.

1gJ01DD04 CEFTRIAXONUM PULB. PT. SOL. INJ.LENDACIN 1 g 1g LEK PHARMACEUTICALS D.D.

NOVOSEF 1 g i.m. 1g ECZACIBASI PHARMACEUTICALS S.R.L.

NOVOSEF 1 g i.v. 1g ECZACIBASI PHARMACEUTICALS S.R.L.

1gJ01DD04 CEFTRIAXONUM PULB. PT. SOL. INJ./PERF.CEFORT 1 g 1g ANTIBIOTICE SA

CEFTRIAXON 1 g 1g OZONE LABORATORIES LTD.

250mgJ01DD04 CEFTRIAXONUM PULB. PT. SOL. INJ.LENDACIN 250 mg 250mg LEK PHARMACEUTICALS D.D.

250mgJ01DD04 CEFTRIAXONUM PULB. PT. SOL. INJ./PERF.CEFORT 250 mg 250mg ANTIBIOTICE SA

2gJ01DD04 CEFTRIAXONUM PULB. PT. SOL. INJ./PERF.CEFORT 2 g 2g ANTIBIOTICE SA

MEDAXONE 2 g 2g MEDOCHEMIE LTD.

2gJ01DD04 CEFTRIAXONUM PULB. PT. SOL. PERF.ROCEPHIN® 2g ROCHE ROMANIA S.R.L.

500mgJ01DD04 CEFTRIAXONUM PULB. PT. SOL. INJ./PERF.CEFORT 500 mg 500mg ANTIBIOTICE SA

0.5gJ01DD04 CEFTRIAXONUM PULB. PT. SOL. INJ.NOVOSEF 0,5 g i.v. 0.5g ECZACIBASI PHARMACEUTICALS S.R.L.

500mgJ01DD04 CEFTRIAXONUM PULB. PT. SOL. INJ./PERF.CEFORT 500 mg 500mg ANTIBIOTICE SA

0.5gJ01DD04 CEFTRIAXONUM PULB. + SOLV. PT. SOL. INJ./PERF.NOVOSEF 0,5 g i.m. 0.5g ECZACIBASI PHARMACEUTICALS S.R.L.

633 CEFIXIMUMJ01DD08

100mg/5mlJ01DD08 CEFIXIMUM GRAN. PT. SUSP. ORALASUPRAX 100mg/5ml GEDEON RICHTER LTD.

200mgJ01DD08 CEFIXIMUM CAPS.EFICEF® 200 mg 200mg ANTIBIOTICE SA

200mgJ01DD08 CEFIXIMUM COMPR. FILM.SUPRAX 200mg GEDEON RICHTER LTD.

92 153/

Page 93: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

634 CEFOPERAZONUMJ01DD12

1gJ01DD12 CEFOPERAZONUM PULB. PT. SOL. INJ.LYZONE 1 g 1g MEDICAROM GROUP S.R.L.

MEDOCEF 1 g 1g MEDOCHEMIE LTD.

2gJ01DD12 CEFOPERAZONUM PULB. PT. SOL. INJ.LYZONE 2 g 2g MEDICAROM GROUP S.R.L.

MEDOCEF 2 g 2g MEDOCHEMIE LTD.

500mgJ01DD12 CEFOPERAZONUM PULB. PT. SOL. INJ.CEFOZON 500 mg 500mg E.I.P.I.CO. MED S.R.L.

1gJ01DD12 CEFOPERAZONUM PULB. PT. SOL. INJ./PERF.I.M./I.V.CEFOZON 1 g 1g E.I.P.I.CO. MED S.R.L.

635 CEFPIROMUMJ01DE02

1gJ01DE02 CEFPIROMUM PULB. PT. SOL. INJ./PERF.CEFROM® 1 g 1g LAB. AVENTIS

2gJ01DE02 CEFPIROMUM PULB. PT. SOL. INJ./PERF.CEFROM® 2 g 2g LAB. AVENTIS

636 MEROPENEMUMJ01DH02

1gJ01DH02 MEROPENEMUM PULB. PT. SOL. INJ. I.V./PERF.MERONEM IV 1 g 1g ASTRAZENECA UK LTD.

500mgJ01DH02 MEROPENEMUM PULB. PT. SOL. INJ. I.V./PERF.MERONEM IV 500 mg 500mg ASTRAZENECA UK LTD.

637 IMIPENEMUM + CILASTATINUMJ01DH51

J01DH51 IMIPENEMUM + CILASTATINUM PULB. PT. SOL. PERF.TIENAM I.V. MERCK SHARP & DOHME ROMANIA S.R.L.

638 SULFAMETHOXAZOLUM + TRIMETHOPRIMUMJ01EE01Exista un risc crescut de reactie adversa severa la administrarea acestui medicament la persoane in varsta.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

200mg/40mg

/5ml

J01EE01 SULFAMETHOXAZOLUM +

TRIMETHOPRIMUM

SUSP. ORALA

EPITRIM 200mg/40mg /5ml E.I.P.I.CO. MED S.R.L.

25mg/5mg/mlJ01EE01 SULFAMETHOXAZOLUM +

TRIMETHOPRIMUM

SIROP

SUMETROLIM 25mg/5mg/ml EGIS PHARMACEUTICALS P.L.C.

400mg/80mgJ01EE01 SULFAMETHOXAZOLUM +

TRIMETHOPRIMUM

COMPR.

BISEPTRIM 400mg/80mg EUROPHARM SA

CO - TRIM ELL 400mg/80mg ARENA GROUP S.A.

SUMETROLIM 400mg/80mg EGIS PHARMACEUTICALS P.L.C.

TAGREMIN 400mg/80mg ZENTIVA S.A.

400mg/80mgJ01EE01 SULFAMETHOXAZOLUM +

TRIMETHOPRIMUM

SOL. PERF.

SEPTRIN 400mg/80mg THE WELLCOME FOUNDATION LTD.

639 SPIRAMYCINUMJ01FA02

1.5 M uiJ01FA02 SPIRAMYCINUM COMPR. FILM.ROVAMYCINE® 1,5 Mil. UI 1.5 M ui LAB. AVENTIS

3M uiJ01FA02 SPIRAMYCINUM COMPR. FILM.ROVAMYCINE® 3 Mil. UI 3M ui LAB. AVENTIS

640 ROXITHROMYCINUMJ01FA06

150mgJ01FA06 ROXITHROMYCINUM COMPR. FILM.ROKSOLIT 150mg ECZACIBASI ILAC SANAYI VE TICARET AS

ROXAMED® 150 150mg DAR AL DAWA PHARMA S.R.L

641 CLARITHROMYCINUMJ01FA09

125mg/5mlJ01FA09 CLARITHROMYCINUM GRAN. PT. SUSP. ORALAFROMILID® 125 mg/5 ml 125mg/5ml KRKA D.D.

KLABAX 125 mg/5 ml 125mg/5ml TERAPIA S.A.

KLACID® 125mg/5ml ABBOTT SPA

LEKOKLAR 125 mg/5 ml 125mg/5ml SANDOZ S.R.L.

250mgJ01FA09 CLARITHROMYCINUM COMPR. FILM.CLAR 250 250mg MEDICAROM GROUP S.R.L.

CLARITROMICINA 250 mg 250mg OZONE LABORATORIES LTD.

FROMILID 250 250mg KRKA D.D. NOVO MESTO

KLABAX 250 mg 250mg TERAPIA S.A.

KLACID® 250mg ABBOTT SPA

KLERIMED® 250 250mg MEDOCHEMIE LTD.

LEKOKLAR® 250 mg 250mg LEK PHARMACEUTICALS D.D.

250mg/5mlJ01FA09 CLARITHROMYCINUM GRAN. PT. SUSP. ORALAKLABAX 250 mg/5 ml 250mg/5ml TERAPIA S.A.

LEKOKLAR 250 mg/5 ml 250mg/5ml SANDOZ SRL

500mgJ01FA09 CLARITHROMYCINUM COMPR. FILM.CLAR 500 500mg MEDICAROM GROUP S.R.L.

CLARITROMICINA 500 mg 500mg OZONE LABORATORIES LTD.

FROMILID 500 500mg KRKA D.D. NOVO MESTO

KLABAX 500 mg 500mg TERAPIA S.A.

KLERIMED® 500 500mg MEDOCHEMIE LTD.

LEKOKLAR® 500 mg 500mg LEK PHARMACEUTICALS D.D.

500mgJ01FA09 CLARITHROMYCINUM COMPR. FILM. ELIB. MODIF.KLABAX MR 500 mg 500mg TERAPIA S.A.

LEKOKLAR XL 500 mg 500mg LEK PHARMACEUTICALS D.D.

500mgJ01FA09 CLARITHROMYCINUM COMPR. FILM. ELIB. PREL.FROMILID® UNO 500mg KRKA D.D.

KLACID SR 500mg ABBOTT LABORATORIES LTD.

93 153/

Page 94: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

500mgJ01FA09 CLARITHROMYCINUM LIOF. PT. SOL. PERF.KLACID I.V. 500mg ABBOTT LABORATORIES LTD.

642 AZITHROMYCINUMJ01FA10

100mg/5mlJ01FA10 AZITHROMYCINUM PULB. PT. SUSP. ORALAAZITROMICINA SANDOZ 100 mg/5 ml 100mg/5ml SANDOZ SRL

125mgJ01FA10 AZITHROMYCINUM COMPR. FILM.SUMAMED 125 mg 125mg PLIVA LJUBLJANA D.O.O.

200 mg/5 mlJ01FA10 AZITHROMYCINUM PULB. PT. SUSP. ORALAAZITROMICINA SANDOZ 200 mg/5 ml 200 mg/5 ml SANDOZ SRL

200mg/5mlJ01FA10 AZITHROMYCINUM PULB. + SOLV. SUSP. ORALAAZITROX 200 mg/5 ml 200mg/5ml ECZACIBASI PHARMACEUTICALS S.R.L.

200mg/5mlJ01FA10 AZITHROMYCINUM PULB. PT. SUSP. ORALASUMAMED FORTE 200mg/5ml PLIVA LJUBLIJANA D.O.O.

250mgJ01FA10 AZITHROMYCINUM CAPS.AZATRIL 250 mg 250mg BALKANPHARMA RAZGRAD AD

250mgJ01FA10 AZITHROMYCINUM COMPR. FILM.AZITROMICINA SANDOZ 250 mg COMPRIMATE FILMATE 250mg SANDOZ S.R.L.

AZITROX® 250 250mg ZENTIVA AS

500mgJ01FA10 AZITHROMYCINUM COMPR. FILM.AZITROMICINA SANDOZ 500 mg COMPRIMATE FILMATE 500mg SANDOZ S.R.L.

AZITROX® 500 500mg ZENTIVA AS

AZRO® 500 mg 500mg ECZACIBASI PHARMACEUTICALS S.R.L.

SUMAMED 500 mg 500mg PLIVA LJUBLJANA D.O.O.

ZITROCIN 500 mg 500mg OZONE LABORATORIES LTD.

500mgJ01FA10 AZITHROMYCINUM LIOF. PT. SOL. PERF.SUMAMED® 500mg PLIVA LJUBLJANA D.O.O.

2gJ01FA10 AZITHROMYCINUM GRAN. ELIB. PREL. PT. SUSP. ORALAZMAX 2 g 2g PFIZER EUROPE MA EEIG

643 GENTAMICINUMJ01GB03

40mg/mlJ01GB03 GENTAMICINUM SOL. INJ.GENTAMICIN KRKA 40mg/ml KRKA D.D. NOVO MESTO

GENTAMICINA SANDOZ® 40 mg/ml 40mg/ml SANDOZ GMBH

40mg/mlJ01GB03 GENTAMICINUM SOL. INJ.GENTAMICIN KRKA 40mg/ml KRKA D.D. NOVO MESTO

GENTAMICINA SANDOZ® 40 mg/ml 40mg/ml SANDOZ GMBH

40mg/mlJ01GB03 GENTAMICINUM SOL. PARENT.LYRAMYCIN 40mg/ml MEDICAROM GROUP S.R.L.

80mg/2mlJ01GB03 GENTAMICINUM SOL. INJ.GENTAMICIN KRKA 80mg/2ml KRKA D.D. NOVO MESTO

80mg/2mlJ01GB03 GENTAMICINUM SOL.INJ.PAN - GENTAMICINE 80mg/2ml LAB. PANPHARMA

644 AMIKACINUMJ01GB06

100mg/2mlJ01GB06 AMIKACINUM SOL. INJ.AMIKOZIT® 100 mg/2 ml 100mg/2ml ECZACIBASI PHARMACEUTICALS S.R.L.

250mg/mlJ01GB06 AMIKACINUM SOL. INJ.AMIKIN 250mg/ml BRISTOL MYERS SQUIBB KFT

500mg/2mlJ01GB06 AMIKACINUM SOL. INJ.AMIKOZIT® 500 mg/2 ml 500mg/2ml ECZACIBASI PHARMACEUTICALS S.R.L.

645 NETILMICINUMJ01GB07

150mg/1.5mlJ01GB07 NETILMICINUM SOL. INJ.NETROMYCINE® 150mg/1.5ml SCHERING PLOUGH EUROPE

200mg/2mlJ01GB07 NETILMICINUM SOL. INJ.NETROMYCINE® 200mg/2ml SCHERING PLOUGH EUROPE

50mg/2mlJ01GB07 NETILMICINUM SOL. INJ.NETROMYCINE® 50mg/2ml SCHERING PLOUGH EUROPE

646 OFLOXACINUMJ01MA01

200mgJ01MA01 OFLOXACINUM COMPR. FILM.OFLOXACIN 200 mg 200mg ANTIBIOTICE SA

OFLOXIN 200 200mg ZENTIVA AS

ZANOCIN 200mg RANBAXY UK LIMITED

400mgJ01MA01 OFLOXACINUM COMPR. FILM. ELIB. PREL.ZANOCIN® OD 400 400mg RANBAXY U.K. LIMITED

647 CIPROFLOXACINUMJ01MA02

100mg/10mlJ01MA02 CIPROFLOXACINUM CONC. PT. SOL. PERF.CIPRINOL® 100mg/10ml KRKA D.D.

CIPROFLOXACINA 100 mg/10 ml 100mg/10ml SICOMED SA

100mg/50mlJ01MA02 CIPROFLOXACINUM SOL. PERF.CIPRINOL 100mg/50ml KRKA D.D. NOVO MESTO

200mg/100mlJ01MA02 CIPROFLOXACINUM SOL. PERF.CIPRINOL 200mg/100ml KRKA D.D. NOVO MESTO

CIPROBAY® 200 200mg/100ml BAYER HEALTHCARE AG

250mgJ01MA02 CIPROFLOXACINUM CAPS.EUCIPRIN 250mg EUROPHARM SA

250mgJ01MA02 CIPROFLOXACINUM COMPR. FILM.CIFRAN 250mg RANBAXY UK LIMITED

CIPHIN 250 250mg ZENTIVA A.S.

CIPRINOL 250 mg 250mg KRKA D.D. NOVO MESTO

CIPROCIN 250 mg 250mg E.I.P.I.CO. MED S.R.L.

CIPROFLOXACIN 250 mg 250mg LAROPHARM SRL

CIPROFLOXACINA ALKALOID 250 mg 250mg ALKALOID D.O.O.

CIPROLEN® 250 mg 250mg AC HELCOR SRL

94 153/

Page 95: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

CIPROLET 250 mg 250mg DR. REDDY'S LABORATORIES

CIPROZONE 250 mg 250mg OZONE LABORATORIES LTD.

CUMINOL 250 mg 250mg GEDEON RICHTER ROMANIA

2mg/mlJ01MA02 CIPROFLOXACINUM SOL. PERF.CIPROBAY® 400 2mg/ml BAYER HEALTHCARE AG

UFEXIL 2mg/ml DEMO SA

400mg/200mlJ01MA02 CIPROFLOXACINUM SOL. PERF.CIPRINOL® 400mg/200ml KRKA D.D.

500mgJ01MA02 CIPROFLOXACINUM COMPR. FILM.CIFRAN 500mg RANBAXY UK LIMITED

CIPHIN 500 500mg ZENTIVA A.S.

CIPRINOL 500 mg 500mg KRKA D.D. NOVO MESTO

CIPRO QUIN® 500mg ANTIBIOTICE SA

CIPROBAY® 500 500mg BAYER HEALTHCARE AG

CIPROCIN 500 mg 500mg E.I.P.I.CO. MED S.R.L.

CIPRODAR 500mg DAR AL DAWA PHARMA S.R.L

CIPROFLOXACINA ALKALOID 500 mg 500mg ALKALOID D.O.O.

CIPROLEN® 500 mg 500mg AC HELCOR SRL

CIPROLET 500 mg 500mg DR. REDDY'S LABORATORIES

CIPROZONE FORTE 500 mg 500mg OZONE LABORATORIES LTD.

CUMINOL 500 mg 500mg GEDEON RICHTER ROMANIA

SIFLOKS® 500mg ECZACIBASI ILAC SANAYI VE TICARET AS

750mgJ01MA02 CIPROFLOXACINUM COMPR. FILM.CIPRINOL 750 mg 750mg KRKA D.D. NOVO MESTO

250mgJ01MA02 CIPROFLOXACINUM COMPR. FILM.CIFRAN 250mg RANBAXY UK LIMITED

CIPHIN 250 250mg ZENTIVA A.S.

CIPRINOL 250 mg 250mg KRKA D.D. NOVO MESTO

CIPROCIN 250 mg 250mg E.I.P.I.CO. MED S.R.L.

CIPROFLOXACIN 250 mg 250mg LAROPHARM SRL

CIPROFLOXACINA ALKALOID 250 mg 250mg ALKALOID D.O.O.

CIPROLEN® 250 mg 250mg AC HELCOR SRL

CIPROLET 250 mg 250mg DR. REDDY'S LABORATORIES

CIPROZONE 250 mg 250mg OZONE LABORATORIES LTD.

CUMINOL 250 mg 250mg GEDEON RICHTER ROMANIA

648 PEFLOXACINUMJ01MA03

400mgJ01MA03 PEFLOXACINUM COMPR. FILM.ABAKTAL 400mg LEK PHARMACEUTICALS D.D.

PEFLOXACIN LAROPHARM 400mg LAROPHARM S.R.L.

400mg/5mlJ01MA03 PEFLOXACINUM CONC. PT. SOL. PERF.ABAKTAL 400mg/5ml 400mg/5ml LEK PHARMACEUTICALS D.D.

649 NORFLOXACINUMJ01MA06

400mgJ01MA06 NORFLOXACINUM COMPR. FILM.EPINOR 400mg E.I.P.I.CO. MED S.R.L.

H - NORFLOXACIN 400 mg 400mg AC HELCOR SRL

NOLICIN 400 mg 400mg KRKA D.D. NOVO MESTO

NORFLOX - 400 400mg LEK PHARMATECH SRL

NORFLOXACIN 400 mg 400mg OZONE LABORATORIES LTD.

NORFLOXACIN OZONE 400 mg 400mg OZONE LABORATORIES LTD.

NORFLOXACINA LPH 400 mg 400mg LABORMED PHARMA SA

650 LEVOFLOXACINUMJ01MA12

250mgJ01MA12 LEVOFLOXACINUM COMPR. FILM.LEVOFLOXACINA ACTAVIS 250 mg 250mg ACTAVIS GROUP PTC EHF.

500mgJ01MA12 LEVOFLOXACINUM COMPR. FILM.LEVOFLOXACINA ACTAVIS 500 mg 500mg ACTAVIS GROUP PTC EHF.

TAVANIC® 500mg AVENTIS PHARMA DEUTSCHLAND GMBH

5mg/mlJ01MA12 LEVOFLOXACINUM SOL. PERF.TAVANIC® I.V. 500 mg 5mg/ml AVENTIS PHARMA DEUTSCHLAND GMBH

651 MOXIFLOXACINUMJ01MA14

400mgJ01MA14 MOXIFLOXACINUM COMPR. FILM.AVELOX® 400 mg 400mg BAYER HEALTHCARE AG

400mg/250mlJ01MA14 MOXIFLOXACINUM SOL. PERF.AVELOX® 400 mg/250 ml 400mg/250ml BAYER HEALTHCARE AG

652 VANCOMYCINUMJ01XA01

Prescriere limitata: Tratamentul este initiat in spital pentru infectiile cu germeni sensibili la vancomicina.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

1gJ01XA01 VANCOMYCINUM LIOF. PT. SOL. PERF.VANCOMYCIN TEVA 1g TEVA PHARM. WORKS PRIVATE LTD. COMPANY

1gJ01XA01 VANCOMYCINUM PULB.LIOF.PT.SOL.PERF./INJEDICIN 1g LEK PHARMACEUTICALS D.D.

500mgJ01XA01 VANCOMYCINUM LIOF. PT. SOL. PERF.VANCOMYCIN TEVA 500mg TEVA PHARM. WORKS PRIVATE LTD. COMPANY

1gJ01XA01 VANCOMYCINUM LIOF. PT. SOL. PERF.VANCOMYCIN TEVA 1g TEVA PHARM. WORKS PRIVATE LTD. COMPANY

1gJ01XA01 VANCOMYCINUM PULB.LIOF.PT.SOL.PERF./INJEDICIN 1g LEK PHARMACEUTICALS D.D.

500mgJ01XA01 VANCOMYCINUM LIOF. PT. SOL. PERF.VANCOMYCIN TEVA 500mg TEVA PHARM. WORKS PRIVATE LTD. COMPANY

500mgJ01XA01 VANCOMYCINUM LIOF. PT. SOL. PERF./INJ.EDICIN 500mg LEK PHARMACEUTICALS D.D.

653 TEICOPLANINUMJ01XA02

400mgJ01XA02 TEICOPLANINUM LIOF. + SOLV. PT. SOL. INJ.TARGOCID® 400 mg 400mg AVENTIS PHARMA LTD.

95 153/

Page 96: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

654 COLISTINUMJ01XB01

1000000uiJ01XB01 COLISTINUM PULB. PT. SOL. PERF.COLISTINA ANTIBIOTICE 1000000 UI 1000000ui ANTIBIOTICE SA

655 METRONIDAZOLUMJ01XD01

Prescriere limitata: Tratamentul infectiilor cu anaerobi

Tratamentul infectiilor cu protozoare sensibile la metronidazol:

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

250mgJ01XD01 METRONIDAZOLUM COMPR.METRONIDAZOL 250 mg (J01XD01) 250mg ARENA GROUP SA

250mgJ01XD01 METRONIDAZOLUM COMPR. FILM.FLAGYL 250mg LABORATOIRE AVENTIS

5g/lJ01XD01 METRONIDAZOLUM SOL. PERF.METRONIDAZOL A 5 g/l 5g/l INFOMED FLUIDS SRL

METRONIDAZOL B 5 g/l 5g/l INFOMED FLUIDS SRL

5mg/mlJ01XD01 METRONIDAZOLUM SOL. PERF.METRONIDAZOL BRAUN 5mg/ml 5mg/ml B. BRAUN MELSUNGEN AG

250mgJ01XD01 METRONIDAZOLUM COMPR.METRONIDAZOL 250 mg (J01XD01) 250mg ARENA GROUP SA

250mgJ01XD01 METRONIDAZOLUM COMPR. FILM.FLAGYL 250mg LABORATOIRE AVENTIS

4%J01XD01 METRONIDAZOLUM SUSP. ORALAFLAGYL 4 % (J01XD01) 4% LABORATOIRE AVENTIS

656 LINEZOLIDUMJ01XX08

100mg/5mlJ01XX08 LINEZOLIDUM GRAN. PT. SUSP. ORALAZYVOXID® 100mg/5ml PFIZER EUROPE MA EEIG

2mg/mlJ01XX08 LINEZOLIDUM SOL. PERF.ZYVOXID® 2mg/ml PFIZER EUROPE MA EEIG

600mgJ01XX08 LINEZOLIDUM COMPR. FILM.ZYVOXID® 600mg PFIZER EUROPE MA EEIG

657 KETOCONAZOLUMJ02AB02

Prescriere limitata: Candidoza genitala simptomatica recurenta dupa tratamentul local a cel putin doua episoade.

Tratamentul candidozelor muco-cutanate cronice si candidozelor orofaringiene care nu pot fi tratate cu antifungice locale, la pacientii care prezinta rezistenta sau

intoleranta la fluconazol si intraconazol.

Micoze sistemice la care alte forme de terapie antifungica nu au avut efect.

A fost raportată hepatotoxicitate la ketoconazol.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

200mgJ02AB02 KETOCONAZOLUM COMPR.KEFUNGIN 200mg ANTIBIOTICE SA

KETOCONAZOL 200 mg 200mg MAGISTRA C & C

KETOSTIN 200 mg 200mg AC HELCOR SRL

NIZORAL 200mg JANSSEN PHARMACEUTICA NV

NIZORAL 200 mg 200mg TERAPIA SA

200mgJ02AB02 KETOCONAZOLUM COMPR.KEFUNGIN 200mg ANTIBIOTICE SA

KETOCONAZOL 200 mg 200mg SLAVIA PHARM SRL

KETOSTIN 200 mg 200mg AC HELCOR SRL

NIZORAL 200mg JANSSEN PHARMACEUTICA NV

NIZORAL 200 mg 200mg TERAPIA SA

658 FLUCONAZOLUMJ02AC01

Prescriere limitata: Tratament de intretinere la pacienti cu meningita criptococica si imunosupresie.

Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie.

Tratamentul meningitei criptococice la pacientii care nu pot lua sau nu tolereaza amfotericina.

Tratamentul candidozelor severe si care pun in pericol viata la pacienti care nu tolereaza amfotericina.

Tratamentul candidozei orofaringiene la pacienti cu imunosupresie.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 100 mg 100mg KRKA D.D.

FLUCONAZOLE TEVA 100 mg 100mg TEVA PHARMACEUTICALS SRL

FLUCORIC 100 mg 100mg TERAPIA S.A.

FLUCOVIM 100 100mg VIM SPECTRUM SRL

FUNGOLON 100 mg 100mg BALKANPHARMA RAZGRAD AD

150mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 150 mg 150mg KRKA D.D.

DIFLUCAN 150 mg 150mg PFIZER EUROPE MA EEIG

FLUCONAZOL 150 mg 150mg OZONE LABORATORIES LTD.

FLUCONAZOL MEDICO UNO 150 mg 150mg MEDICO UNO PHARMACEUTICAL SRL

FLUCONAZOL MEDOCHEMIE 150 mg 150mg MEDOCHEMIE ROMANIA SRL

FLUCONAZOL SANDOZ® 150 150mg SANDOZ SRL

FLUCONAZOL TERAPIA 150 mg 150mg TERAPIA SA

FLUCONAZOLE TEVA 150 mg 150mg TEVA PHARMACEUTICALS SRL

FLUCORIC 150 mg 150mg TERAPIA S.A.

FLUCOVIM 150 150mg VIM SPECTRUM SRL

MYCOMAX 150 150mg ZENTIVA AS

MYCOSYST® 150 mg 150mg GEDEON RICHTER PLC.

200mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 200 mg 200mg KRKA D.D.

FLUCONAZOLE TEVA 200 mg 200mg TEVA PHARMACEUTICALS SRL

2mg/mlJ02AC01 FLUCONAZOLUM SOL. PERF.DIFLAZON® 2mg/ml KRKA D.D.

DIFLUCAN® 2mg/ml PFIZER EUROPE MA EEIG

MYCOMAX® INF 2mg/ml ZENTIVA AS

50mgJ02AC01 FLUCONAZOLUM CAPS.

96 153/

Page 97: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

DIFLAZON 50 mg 50mg KRKA D.D.

DIFLUCAN 50 mg 50mg PFIZER EUROPE MA EEIG

FLUCONAZOL 50 mg 50mg ARENA GROUP SA

FLUCONAZOL MEDOCHEMIE 50 mg 50mg MEDOCHEMIE ROMANIA SRL

FLUCONAZOL SANDOZ® 50 50mg SANDOZ SRL

FLUCONAZOL TERAPIA 50 mg 50mg TERAPIA S.A.

FLUCONAZOLE TEVA 50 mg 50mg TEVA PHARMACEUTICALS SRL

FLUCORIC 50 mg 50mg TERAPIA S.A.

FLUCOVIM 50 50mg VIM SPECTRUM SRL

FUNGOLON 50 mg 50mg BALKANPHARMA RAZGRAD AD

50mg/5mlJ02AC01 FLUCONAZOLUM PULB. PT. SUSP. ORALADIFLUCAN® 50 mg/5 ml 50mg/5ml PFIZER EUROPE MA EEIG

659 ITRACONAZOLUMJ02AC02

Prescriere limitata: Aspergiloza sistemica.

Histoplasmoza sistemica.

Tratament si terapia de intretinere la pacienti cu SIDA si histoplasmoza pulmonara diseminata.

Tratament si terapia de intretinere la pacienti cu SIDA si histoplasmoza pulmonara cronica;

Criptococoza sistemica inclusiv meningeala.

Cromoblastomicoză şi micetom.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgJ02AC02 ITRACONAZOLUM CAPS.ITRACONAZOL 100 mg 100mg SLAVIA PHARM SRL

OMICRAL 100 mg 100mg MEDICO UNO PHARMACEUTICAL S.R.L.

ORUNGAL 100mg JANSSEN PHARMACEUTICA NV

SPORILIN 100 mg 100mg GEDEON RICHTER ROMANIA S.A.

660 VORICONAZOLUM ** Protocol: J012BJ02AC03

200mgJ02AC03 VORICONAZOLUM COMPR. FILM.VFEND 200mg 200mg PFIZER LTD.

200mgJ02AC03 VORICONAZOLUM PULB. PT. SOL. PERF.VFEND 200mg 200mg PFIZER LTD.

40mg/mlJ02AC03 VORICONAZOLUM PULB. PT. SUSP. ORALAVFEND 40 mg/ml 40mg/ml PFIZER LTD.

50mgJ02AC03 VORICONAZOLUM COMPR. FILM.VFEND 50mg 50mg PFIZER LTD.

661 POSACONAZOLUM **J02AC04

Prescriere limitata: Aspergiloză invazivă la pacienţi cu boală rezistentă la amfotericina B sau itraconazol sau la pacienţi care nu tolerează aceste medicamente;

Fusarioză la pacienţii cu boală rezistentă la amfotericina B sau la pacienţi care nu tolerează amfotericina B;

Cromoblastomicoză şi micetom la pacienţii cu boală rezistentă la itraconazol sau la pacienţi care nu tolerează itraconazolul;

Coccidioidomicoză la pacienţi cu boală rezistentă la amfotericina B, itraconazol sau fluconazol sau la pacienţi care nu tolerează aceste medicamente.

Candidoză oro-faringiană: ca terapie de primă intenţie la pacienţii cu forme severe sau la pacienţii cu imunitate scăzută, la care este de aşteptat ca răspunsul la

tratamentul topic să fie scăzut.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

40mg/mlJ02AC04 POSACONAZOLUM SUSP. ORALANOXAFIL SP 40mg/ml 40mg/ml SP EUROPE

662 CASPOFUNGINUM ** Protocol: J010DJ02AX04

50mgJ02AX04 CASPOFUNGINUM PULB. PT. CONC. PT. SOL. PERF.CANCIDAS 50 mg 50mg MERCK SHARP & DOHME LTD

70mgJ02AX04 CASPOFUNGINUM PULB. PT. CONC. PT. SOL. PERF.CANCIDAS 70 mg 70mg MERCK SHARP & DOHME LTD

664 RIFABUTINUMJ04AB04

Prescriere limitata: Tratamentul contra infectiilor complexe cu Mycobacterium avium la pacientii HIV-pozitivi.

Profilaxia contra infectiilor complexe cu Mycobacterium avium la pacientii HIV-pozitivi cu celule CD4 mai putin de 75 pe milimetru cub.

150mgJ04AB04 RIFABUTINUM CAPS.MYCOBUTIN 150 mg 150mg PFIZER EUROPE MA EEIG

665 ISONIAZIDUMJ04AC01

100mgJ04AC01 ISONIAZIDUM COMPR.ISONIAZIDA 100 mg 100mg ANTIBIOTICE SA

300mgJ04AC01 ISONIAZIDUM COMPR.ISONIAZIDA 300mg ANTIBIOTICE SA

500mg/10mlJ04AC01 ISONIAZIDUM SOL. INJ.IZONIAZIDA 500 mg 500mg/10ml TERAPIA SA

666 PYRAZINAMIDUMJ04AK01

500mgJ04AK01 PYRAZINAMIDUM COMPR.PIRAZINAMIDA ANTIBIOTICE 500 mg 500mg ANTIBIOTICE S.A.

667 ETHAMBUTOLUMJ04AK02

250mgJ04AK02 ETHAMBUTOLUM COMPR. FILM.ETAMBUTOL 250 mg 250mg ANTIBIOTICE SA

668 COMBINATII (RIFAMPICINUM+IZONIAZIDUM)J04AM02

300mg+150mgJ04AM02 COMBINATII (RIFAMPICINUM+IZONIAZIDUM) CAPS.SINERDOL ISO 300mg+150mg ANTIBIOTICE SA

669 ACICLOVIRUMJ05AB01

200mgJ05AB01 ACICLOVIRUM CAPS.ACICLOVIR 200 mg 200mg ARENA GROUP SA

EUVIROX 200 mg 200mg EUROPHARM SA

200mgJ05AB01 ACICLOVIRUM COMPR.ACICLOVIR 200 mg 200mg TERAPIA SA

CLOVIRAL 200 mg 200mg ANTIBIOTICE SA

ZOVIRAX 200mg GLAXO WELLCOME FOUNDATION LTD.

200mgJ05AB01 ACICLOVIRUM COMPR. DISP.ACICLOVIR 200 mg 200mg OZONE LABORATORIES LTD.

97 153/

Page 98: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

LOVIR 200 mg 200mg RANBAXY UK LIMITED

250mgJ05AB01 ACICLOVIRUM PULB. PT. SOL. INJ./PERF.VIROLEX 250mg KRKA D.D. NOVO MESTO

400mgJ05AB01 ACICLOVIRUM CAPS.ACICLOVIR 400 mg 400mg ARENA GROUP S.A.

400mgJ05AB01 ACICLOVIRUM COMPR.ACICLOVIR 400 mg 400mg EGIS PHARMACEUTICALS P.L.C.

400mgJ05AB01 ACICLOVIRUM COMPR. FILM.ACIKLOVIR 400mg A & G MED TRADING S.R.L.

670 RIBAVIRINUMJ05AB04

200mgJ05AB04 RIBAVIRINUM CAPS.REBETOL 200 mg 200mg SP EUROPE

200mgJ05AB04 RIBAVIRINUM COMPR. FILM.COPEGUS® 200mg ROCHE ROMANIA SRL

671 GANCICLOVIRUMJ05AB06

Prescriere limitata: Infectii severe cu citomegalovirus (CMV) la pacienti imunocompromisi inclusiv cu localizare oculara.

500mgJ05AB06 GANCICLOVIRUM LIOF. PT. SOL. INJ.CYMEVENE 500mg ROCHE ROMANIA S.R.L.

672 VALACYCLOVIRUMJ05AB11

500mgJ05AB11 VALACYCLOVIRUM COMPR. FILM.VALTREX 500 mg 500mg THE WELLCOME FOUNDATION LTD.

673 VALGANCICLOVIRUM **J05AB14

Prescriere limitata: Tratamentul de initiere si mentinere pentru retinita cu citomegalovirus (CMV) la pacienti imunocompromisi.

450mgJ05AB14 VALGANCICLOVIRUM COMPR. FILM.VALCYTE® 450 mg 450mg ROCHE ROMANIA SRL

674 BRIVUDINUMJ05ABN1

125mgJ05ABN1 BRIVUDINUM COMPR.BRIVAL® 125mg BERLIN CHEMIE AG MENARINI GROUP

676 PALIVIZUMABUM **J06BB16

Prescriere limitata: Prevenirea bolilor severe ale tractului respirator inferior care necesită spitalizare, provocate de virusul sinciţial respirator (VSR) la copii născuţi la 35 săptămâni de

gestaţie sau mai puţin şi cu vârsta mai mică de 6 luni la începutul sezonului de îmbolnăviri cu VSR sau la copii cu vârsta mai mică de 2 ani care au necesitat tratament

pentru displazie bronhopulmonară în ultimele 6 luni.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgJ06BB16 PALIVIZUMABUM PULB. + SOLV. PT. SOL. INJ.SYNAGIS 100 mg 100mg ABBOTT LABORATORIES LTD.

50mgJ06BB16 PALIVIZUMABUM PULB. + SOLV. PT. SOL. INJ.SYNAGIS 50 mg 50mg ABBOTT LABORATORIES LTD.

681 FILGRASTIMUM (G-CSF) **L03AA02

Prescriere limitata: Tratamentul neutropeniei persistente (ANC mai mic sau egal cu 1,0 x 109/L) la pacienţii cu infecţie HIV aflaţi în stadii avansate, în scopul scăderii riscului de infecţii

bacteriene în situaţiile în care alte opţiuni în tratamentul neutropeniei sunt inadecvate.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

30MU/0.5mlL03AA02 FILGRASTIMUM (G-CSF) SOL. INJ.NEUPOGEN® 30MU/0.5ml AMGEN EUROPE B.V.

48MU/0.5mlL03AA02 FILGRASTIMUM (G-CSF) SOL. INJ.NEUPOGEN® 48MU/0.5ml AMGEN EUROPE B.V.

682 NETILMICINUMS01AA23

0.3%S01AA23 NETILMICINUM PICATURI OFT.-SOL.NETTACIN® 0.3% S.I.F.I. SPA

3mg/gS01AA23 NETILMICINUM UNG. OFT.NETTAVISC 3mg/g 3mg/g S.I.F.I. SPA

0.3%S01AA23 NETILMICINUM PIC. OFT., SOLNETTACIN® 0.3% S.I.F.I. SPA

683 LOMEFLOXACINUMS01AX17

3mg/mlS01AX17 LOMEFLOXACINUM PICATURI OFT.-SOL.OKACIN 3mg/ml NOVARTIS PHARMA GMBH

684 NORFLOXACINUMS03AAN2

0.3%S03AAN2 NORFLOXACINUM PICATURI OFT./AURIC.-SOL.NORFLOX 0.3% CIPLA (UK) LIMITED

685 DEXAMETHASONUMS01BA01

0.1%S01BA01 DEXAMETHASONUM PICATURI OFT.-SUSP.MAXIDEX® 0.1% ALCON COUVREUR NV

1mg/mlS01BA01 DEXAMETHASONUM PIC. OFT. SUSP.DEXAMETAZONA RPH 1mg/ml 1mg/ml ROMPHARM COMPANY SRL

1207 AMPHOTERICINUM B LIPOSOMAL (4)J02AA01

J02AA01 AMPHOTERICINUM B LIPOSOMAL

1208 ATOVAQUONA (4)P01AX06

P01AX06 ATOVAQUONA

1209 FLUCYTOSINUM (4)J02AX01

J02AX01 FLUCYTOSINUM

1210 MEFLOQUINE (4)P01BC02

P01BC02 MEFLOQUINE

1211 MUPIROCINUM (4)R01AX06

R01AX06 MUPIROCINUM

98 153/

Page 99: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

1212 PAROMOMYCINUM (4)A07AA06

A07AA06 PAROMOMYCINUM

1213 PENTAMIDINUM (4)P01CX01

P01CX01 PENTAMIDINUM

1214 PRIMAQUINUM (4)P01BA03

P01BA03 PRIMAQUINUM

1215 PYRIMETHAMINUM (4)P01BD01

P01BD01 PYRIMETHAMINUM

1216 PYRIMETHAMINUM+SULFADIAZINUM (4)P01BD51

P01BD51 PYRIMETHAMINUM+SULFADIAZINUM

1217 TRIMETHOPRIM (4)J01EA01

J01EA01 TRIMETHOPRIM

99 153/

Page 100: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

SUBLISTA C2-P1: PROGRAMUL NATIONAL DE BOLI TRANSMISIBILE. B) SUBPROGRAMUL DE TRATAMENT AL BOLNAVILOR

CU TUBERCULOZA

686 PYRIDOXINUMA11HA02

250 mgA11HA02 PYRIDOXINUM COMPR.VITAMINA B6 250 mg 250 mg ARENA GROUP SA

250mgA11HA02 PYRIDOXINUM COMPR.SICOVIT B6 250 mg 250mg ZENTIVA SA

250mg/5mlA11HA02 PYRIDOXINUM SOL. INJ.SICOVIT B6 250 mg/5 ml 250mg/5ml ZENTIVA SA

50mg/2mlA11HA02 PYRIDOXINUM SOL. INJ.SICOVIT B6 50 mg/2ml 50mg/2ml ZENTIVA SA

687 PREDNISONUMH02AB07

5mgH02AB07 PREDNISONUM COMPR.N - PREDNISON 5mg MEDUMAN SA

PREDNISON 5 mg 5mg SINTOFARM SA

PREDNISON ARENA 5 mg 5mg ARENA GROUP SA

PREDNISON GEDEON RICHTER 5 mg 5mg GEDEON RICHTER ROMANIA SA

PREDNISON MAGISTRA 5 mg 5mg MAGISTRA C & C

688 CLARITHROMYCINUMJ01FA09

125mg/5mlJ01FA09 CLARITHROMYCINUM GRAN. PT. SUSP. ORALAFROMILID® 125 mg/5 ml 125mg/5ml KRKA D.D.

KLABAX 125 mg/5 ml 125mg/5ml TERAPIA S.A.

KLACID® 125mg/5ml ABBOTT SPA

LEKOKLAR 125 mg/5 ml 125mg/5ml SANDOZ S.R.L.

250mgJ01FA09 CLARITHROMYCINUM COMPR. FILM.CLAR 250 250mg MEDICAROM GROUP S.R.L.

CLARITROMICINA 250 mg 250mg OZONE LABORATORIES LTD.

FROMILID 250 250mg KRKA D.D. NOVO MESTO

KLABAX 250 mg 250mg TERAPIA S.A.

KLACID® 250mg ABBOTT SPA

KLERIMED® 250 250mg MEDOCHEMIE LTD.

LEKOKLAR® 250 mg 250mg LEK PHARMACEUTICALS D.D.

250mg/5mlJ01FA09 CLARITHROMYCINUM GRAN. PT. SUSP. ORALAKLABAX 250 mg/5 ml 250mg/5ml TERAPIA S.A.

LEKOKLAR 250 mg/5 ml 250mg/5ml SANDOZ SRL

500mgJ01FA09 CLARITHROMYCINUM COMPR. FILM.CLAR 500 500mg MEDICAROM GROUP S.R.L.

CLARITROMICINA 500 mg 500mg OZONE LABORATORIES LTD.

FROMILID 500 500mg KRKA D.D. NOVO MESTO

KLABAX 500 mg 500mg TERAPIA S.A.

KLERIMED® 500 500mg MEDOCHEMIE LTD.

LEKOKLAR® 500 mg 500mg LEK PHARMACEUTICALS D.D.

500mgJ01FA09 CLARITHROMYCINUM COMPR. FILM. ELIB. MODIF.KLABAX MR 500 mg 500mg TERAPIA S.A.

LEKOKLAR XL 500 mg 500mg LEK PHARMACEUTICALS D.D.

500mgJ01FA09 CLARITHROMYCINUM COMPR. FILM. ELIB. PREL.FROMILID® UNO 500mg KRKA D.D.

KLACID SR 500mg ABBOTT LABORATORIES LTD.

500mgJ01FA09 CLARITHROMYCINUM LIOF. PT. SOL. PERF.KLACID I.V. 500mg ABBOTT LABORATORIES LTD.

691 AMIKACINUMJ01GB06

100mg/2mlJ01GB06 AMIKACINUM SOL. INJ.AMIKOZIT® 100 mg/2 ml 100mg/2ml ECZACIBASI PHARMACEUTICALS S.R.L.

250mg/mlJ01GB06 AMIKACINUM SOL. INJ.AMIKIN 250mg/ml BRISTOL MYERS SQUIBB KFT

500mg/2mlJ01GB06 AMIKACINUM SOL. INJ.AMIKOZIT® 500 mg/2 ml 500mg/2ml ECZACIBASI PHARMACEUTICALS S.R.L.

692 OFLOXACINUMJ01MA01

200mgJ01MA01 OFLOXACINUM COMPR. FILM.OFLOXACIN 200 mg 200mg ANTIBIOTICE SA

OFLOXIN 200 200mg ZENTIVA AS

ZANOCIN 200mg RANBAXY UK LIMITED

400mgJ01MA01 OFLOXACINUM COMPR. FILM. ELIB. PREL.ZANOCIN® OD 400 400mg RANBAXY U.K. LIMITED

693 CIPROFLOXACINUMJ01MA02

100mg/10mlJ01MA02 CIPROFLOXACINUM CONC. PT. SOL. PERF.CIPRINOL® 100mg/10ml KRKA D.D.

CIPROFLOXACINA 100 mg/10 ml 100mg/10ml SICOMED SA

100mg/50mlJ01MA02 CIPROFLOXACINUM SOL. PERF.CIPRINOL 100mg/50ml KRKA D.D. NOVO MESTO

200mg/100mlJ01MA02 CIPROFLOXACINUM SOL. PERF.CIPRINOL 200mg/100ml KRKA D.D. NOVO MESTO

CIPROBAY® 200 200mg/100ml BAYER HEALTHCARE AG

250mgJ01MA02 CIPROFLOXACINUM CAPS.EUCIPRIN 250mg EUROPHARM SA

250mgJ01MA02 CIPROFLOXACINUM COMPR. FILM.CIFRAN 250mg RANBAXY UK LIMITED

CIPHIN 250 250mg ZENTIVA A.S.

CIPRINOL 250 mg 250mg KRKA D.D. NOVO MESTO

CIPROCIN 250 mg 250mg E.I.P.I.CO. MED S.R.L.

CIPROFLOXACIN 250 mg 250mg LAROPHARM SRL

100 153/

Page 101: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

CIPROFLOXACINA ALKALOID 250 mg 250mg ALKALOID D.O.O.

CIPROLEN® 250 mg 250mg AC HELCOR SRL

CIPROLET 250 mg 250mg DR. REDDY'S LABORATORIES

CIPROZONE 250 mg 250mg OZONE LABORATORIES LTD.

CUMINOL 250 mg 250mg GEDEON RICHTER ROMANIA

2mg/mlJ01MA02 CIPROFLOXACINUM SOL. PERF.CIPROBAY® 400 2mg/ml BAYER HEALTHCARE AG

UFEXIL 2mg/ml DEMO SA

400mg/200mlJ01MA02 CIPROFLOXACINUM SOL. PERF.CIPRINOL® 400mg/200ml KRKA D.D.

500mgJ01MA02 CIPROFLOXACINUM COMPR. FILM.CIFRAN 500mg RANBAXY UK LIMITED

CIPHIN 500 500mg ZENTIVA A.S.

CIPRINOL 500 mg 500mg KRKA D.D. NOVO MESTO

CIPRO QUIN® 500mg ANTIBIOTICE SA

CIPROBAY® 500 500mg BAYER HEALTHCARE AG

CIPROCIN 500 mg 500mg E.I.P.I.CO. MED S.R.L.

CIPRODAR 500mg DAR AL DAWA PHARMA S.R.L

CIPROFLOXACINA ALKALOID 500 mg 500mg ALKALOID D.O.O.

CIPROLEN® 500 mg 500mg AC HELCOR SRL

CIPROLET 500 mg 500mg DR. REDDY'S LABORATORIES

CIPROZONE FORTE 500 mg 500mg OZONE LABORATORIES LTD.

CUMINOL 500 mg 500mg GEDEON RICHTER ROMANIA

SIFLOKS® 500mg ECZACIBASI ILAC SANAYI VE TICARET AS

750mgJ01MA02 CIPROFLOXACINUM COMPR. FILM.CIPRINOL 750 mg 750mg KRKA D.D. NOVO MESTO

694 MOXIFLOXACINUMJ01MA14

400mgJ01MA14 MOXIFLOXACINUM COMPR. FILM.AVELOX® 400 mg 400mg BAYER HEALTHCARE AG

400mg/250mlJ01MA14 MOXIFLOXACINUM SOL. PERF.AVELOX® 400 mg/250 ml 400mg/250ml BAYER HEALTHCARE AG

696 CICLOSERINUMJ04AB01

250mgJ04AB01 CICLOSERINUM CAPS.CICLOSERINA ANTIBIOTICE 250 mg 250mg ANTIBIOTICE S.A.

HELPOCERIN 250mg HELP PHARMACEUTICALS LTD.

697 RIFAMPICINUMJ04AB02

150mgJ04AB02 RIFAMPICINUM CAPS.SINERDOL 150 mg 150mg ANTIBIOTICE SA

300mgJ04AB02 RIFAMPICINUM CAPS.SINERDOL 300 mg 300mg ANTIBIOTICE SA

698 RIFABUTINUMJ04AB04

150mgJ04AB04 RIFABUTINUM CAPS.MYCOBUTIN 150 mg 150mg PFIZER EUROPE MA EEIG

699 CAPREOMYCINUM (4)J04AB30

J04AB30 CAPREOMYCINUM

700 ISONIAZIDUMJ04AC01

100mgJ04AC01 ISONIAZIDUM COMPR.ISONIAZIDA 100 mg 100mg ANTIBIOTICE SA

300mgJ04AC01 ISONIAZIDUM COMPR.ISONIAZIDA 300mg ANTIBIOTICE SA

500mg/10mlJ04AC01 ISONIAZIDUM SOL. INJ.IZONIAZIDA 500 mg 500mg/10ml TERAPIA SA

701 PROTIONAMIDUMJ04AD01

250mgJ04AD01 PROTIONAMIDUM COMPR. FILM.PROTIONAMIDA 250 mg 250mg ANTIBIOTICE SA

702 PYRAZINAMIDUMJ04AK01

500mgJ04AK01 PYRAZINAMIDUM COMPR.PIRAZINAMIDA ANTIBIOTICE 500 mg 500mg ANTIBIOTICE S.A.

703 ETHAMBUTOLUMJ04AK02

250mgJ04AK02 ETHAMBUTOLUM COMPR. FILM.ETAMBUTOL 250 mg 250mg ANTIBIOTICE SA

704 COMBINATII (RIFAMPICINUM+IZONIAZIDUM)J04AM02

300mg+150mgJ04AM02 COMBINATII (RIFAMPICINUM+IZONIAZIDUM) CAPS.SINERDOL ISO 300mg+150mg ANTIBIOTICE SA

101 153/

Page 102: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

SUBLISTA C2-P3: PROGRAMUL NATIONAL DE ONCOLOGIE.

705 CYPROTERONUM Protocol: L025CG03HA01

50mgG03HA01 CYPROTERONUM COMPR.ANDROCUR 50mg SCHERING AG

706 CYCLOPHOSPHAMIDUML01AA01

1gL01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. INJ./PERF.ENDOXAN® 1 g 1g BAXTER ONCOLOGY GMBH

200mgL01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. PERF./INJ. I.V.ENDOXAN 200 mg 200mg ACTAVIS S.R.L.

500mgL01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. INJ./PERF.ENDOXAN® 500 mg 500mg BAXTER ONCOLOGY GMBH

50mgL01AA01 CYCLOPHOSPHAMIDUM DRAJ.ENDOXAN® 50 mg 50mg BAXTER ONCOLOGY GMBH

707 CHLORAMBUCILUML01AA02

Indicat in schemele de tratament al limfomului Hodgkin.

Indicat in schemele de tratament ale anumitor forme de limfoame non-Hodgkin.

Indicat in schemele de tratament al leucemiei limfocitare cronice.

Indicat in schemele de tratament a macroglobulinemiei Waldenstrom.

NOTA:

2mgL01AA02 CHLORAMBUCILUM COMPR. FILM.LEUKERAN 2mg THE WELLCOME FOUNDATION LTD.

708 MELPHALANUML01AA03

Indicat in schemele de tratament al mielomului multiplu.

Indicat in schemele de tratament ale adenocarcinomuluii ovarian avansat.

Indicat in schemele de tratament al cancerului de san avansat.

Indicat in schemele de tratament a policitemia vera.

NOTA:

2mgL01AA03 MELPHALANUM COMPR. FILM.ALKERAN 2 mg 2mg THE WELLCOME FOUNDATION LTD.

709 IFOSFAMIDUML01AA06

1gL01AA06 IFOSFAMIDUM PULB. PT. SOL. PERF.HOLOXAN 1 g 1g BAXTER ONCOLOGY GMBH

2gL01AA06 IFOSFAMIDUM PULB. PT. SOL. PERF.HOLOXAN 2 g 2g BAXTER ONCOLOGY GMBH

500mgL01AA06 IFOSFAMIDUM PULB. PT. SOL. PERF.HOLOXAN 500 mg 500mg BAXTER ONCOLOGY GMBH

710 BUSULFANUML01AB01

Indicat in schemele de tratament paliativ al fazei cronice in Leucemia Granulocitara Cronica.

Indicat in schemele de tratament a polcitemiei vera.

Indicat in schemele de tratament a mielofibrozei si trombocitemiei esentiale.

NOTA:

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

2mgL01AB01 BUSULFANUM COMPR. FILM.MYLERAN 2mg THE WELLCOME FOUNDATION LTD.

712 TEMOZOLOMIDUM ** Protocol: L046CL01AX03

Tratamentul glioblastomului multiform nou diagnosticat, în asociere cu radioterapia şi apoi ca monoterapie.

Tratamentul glioamelor maligne, (glioblastomul multiform sau astrocitomul anaplazic), care au prezentat recurenţă sau progresie după terapia standard.

NOTA:

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgL01AX03 TEMOZOLOMIDUM CAPS.TEMODAL 100 mg 100mg SP EUROPE

20mgL01AX03 TEMOZOLOMIDUM CAPS.TEMODAL 20 mg 20mg SP EUROPE

250mgL01AX03 TEMOZOLOMIDUM CAPS.TEMODAL 250 mg 250mg SP EUROPE

5mgL01AX03 TEMOZOLOMIDUM CAPS.TEMODAL 5 mg 5mg SP EUROPE

L01AX03 TEMOZOLOMIDUMTEMODAL 100 mg 100mg SP EUROPE

L01AX03 TEMOZOLOMIDUMTEMODAL 20 mg 20mg SP EUROPE

L01AX03 TEMOZOLOMIDUMTEMODAL 5 mg 5mg SP EUROPE

713 DACARBAZINUML01AX04

200mgL01AX04 DACARBAZINUM LIOF. PT. SOL. PERF.DALTRIZEN® 200 mg 200mg ACTAVIS S.R.L.

714 METHOTREXATUML01BA01

100mg/mlL01BA01 METHOTREXATUM CONC. PT. SOL. INJ./PERF.METHOTREXAT "EBEWE" 1000 mg 100mg/ml EBEWE PHARMA GMBH NFG. KG

METHOTREXAT "EBEWE" 500 mg 100mg/ml EBEWE PHARMA GMBH NFG. KG

METHOTREXAT "EBEWE" 5000 mg 100mg/ml EBEWE PHARMA GMBH NFG. KG

10mg/mlL01BA01 METHOTREXATUM SOL. INJ./PERF.METHOTREXAT "EBEWE" 50 mg 10mg/ml EBEWE PHARMA GMBH NFG. KG

50mgL01BA01 METHOTREXATUM PULB. PT. SOL. INJ./PERF.ANTIFOLAN® 50 mg 50mg SINDAN SRL

5mg/mlL01BA01 METHOTREXATUM SOL. INJ.METHOTREXAT "EBEWE" 5 mg 5mg/ml EBEWE PHARMA GMBH NFG. KG

715 PEMETREXEDUM **** Protocol: L047CL01BA04

102 153/

Page 103: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

Tratamentul în asociere cu cisplatină al pacienţilor cu mezoteliom pleural malign nerezecabil fără chimioterapie anterioară.

Tratamentul ca monoterapie al pacienţilor cu cancer pulmonar cu alt tip de celulă decât cu celulă mică, avansat local sau metastazat, după chimioterapie anterioară.

Doze mai mari de 500 mg pe metru pătrat de suprafaţă corporală nu se vor aproba pentru compensare. Suprafata corporala a pacientului va trebui declarata in dosarul de

aprobare.

NOTA:

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

500mgL01BA04 PEMETREXEDUM PULB. PT. CONC. PT. SOL. PERF.ALIMTA 500mg 500mg ELI LILLY NEDERLAND BV

716 MERCAPTOPURINUML01BB02

50mgL01BB02 MERCAPTOPURINUM COMPR.PURI - NETHOL 50mg THE WELLCOME FOUNDATION LTD.

717 TIOGUANINUML01BB03

40mgL01BB03 TIOGUANINUM COMPR.LANVIS 40mg THE WELLCOME FOUNDATION LTD.

718 CLADRIBINUML01BB04

Prescriere limitata: Leucemia cu celule paroase.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

2mg/mlL01BB04 CLADRIBINUM SOL. INJ.LITAK 2 mg/ml 2mg/ml LIPOMED GMBH

719 FLUDARABINUM **** Protocol: L048CL01BB05

Tratamentul pacienţilor cu leucemie limfocitară cronică cu celule B (LLC), cu rezervă medulară suficientă, care nu au răspuns la tratament sau a căror boală a avansat în timpul

tratamentului cu o schemă conţinând cel puţin un agent alchilant standard sau ulterior acestuia.

NOTA:

10mgL01BB05 FLUDARABINUM COMPR. FILM.FLUDARA® ORAL 10mg SCHERING AG

720 CYTARABINUML01BC01

100mgL01BC01 CYTARABINUM PULB. + SOLV. PT. SOL. INJ.CYTOSAR™ 100 mg 100mg PFIZER EUROPE MA EEIG

20mg/mlL01BC01 CYTARABINUM SOL. INJ.ALEXAN 20mg/ml 20mg/ml EBEWE PHARMA GMBH NFG. KG

50mgL01BC01 CYTARABINUM SUSP. INJ.DEPOCYTE 50mg 50mg SKYEPHARMKA PLC

50mg/mlL01BC01 CYTARABINUM SOL. INJ.ALEXAN 50mg/ml 50mg/ml EBEWE PHARMA GMBH NFG. KG

721 FLUOROURACILUML01BC02

250mg/5mlL01BC02 FLUOROURACILUM SOL. PERF./INJ.FLUOROSINDAN 250mg/5ml 250mg/5ml ACTAVIS S.R.L.

50 mg/gL01BC02 FLUOROURACILUM UNGUENTEFUDIX 50 mg/g ICN HUNGARY CO. LTD.

50mg/mlL01BC02 FLUOROURACILUM CONC. PT. SOL. INJ./PERF.5 - FLUOROURACIL EBEWE 50mg/ml 50mg/ml EBEWE PHARMA GMBH NFG. KG

722 GEMCITABINUM **L01BC05

Prescriere limitata: Terapia asociata a cancerului mamar avansat cu paclitaxelum dupa esecul terapiei anterioare cu un derivat de antraciclina.

Terapia asociata a cancerului ovarian epitelial avansat cu carboplatinum la pacientele cu recadere la mai mult de 6 luni dupa chimioterpia cu derivati de platinum.

Tratamentul de prima intentie al cancerului pulmonar cu alt tip de celule decat cu celule mici, stadiile IIIA sau IIIB sau IV in asociere cu cisplatin.

Tratamentul paliativ al cancerului pulmonar cu alt tip de celule decat cu celule mici avansat local sau metastatic.

Adenocarcinom pancreatic avansat local sau metastatic.

Tratamentul asociat al cancerului vezical avansat local sau metastatic in combinatie cu cisplatin.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

1gL01BC05 GEMCITABINUM PULB. PT. SOL. PERF.GEMCITABINA SINDAN 1 g 1g ACTAVIS S.R.L.

200mgL01BC05 GEMCITABINUM PULB. PT. SOL. PERF.GEMCITABINA SINDAN 200 mg 200mg ACTAVIS S.R.L.

723 CAPECITABINUML01BC06

Prescriere limitata: Cancer mamar avansat local sau metastazat dupa esecul terapiei anterioare cu un taxan si un derivat de antraciclina.

Cancer mamar avansat local sau metastazat in care terapia cu un derivat de antraciclina nu mai este indicata.

Terapia asociata a cancerului mamar avansat local sau metastazat cu docetaxelum dupa esecul terapiei anterioare cu un derivat de antraciclina.

Tratamentul de prima linie al cancerului colorectal metastatic avansat.

Tratamentul adjuvant al cancerului de colon stadiul III (Dukes C), dupa rezectia completa a tumorii primare.

Durata recomandata a tratamentului adjuvant este de 24 de saptamani; nu se compenseaza tratamentul cu Capecitabinum pentru cancerul de colon stadiul II (Dukes B) si

tratamentul adjuvant al pacientilor cu cancer rectal.

NOTA:

150mgL01BC06 CAPECITABINUM COMPR. FILM.XELODA 150 mg 150mg ROCHE REGISTRATION LTD.

500mgL01BC06 CAPECITABINUM COMPR. FILM.XELODA 500 mg 500mg ROCHE REGISTRATION LTD.

724 COMBINATII (TEGAFUR+URACIL)L01BC53

100mg+224mgL01BC53 COMBINATII (TEGAFUR+URACIL) CAPS.UFT 100mg+224mg MERCK KGAA

726 VINCRISTINUML01CA02

1mgL01CA02 VINCRISTINUM LIOF. PT. SOL. INJ./PERF. I.V.SINDOVIN 1 mg 1mg ACTAVIS S.R.L.

727 VINORELBINUML01CA04

10mg/mlL01CA04 VINORELBINUM CONC. PT. SOL. INJ./PERF.VINORELBIN EBEWE 10 mg/ ml 10mg/ml EBEWE PHARMA GES.M.B.H. NFG KG

10mg/mlL01CA04 VINORELBINUM CONC. PT. SOL. PERF.VINORELBIN ACTAVIS 10 mg/ml 10mg/ml ACTAVIS S.R.L.

VINORELBIN TEVA 10 mg/ml 10mg/ml TEVA PHARMACEUTICALS SRL

10mg/mlL01CA04 VINORELBINUM SOL. INJ.NAVELBINE® 10mg/ml LAB. PIERRE FABRE

Tratamentul cancerului mamar avansat dupa esecul terapiei anterioare cu un derivat de antraciclina.Prescriere limitata:

103 153/

Page 104: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

Tratamentul de prima intentie singular sau asociat al cancerului pulmonar cu alte celule decat celule mici avansat local sau metastatic.Prescriere limitata:

20mgL01CA04 VINORELBINUM CAPS. MOINAVELBINE 20 mg 20mg PIERRE FABRE MEDICAMENT

Tratamentul cancerului mamar avansat dupa esecul terapiei anterioare cu un derivat de antraciclina.Prescriere limitata:

Tratamentul de prima intentie singular sau asociat al cancerului pulmonar cu alte celule decat celule mici avansat local sau metastatic.Prescriere limitata:

30mgL01CA04 VINORELBINUM CAPS. MOINAVELBINE 30 mg 30mg PIERRE FABRE MEDICAMENT

Tratamentul cancerului mamar avansat dupa esecul terapiei anterioare cu un derivat de antraciclina.Prescriere limitata:

Tratamentul de prima intentie singular sau asociat al cancerului pulmonar cu alte celule decat celule mici avansat local sau metastatic.Prescriere limitata:

728 ETOPOSIDUML01CB01

100mgL01CB01 ETOPOSIDUM CAPS. MOIVEPESID 100mg BRISTOL MYERS SQUIBB KFT

100mg/5mlL01CB01 ETOPOSIDUM CONC. PT. SOL. PERF.ETOPOSID "EBEWE" 100 mg/5 ml 100mg/5ml EBEWE PHARMA GMBH NFG. KG

SINTOPOZID 100 mg/5 ml 100mg/5ml ACTAVIS S.R.L.

20mg/mlL01CB01 ETOPOSIDUM CONC. PT. SOL. PERF.ETOPOSIDE - TEVA 20mg/ml TEVA PHARMACEUTICALS S.R.L.

50mgL01CB01 ETOPOSIDUM CAPS. MOIVEPESID 50mg BRISTOL MYERS SQUIBB KFT

729 PACLITAXELUM **L01CD01

Prescriere limitata: Tratamentul adjuvant al cancerului mamar cu ganglioni pozitivi administrat secvential cu un derivat de antraciclina si ciclofosfamida.

Cancer mamar avansat dupa esecul terapiei anterioare sau intoleranta la un derivat de antraciclina.

Terapia de linia a doua cancerului ovarian avansat la pacientele cu esec anterior la chimioterapia cu derivati de platinum.

Cancer pulmonar cu celule altele decat celule mici avansat local sau metastatic.

Terapia asociata a cancerului de san in stadiu precoce (HER2 pozitiv) cu trastuzumab si care nu sunt eeligibili pentru tratament cu un derivat de antraciclina.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

6mg/mlL01CD01 PACLITAXELUM CONC. PT. SOL. PERF.ONXOL 6mg/ml 6mg/ml IVAX - PHARMACEUTICALS S.R.O.

PACLITAXEL 6 mg/ml 6mg/ml PHARMEXPRESS S.R.L.

PACLITAXEL EBEWE 6mg/ml 6mg/ml EBEWE PHARMA GES.M.B.H. NFG KG

SINDAXEL 6mg/ml ACTAVIS S.R.L.

730 DOCETAXELUM ** Protocol: L049CL01CD02

Tratamentul adjuvant în asociere cu doxorubicină şi ciclofosfamidă, adjuvant al pacientelor cu cancer mamar operabil, cu ganglioni pozitivi.

Tratamentul în asociere cu doxorubicină, al pacientelor cancer mamar avansat loco-regional sau metastazat, care nu au primit anterior tratament citotoxic pentru această

afecţiune.

Tratamentul in monoterapie al pacientelor cu cancer mamar avansat loco-regional sau metastazat, după eşecul tratamentului citotoxic. Chimioterapia anterioară trebuie să fi

inclus o antraciclină sau un agent alchilant.

Tratamentul în asociere cu trastuzumab, al pacientelor cu cancer mamar metastazat ale căror tumori exprimă în exces HER2 şi care nu au primit anterior chimioterapie pentru

boala metastatică.

Tratamentul în asociere cu capecitabină, al pacientelor cu cancer mamar avansat loco-regional sau metastazat, după eşecul chimioterapiei citotoxice. Tratamentul anterior trebuie

să fi inclus o antraciclină.

Tratamentul pacienţilor cu cancer bronhopulmonar, altul decât cel cu celule mici, avansat loco-regional sau metastazat, după eşecul chimioterapiei sau înainte de aceasta.

Tratamentul în asociere cu cisplatină, al pacienţilor cu cancer bronhopulmonar, altul decât cel cu celule mici, nerezecabil, avansat loco-regional sau metastazat, la pacienţii care

nu au primit anterior chimioterapie pentru această afecţiune.

Tratamentul în asociere cu prednison sau prednisolon, al pacienţilor cu cancer de prostată metastazat, hormono-rezistent.

Tratamentul în asociere cu cisplatină şi 5-fluorouracil, al pacienţilor cu adenocarcinom gastric metastazat, inclusiv adenocarcinom al joncţiunii gastroesofagiene, care nu au

primit anterior chimioterapie pentru boala metastatică.

Tratamentul în asociere cu cisplatină şi 5-fluorouracil de inducţie la pacienţi cu carcinom cu celule scuamoase, al capului şi gâtului, avansat local.

NOTA:

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

20mgL01CD02 DOCETAXELUM CONC. + SOLV. PT. SOL. PERF.TAXOTERE 20 mg 20mg AVENTIS PHARMA SA

80mgL01CD02 DOCETAXELUM CONC. + SOLV. PT. SOL. PERF.TAXOTERE 80 mg 80mg AVENTIS PHARMA SA

732 DOXORUBICINUML01DB01

10mgL01DB01 DOXORUBICINUM LIOF. PT. SOL. INJ.ADRIBLASTINA RD 10 mg 10mg ACTAVIS S.R.L.

2mg/mlL01DB01 DOXORUBICINUM CONC. PT. SOL. PERF.CAELYX 2 mg/ml 2mg/ml SP EUROPE

Tratamentul ca monoterapie al cancerului mamar metastatic, la paciente cu risc cardiac crescut.Prescriere limitata:

Tratamentul cancerului ovarian în stadiu avansat, la paciente care nu au răspuns la regimul chimioterapic de primă linie, cu compuşi de platină.Prescriere limitata:

Tratamentul sarcomului Kaposi (SK) corelat cu SIDA (SK-SIDA), la pacienţii cu număr mic de limfocite CD4 (< 200 limfocite CD4/mm3) şi cu afectare mucocutanată sau

viscerală extinsă. Poate fi utilizat în chimioterapia sistemică de primă linie sau în chimioterapia de linia a doua la pacienţii cu SK-SIDA la care boala a avansat sau la

pacienţii cu intoleranţă la tratament, la care s-a administrat anterior chimioterapie sistemică combinată, cuprinzând cel puţin două dintre următoarele chimioterapice:

alcaloid de vinca, bleomicină şi doxorubicină standard (sau altă antraciclină).

Prescriere limitata:

2mg/mlL01DB01 DOXORUBICINUM CONC. PT. SOL. PERF.DOXORUBICIN "EBEWE" 2mg/ml 2mg/ml EBEWE PHARMA GMBH NFG. KG

2mg/mlL01DB01 DOXORUBICINUM PULB. PT. SOL. PERF.SINDROXOCIN 2mg/ml 2mg/ml ACTAVIS S.R.L

2mg/mlL01DB01 DOXORUBICINUM SOL. INJ.DOXORUBICIN TEVA 2 mg/ml 2mg/ml TEVA PHARMACEUTICALS S.R.L

50mgL01DB01 DOXORUBICINUM LIOF. PT. SOL. INJ.ADRIBLASTINA RD 50 mg 50mg ACTAVIS S.R.L.

733 EPIRUBICINUML01DB03

10mgL01DB03 EPIRUBICINUM LIOF. PT. SOL. INJ.EPISINDAN 10 mg 10mg ACTAVIS S.R.L.

FARMORUBICIN RD 10 mg 10mg ACTAVIS S.R.L.

2mg/mlL01DB03 EPIRUBICINUM CONC. PT. SOL. INJ.EPIRUBICIN "EBEWE" 2 mg/ml 2mg/ml EBEWE PHARMA GMBH NFG. KG

50mgL01DB03 EPIRUBICINUM LIOF. PT. SOL. INJ.EPISINDAN 50 mg 50mg ACTAVIS S.R.L.

104 153/

Page 105: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

FARMORUBICIN® RD 50 mg 50mg ACTAVIS S.R.L.

734 IDARUBICINUML01DB06

10mgL01DB06 IDARUBICINUM CAPS.ZAVEDOS 10mg PFIZER EUROPE MA EEIG

5mgL01DB06 IDARUBICINUM LIOF. PT. SOL. INJ.ZAVEDOS 5 mg 5mg PFIZER EUROPE MA EEIG

735 MITOXANTRONUM **L01DB07

2 mg/mlL01DB07 MITOXANTRONUM CONC. PT. SOL. PERF.MITOXANTRONE TEVA 2 mg/ml 2 mg/ml TEVA PHARMACEUTICALS SRL

20mg/10mlL01DB07 MITOXANTRONUM SOL. PERF.NOVANTRONE 20mg/10ml WYETH LEDERLE PHARMA GMBH

2mg/mlL01DB07 MITOXANTRONUM CONC. PT. SOL. INJ.ONKOTRONE 2mg/ml BAXTER ONCOLOGY GMBH

736 BLEOMYCINUM SULFASL01DC01

15mgL01DC01 BLEOMYCINUM SULFAS LIOF. PT. SOL. INJ.BLEOCIN 15mg EURO NIPPON KAYAKU GMBH

738 CISPLATINUML01XA01

10mgL01XA01 CISPLATINUM LIOF. PT. SOL. PERF.SINPLATIN 10 mg 10mg ACTAVIS S.R.L.

10mg/20mlL01XA01 CISPLATINUM CONC. PT. SOL. PERF.CISPLATIN "EBEWE" 10 mg/20 ml 10mg/20ml EBEWE PHARMA GMBH NFG. KG

CISPLATIN TEVA 10 mg/20 ml 10mg/20ml TEVA PHARMACEUTICALS S.R.L.

1mg/1mlL01XA01 CISPLATINUM CONC. PT. SOL. PERF.SINPLATIN 1 mg/1 ml 1mg/1ml ACTAVIS S.R.L.

25mg/50mlL01XA01 CISPLATINUM CONC. PT. SOL. PERF.CISPLATIN "EBEWE" 25 mg/50 ml 25mg/50ml EBEWE PHARMA GMBH NFG. KG

50mgL01XA01 CISPLATINUM LIOF. PT. SOL. PERF.SINPLATIN 50 mg 50mg ACTAVIS S.R.L.

50mg/100mlL01XA01 CISPLATINUM CONC. PT. SOL. PERF.CISPLATIN "EBEWE" 50 mg/100 ml 50mg/100ml EBEWE PHARMA GMBH NFG. KG

739 CARBOPLATINUML01XA02

10mg/mlL01XA02 CARBOPLATINUM CONC. PT. SOL. PERF.CARBOPLATIN "EBEWE" 10 mg/ml 10mg/ml EBEWE PHARMA GES.M.B.H. NFG KG

CARBOPLATIN ACTAVIS 10mg/ml 10mg/ml ACTAVIS S.R.L.

CARBOPLATIN TEVA 10mg/ml 10mg/ml TEVA PHARMACEUTICALS S.R.L.

740 OXALIPLATINUML01XA03

Prescriere limitata: Cancer colorectal metastazat in combinatie cu 5-FU si acid folic.

Tratament adjuvant al cancerului de colon stadiul III (Dukes C) in combinatie cu 5-FU si acid folic dupa rezectia completa a tumorii primare.

Nu se compenseaza tratamentul cu Oxaliplatinum pentru cancerul de colon stadiul II (Dukes B) si tratamentul adjuvant al pacientilor cu cancer rectal.NOTA:

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

5mg/mlL01XA03 OXALIPLATINUM LIOF. PT. SOL. PERF.ELOXATIN 5 mg/ml 5mg/ml SANOFI-AVENTIS FRANCE

OXALIPLATIN ACTAVIS 5 mg/ml 5mg/ml ACTAVIS S.R.L.

NOTA: Nu se compenseaza tratamentul cu Oxaliplatinum pentru cancerul de colon stadiul II (Dukes B) si tratamentul adjuvant al pacientilor cu cancer rectal..

742 ALEMTUZUMABUM **** Protocol: L024CL01XC04

10mg/mlL01XC04 ALEMTUZUMABUM CONC. PT. SOL. PERF.MABCAMPATH 10 mg/ml 10mg/ml GENZYME EUROPE BV

30mg/mlL01XC04 ALEMTUZUMABUM CONC. PT. SOL. PERF.MABCAMPATH 30 mg/ml 30mg/ml GENZYME EUROPE BV

743 RITUXIMABUM **** Protocol: L014CL01XC02

10mg/mlL01XC02 RITUXIMABUM CONC. PT. SOL. PERF.MABTHERA 100 mg 10mg/ml ROCHE REGISTRATION LTD.

MABTHERA 500 mg 10mg/ml ROCHE REGISTRATION LTD.

10mg/mlL01XC02 RITUXIMABUM CONC. PT. SOL. PERF.MABTHERA 100 mg 10mg/ml ROCHE REGISTRATION LTD.

MABTHERA 500 mg 10mg/ml ROCHE REGISTRATION LTD.

744 TRASTUZUMABUM **** Protocol: L026CL01XC03

Tratamentul pacienţilor cu neoplasm de sân metastatic cu HER2 amplificat:

a) ca monoterapie în cazul pacienţilor trataţi cu cel puţin două regimuri chimioterapice pentru boala lor metastatică. Chimioterapia anterioară trebuie să fi inclus cel puţin o

antraciclină şi un taxan, cu excepţia cazurilor în care aceste chimioterapice nu erau indicate. Pacienţii pozitivi la receptorii hormonali trebuie de asemenea să fi prezentat un eşec

la tratamentul hormonal, cu excepţia cazurilor în care acest tip de tratament nu a fost indicat

b) în asociere cu Paclitaxel pentru tratamentul pacienţilor care nu au primit chimioterapie pentru boala lor metastatică şi pentru care nu este indicat tratamentul cu antracicline.

Herceptin trebuie folosit numai la pacienţii ale căror tumori prezintă HER2 amplificat la nivel 3+ , determinat prin imunohistochimie.

NOTA:

Trastuzumab nu trebuie utilizat la pacienti cu o fractie de ejectie ventriculara a ventriculului stang mai mica de 45% si/sau cu insuficienta cardiaca simptomatica. Functia cardiaca

trebuie testata.

150mgL01XC03 TRASTUZUMABUM PULB. PT. CONC. PT. SOL. PERF.HERCEPTIN 150mg 150mg ROCHE REGISTRATION LTD.

745 CETUXIMABUM **** Protocol: L037CL01XC06

2mg/mlL01XC06 CETUXIMABUM SOL. PERF.ERBITUX 2mg/ml 2mg/ml MERCK KGAA

5mg/mlL01XC06 CETUXIMABUM SOL. PERF.ERBITUX 5mg/ml 5mg/ml MERCK KGAA

5mg/mlL01XC06 CETUXIMABUM SOL. PERF.ERBITUX 5mg/ml 5mg/ml MERCK KGAA

746 BEVACIZUMABUM **** Protocol: L004CL01XC07

25mg/mlL01XC07 BEVACIZUMABUM CONC. PT. SOL. PERF.AVASTIN 25mg/ml 25mg/ml ROCHE REGISTRATION LTD.

747 IMATINIBUM **** Protocol: L008CL01XE01

105 153/

Page 106: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

100mgL01XE01 IMATINIBUM CAPS.GLIVEC 100 mg 100mg NOVARTIS EUROPHARM LTD.

100mgL01XE01 IMATINIBUM CAPS.GLIVEC 100 mg 100mg NOVARTIS EUROPHARM LTD.

100mgL01XE01 IMATINIBUM CAPS.GLIVEC 100 mg 100mg NOVARTIS EUROPHARM LTD.

748 ERLOTINIBUM **** Protocol: L031CL01XE03

100mgL01XE03 ERLOTINIBUM COMPR. FILM.TARCEVA 100 mg 100mg ROCHE REGISTRATION LTD.

150mgL01XE03 ERLOTINIBUM COMPR. FILM.TARCEVA 150 mg 150mg ROCHE REGISTRATION LTD.

25mgL01XE03 ERLOTINIBUM COMPR. FILM.TARCEVA 25 mg 25mg ROCHE REGISTRATION LTD.

749 SUNITINIBUM **** Protocol: L042CL01XE04

12,5mgL01XE04 SUNITINIBUM CAPS.SUTENT 12,5 mg 12,5mg PFIZER LIMITED

25mgL01XE04 SUNITINIBUM CAPS.SUTENT 25mg 25mg PFIZER LIMITED

50mgL01XE04 SUNITINIBUM CAPS.SUTENT 50 mg 50mg PFIZER LIMITED

750 SORAFENIBUM **** Protocol: L038CL01XE05

200mgL01XE05 SORAFENIBUM COMPR. FILM.NEXAVAR 200 mg 200mg BAYER HEALTHCARE AG

751 DASATINIBUM **** Protocol: L035CL01XE06

20 mgL01XE06 DASATINIBUM COMPR. FILM.SPRYCEL 20mg 20 mg BRISTOL-MYERS SQUIBB PHARMA EEIG

50 mgL01XE06 DASATINIBUM COMPR. FILM.SPRYCEL 50mg 50 mg BRISTOL-MYERS SQUIBB PHARMA EEIG

70 mgL01XE06 DASATINIBUM COMPR. FILM.SPRYCEL 70mg 70 mg BRISTOL-MYERS SQUIBB PHARMA EEIG

20 mgL01XE06 DASATINIBUM COMPR. FILM.SPRYCEL 20mg 20 mg BRISTOL-MYERS SQUIBB PHARMA EEIG

50 mgL01XE06 DASATINIBUM COMPR. FILM.SPRYCEL 50mg 50 mg BRISTOL-MYERS SQUIBB PHARMA EEIG

70 mgL01XE06 DASATINIBUM COMPR. FILM.SPRYCEL 70mg 70 mg BRISTOL-MYERS SQUIBB PHARMA EEIG

753 ASPARAGINAZUML01XX02

10000uiL01XX02 ASPARAGINAZUM LIOF. PT. SOL. INJ./PERF.ASPARAGINASE 10000 MEDAC 10000ui MEDAC GESELLSCAFT FUR KLINISCHE SPEZIALPRÄPARATE

5000uiL01XX02 ASPARAGINAZUM LIOF. PT. SOL. INJ./PERF.ASPARAGINASE 5000 MEDAC 5000ui MEDAC GESELLSCAFT FUR KLINISCHE SPEZIALPRÄPARATE

754 HYDROXYCARBAMIDUML01XX05

500mgL01XX05 HYDROXYCARBAMIDUM CAPS.HYDREA 500mg BRISTOL MYERS SQUIBB KFT

755 ESTRAMUSTINUML01XX11

140mgL01XX11 ESTRAMUSTINUM CAPS.ESTRACYT 140mg PFIZER EUROPE MA EEIG

757 TOPOTECAMUML01XX17

4mgL01XX17 TOPOTECAMUM PULB.CONC.SOL.PERF.HYCAMTIN 4 mg 4mg SMITHKLINE BEECHAM PLC

758 IRINOTECANUML01XX19

20mg/mlL01XX19 IRINOTECANUM CONC. PT. SOL. PERF.CAMPTO 100 mg/5 ml 20mg/ml PFIZER EUROPE MA EEIG

IRINOTESIN 20mg/ml 20mg/ml ACTAVIS S.R.L.

20mg/mlL01XX19 IRINOTECANUM CONC. PT. SOL. PERF.CAMPTO 100 mg/5 ml 20mg/ml PFIZER EUROPE MA EEIG

IRINOTESIN 20mg/ml 20mg/ml ACTAVIS S.R.L.

759 BORTEZOMIBUM **** Protocol: L012CL01XX32

3.5mgL01XX32 BORTEZOMIBUM PULB. PT. SOL. INJ.VELCADE 3,5 mg 3.5mg JANSSEN-CILAG INTERNATIONAL NV

760 MEGESTROLUML02AB01

160mgL02AB01 MEGESTROLUM COMPR.MEGESIN 160 mg 160mg ACTAVIS S.R.L.

40mg/mlL02AB01 MEGESTROLUM SUSP. ORALAMEGACE 40mg/ml BRISTOL MYERS SQUIBB KFT

761 LEUPRORELINUM **L02AE02

Prescriere limitata: Cancer de prostata hormonodependent avansat local (echivalent stadiului C) sau metastatic (echivalent stadiului D).

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

11.25mgL02AE02 LEUPRORELINUM LIOF.+ SOLV. PT. SUSP. INJ. ELIB. PREL.LUCRIN DEPOT 11,25mg 11.25mg ABBOTT LABORATORIES S.A.

11.25mgL02AE02 LEUPRORELINUM LIOF.+ SOLV. PT. SUSP. INJ. ELIB. PREL.ELIGARD 22,5 mg 22.5mg ASTELLAS PHARMA EUROPE B.V.

11.25mgL02AE02 LEUPRORELINUM LIOF.+ SOLV. PT. SUSP. INJ. ELIB. PREL.ELIGARD 22,5 mg 22.5mg ASTELLAS PHARMA EUROPE B.V.

11.25mgL02AE02 LEUPRORELINUM LIOF.+ SOLV. PT. SUSP. INJ. ELIB. PREL.ELIGARD 7,5 mg 7.5mg ASTELLAS PHARMA EUROPE B.V.

L02AE02 LEUPRORELINUM LIOF.+ SOLV. PT. SUSP. INJ. ELIB. PREL.LUCRIN DEPOT 3,75mg 3.75mg ABBOTT LABORATORIES

106 153/

Page 107: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

762 GOSERELINUM **L02AE03

3.6mgL02AE03 GOSERELINUM IMPLANTZOLADEX® 3.6mg ASTRAZENECA UK LTD.

Cancer de prostata hormonodependent avansat local (echivalent stadiului T3 – T4) sau metastatic (echivalent stadiului M1).Prescriere limitata:

Cancer de sân hormonodependent avansat local (echivalent cu stadiul III) sau metastatic (echivalent cu stadiul IV) la femei în premenopauză.Prescriere limitata:

763 TRIPTORELINUM **L02AE04

Prescriere limitata: Cancer de prostata hormonodependent avansat local (echivalent stadiului T3 – T4) sau metastatic (echivalent stadiului M1).

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

0.1mgL02AE04 TRIPTORELINUM LIOF. + SOLV. PT. SOL. INJ.DIPHERELINE 0,1 mg 0.1mg BEAUFOUR IPSEN PHARMA

11.25mgL02AE04 TRIPTORELINUM LIOF.+ SOLV. PT. SUSP. INJ. I.M. ELIB. PREL.DIPHERELINE® 11,25 mg 11.25mg BEAUFOUR IPSEN PHARMA

3.75mgL02AE04 TRIPTORELINUM LIOF.+ SOLV. PT. SUSP. INJ. I.M. ELIB. PREL.DIPHERELINE® 3,75 mg 3.75mg BEAUFOUR IPSEN PHARMA

764 TAMOXIFENUM L02BA01

10mgL02BA01 TAMOXIFENUM COMPR.TAMONEPRIN® 10 mg 10mg ACTAVIS S.R.L.

TAMOXIFEN 10 TEVA 10mg PHARMACHEMIE BV

10mgL02BA01 TAMOXIFENUM COMPR. FILM.TAMOXIFEN® 10 HEXAL 10mg HEXAL AG

765 FULVESTRANTUM ** Protocol: L003CL02BA03

250mg/5mlL02BA03 FULVESTRANTUM SOL. INJ.FASLODEX 250mg/5ml 250mg/5ml ASTRAZENECA UK LTD.

766 FLUTAMIDUML02BB01

250mgL02BB01 FLUTAMIDUM COMPR.FLUTAN 250mg MEDOCHEMIE LTD.

FLUTASIN® 250 mg 250mg ACTAVIS S.R.L.

767 BICALUTAMIDUML02BB03

150mgL02BB03 BICALUTAMIDUM COMPR. FILM.CASODEX 150 mg 150mg ASTRAZENECA UK LTD.

50mgL02BB03 BICALUTAMIDUM COMPR. FILM.CALUMID 50mg GEDEON RICHTER PLC.

CASODEX 50 mg 50mg ASTRAZENECA UK LTD.

768 AMINOGLUTETHIMIDUML02BG01

250mgL02BG01 AMINOGLUTETHIMIDUM COMPR.ROGLUTEN® 250 mg 250mg ACTAVIS S.R.L.

769 ANASTROZOLUML02BG03

1mgL02BG03 ANASTROZOLUM COMPR. FILM.ARIMIDEX 1mg ACTAVIS S.R.L.

ARIMIDEX 1 mg 1mg ASTRAZENECA UK LTD.

770 LETROZOLUML02BG04

2.5mgL02BG04 LETROZOLUM COMPR. FILM.FEMARA 2,5 mg 2.5mg NOVARTIS PHARMA GMBH

771 EXEMESTANUML02BG06

25mgL02BG06 EXEMESTANUM DRAJ.AROMASIN 25 mg 25mg PFIZER EUROPE MA EEIG

772 FILGRASTIMUM (G-CSF) **L03AA02

Prescriere limitata: Reducerea duratei neutropeniei şi a incidenţei neutropeniei febrile la pacienţii trataţi cu chimioterapie citotoxică standard pentru bolile maligne (cu excepţia leucemiei

mieloide cronice şi a sindroamelor mielodisplazice), precum şi pentru reducerea duratei neutropeniei la pacienţii care primesc terapie mieloablativă urmată de

transplant de măduvă osoasă.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

30MU/0.5mlL03AA02 FILGRASTIMUM (G-CSF) SOL. INJ.NEUPOGEN® 30MU/0.5ml AMGEN EUROPE B.V.

48MU/0.5mlL03AA02 FILGRASTIMUM (G-CSF) SOL. INJ.NEUPOGEN® 48MU/0.5ml AMGEN EUROPE B.V.

773 PEGFILGRASTIMUM ***L03AA13

Prescriere limitata: Reducerea duratei neutropeniei şi a incidenţei neutropeniei febrile la pacienţii trataţi cu chimioterapie citotoxică standard pentru bolile maligne (cu excepţia leucemiei

mieloide cronice şi a sindroamelor mielodisplazice).

Pentru indicatia mai sus mentionata, o doză de 6 mg (o singură seringă preumplută) de Pegfilgrastimum este recomandată pentru fiecare ciclu de chimioterapie, administrată ca

injecţie subcutanată la aproximativ 24 de ore după chimioterapia citotoxică.

NOTA:

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

6mgL03AA13 PEGFILGRASTIMUM SOL. INJ.NEULASTA 6mg 6mg AMGEN EUROPE B.V.

774 INTERFERONUM ALFA 2a *** Protocol: L050CL03AB04

Tratamentul cu interferon alfa a fost asociat cu depresie şi suicid la unii pacienţi. Pacienţii cu istoric de ideaţie suicidară sau boală depresivă trebuie avertizaţi de riscuri. Trebuie

monitorizat statusul psihiatric în timpul tratamentului.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

18Mui/0.6mlL03AB04 INTERFERONUM ALFA 2a SOL. INJ.ROFERON A 18Mui/0.6ml ROCHE ROMANIA S.R.L.

3Mui/0.5mlL03AB04 INTERFERONUM ALFA 2a SOL. INJ.ROFERON A 3Mui/0.5ml ROCHE ROMANIA S.R.L.

4.5Mui/0.5mlL03AB04 INTERFERONUM ALFA 2a SOL. INJ.ROFERON A 4.5Mui/0.5ml ROCHE ROMANIA S.R.L.

9Mui/0.5mlL03AB04 INTERFERONUM ALFA 2a SOL. INJ.ROFERON A 9Mui/0.5ml ROCHE ROMANIA S.R.L.

775 INTERFERONUM ALFA 2b *** Protocol: L016CL03AB05

107 153/

Page 108: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

Tratamentul cu interferon alfa a fost asociat cu depresie şi suicid la unii pacienţi. Pacienţii cu istoric de ideaţie suicidară sau boală depresivă trebuie avertizaţi de riscuri. Trebuie

monitorizat statusul psihiatric în timpul tratamentului.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

18 milioane U.I.L03AB05 INTERFERONUM ALFA 2b SOL. INJ. PEN MULTIDOZAINTRON A 18 milioane U.I. 18 milioane U.I. SP EUROPE

30 milioane U.I.L03AB05 INTERFERONUM ALFA 2b SOL. INJ. PEN MULTIDOZAINTRON A 30 milioane U.I. 30 milioane U.I. SP EUROPE

INTRON A 60 milioane U.I. 60 milioane U.I. SP EUROPE

60 milioane U.I.L03AB05 INTERFERONUM ALFA 2b SOL. INJ. PEN MULTIDOZAINTRON A 30 milioane U.I. 30 milioane U.I. SP EUROPE

INTRON A 60 milioane U.I. 60 milioane U.I. SP EUROPE

777 ACIDUM CLODRONICUM **M05BA02

400mgM05BA02 ACIDUM CLODRONICUM CAPS.BONEFOS® 400 mg 400mg SCHERING OY (SCHERING AG)

SINDRONAT® 400 mg 400mg ACTAVIS S.R.L.

Metastaze osoase consecutive cancerului de san.Prescriere limitata:

Tratament de întreţinere in hipercalcemia din cancerele refractare la terapia antineoplazicaPrescriere limitata:

Mielomul multipluPrescriere limitata:

60mg/mlM05BA02 ACIDUM CLODRONICUM CONC. PT. SOL. PERF.BONEFOS® 60 mg/ml 60mg/ml SCHERING OY

Tratamentul hipercalcemiei asociata canceruluiPrescriere limitata:

800mgM05BA02 ACIDUM CLODRONICUM COMPR. FILM.BONEFOS® 800 mg 800mg SCHERING OY

Metastaze osoase consecutive cancerului de san.Prescriere limitata:

Tratament de întreţinere in hipercalcemia din cancerele refractare la terapia antineoplazicaPrescriere limitata:

Mielomul multipluPrescriere limitata:

778 ACIDUM PAMIDRONICUM **M05BA03

Prescriere limitata: Metastaze osoase consecutive cancerului de san.

Tratament de întreţinere in hipercalcemia din cancerele refractare la terapia antineoplazica.

Mielomul multiplu.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

15mgM05BA03 ACIDUM PAMIDRONICUM LIOF.+ SOLV. PT. SOL. PERF.AREDIA® 15 mg 15mg NOVARTIS PHARMA GMBH

15mg/mlM05BA03 ACIDUM PAMIDRONICUM CONC. PT. SOL. PERF.PAMIDRONAT TORREX 15mg/ml TORREX CHIESI PHARMA GMBH

30mgM05BA03 ACIDUM PAMIDRONICUM LIOF. PT. SOL. PERF. I.V.PAMIRED 30 30mg DR. REDDY'S LABORATORIES

60mgM05BA03 ACIDUM PAMIDRONICUM LIOF. PT. SOL. PERF. I.V.PAMIRED 60 60mg DR. REDDY'S LABORATORIES

779 ACIDUM IBANDRONICUM **M05BA06

50mgM05BA06 ACIDUM IBANDRONICUM COMPR. FILM.BONDRONAT 50mg 50mg ROCHE REGISTRATION LTD.

Preventia afectarii osoase (fracturi patologice, complicatii osoase care necesita radioterapie sau interventii chirurgicale) la pacientii cu cancer de san si metastaze

osoase.

Prescriere limitata:

6mg/6mlM05BA06 ACIDUM IBANDRONICUM CONC. PT. SOL. PERF.BONDRONAT 6mg/6ml 6mg/6ml ROCHE REGISTRATION LTD.

Preventia afectarii osoase (fracturi patologice, complicatii osoase care necesita radioterapie sau interventii chirurgicale) la pacientii cu cancer de san si metastaze

osoase.

Prescriere limitata:

Tratamentul hipercalcemiei induse de tumora cu sau fara metastaze osoase.Prescriere limitata:

3mg/3mlM05BA06 ACIDUM IBANDRONICUM SOL. INJ. IN SERINGA PREUMPLUTABONVIVA 3mg/3ml 3mg/3ml ROCHE REGISTRATION LTD

780 ACIDUM ZOLEDRONICUM **M05BA08

Prescriere limitata: Prevenirea manifestărilor osoase (fracturi patologice, compresie spinală, iradiere sau chirurgie osoasă sau hipercalcemie indusă de tumori) la pacienţi cu tumori

maligne avansate, cu implicare osoasă.

Tratamentul hipercalcemiei induse de tumori.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

4mgM05BA08 ACIDUM ZOLEDRONICUM PULB. + SOLV. SOL. PERF.ZOMETA 4 mg 4mg NOVARTIS EUROPHARM LTD.

5mg/100mlM05BA08 ACIDUM ZOLEDRONICUM SOL. PERF.ACLASTA 5mg/100ml 5mg/100ml NOVARTIS EUROPHARM LTD.

781 MESNUMV03AF01

400mg/4mlV03AF01 MESNUM SOL. INJ.UROMITEXAN® 400 mg 400mg/4ml BAXTER ONCOLOGY GMBH

782 CALCII FOLINASV03AF03

10mg/mlV03AF03 CALCII FOLINAS SOL. INJ.FOLCASIN 10 mg/ml 10mg/ml ACTAVIS S.R.L.

FOLCASIN® 100 mg/10 ml 10mg/ml ACTAVIS S.R.L.

LEUCOVORIN-TEVA 100 mg/10 ml 10mg/ml TEVA PHARM. IND. LTD.

LEUCOVORIN-TEVA 50 mg/5 ml 10mg/ml TEVA PHARMACEUTICALS S.R.L.

10mg/mlV03AF03 CALCII FOLINAS SOL. INJ.FOLCASIN 10 mg/ml 10mg/ml ACTAVIS S.R.L.

FOLCASIN® 100 mg/10 ml 10mg/ml ACTAVIS S.R.L.

LEUCOVORIN-TEVA 100 mg/10 ml 10mg/ml TEVA PHARM. IND. LTD.

LEUCOVORIN-TEVA 50 mg/5 ml 10mg/ml TEVA PHARMACEUTICALS S.R.L.

10mg/mlV03AF03 CALCII FOLINAS SOL. INJ./PERF.CALCIUMFOLINAT "EBEWE" 10 mg/ml 10mg/ml EBEWE PHARMA GMBH NFG. KG

15mgV03AF03 CALCII FOLINAS CAPS.CALCIUM FOLINAT "EBEWE" 15 mg 15mg EBEWE PHARMA GES.M.B.H. NFG KG

3mg/mlV03AF03 CALCII FOLINAS SOL. INJ.FOLCASIN® 30 mg/10 ml 3mg/ml ACTAVIS S.R.L.

108 153/

Page 109: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

783 AMIFOSTINUM **V03AF05

375mgV03AF05 AMIFOSTINUM LIOF. PT. SOL. PERF.ETHYOL 375mg SCHERING PLOUGH EUROPE

500mgV03AF05 AMIFOSTINUM LIOF. PT. SOL. PERF.ETHYOL® 500mg SCHERING PLOUGH EUROPE

Protocol: L002GSUBLISTA C2-P4: PROGRAMUL NATIONAL DE BOLI NEUROLOGICE. SUBPROGRAMUL DE TRATAMENT AL SCLEROZEI

MULTIPLE

784 INTERFERONUM BETA 1a ****L03AB07

22µg/0,5mlL03AB07 INTERFERONUM BETA 1a SOL. INJ.REBIF 22 micrograme 22µg/0,5ml SERONO EUROPE LTD.

30µg (6 mil. UI)L03AB07 INTERFERONUM BETA 1a PULB. + SOLV. PT. SOL. INJ.AVONEX 30 µg BIO-SET 30µg (6 mil. UI) BIOGEN IDEC LIMITED

44µgL03AB07 INTERFERONUM BETA 1a SOL. INJ.REBIF 44 micrograme 44µg SERONO EUROPE LTD.

785 INTERFERONUM BETA 1B ****L03AB08

250µg/mlL03AB08 INTERFERONUM BETA 1B PULB. + SOLV. PT. SOL. INJ.BETAFERON 250µg/ml 250µg/ml BAYER SCHERING AG

786 GLATIRAMER ACETAT ****L03AX13

20mg/mlL03AX13 GLATIRAMER ACETAT SOL. INJ.COPAXONE 20mg/ml TEVA PHARMACEUTICALS S.R.L.

787 NATALIZUMABUM ****L04AA23

20mg/mlL04AA23 NATALIZUMABUM CONC. PT. SOL. PERF.TYSABRI 300mg 20mg/ml ELAN PHARMA INTERNATIONAL LTD

A fost raportat la acest medicament leucoencefalopatie multifocala progresiva.

788 AZATHIOPRINUM *L04AX01

50mgL04AX01 AZATHIOPRINUM COMPR. FILM.IMURAN® 50mg THE WELLCOME FOUNDATION LTD.

109 153/

Page 110: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

Protocol: AE01ESUBLISTA C2-P5: PROGRAMUL NATIONAL DE DIABET ZAHARAT.

789 INSULINE UMANEA10AB01

100UI/mlA10AB01 INSULINE UMANE SOL. INJ.HUMULIN R 100UI/ml LILLY FRANCE SAS

100UI/mlA10AB01 INSULINE UMANE SOL. INJ.HUMULIN R 100UI/ml LILLY FRANCE SAS

100UI/mlA10AB01 INSULINE UMANE SOL. INJ. IN CARTUSACTRAPID PENFILL 100 UI/ml 100UI/ml NOVO NORDISK A/S

INSUMAN RAPID 100UI/ml 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH

100UI/mlA10AB01 INSULINE UMANE SOL. INJ. IN FLACONACTRAPID 100 UI/ml 100UI/ml NOVO NORDISK A/S

INSUMAN RAPID 100UI/ml 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH

100UI/mlA10AB01 INSULINE UMANE SOL. INJ. IN FLACONACTRAPID 100 UI/ml 100UI/ml NOVO NORDISK A/S

INSUMAN RAPID 100UI/ml 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH

100UI/mlA10AB01 INSULINE UMANE SOL. INJ. IN STILOU INJECTOR PREUMPLUTACTRAPID NOVOLET 100 UI/ml 100UI/ml NOVO NORDISK A/S

INSUMAN RAPID 100 UI/ml OPTISET 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH

790 INSULINUM LISPRO **A10AB04

100U/mlA10AB04 INSULINUM LISPRO SOL. INJ.HUMALOG 100 U/ml 100U/ml ELI LILLY NEDERLAND BV

791 INSULINUM ASPART ** Protocol: A016EA10AB05

100UmlA10AB05 INSULINUM ASPART SOL. INJ. IN CARTUSNOVORAPID PENFILL 100 U/ml 100Uml NOVO NORDISK A/S

792 INSULINUM GLULIZINA **A10AB06

100U/mlA10AB06 INSULINUM GLULIZINA SOL. INJ. IN CARTUSAPIDRA 100U/ml 100U/ml SANOFI - AVENTIS DEUTSCHLAND GMBH

100U/mlA10AB06 INSULINUM GLULIZINA SOL. INJ. IN FLACONAPIDRA 100U/ml 100U/ml SANOFI - AVENTIS DEUTSCHLAND GMBH

100U/mlA10AB06 INSULINUM GLULIZINA SOL. INJ. IN STILOU INJECTOR PREUMPLUTAPIDRA 100U/ml 100U/ml SANOFI - AVENTIS DEUTSCHLAND GMBH

793 INSULINE UMANEA10AC01

100UI/mlA10AC01 INSULINE UMANE SUSP. INJ.HUMULIN N 100UI/ml LILLY FRANCE SAS

100UI/mlA10AC01 INSULINE UMANE SUSP. INJ. IN STILOU INJECTOR PREUMPLUTINSULATARD NOVOLET 100 UI/ml 100UI/ml NOVO NORDISK A/S

INSUMAN BASAL 100UI/ml OPTISET 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH

100UI/mlA10AC01 INSULINE UMANE SUSP. INJ. IN CARTUSINSULATARD PENFILL 100 UI/ml 100UI/ml NOVO NORDISK A/S

INSUMAN BASAL 100UI/ml 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH

100UI/mlA10AC01 INSULINE UMANE SUSP. INJ. IN FLACONINSULATARD 100 UI/ml 100UI/ml NOVO NORDISK A/S

INSUMAN BASAL 100UI/ml 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH

100UI/mlA10AC01 INSULINE UMANE SUSP. INJ. IN FLACONINSULATARD 100 UI/ml 100UI/ml NOVO NORDISK A/S

INSUMAN BASAL 100UI/ml 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH

794 INSULINUM LISPRO ** Protocol: A029EA10AC04

100U/mlA10AC04 INSULINUM LISPRO SOL. INJ.HUMALOG NPL 100 U/ml 100U/ml ELI LILLY NEDERLAND BV

795 INSULINE UMANEA10AD01

A10AD01 INSULINE UMANE SUSP. INJ.HUMULIN M3 100ui/ml LILLY FRANCE S.A.S

100UI/mlA10AD01 INSULINE UMANE SUSP. INJ. IN STILOU INJECTOR PREUMPLUTINSUMAN COMB 25 100UI/ml OPTISET 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH

INSUMAN COMB 50 100UI/ml OPTISET 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH

MIXTARD 30 NOVOLET 100 UI/ml 100UI/ml NOVO NORDISK A/S

100UI/mlA10AD01 INSULINE UMANE SUSP. INJ. IN CARTUSINSUMAN COMB 25 100UI/ml 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH

INSUMAN COMB 50 100UI/ml 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH

MIXTARD 20 PENFILL 100 UI/ml 100UI/ml NOVO NORDISK A/S

MIXTARD 30 PENFILL 100 UI/ml 100UI/ml NOVO NORDISK A/S

MIXTARD 40 PENFILL 100 UI/ml 100UI/ml NOVO NORDISK A/S

100UI/mlA10AD01 INSULINE UMANE SUSP. INJ. IN FLACONINSUMAN COMB 25 100UI/ml 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH

INSUMAN COMB 50 100UI/ml 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH

MIXTARD 30 100UI/ml 100UI/ml NOVO NORDISK A/S

100UI/mlA10AD01 INSULINE UMANE SUSP. INJ. IN FLACONINSUMAN COMB 25 100UI/ml 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH

INSUMAN COMB 50 100UI/ml 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH

MIXTARD 30 100UI/ml 100UI/ml NOVO NORDISK A/S

796 INSULINUM LISPRO ** Protocol: A015EA10AD04

100U/mlA10AD04 INSULINUM LISPRO SUSP. INJ.HUMALOG MIX25 100U/ml ELI LILLY NEDERLAND BV

HUMALOG MIX50 100U/ml ELI LILLY NEDERLAND BV

797 INSULINUM ASPART ** Protocol: A018EA10AD05

100UImlA10AD05 INSULINUM ASPART SUSP. INJ. IN STILOU INJECTOR PREUMPLUTNOVOMIX 30 FLEXPEN 100UIml NOVO NORDISK A/S

798 INSULINUM GLARGINE ** Protocol: A024EA10AE04

100UI/mlA10AE04 INSULINUM GLARGINE SOL. INJ. IN CARTUSLANTUS 100UI/ml 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH

110 153/

Page 111: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

100UI/mlA10AE04 INSULINUM GLARGINE SOL. INJ. IN FLACONLANTUS 100UI/ml 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH

100UI/mlA10AE04 INSULINUM GLARGINE SOL. INJ. IN STILOU INJECTOR PREUMPLUTLANTUS OptiSet 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH

LANTUS SoloStar 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH

799 INSULINUM DETEMIR ** Protocol: A023EA10AE05

100U/mlA10AE05 INSULINUM DETEMIR SOL. INJ. IN CARTUSLEVEMIR PENFILL 100 U/ml 100U/ml NOVO NORDISK A/S

100U/mlA10AE05 INSULINUM DETEMIR SOL. INJ. IN STILOU INJECTOR PREUMPLUTLEVEMIR FLEXPEN 100 U/ml 100U/ml NOVO NORDISK A/S

800 METFORMINUMA10BA02

1000mgA10BA02 METFORMINUM COMPR.METFORMIN 1000 mg 1000mg ARENA GROUP S.A.

1000mgA10BA02 METFORMINUM COMPR. FILM.GLUCOPHAGE 1000 mg 1000mg MERCK SANTE

METFOGAMMA 1000mg 1000mg WORWAG PHARMA GMBH & CO. KG

SIOFOR 1000 1000mg BERLIN CHEMIE AG MENARINI GROUP

1000mgA10BA02 METFORMINUM COMPR. PT. SOL. ORALAFORMIRAN 1000 mg 1000mg TERAPIA S.A.

500mgA10BA02 METFORMINUM COMPR.DIGUAN® 500 mg 500mg ZENTIVA S.A.

METFORMIN 500 mg 500mg ARENA GROUP SA

500mgA10BA02 METFORMINUM COMPR. ELIB. PREL.GLUCOPHAGE XR 500mg MERCK SANTE S.A.S.

500mgA10BA02 METFORMINUM COMPR. FILM.DIPIMET 500 mg 500mg ANTIBIOTICE SA

GLUCOPHAGE 500 500mg MERCK SANTE

MEGUAN® 500 mg 500mg GEDEON RICHTER ROMANIA SA

METFOGAMMA® 500 500mg WORWAG PHARMA GMBH & CO. KG

METFORMIN AL 500 500mg ALIUD PHARMA GMBH & CO.KG

METFORMIN LPH® 500 mg 500mg LABORMED PHARMA SA

METFORMIN-TEVA 500 mg 500mg TEVA PHARMACEUTICAL S.R.L.

500mgA10BA02 METFORMINUM COMPR. PT. SOL. ORALAFORMIRAN 500 mg 500mg TERAPIA S.A.

850mgA10BA02 METFORMINUM COMPR.DIAFORMIN® 850 mg 850mg TERAPIA SA

METFORMIN 850 mg 850mg ARENA GROUP SA

850mgA10BA02 METFORMINUM COMPR. FILM.GLUCOPHAGE 850 mg 850mg MERCK SANTE

MEDIFOR 850 850mg STD CHEMICALS LTD.

MEGUAN® 850 mg 850mg GEDEON RICHTER ROMANIA SA

METFOGAMMA 850 850mg WORWAG PHARMA GMBH & CO. KG

METFORMIN AL 850 850mg ALIUD PHARMA GMBH & CO.KG

METFORMIN LPH® 850 mg 850mg LABORMED PHARMA SA

METFORMIN-TEVA 850 mg 850mg TEVA PHARMACEUTICAL S.R.L.

SIOFOR® 850 850mg BERLIN CHEMIE AG MENARINI GROUP

850mgA10BA02 METFORMINUM COMPR. PT. SOL. ORALAFORMIRAN 850 mg 850mg TERAPIA S.A.

801 BUFORMINUMA10BA03

100mgA10BA03 BUFORMINUM DRAJ. RET.SILUBIN RETARD 100mg DITA IMPORT EXPORT SRL

802 GLIBENCLAMIDUMA10BB01

1,75 mgA10BB01 GLIBENCLAMIDUM COMPR.GLIBENCLAMID ANTIBIOTICE 1,75 mg 1,75 mg ANTIBIOTICE S.A.

1.75mgA10BB01 GLIBENCLAMIDUM COMPR.GLIBENCLAMID LPH 1,75 mg 1.75mg LABORMED PHARMA SA

GLIBENCLAMID ARENA 1,75 mg 1.75mg ARENA GROUP SA

MANINIL 1,75 mg 1.75mg BERLIN CHEMIE AG MENARINI GROUP

3,5mgA10BB01 GLIBENCLAMIDUM COMPR.GLIBENCLAMID ANTIBIOTICE 3,5 mg 3,5mg ANTIBIOTICE S.A.

3.5mgA10BB01 GLIBENCLAMIDUM COMPR.GLIBENCLAMID ARENA 3,5 mg 3.5mg ARENA GROUP SA

GLIBENCLAMID LPH 3,5 mg 3.5mg LABORMED PHARMA SA

MANINIL 3,5 mg 3.5mg BERLIN CHEMIE AG MENARINI GROUP

5mgA10BB01 GLIBENCLAMIDUM COMPR.GLIBENCLAMID 5 mg 5mg ARENA GROUP SA

803 TOLBUTAMIDUMA10BB03

500mgA10BB03 TOLBUTAMIDUM COMPR.TOLBUTAMID 500mg SINTOFARM SA

804 GLIPIZIDUMA10BB07Sulfonilurea poate cauza hipoglicemie, in mod particular la vârstnici.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

10mgA10BB07 GLIPIZIDUM COMPR. FILM. ELIB. MODIF.GLUCOTROL XL 10 mg 10mg PFIZER EUROPE MA EEIG

5mgA10BB07 GLIPIZIDUM COMPR.GLIPIZID LPH 5 mg 5mg LABORMED PHARMA SA

5mgA10BB07 GLIPIZIDUM COMPR. FILM. ELIB. MODIF.GLUCOTROL XL 5mg 5mg PFIZER EUROPE MA EEIG

805 GLIQUIDONUMA10BB08Sulfonilurea poate cauza hipoglicemie, in mod particular la vârstnici.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

111 153/

Page 112: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

30mgA10BB08 GLIQUIDONUM COMPR.GLURENORM 30mg BOEHRINGER INGELHEIM INT. GMBH

806 GLICLAZIDUMA10BB09Sulfonilurea poate cauza hipoglicemie, in mod particular la vârstnici

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

30mgA10BB09 GLICLAZIDUM COMPR. ELIB. MODIF.DIAPREL MR 30mg LES LABORATOIRES SERVIER

30mgA10BB09 GLICLAZIDUM COMPR. ELIB. PREL.GLICLAZID MR LPH 30 mg 30mg LABORMED PHARMA SA

80mgA10BB09 GLICLAZIDUM COMPR.DIABREZIDE 80mg L. MOLTENI

ESQUEL® 80 mg 80mg GEDEON RICHTER ROMANIA SA

GLICLAZID LPH 80mg LABORMED PHARMA SA

GLIDIET 80mg MEDICAROM GROUP S.R.L.

80mgA10BB09 GLICLAZIDUM COMPR. DIVIZ.DIAPREL 80mg LES LABORATOIRES SERVIER

807 GLIMEPIRIDUMA10BB12Sulfonilurea poate cauza hipoglicemie, in mod particular la vârstnici

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

1 mgA10BB12 GLIMEPIRIDUM COMPR.AMYX 1 1 mg ZENTIVA A.S.

1mgA10BB12 GLIMEPIRIDUM COMPR.AMARYL 1mg 1mg AVENTIS PHARMA DEUTSCHLAND

GLEMPID 1 mg 1mg EGIS PHARMACEUTICALS P.L.C.

GLIME TAD 1 mg 1mg TAD PHARMA GMBH

GLIMEPIRID LPH 1 mg 1mg LABORMED PHARMA SA

GLIMERAN 1 mg 1mg RANBAXY UK LIMITED

GLIPREX 1 mg 1mg MEDICO UNO PHARMACEUTICAL SRL

MEGLIMID 1 mg 1mg KRKA D.D.

OLTAR 1 mg 1mg BERLIN CHEMIE AG (MENARINI GROUP)

TINERIL 1 mg 1mg GEDEON RICHTER ROMANIA S.A.

2mgA10BB12 GLIMEPIRIDUM COMPR.AMARYL 2 mg 2mg AVENTIS PHARMA DEUTSCHLAND

AMYX 2 2mg ZENTIVA A.S.

DIBIGLIM 2 mg 2mg SANDOZ SRL

GLEMPID 2 mg 2mg EGIS PHARMACEUTICALS P.L.C.

GLIME TAD 2 mg 2mg TAD PHARMA GMBH

GLIMEPIRID LPH 2 mg 2mg LABORMED PHARMA SA

GLIMEPIRIDE 2 mg 2mg ACTAVIS GROUP HF.

GLIMERAN 2 mg 2mg RANBAXY UK LIMITED

GLIPREX 2 mg 2mg MEDICO UNO PHARMACEUTICAL SRL

MEGLIMID 2 mg 2mg KRKA D.D.

TINERIL 2 mg 2mg GEDEON RICHTER ROMANIA S.A.

3mgA10BB12 GLIMEPIRIDUM COMPR.AMARYL 3 mg 3mg AVENTIS PHARMA DEUTSCHLAND

AMYX 3 3mg ZENTIVA A.S.

DIBIGLIM 3 mg 3mg SANDOZ SRL

GLEMPID 3 mg 3mg EGIS PHARMACEUTICALS P.L.C.

GLIME TAD 3 mg 3mg TAD PHARMA GMBH

GLIMEPIRID LPH 3 mg 3mg LABORMED PHARMA SA

GLIMEPIRIDE 3 mg 3mg ACTAVIS GROUP HF.

GLIMERAN 3 mg 3mg RANBAXY UK LIMITED

GLIPREX 3 mg 3mg MEDICO UNO PHARMACEUTICAL SRL

MEGLIMID 3 mg 3mg KRKA D.D.

OLTAR 3 mg 3mg BERLIN CHEMIE AG (MENARINI GROUP)

TINERIL 3 mg 3mg GEDEON RICHTER ROMANIA S.A.

4mgA10BB12 GLIMEPIRIDUM COMPR.AMYX 4 4mg ZENTIVA A.S.

GLEMPID 4 mg 4mg EGIS PHARMACEUTICALS P.L.C.

GLIMERAN 4 mg 4mg RANBAXY UK LIMITED

GLIPREX 4 mg 4mg MEDICO UNO PHARMACEUTICAL SRL

MEGLIMID 4 mg 4mg KRKA D.D.

6mgA10BB12 GLIMEPIRIDUM COMPR.MEGLIMID 6 mg 6mg KRKA D.D.

4mgA10BB12 GLIMEPIRIDUM COMPRTINERIL 4 mg 4mg GEDEON RICHTER ROMANIA S.A.

808 COMBINATII(GLIBENCLAMIDUM+METFORMINUM) Protocol: A027EA10BD02Sulfonilurea poate cauza hipoglicemie, in mod particular la vârstnici

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

2,5mg/400mgA10BD02 COMBINATII(GLIBENCLAMIDUM+METFORMIN

UM)

COMPR. FILM.

GLIBOMET® 2,5mg/400mg LAB. GUIDOTTI SPA

400mg + 2.5mgA10BD02 COMBINATII(GLIBENCLAMIDUM+METFORMIN

UM)

COMPR. FILM.

GLIFORMIN 400mg + 2.5mg LABORMED PHARMA SA

400mg+2.5mgA10BD02 COMBINATII(GLIBENCLAMIDUM+METFORMIN

UM)

CAPS.

BIDIAB 400mg+2.5mg ARENA GROUP SA

500mg/2.5mgA10BD02 COMBINATII(GLIBENCLAMIDUM+METFORMIN

UM)

COMPR. FILM.

GLUCOVANCE® 500 mg/2,5 mg 500mg/2.5mg MERCK SANTE

500mg/5mgA10BD02 COMBINATII(GLIBENCLAMIDUM+METFORMIN

UM)

COMPR. FILM.

112 153/

Page 113: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

GLUCOVANCE® 500 mg/5 mg 500mg/5mg MERCK SANTE

809 COMBINATII(ROSIGLITAZONUM+METFORMINUM) *** Protocol: A026EA10BD03

1mg/500mgA10BD03 COMBINATII(ROSIGLITAZONUM+METFORMIN

UM)

COMPR. FILM.

AVANDAMET 1mg/500mg 1mg/500mg SMITHKLINE BEECHAM PLC

2mg/1000mgA10BD03 COMBINATII(ROSIGLITAZONUM+METFORMIN

UM)

COMPR. FILM.

AVANDAMET 2mg/1000mg 2mg/1000mg SMITHKLINE BEECHAM PLC

2mg/500mgA10BD03 COMBINATII(ROSIGLITAZONUM+METFORMIN

UM)

COMPR. FILM.

AVANDAMET 2mg/500mg 2mg/500mg SMITHKLINE BEECHAM PLC

4mg/1000mgA10BD03 COMBINATII(ROSIGLITAZONUM+METFORMIN

UM)

COMPR. FILM.

AVANDAMET 4mg/1000mg 4mg/1000mg SMITHKLINE BEECHAM PLC

810 COMBINATII (ROSIGLITAZONUM + GLIMEPIRIDUM) *** Protocol: A027EA10BD04

4mg/4mgA10BD04 COMBINATII (ROSIGLITAZONUM +

GLIMEPIRIDUM)

COMPR. FILM.

AVAGLIM 4mg/4mg 4mg/4mg SMITHKLINE BEECHAM PLC

8mg/4mgA10BD04 COMBINATII (ROSIGLITAZONUM +

GLIMEPIRIDUM)

COMPR. FILM.

AVAGLIM 8mg/4mg 8mg/4mg SMITHKLINE BEECHAM PLC

811 COMBINATII (PIOGLITAZONUM + METFORMINUM) *** Protocol: A025EA10BD05

15mg/850mgA10BD05 COMBINATII (PIOGLITAZONUM +

METFORMINUM)

COMPR. FILM.

COMPETACT 15mg/850mg TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTRE LTD

812 ACARBOSUMA10BF01

100mgA10BF01 ACARBOSUM COMPR.GLUCOBAY® 100 100mg BAYER HEALTHCARE AG

50mgA10BF01 ACARBOSUM COMPR.GLUCOBAY® 50 50mg BAYER HEALTHCARE AG

813 ROSIGLITAZONUM *** Protocol: A020EA10BG02

4mgA10BG02 ROSIGLITAZONUM COMPR. FILM.AVANDIA 4mg 4mg SMITHKLINE BEECHAM PLC

814 PIOGLITAZONUM *** Protocol: A020EA10BG03

15mgA10BG03 PIOGLITAZONUM COMPR.ACTOS 15mg 15mg TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTRE LTD

30mgA10BG03 PIOGLITAZONUM COMPR.ACTOS 30mg 30mg TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTRE LTD

45mgA10BG03 PIOGLITAZONUM COMPR.ACTOS 45mg 45mg TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTRE LTD

815 SITAGLIPTINUM *** Protocol: A022EA10BH01

100mgA10BH01 SITAGLIPTINUM COMPR. FILM.JANUVIA 100mg 100mg MERCK SHARP & DOHME LTD.

816 REPAGLINIDUMA10BX02

0.5mgA10BX02 REPAGLINIDUM COMPR.NOVONORM 0,5 mg 0.5mg NOVO NORDISK A/S

1mgA10BX02 REPAGLINIDUM COMPR.NOVONORM 1 mg 1mg NOVO NORDISK A/S

2mgA10BX02 REPAGLINIDUM COMPR.NOVONORM 2 mg 2mg NOVO NORDISK A/S

817 EXENATIDUM *** Protocol: A028EA10BX04

10µg/dozaA10BX04 EXENATIDUM SOL. INJ. IN STILOU INJECTOR PREUMPLUTBYETTA 10µg/doza 10µg/doza ELI LILLY NEDERLAND BV

5µg/dozaA10BX04 EXENATIDUM SOL. INJ. IN STILOU INJECTOR PREUMPLUTBYETTA 5µg/doza 5µg/doza ELI LILLY NEDERLAND BV

818 BENFOTIAMINUMA11DA03

50mgA11DA03 BENFOTIAMINUM DRAJ.BENFOGAMMA 50mg WORWAG PHARMA GMBH & CO. KG

819 COMBINATII **A11DBN1

A11DBN1 COMBINATII CAPS. MOIMILGAMMA® N WORWAG PHARMA GMBH & CO. KG

A11DBN1 COMBINATII SOL. INJ.MILGAMMA® N WORWAG PHARMA GMBH & CO. KG

820 GLUCAGONUMH04AA01

1mgH04AA01 GLUCAGONUM PULB. + SOLV. PT. SOL. INJ.GLUCAGEN HYPOKIT 1 mg 1mg NOVO NORDISK A/S

113 153/

Page 114: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

SUBLISTA C2-P6: PROGRAMUL NATIONAL DE HEMOFILIE, TALASEMIE SI ALTE BOLI RARE. P6.1: HEMOFILIE SI TALASEMIE

827 DEFEROXAMINUM **(3) Protocol: V001DV03AC01

500mgV03AC01 DEFEROXAMINUM LIOF. PT. SOL. INJ./PERF.DESFERAL 500mg NOVARTIS PHARMA GMBH

828 DEFERASIROXUM **** Protocol: V002DV03AC03

125mgV03AC03 DEFERASIROXUM COMPR. DISP.EXJADE 125mg 125mg NOVARTIS EUROPHARM LTD.

250mgV03AC03 DEFERASIROXUM COMPR. DISP.EXJADE 250mg 250mg NOVARTIS EUROPHARM LTD.

500mgV03AC03 DEFERASIROXUM COMPR. DISP.EXJADE 500mg 500mg NOVARTIS EUROPHARM LTD.

SUBLISTA C2-P6: PROGRAMUL NATIONAL DE HEMOFILIE, TALASEMIE SI ALTE BOLI RARE. P6.2: EPIDERMOLIZA BULOASA

830 TETRACYCLINUMD06AA04

3,00%D06AA04 TETRACYCLINUM UNGUENTTETRACICLINA CLORHIDRAT 3% ANTIBIOTICE SA

831 ACIDUM FUSIDICUMD06AX01

2,00%D06AX01 ACIDUM FUSIDICUM CREMAFUCIDIN® 2% LEO PHARMACEUTICAL PRODUCTS

2,00%D06AX01 ACIDUM FUSIDICUM UNGUENTFUCIDIN® 2% LEO PHARMACEUTICAL PRODUCTS

832 SULFADIAZINUMD06BA01

1,00%D06BA01 SULFADIAZINUM CREMADERMAZIN® 1% 1% LEK PHARMACEUTICALS D.D.

833 COMBINATII (ACIDUM FUSIDICUM + HYDROCORTISONUM) Protocol: D001LD07CA01

D07CA01 COMBINATII (ACIDUM FUSIDICUM +

HYDROCORTISONUM)

CREMA

FUCIDIN® H LEO PHARMACEUTICAL PRODUCTS

834 COMBINATII Protocol: D001LD07CC01

D07CC01 COMBINATII CREMABELOGENT A & G MED TRADING S.R.L.

DIPROGENTA® SCHERING PLOUGH EUROPE

TRIDERM® SCHERING PLOUGH EUROPE

D07CC01 COMBINATII UNGUENTBELOGENT A & G MED TRADING S.R.L.

DIPROGENTA® SCHERING PLOUGH EUROPE

TRIDERM SCHERING PLOUGH EUROPE

836 TETRACYCLINUMJ01AA07

250mgJ01AA07 TETRACYCLINUM CAPS.TETRACICLINA 250 mg 250mg EUROPHARM SA

TETRACICLINA SANDOZ 250 mg 250mg SANDOZ SRL

838 PHENYTOINUMN03AB02

100mgN03AB02 PHENYTOINUM COMPR.FENITOIN 100 mg 100mg GEDEON RICHTER ROMANIA SA

50mg/mlN03AB02 PHENYTOINUM SOL. INJ.PHENHYDAN®SOLUTIE INJECTABILA 50mg/ml DESITIN

SUBLISTA C2-P6: PROGRAMUL NATIONAL DE HEMOFILIE, TALASEMIE SI ALTE BOLI RARE. P6.3: HIPERTENSIUNEA

PULMONARA

839 BOSENTANUM ** Protocol: CI01IC02KX01

125mgC02KX01 BOSENTANUM COMPR. FILM.TRACLEER 125 mg 125mg ACTELION REGISTRATION LTD.

Bosentanum este un medicament care nu trebuie administrat la gravide. Sarcina trebuie evitată timp de trei luni după întreruperea tratamentului.

840 SILDENAFILUM ** Protocol: CI01IG04BE03

20mgG04BE03 SILDENAFILUM COMPR. FILM.REVATIO 20 mg 20mg PFIZER LTD.

114 153/

Page 115: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

SUBLISTA C2-P6: PROGRAMUL NATIONAL DE HEMOFILIE, TALASEMIE SI ALTE BOLI RARE. P6.4: MUCOVISCIDOZA

841 CLARITHROMYCINUMJ01FA09

125mg/5mlJ01FA09 CLARITHROMYCINUM GRAN. PT. SUSP. ORALAFROMILID® 125 mg/5 ml 125mg/5ml KRKA D.D.

KLABAX 125 mg/5 ml 125mg/5ml TERAPIA S.A.

KLACID® 125mg/5ml ABBOTT SPA

LEKOKLAR 125 mg/5 ml 125mg/5ml SANDOZ S.R.L.

250mgJ01FA09 CLARITHROMYCINUM COMPR. FILM.CLAR 250 250mg MEDICAROM GROUP S.R.L.

CLARITROMICINA 250 mg 250mg OZONE LABORATORIES LTD.

FROMILID 250 250mg KRKA D.D. NOVO MESTO

KLABAX 250 mg 250mg TERAPIA S.A.

KLACID® 250mg ABBOTT SPA

KLERIMED® 250 250mg MEDOCHEMIE LTD.

LEKOKLAR® 250 mg 250mg LEK PHARMACEUTICALS D.D.

250mg/5mlJ01FA09 CLARITHROMYCINUM GRAN. PT. SUSP. ORALAKLABAX 250 mg/5 ml 250mg/5ml TERAPIA S.A.

LEKOKLAR 250 mg/5 ml 250mg/5ml SANDOZ SRL

500mgJ01FA09 CLARITHROMYCINUM COMPR. FILM.CLAR 500 500mg MEDICAROM GROUP S.R.L.

CLARITROMICINA 500 mg 500mg OZONE LABORATORIES LTD.

FROMILID 500 500mg KRKA D.D. NOVO MESTO

KLABAX 500 mg 500mg TERAPIA S.A.

KLERIMED® 500 500mg MEDOCHEMIE LTD.

LEKOKLAR® 500 mg 500mg LEK PHARMACEUTICALS D.D.

500mgJ01FA09 CLARITHROMYCINUM COMPR. FILM. ELIB. MODIF.KLABAX MR 500 mg 500mg TERAPIA S.A.

LEKOKLAR XL 500 mg 500mg LEK PHARMACEUTICALS D.D.

500mgJ01FA09 CLARITHROMYCINUM COMPR. FILM. ELIB. PREL.FROMILID® UNO 500mg KRKA D.D.

KLACID SR 500mg ABBOTT LABORATORIES LTD.

500mgJ01FA09 CLARITHROMYCINUM LIOF. PT. SOL. PERF.KLACID I.V. 500mg ABBOTT LABORATORIES LTD.

842 TOBRAMYCINUM **J01GB01

300mg/5mlJ01GB01 TOBRAMYCINUM SOL. INHAL.TOBI® 300mg/5ml NOVARTIS PHARMA GMBH

Infectii cu agent patogen sensibil confirmat pentru acest tip de antibiotic.Prescriere limitata:

843 DORNAZA ALFA **R05CB13

1mg/mlR05CB13 DORNAZA ALFA SOL. INHAL.PULMOZYME 1mg/ml ROCHE ROMANIA S.R.L.

SUBLISTA C2-P6: PROGRAMUL NATIONAL DE HEMOFILIE, TALASEMIE SI ALTE BOLI RARE. P6.5: BOLI NEUROLOGICE

DEGENERATIVE / INFLAMATORII (POLIRADICULONEVRITA PRIMITIVA, POLINEUROPATIE INFLAMATORIE CRONICA

DEMIELINIZANTA, SCLEROZA LATERALA AMIOTROFICA) SI MIASTENIA GRAVIS

844 RILUZOLUM ** Protocol: N024GN07XX02

50mgN07XX02 RILUZOLUM COMPR. FILM.RILUTEK 50 mg 50mg AVENTIS PHARMA SA

SUBLISTA C2-P6: PROGRAMUL NATIONAL DE HEMOFILIE, TALASEMIE SI ALTE BOLI RARE. P6.6: OSTEOGENEZA

IMPERFECTA

846 ACIDUM PAMIDRONICUM Protocol: M002QM05BA03

15mgM05BA03 ACIDUM PAMIDRONICUM LIOF.+ SOLV. PT. SOL. PERF.AREDIA® 15 mg 15mg NOVARTIS PHARMA GMBH

15mg/mlM05BA03 ACIDUM PAMIDRONICUM CONC. PT. SOL. PERF.PAMIDRONAT TORREX 15mg/ml TORREX CHIESI PHARMA GMBH

30mgM05BA03 ACIDUM PAMIDRONICUM LIOF. PT. SOL. PERF. I.V.PAMIRED 30 30mg DR. REDDY'S LABORATORIES

60mgM05BA03 ACIDUM PAMIDRONICUM LIOF. PT. SOL. PERF. I.V.PAMIRED 60 60mg DR. REDDY'S LABORATORIES

SUBLISTA C2-P6: PROGRAMUL NATIONAL DE HEMOFILIE, TALASEMIE SI ALTE BOLI RARE. P6.7: SINDROM PRADER WILLI

847 SOMATROPINUM ** Protocol: H011QH01AC01

10mg/1.5mlH01AC01 SOMATROPINUM SOL. INJ.NORDITROPIN SIMPLEX x 10mg/1,5ml 10mg/1.5ml NOVO NORDISK A/S

10mg/2mlH01AC01 SOMATROPINUM SOL. INJ.NUTROPINAq 10 mg/2 ml 10mg/2ml IPSEN LIMITED

3,3mg/mlH01AC01 SOMATROPINUM SOL. INJ.OMNITROPE 3,3mg/ml 3,3mg/ml SANDOZ GMBH

4mg (12ui)H01AC01 SOMATROPINUM LIOF. + SOLV. PT. SOL. INJ.ZOMACTON 4mg (12ui) FERING GMBH

5.3mg/ml (16ui)H01AC01 SOMATROPINUM PULB. + SOLV. PT. SOL. INJ.GENOTROPIN® 16 ui (5,3 mg) 5.3mg/ml (16ui) PFIZER EUROPE MA EEIG

5mg/1.5mlH01AC01 SOMATROPINUM SOL. INJ.NORDITROPIN SIMPLEXx 5 mg/1,5 ml 5mg/1.5ml NOVO NORDISK A/S

SUBLISTA C2-P6: PROGRAMUL NATIONAL DE HEMOFILIE, TALASEMIE SI ALTE BOLI RARE. P6.8: BOALA FABRY

848 AGALSIDASUM BETA ** Protocol: A014EA16AB04

35mgA16AB04 AGALSIDASUM BETA PULB. PT. CONC. PT. SOL. PERF.FABRAZYME 35 mg 35mg GENZYME EUROPE BV

115 153/

Page 116: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

SUBLISTA C2-P6: PROGRAMUL NATIONAL DE HEMOFILIE, TALASEMIE SI ALTE BOLI RARE. P6.9: BOALA POMPE

849 ALGLUCOSIDASUM ALPHA ** Protocol: A030QA16AB07

50mgA16AB07 ALGLUCOSIDASUM ALPHA PULB. PT. CONC. PT. SOL. PERF.MYOZYME 50mg 50mg GENZYME EUROPE B.V.

116 153/

Page 117: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

SUBLISTA C2-P7: PROGRAMUL NATIONAL DE BOLI ENDOCRINE. TRATAMENTUL MEDICAMENTOS AL BOLNAVILOR CU

OSTEOPOROZA, GUSA DATORATA CARENTEI DE IOD SI PROLIFERARII MALIGNE

850 DIHYDROTACHYSTEROLUMA11CC02

0.1mg/mlA11CC02 DIHYDROTACHYSTEROLUM PICATURI ORALE-SOL.TACHYSTIN 0.1mg/ml CHAUVIN ANKERPHARM GMBH

1mg/mlA11CC02 DIHYDROTACHYSTEROLUM PICATURI ORALE-SOL.A.T. 10® 1mg/ml MERCK KGAA

851 ALFACALCIDOLUMA11CC03

0.25µgA11CC03 ALFACALCIDOLUM CAPS. MOIALPHA D3 0,25 µg 0.25µg TEVA PHARMACEUTICALS SRL

0.50µgA11CC03 ALFACALCIDOLUM CAPS. MOIALPHA D3 0.50 µg 0.50µg TEVA PHARMACEUTICALS S.R.L.

852 CALCITRIOLUMA11CC04

0.25µgA11CC04 CALCITRIOLUM CAPS. MOIROCALTROL 0.25µg ROCHE ROMANIA S.R.L.

853 ESTRADIOLUMG03CA03

Prescriere limitata: Utilizat in simptomele caracteristice post-menopauzei, in cazul in care terapia estrogenica in doze reduse a demonstrat intoleranta la administrarea orala cu estrogeni.

Aceasta limitare este valabila doar pentru formele farmaceutice Sistem terapeutic transdermic si plasture transdermic.

Estradiol trebuie folosit împreuna cu un progestativ oral la femeile nehisterectomizate.NOTA:

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

0.06%G03CA03 ESTRADIOLUM GELOESTROGEL® 0.06% LAB. BESINS INTERNATIONAL

0.1%G03CA03 ESTRADIOLUM GELESTREVA® 0.1% LAB. THERAMEX

1mgG03CA03 ESTRADIOLUM COMPR. FILM.ESTROFEM 1 mg 1mg NOVO NORDISK A/S

25µgG03CA03 ESTRADIOLUM COMPR. VAG.VAGIFEM 25µg NOVO NORDISK A/S

25mgG03CA03 ESTRADIOLUM IMPLANTRISELLE 25 mg 25mg ORGANON NV

50µg/24oreG03CA03 ESTRADIOLUM PLASTURE TRANSDERM.CLIMARA 50µg/24ore SCHERING AG

854 TIBOLONUM Protocol: G007NG03DC05

2,5mgG03DC05 TIBOLONUM COMPR.LADYBON 2,5mg ZENTIVA A.S.

2.5mgG03DC05 TIBOLONUM COMPR.LIVIAL® 2,5 mg 2.5mg ORGANON NV

855 ESTRADIOLUMVALERAT+DIENOGEST Protocol: G002NG03FA15

G03FA15 ESTRADIOLUMVALERAT+DIENOGEST DRAJ.KLIMODIEN SCHERING AG

856 RALOXIFENUMG03XC01

Cod restrictie 2647: Monoterapie cu medicamente antiresorbtive pentru tratamentul osteoporozei sexoidoprive la femeile pana la varsta de 60 ani, cu scor T</= -2,5, masurat DEXA

(coloana vertebrala sau sold).

60mgG03XC01 RALOXIFENUM COMPR. FILM.EVISTA 60mg 60mg ELI LILLY NEDERLAND BV

857 TIREOTROPINUM ALFAH01AB01

Prescriere limitata: Anterior administrarii iodului radioactiv pentru tratamentul carcinomului tiroidian diferentiat posttiroidectomie totala.

0.9mgH01AB01 TIREOTROPINUM ALFA PULB. PT. SOL. INJ.THYROGEN 0,9 mg 0.9mg GENZYME EUROPE BV

858 METHYLPREDNISOLONUMH02AB04

125mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 125 mg 125mg HEMOFARM S.R.L.

125mg/2mlH02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV.PT.SOL.INJSOLU - MEDROL ACT-O-VIAL 125mg/2ml PFIZER EUROPE MA EEIG

16mgH02AB04 METHYLPREDNISOLONUM COMPR.MEDROL A 16 16mg PFIZER EUROPE MA EEIG

20mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 20 mg 20mg HEMOFARM S.R.L.

250mg/4mlH02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV.PT.SOL.INJSOLU - MEDROL ACT-O-VIAL 250mg/4ml PFIZER EUROPE MA EEIG

32mgH02AB04 METHYLPREDNISOLONUM COMPR.MEDROL 32 32mg PFIZER EUROPE MA EEIG

40mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 40 mg 40mg HEMOFARM S.R.L.

40mg/1mlH02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV.PT.SOL.INJSOLU - MEDROL ACT-O-VIAL 40mg/1ml PFIZER EUROPE MA EEIG

4mgH02AB04 METHYLPREDNISOLONUM COMPR.MEDROL 4 mg 4mg PFIZER EUROPE MA EEIG

500mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 500 mg 500mg HEMOFARM S.R.L.

500mg/7.8mlH02AB04 METHYLPREDNISOLONUM LIOF. + SOLV. PT. SOL. INJ.SOLU - MEDROL 500 mg/7,8 ml 500mg/7.8ml PFIZER EUROPE MA EEIG

859 LEVOTHYROXINUMH03AA01

100µgH03AA01 LEVOTHYROXINUM COMPR.EUTHYROX® 100 100µg MERCK KGAA

L-THYROXIN 100 BERLIN - CHEMIE 100µg BERLIN CHEMIE AG MENARINI GROUP

200µgH03AA01 LEVOTHYROXINUM COMPR.

117 153/

Page 118: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

EUTHYROX® 200 200µg MERCK KGAA

25µgH03AA01 LEVOTHYROXINUM COMPR.EUTHYROX® 25 25µg MERCK KGAA

50µgH03AA01 LEVOTHYROXINUM COMPR.EUTHYROX® 50 50µg MERCK KGAA

L-THYROXIN 50 50µg BERLIN CHEMIE AG MENARINI GROUP

860 LEVOTHYROXINUM+KALII IODIDUMH03AAN1

H03AAN1 LEVOTHYROXINUM+KALII IODIDUM COMPR.JODTHYROX® 100/130,8 MERCK KGAA

861 THIAMAZOLUMH03BB02

10mgH03BB02 THIAMAZOLUM COMPR. FILM.THYROZOL® 10 mg 10mg MERCK KGAA

20mgH03BB02 THIAMAZOLUM COMPR. FILM.THYROZOL® 20 mg 20mg MERCK KGAA

5mgH03BB02 THIAMAZOLUM COMPR. FILM.THYROZOL® 5 mg 5mg MERCK KGAA

862 KALII IODIDUMH03CA01

100µgH03CA01 KALII IODIDUM COMPR.JODID 100 100µg MERCK KGAA

200µgH03CA01 KALII IODIDUM COMPR.JODID 200 200µg MERCK KGAA

863 TERIPARATIDUM ** Protocol: M003MH05AA02

20µg/80µgH05AA02 TERIPARATIDUM SOL. INJ.FORSTEO 20µg/80µg 20µg/80µg ELI LILLY NEDERLAND BV

864 CALCITONINUM (SOMON)H05BA01

100UIH05BA01 CALCITONINUM (SOMON) SOL. INJ.TONOCALCIN 100 UI 100UI ALFA WASSERMANN SPA

100ui/dozaH05BA01 CALCITONINUM (SOMON) SPRAY NAZ.,SOL.NYLEX 100 UI/doza 100UI/doza PHARMACEUTICAL IND. PROEL EPAM. G.CORONIS SA

100UI/mlH05BA01 CALCITONINUM (SOMON) SOL. INJ.NYLEX® 100UI/ml PROEL E.P. CORONIS SA

200UI/dozaH05BA01 CALCITONINUM (SOMON) SPRAY NAZAL - SOL.MIACALCIC® NASAL 200 200ui/doza NOVARTIS PHARMA GMBH

NYLEX® 200UI/doza PROEL E.P. CORONIS SA

50ui/mlH05BA01 CALCITONINUM (SOMON) SOL. INJ.MIACALCIC® 50ui/ml NOVARTIS PHARMA GMBH

865 ACIDUM ALENDRONICUM ** Protocol: M003MM05BA04

10mgM05BA04 ACIDUM ALENDRONICUM COMPR.FOSAMAX 10 mg 10mg MERCK SHARP & DOHME S.R.L.

70 mgM05BA04 ACIDUM ALENDRONICUM COMPR.TEVA NAT 70 mg TEVA PHARMACEUTICALS SRL

70mgM05BA04 ACIDUM ALENDRONICUM COMPR.FOSAMAX 70 mg 70mg MERCK SHARP & DOHME S.R.L.

866 ACIDUM IBANDRONICUM ** Protocol: M003MM05BA06

3mg/3mlM05BA06 ACIDUM IBANDRONICUM SOL. INJ. IN SERINGA PREUMPLUTABONVIVA 3mg/3ml 3mg/3ml ROCHE REGISTRATION LTD

M05BA06 ACIDUM IBANDRONICUM CONC. PT. SOL. PERF.BONDRONAT 6 mg/6 ml 6mg/6ml ROCHE REGISTRATION L

M05BA06 ACIDUM IBANDRONICUM COMPR. FILM.BONDRONAT 50 mg 50mg ROCHE REGISTRATION L

M05BA06 ACIDUM IBANDRONICUM COMPR. FILM.BONDRONAT 50 mg 50mg ROCHE REGISTRATION L

867 ACIDUM RISEDRONICUM ** Protocol: M003MM05BA07

35mgM05BA07 ACIDUM RISEDRONICUM COMPR. FILM.ACTONEL® SAPTAMANAL 35mg AVENTIS PHARMA AB

RISENDROS 35 mg 35mg ZENTIVA A.S.

868 COMBINATII (ACIDUM

ALENDRONICUM+COLECALCIFEROLUM) **

Protocol: M003MM05BB03

70mg/2800UIM05BB03 COMBINATII (ACIDUM

ALENDRONICUM+COLECALCIFEROLUM)

COMPR.

FOSAVANCE 70mg/2800UI 70mg/2800UI MERCK SHARP & DOHME LTD.

869 STRONTIUM RANELATUMM05BX03

2gM05BX03 STRONTIUM RANELATUM GRAN. PT. SUSP. ORALAOSSEOR 2 g 2g LES LAB. SERVIER

872 ACIDUM ZOLEDRONICUM ** Protocol: M001MM05BA08

5mg/100mlM05BA08 ACIDUM ZOLEDRONICUM SOL. PERF.ACLASTA 5mg/100ml 5mg/100ml NOVARTIS EUROPHARM LTD.

M05BA08 ACIDUM ZOLEDRONICUM PULB. + SOLV. SOL. PERF.ZOMETA 4 mg 4mg NOVARTIS EUROPHARM L

1218 CARBIMAZOLUMH03BB01

5mgH03BB01 CARBIMAZOLUM COMPR. FILM.CARBIMAZOLE 5 5mg REMEDICA LTD.

118 153/

Page 119: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

SUBLISTA C2-P9: PROGRAM NATIONAL DE TRANSPLANT DE ORGANE, TESUTURI SI CELULE DE ORIGINE UMANA. P9.1:

TRANSPLANT MEDULAR

873 ONDANSETRONUM **A04AA01

A04AA01 ONDANSETRONUM SOL. INJ.OSETRON 4 mg 2mg/ml DR. REDDY'S LABORATO

OSETRON 8 mg 2mg/ml DR. REDDY'S LABORATORIES

2mg/mlA04AA01 ONDANSETRONUM SOL. INJ./PERF.EMESET 4 mg/2 ml 2mg/ml CIPLA (UK) LIMITED

EMESET 8 mg/4 ml 2mg/ml CIPLA (UK) LIMITED

4mgA04AA01 ONDANSETRONUM COMPR. FILM.ONDANSETRON TEVA 4mg 4mg TEVA PHARMACEUTICALS SRL

ONDANTOR 4 mg 4mg SANDOZ SRL

OSETRON 4 mg 4mg DR. REDDY'S LABORATORIES

SETRONON 4 mg 4mg PLIVA LJUBLJANA D.O.O.

ZOFRAN 4 mg 4mg GLAXO WELLCOME UK LTD.

4mgA04AA01 ONDANSETRONUM COMPR. ORODISPERSABILEONDARAN MD 4mg 4mg RANBAXY UK LTD.

4mg/2mlA04AA01 ONDANSETRONUM SOL. INJ.ZOFRAN 4mg/2ml 4mg/2ml GLAXO WELLCOME UK LIMITED

4mg/2mlA04AA01 ONDANSETRONUM SOL. INJ./PERF.SETRONON 4 mg/2 ml 4mg/2ml PLIVA LJUBLJANA D.O.O.

8mgA04AA01 ONDANSETRONUM COMPR. FILM.ONDANSETRON TEVA 8 mg 8mg TEVA PHARMACEUTICALS SRL

ONDANTOR 8 mg 8mg SANDOZ SRL

OSETRON 8 mg 8mg DR. REDDY'S LABORATORIES (UK) LTD

SETRONON 8 mg 8mg PLIVA LJUBLJANA D.O.O.

ZOFRAN 8 mg 8mg GLAXO WELLCOME UK LTD.

8mgA04AA01 ONDANSETRONUM COMPR. ORODISPERSABILEONDARAN MD 8 mg 8mg RANBAXY UK LIMITED

8mg/4mlA04AA01 ONDANSETRONUM SOL. INJ.ZOFRAN 8mg/4ml 8mg/4ml GLAXO WELLCOME UK LIMITED

8mg/4 mlA04AA01 ONDANSETRONUM SOL. INJ./PERF.SETRONON 8 mg/4 ml 8mg/4 ml PLIVA LJUBLJANA D.O.O.

874 ACIDUM URSODEOXYCHOLICUMA05AA02

Nu se va prescrie in regim compensat pentru tratamentul litiazei biliare.NOTA:

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

250mgA05AA02 ACIDUM URSODEOXYCHOLICUM CAPS.URSOFALK® 250mg DR. FALK PHARMA GMBH

URSOSAN 250mg PRO. MED. CS PRAHA AS

875 REVIPARINUMB01AB08

1432ui/0.25mlB01AB08 REVIPARINUM SOL. INJ.CLIVARIN® 1432UI/0,25 ml 1432ui/0.25ml ABBOTT GMBH&CO.KG

3436ui/0.6mlB01AB08 REVIPARINUM SOL. INJ.CLIVARIN® 3436 UI/0,6 ml 3436ui/0.6ml ABBOTT GMBH&CO.KG

878 EPOETINUM ALFAB03XA01

10000ui/mlB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 10000 UI 10000ui/ml JOHNSON & JOHNSON D.O.O.

1000UI/0.5mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 1000 UI/0,5 ml 1000UI/0.5ml RENAMED FARMA S.R.L.

EPREX® 1000 UI 1000ui/0.5ml JOHNSON & JOHNSON D.O.O.

2000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPOPHAR 2000 U.I. 2000UI GULF PHARMACEUTICAL IND. S.R.L.

2000ui/0.5mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 2000 UI/0,5 ml 2000UI/0.5ml RENAMED FARMA S.R.L.

EPREX® 2000 UI 2000ui/0.5ml JOHNSON & JOHNSON D.O.O.

2000UI/1mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 2000 UI/1 ml 2000UI/1ml RENAMED FARMA S.R.L.

3000ui/0.3mlB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 3000 UI 3000ui/0.3ml JOHNSON & JOHNSON D.O.O.

40 000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 40 000 UI 40 000UI JOHNSON & JOHNSON D.O.O.

4000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPOPHAR 4000 U.I. 4000UI GULF PHARMACEUTICAL IND. S.R.L.

4000ui/0.4mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 4000 UI/0,4 ml 4000UI/0.4ml RENAMED FARMA S.R.L.

EPREX® 4000 UI 4000ui/0.4ml JOHNSON & JOHNSON D.O.O.

4000UI/1mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 4000 UI/1 ml 4000UI/1ml RENAMED FARMA S.R.L.

B03XA01 EPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTABINOCRIT 1000UI/0,5ml SANDOZ GMBH

B03XA01 EPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTABINOCRIT 2000UI/1,0ml SANDOZ GMBH

B03XA01 EPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTABINOCRIT 3000UI/0,3ml SANDOZ GMBH

B03XA01 EPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTABINOCRIT 4000UI/0,4ml SANDOZ GMBH

879 EPOETINUM BETAB03XA01

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 10000 UI 10000UI/0,6ml ROCHE REGISTRATION L

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTA

119 153/

Page 120: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

NEORECORMON 1000 UI 1000UI/0,3ml ROCHE REGISTRATION L

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 2000 UI 2000UI/0,3ml ROCHE REGISTRATION L

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 4000 UI 4000UI/0,3ml ROCHE REGISTRATION L

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 5000 UI 5000UI/0,3ml ROCHE REGISTRATION L

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 500 UI 500UI/0,3ml ROCHE REGISTRATION L

880 TICARCILLINUM + ACIDUM CLAVULANICUMJ01CR03

3.2gJ01CR03 TICARCILLINUM + ACIDUM CLAVULANICUM PULB. PT. SOL. INJ./PERF.TIMENTIN 3,2 g 3.2g BEECHAM GROUP PLC

881 PIPERACILLINUM + TAZOBACTAMUMJ01CR05

J01CR05 PIPERACILLINUM + TAZOBACTAMUM LIOF. PT. SOL. INJ.TAZOCIN 2,25 WYETH LEDERLE PHARMA GMBH

TAZOCIN 4,5 WYETH LEDERLE PHARMA GMBH

882 MEROPENEMUMJ01DH02

1gJ01DH02 MEROPENEMUM PULB. PT. SOL. INJ. I.V./PERF.MERONEM IV 1 g 1g ASTRAZENECA UK LTD.

500mgJ01DH02 MEROPENEMUM PULB. PT. SOL. INJ. I.V./PERF.MERONEM IV 500 mg 500mg ASTRAZENECA UK LTD.

883 IMIPENEMUM + CILASTATINUMJ01DH51

J01DH51 IMIPENEMUM + CILASTATINUM PULB. PT. SOL. PERF.TIENAM I.V. MERCK SHARP & DOHME ROMANIA S.R.L.

884 VANCOMYCINUMJ01XA01

1gJ01XA01 VANCOMYCINUM LIOF. PT. SOL. PERF.VANCOMYCIN TEVA 1g TEVA PHARM. WORKS PRIVATE LTD. COMPANY

1gJ01XA01 VANCOMYCINUM PULB.LIOF.PT.SOL.PERF./INJEDICIN 1g LEK PHARMACEUTICALS D.D.

500mgJ01XA01 VANCOMYCINUM LIOF. PT. SOL. PERF.VANCOMYCIN TEVA 500mg TEVA PHARM. WORKS PRIVATE LTD. COMPANY

500mgJ01XA01 VANCOMYCINUM LIOF. PT. SOL. PERF./INJ.EDICIN 500mg LEK PHARMACEUTICALS D.D.

885 TEICOPLANINUMJ01XA02

400mgJ01XA02 TEICOPLANINUM LIOF. + SOLV. PT. SOL. INJ.TARGOCID® 400 mg 400mg AVENTIS PHARMA LTD.

887 LINEZOLIDUMJ01XX08

100mg/5mlJ01XX08 LINEZOLIDUM GRAN. PT. SUSP. ORALAZYVOXID® 100mg/5ml PFIZER EUROPE MA EEIG

2mg/mlJ01XX08 LINEZOLIDUM SOL. PERF.ZYVOXID® 2mg/ml PFIZER EUROPE MA EEIG

600mgJ01XX08 LINEZOLIDUM COMPR. FILM.ZYVOXID® 600mg PFIZER EUROPE MA EEIG

888 FLUCONAZOLUMJ02AC01

Prescriere limitata: Tratament de intretinere la pacienti cu meningita criptococica si imunosupresie.

Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie.

Tratamentul meningitei criptococice la pacientii care nu pot lua sau nu tolereaza amfotericina.

Tratamentul candidozelor severe si care pun in pericol viata la pacienti care nu tolereaza amfotericina.

Tratamentul candidozei orofaringiene la pacienti cu imunosupresie.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 100 mg 100mg KRKA D.D.

FLUCONAZOLE TEVA 100 mg 100mg TEVA PHARMACEUTICALS SRL

FLUCORIC 100 mg 100mg TERAPIA S.A.

FLUCOVIM 100 100mg VIM SPECTRUM SRL

FUNGOLON 100 mg 100mg BALKANPHARMA RAZGRAD AD

150mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 150 mg 150mg KRKA D.D.

DIFLUCAN 150 mg 150mg PFIZER EUROPE MA EEIG

FLUCONAZOL 150 mg 150mg OZONE LABORATORIES LTD.

FLUCONAZOL MEDICO UNO 150 mg 150mg MEDICO UNO PHARMACEUTICAL SRL

FLUCONAZOL MEDOCHEMIE 150 mg 150mg MEDOCHEMIE ROMANIA SRL

FLUCONAZOL SANDOZ® 150 150mg SANDOZ SRL

FLUCONAZOL TERAPIA 150 mg 150mg TERAPIA SA

FLUCONAZOLE TEVA 150 mg 150mg TEVA PHARMACEUTICALS SRL

FLUCORIC 150 mg 150mg TERAPIA S.A.

FLUCOVIM 150 150mg VIM SPECTRUM SRL

MYCOMAX 150 150mg ZENTIVA AS

MYCOSYST® 150 mg 150mg GEDEON RICHTER PLC.

200mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 200 mg 200mg KRKA D.D.

FLUCONAZOLE TEVA 200 mg 200mg TEVA PHARMACEUTICALS SRL

2mg/mlJ02AC01 FLUCONAZOLUM SOL. PERF.DIFLAZON® 2mg/ml KRKA D.D.

DIFLUCAN® 2mg/ml PFIZER EUROPE MA EEIG

MYCOMAX® INF 2mg/ml ZENTIVA AS

50mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 50 mg 50mg KRKA D.D.

DIFLUCAN 50 mg 50mg PFIZER EUROPE MA EEIG

FLUCONAZOL 50 mg 50mg ARENA GROUP SA

FLUCONAZOL MEDOCHEMIE 50 mg 50mg MEDOCHEMIE ROMANIA SRL

120 153/

Page 121: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

FLUCONAZOL SANDOZ® 50 50mg SANDOZ SRL

FLUCONAZOL TERAPIA 50 mg 50mg TERAPIA S.A.

FLUCONAZOLE TEVA 50 mg 50mg TEVA PHARMACEUTICALS SRL

FLUCORIC 50 mg 50mg TERAPIA S.A.

FLUCOVIM 50 50mg VIM SPECTRUM SRL

FUNGOLON 50 mg 50mg BALKANPHARMA RAZGRAD AD

50mg/5mlJ02AC01 FLUCONAZOLUM PULB. PT. SUSP. ORALADIFLUCAN® 50 mg/5 ml 50mg/5ml PFIZER EUROPE MA EEIG

889 VORICONAZOLUM ** Protocol: J012BJ02AC03

200mgJ02AC03 VORICONAZOLUM COMPR. FILM.VFEND 200mg 200mg PFIZER LTD.

200mgJ02AC03 VORICONAZOLUM PULB. PT. SOL. PERF.VFEND 200mg 200mg PFIZER LTD.

40mg/mlJ02AC03 VORICONAZOLUM PULB. PT. SUSP. ORALAVFEND 40 mg/ml 40mg/ml PFIZER LTD.

50mgJ02AC03 VORICONAZOLUM COMPR. FILM.VFEND 50mg 50mg PFIZER LTD.

890 POSACONAZOLUM **J02AC04

Prescriere limitata: Profilaxia si tratamentul infectiilor fungice invazive la pacientii aflati sub chimioterapie de inductie-remisie pentru LAM sau pentru sindroame mielodisplazice si care

prezinta risc inalt de a dezvolta infectii fungice masive.

Profilaxia si tratamentul infectiilor fungice invazive la pacientii in procedura de transplant medular si aflati sub terapie imunosupresoare cu doze mari, cu risc mare de

a dezvolta infectii fungice masive.

40mg/mlJ02AC04 POSACONAZOLUM SUSP. ORALANOXAFIL SP 40mg/ml 40mg/ml SP EUROPE

891 CASPOFUNGINUM ** Protocol: J010DJ02AX04

50mgJ02AX04 CASPOFUNGINUM PULB. PT. CONC. PT. SOL. PERF.CANCIDAS 50 mg 50mg MERCK SHARP & DOHME LTD

70mgJ02AX04 CASPOFUNGINUM PULB. PT. CONC. PT. SOL. PERF.CANCIDAS 70 mg 70mg MERCK SHARP & DOHME LTD

893 ACICLOVIRUMJ05AB01

200mgJ05AB01 ACICLOVIRUM CAPS.ACICLOVIR 200 mg 200mg ARENA GROUP SA

EUVIROX 200 mg 200mg EUROPHARM SA

200mgJ05AB01 ACICLOVIRUM COMPR.ACICLOVIR 200 mg 200mg TERAPIA SA

CLOVIRAL 200 mg 200mg ANTIBIOTICE SA

ZOVIRAX 200mg GLAXO WELLCOME FOUNDATION LTD.

200mgJ05AB01 ACICLOVIRUM COMPR. DISP.ACICLOVIR 200 mg 200mg OZONE LABORATORIES LTD.

LOVIR 200 mg 200mg RANBAXY UK LIMITED

250mgJ05AB01 ACICLOVIRUM PULB. PT. SOL. INJ./PERF.VIROLEX 250mg KRKA D.D. NOVO MESTO

400mgJ05AB01 ACICLOVIRUM CAPS.ACICLOVIR 400 mg 400mg ARENA GROUP S.A.

400mgJ05AB01 ACICLOVIRUM COMPR.ACICLOVIR 400 mg 400mg EGIS PHARMACEUTICALS P.L.C.

400mgJ05AB01 ACICLOVIRUM COMPR. FILM.ACIKLOVIR 400mg A & G MED TRADING S.R.L.

894 VALACYCLOVIRUMJ05AB11

500mgJ05AB11 VALACYCLOVIRUM COMPR. FILM.VALTREX 500 mg 500mg THE WELLCOME FOUNDATION LTD.

895 VALGANCICLOVIRUM **J05AB14

Prescriere limitata: Tratamentul de initiere si mentinere pentru retinita cu citomegalovirus (CMV) la pacienti imunocompromisi.

450mgJ05AB14 VALGANCICLOVIRUM COMPR. FILM.VALCYTE® 450 mg 450mg ROCHE ROMANIA SRL

897 CYCLOPHOSPHAMIDUML01AA01

1gL01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. INJ./PERF.ENDOXAN® 1 g 1g BAXTER ONCOLOGY GMBH

200mgL01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. PERF./INJ. I.V.ENDOXAN 200 mg 200mg ACTAVIS S.R.L.

500mgL01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. INJ./PERF.ENDOXAN® 500 mg 500mg BAXTER ONCOLOGY GMBH

50mgL01AA01 CYCLOPHOSPHAMIDUM DRAJ.ENDOXAN® 50 mg 50mg BAXTER ONCOLOGY GMBH

898 MELPHALANUML01AA03

2mgL01AA03 MELPHALANUM COMPR. FILM.ALKERAN 2 mg 2mg THE WELLCOME FOUNDATION LTD.

899 IFOSFAMIDUML01AA06

1gL01AA06 IFOSFAMIDUM PULB. PT. SOL. PERF.HOLOXAN 1 g 1g BAXTER ONCOLOGY GMBH

2gL01AA06 IFOSFAMIDUM PULB. PT. SOL. PERF.HOLOXAN 2 g 2g BAXTER ONCOLOGY GMBH

500mgL01AA06 IFOSFAMIDUM PULB. PT. SOL. PERF.HOLOXAN 500 mg 500mg BAXTER ONCOLOGY GMBH

900 BUSULFANUML01AB01

2mgL01AB01 BUSULFANUM COMPR. FILM.MYLERAN 2mg THE WELLCOME FOUNDATION LTD.

901 METHOTREXATUML01BA01

100mg/mlL01BA01 METHOTREXATUM CONC. PT. SOL. INJ./PERF.

121 153/

Page 122: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

METHOTREXAT "EBEWE" 1000 mg 100mg/ml EBEWE PHARMA GMBH NFG. KG

METHOTREXAT "EBEWE" 500 mg 100mg/ml EBEWE PHARMA GMBH NFG. KG

METHOTREXAT "EBEWE" 5000 mg 100mg/ml EBEWE PHARMA GMBH NFG. KG

10mg/mlL01BA01 METHOTREXATUM SOL. INJ./PERF.METHOTREXAT "EBEWE" 50 mg 10mg/ml EBEWE PHARMA GMBH NFG. KG

50mgL01BA01 METHOTREXATUM PULB. PT. SOL. INJ./PERF.ANTIFOLAN® 50 mg 50mg SINDAN SRL

5mg/mlL01BA01 METHOTREXATUM SOL. INJ.METHOTREXAT "EBEWE" 5 mg 5mg/ml EBEWE PHARMA GMBH NFG. KG

902 FLUDARABINUML01BB05

10mgL01BB05 FLUDARABINUM COMPR. FILM.FLUDARA® ORAL 10mg SCHERING AG

50mgL01BB05 FLUDARABINUM LIOF. PT. SOL. INJ./PERF.FLUDARA 50mg SCHERING AG

903 ETOPOSIDUML01CB01

100mgL01CB01 ETOPOSIDUM CAPS. MOIVEPESID 100mg BRISTOL MYERS SQUIBB KFT

100mg/5mlL01CB01 ETOPOSIDUM CONC. PT. SOL. PERF.ETOPOSID "EBEWE" 100 mg/5 ml 100mg/5ml EBEWE PHARMA GMBH NFG. KG

SINTOPOZID 100 mg/5 ml 100mg/5ml ACTAVIS S.R.L.

20mg/mlL01CB01 ETOPOSIDUM CONC. PT. SOL. PERF.ETOPOSIDE - TEVA 20mg/ml TEVA PHARMACEUTICALS S.R.L.

50mgL01CB01 ETOPOSIDUM CAPS. MOIVEPESID 50mg BRISTOL MYERS SQUIBB KFT

904 IDARUBICINUML01DB06

10mgL01DB06 IDARUBICINUM CAPS.ZAVEDOS 10mg PFIZER EUROPE MA EEIG

5mgL01DB06 IDARUBICINUM LIOF. PT. SOL. INJ.ZAVEDOS 5 mg 5mg PFIZER EUROPE MA EEIG

905 MITOXANTRONUM **L01DB07

2 mg/mlL01DB07 MITOXANTRONUM CONC. PT. SOL. PERF.MITOXANTRONE TEVA 2 mg/ml 2 mg/ml TEVA PHARMACEUTICALS SRL

20mg/10mlL01DB07 MITOXANTRONUM SOL. PERF.NOVANTRONE 20mg/10ml WYETH LEDERLE PHARMA GMBH

2mg/mlL01DB07 MITOXANTRONUM CONC. PT. SOL. INJ.ONKOTRONE 2mg/ml BAXTER ONCOLOGY GMBH

906 CISPLATINUML01XA01

10mgL01XA01 CISPLATINUM LIOF. PT. SOL. PERF.SINPLATIN 10 mg 10mg ACTAVIS S.R.L.

10mg/20mlL01XA01 CISPLATINUM CONC. PT. SOL. PERF.CISPLATIN "EBEWE" 10 mg/20 ml 10mg/20ml EBEWE PHARMA GMBH NFG. KG

CISPLATIN TEVA 10 mg/20 ml 10mg/20ml TEVA PHARMACEUTICALS S.R.L.

1mg/1mlL01XA01 CISPLATINUM CONC. PT. SOL. PERF.SINPLATIN 1 mg/1 ml 1mg/1ml ACTAVIS S.R.L.

25mg/50mlL01XA01 CISPLATINUM CONC. PT. SOL. PERF.CISPLATIN "EBEWE" 25 mg/50 ml 25mg/50ml EBEWE PHARMA GMBH NFG. KG

50mgL01XA01 CISPLATINUM LIOF. PT. SOL. PERF.SINPLATIN 50 mg 50mg ACTAVIS S.R.L.

50mg/100mlL01XA01 CISPLATINUM CONC. PT. SOL. PERF.CISPLATIN "EBEWE" 50 mg/100 ml 50mg/100ml EBEWE PHARMA GMBH NFG. KG

907 CARBOPLATINUML01XA02

10mg/mlL01XA02 CARBOPLATINUM CONC. PT. SOL. PERF.CARBOPLATIN "EBEWE" 10 mg/ml 10mg/ml EBEWE PHARMA GES.M.B.H. NFG KG

CARBOPLATIN ACTAVIS 10mg/ml 10mg/ml ACTAVIS S.R.L.

CARBOPLATIN TEVA 10mg/ml 10mg/ml TEVA PHARMACEUTICALS S.R.L.

908 ALEMTUZUMABUM **L01XC04

10mg/mlL01XC04 ALEMTUZUMABUM CONC. PT. SOL. PERF.MABCAMPATH 10 mg/ml 10mg/ml GENZYME EUROPE BV

30mg/mlL01XC04 ALEMTUZUMABUM CONC. PT. SOL. PERF.MABCAMPATH 30 mg/ml 30mg/ml GENZYME EUROPE BV

909 RITUXIMABUM **L01XC02

10mg/mlL01XC02 RITUXIMABUM CONC. PT. SOL. PERF.MABTHERA 100 mg 10mg/ml ROCHE REGISTRATION LTD.

MABTHERA 500 mg 10mg/ml ROCHE REGISTRATION LTD.

910 FILGRASTIMUM (G-CSF) **L03AA02

Prescriere limitata: Reducerea duratei neutropeniei şi a incidenţei neutropeniei febrile la pacienţii trataţi cu chimioterapie citotoxică standard pentru bolile maligne (cu excepţia leucemiei

mieloide cronice şi a sindroamelor mielodisplazice), precum şi pentru reducerea duratei neutropeniei la pacienţii care primesc terapie mieloablativă urmată de

transplant de măduvă osoasă.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

30MU/0.5mlL03AA02 FILGRASTIMUM (G-CSF) SOL. INJ.NEUPOGEN® 30MU/0.5ml AMGEN EUROPE B.V.

48MU/0.5mlL03AA02 FILGRASTIMUM (G-CSF) SOL. INJ.NEUPOGEN® 48MU/0.5ml AMGEN EUROPE B.V.

911 CICLOSPORINUML04AA01

Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant.

Monitorizarea atentă a pacienţilor este obligatorie.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgL04AA01 CICLOSPORINUM CAPS. MOIEQUORAL® 100 mg 100mg IVAX - PHARMACEUTICALS S.R.O.

122 153/

Page 123: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

100mg/mlL04AA01 CICLOSPORINUM SOL. ORALAEQUORAL® 100mg/ml IVAX - PHARMACEUTICALS S.R.O.

SANDIMMUN NEORAL® 100mg/ml NOVARTIS PHARMA GMBH

25mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL® 25 mg 25mg HEXAL AG

EQUORAL® 25 mg 25mg IVAX - PHARMACEUTICALS S.R.O.

SANDIMMUN NEORAL® 25mg NOVARTIS PHARMA GMBH

50mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL 50 mg 50mg HEXAL AG

EQUORAL® 50 mg 50mg IVAX - PHARMACEUTICALS S.R.O.

SANDIMMUN NEORAL® 50mg NOVARTIS PHARMA GMBH

913 TACROLIMUSUM **L04AA05

Prescriere limitata: Tratamentul rejetului de alogrefă rezistent la alte terapii imunosupresoare, la pacienţii adulţi.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

0,5mgL04AA05 TACROLIMUSUM CAPS. ELIB. PREL.ADVAGRAF 0,5mg 0,5mg ASTELLAS PHARMA GMBH

0.5mgL04AA05 TACROLIMUSUM CAPS.PROGRAF® 0,5 mg 0.5mg ASTELLAS PHARMA GMBH

1mgL04AA05 TACROLIMUSUM CAPS.PROGRAF® 1 mg 1mg ASTELLAS IRELAND CO. LTD.

1mgL04AA05 TACROLIMUSUM CAPS. ELIB. PREL.ADVAGRAF 1mg 1mg ASTELLAS PHARMA GMBH

5mgL04AA05 TACROLIMUSUM CAPS.PROGRAF® 5 mg 5mg ASTELLAS PHARMA GMBH

5mgL04AA05 TACROLIMUSUM CAPS. ELIB. PREL.ADVAGRAF 5mg 5mg ASTELLAS PHARMA GMBH

5mg/mlL04AA05 TACROLIMUSUM CONC. PT. SOL. PERF.PROGRAF® 5 mg/ml 5mg/ml ASTELLAS PHARMA GMBH

914 MYCOPHENOLATUM **L04AA06

180mgL04AA06 MYCOPHENOLATUM COMPR. FILM. GASTROREZ.MYFORTIC 180 mg 180mg NOVARTIS PHARMA GMBH

1g/5mlL04AA06 MYCOPHENOLATUM PULB. PT. SUSP. ORALACELLCEPT 1mg/5ml 1g/5ml ROCHE REGISTRATION LTD.

250mgL04AA06 MYCOPHENOLATUM CAPS.CELLCEPT 250mg 250mg ROCHE REGISTRATION LTD.

MYFENAX 250mg 250mg TEVA PHARMA BV

360mgL04AA06 MYCOPHENOLATUM COMPR. FILM. GASTROREZ.MYFORTIC 360 mg 360mg NOVARTIS PHARMA GMBH

500mgL04AA06 MYCOPHENOLATUM CAPS.MYFENAX 500mg 500mg TEVA PHARMA BV

500mgL04AA06 MYCOPHENOLATUM COMPR. FILM.CELLCEPT 500mg 500mg ROCHE REGISTRATION LTD.

500mgL04AA06 MYCOPHENOLATUM PULB. PT. CONC. PT. SOL. PERF.CELLCEPT 500mg 500mg ROCHE REGISTRATION LTD.

915 DACLIZUMABUM **L04AA08

5mg/mlL04AA08 DACLIZUMABUM CONC. PT. SOL. PERF.ZENAPAX 5 mg/ml 5mg/ml ROCHE REGISTRATION LTD.

916 SIROLIMUS **L04AA10Monitorizarea atentă a pacienţilor este obligatorie

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

1mgL04AA10 SIROLIMUS COMPR. FILM.RAPAMUNE 1mg 1mg WYETH EUROPA LTD.

917 ETANERCEPTUM **L04AA11

25mgL04AA11 ETANERCEPTUM PULB. + SOLV. PT. SOL. INJ.ENBREL 25mg 25mg WYETH EUROPA LIMITED

50mgL04AA11 ETANERCEPTUM PULB+SOLV.PT.SOL.INJENBREL 50 mg 50mg WYETH EUROPA LIMITED

25mgL04AA11 ETANERCEPTUM SOL. INJ. IN SERINGA PREUMPLUTAENBREL 25mg 25mg WYETH EUROPA LIMITED

50mgL04AA11 ETANERCEPTUM SOL. INJ. IN SERINGA PREUMPLUTAENBREL 50mg 50mg WYETH EUROPA LIMITED

918 TRAMADOLUMN02AX02

Prescriere limitata: Durere severa, care nu raspunde la analgezice non-opioide

Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgN02AX02 TRAMADOLUM COMPR. ELIB. MODIF.TRAMADOLOR® 100 ID 100mg HEXAL AG

100mgN02AX02 TRAMADOLUM COMPR. ELIB. PREL.NOAX UNO 100 mg 100mg LABOPHARM EUROPE LIMITED

TRALGIT SR 100 100mg ZENTIVA AS

TRAMADOL® RETARD 100mg KRKA D.D.

100mgN02AX02 TRAMADOLUM COMPR. FILM. ELIB. PREL.TRAMAL RETARD 100 mg 100mg GRUNENTHAL GMBH

100mgN02AX02 TRAMADOLUM SOL. INJ.MABRON 100mg MEDOCHEMIE LTD.

TRADOLAN 100mg LANNACHER HEILMITTEL GMBH

Tratamentul de scurta durata al durerii acutePrescriere limitata:

100mgN02AX02 TRAMADOLUM SUPOZ.TRADOLAN 100mg LANNACHER HEILMITTEL GMBH

TRAMADOL 100mg KRKA D.D.

123 153/

Page 124: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

TRAMAG 100 100mg MAGISTRA C & C

TRAMAL® 100mg GRUNENTHAL GMBH

100mg/2mlN02AX02 TRAMADOLUM SOL. INJ.TRALGIT 100 100mg/2ml ZENTIVA A.S.

Tratamentul de scurta durata al durerii acutePrescriere limitata:

100mg/mlN02AX02 TRAMADOLUM PIC. ORALE, SOL.TRALGIT 100mg/ml ZENTIVA A.S.

100mg/mlN02AX02 TRAMADOLUM SOL. ORALATRADOLAN 100mg/ml LANNACHER HEILMITTEL GMBH

150mgN02AX02 TRAMADOLUM COMPR. ELIB. PREL.TRALGIT SR 150 150mg ZENTIVA AS

150mgN02AX02 TRAMADOLUM COMPR. FILM. ELIB. PREL.TRAMADOL RETARD 150 mg 150mg KRKA D.D. NOVO MESTO

TRAMAL RETARD 150 mg 150mg GRUNENTHAL GMBH

200mgN02AX02 TRAMADOLUM COMPR. ELIB. PREL.NOAX UNO 200 mg 200mg LABOPHARM EUROPE LIMITED

TRALGIT SR 200 200mg ZENTIVA AS

200mgN02AX02 TRAMADOLUM COMPR. FILM. ELIB. PREL.TRAMADOL RETARD 200 mg 200mg KRKA D.D. NOVO MESTO

TRAMAL RETARD 200 mg 200mg GRUNENTHAL GMBH

300mgN02AX02 TRAMADOLUM COMPR. ELIB. PREL.NOAX UNO 300 mg 300mg LABOPHARM EUROPE LIMITED

50mgN02AX02 TRAMADOLUM CAPS.K-ALMA® 50mg ANTIBIOTICE SA

MABRON 50 mg 50mg MEDOCHEMIE LTD.

TRALGIT 50 50mg ZENTIVA A.S.

TRAMACALM 50mg AC HELCOR SRL

TRAMADOL 50mg KRKA D.D.

TRAMADOL LPH 50 mg 50mg LABORMED PHARMA SA

TRAMADOL AL 50 50mg ALIUD® PHARMA GMBH & CO.KG

TRAMADOL ARENA 50mg ARENA GROUP S.A.

TRAMAL® 50mg GRUNENTHAL GMBH

URGENDOL 50mg MEDICAROM GROUP SRL

50mgN02AX02 TRAMADOLUM COMPR.TRAMADOL 50 mg 50mg OZONE LABORATORIES LTD.

TRAMADOL EEL 50mg BIO EEL SRL

TRAMAG 50 50mg MAGISTRA C & C

50mgN02AX02 TRAMADOLUM COMPR. FILM.TRADOLAN 50 mg 50mg LANNACHER HEILMITTEL GMBH

50mgN02AX02 TRAMADOLUM SOL. INJ.TRADOLAN 50 mg 50mg LANNACHER HEILMITTEL GMBH

Tratamentul de scurta durata al durerii acutePrescriere limitata:

50mg/mlN02AX02 TRAMADOLUM SOL. INJ.TRALGIT 50 50mg/ml ZENTIVA A.S.

TRAMADOL 50mg/ml KRKA D.D.

TRAMADOL® AL 100 Fiole 50mg/ml ALIUD® PHARMA GMBH & CO.KG

TRAMAL® 100 50mg/ml GRUNENTHAL GMBH

TRAMAL® 50 50mg/ml GRUNENTHAL GMBH

URGENDOL 50mg/ml MEDICAROM GROUP SRL

Tratamentul de scurta durata al durerii acutePrescriere limitata:

N02AX02 TRAMADOLUM PIC. ORALE, SOL.TRAMADOL AL PICATURI ALIUD PHARMA GMBH & CO.KG

100mg/mlN02AX02 TRAMADOLUM PICATURI ORALE-SOL.TRAMAL® 100mg/ml GRUNENTHAL GMBH

919 DORNAZA ALFA **R05CB13

1mg/mlR05CB13 DORNAZA ALFA SOL. INHAL.PULMOZYME 1mg/ml ROCHE ROMANIA S.R.L.

920 DEFERASIROXUM **V03AC03

125mgV03AC03 DEFERASIROXUM COMPR. DISP.EXJADE 125mg 125mg NOVARTIS EUROPHARM LTD.

250mgV03AC03 DEFERASIROXUM COMPR. DISP.EXJADE 250mg 250mg NOVARTIS EUROPHARM LTD.

500mgV03AC03 DEFERASIROXUM COMPR. DISP.EXJADE 500mg 500mg NOVARTIS EUROPHARM LTD.

921 MESNUMV03AF01

400mg/4mlV03AF01 MESNUM SOL. INJ.UROMITEXAN® 400 mg 400mg/4ml BAXTER ONCOLOGY GMBH

124 153/

Page 125: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

SUBLISTA C2-P9: PROGRAM NATIONAL DE TRANSPLANT DE ORGANE, TESUTURI SI CELULE DE ORIGINE UMANA. P9.2:

TRANSPLANT DE CORD

922 REVIPARINUMB01AB08

1432ui/0.25mlB01AB08 REVIPARINUM SOL. INJ.CLIVARIN® 1432UI/0,25 ml 1432ui/0.25ml ABBOTT GMBH&CO.KG

3436ui/0.6mlB01AB08 REVIPARINUM SOL. INJ.CLIVARIN® 3436 UI/0,6 ml 3436ui/0.6ml ABBOTT GMBH&CO.KG

923 POLYGELINUMB05AA06

3.5%B05AA06 POLYGELINUM SOL. PERF.HAEMACCEL 3.5% THERASELECT GMBH

924 EPINEPHRINUMC01CA24

1mg/mlC01CA24 EPINEPHRINUM SOL. INJ.ADRENALINA 1 mg 1mg/ml TERAPIA SA

925 PIPERACILLINUM + TAZOBACTAMUMJ01CR05

J01CR05 PIPERACILLINUM + TAZOBACTAMUM LIOF. PT. SOL. INJ.TAZOCIN 2,25 WYETH LEDERLE PHARMA GMBH

TAZOCIN 4,5 WYETH LEDERLE PHARMA GMBH

926 CEFOPERAZONUMJ01DD12

1gJ01DD12 CEFOPERAZONUM PULB. PT. SOL. INJ.LYZONE 1 g 1g MEDICAROM GROUP S.R.L.

MEDOCEF 1 g 1g MEDOCHEMIE LTD.

2gJ01DD12 CEFOPERAZONUM PULB. PT. SOL. INJ.LYZONE 2 g 2g MEDICAROM GROUP S.R.L.

MEDOCEF 2 g 2g MEDOCHEMIE LTD.

500mgJ01DD12 CEFOPERAZONUM PULB. PT. SOL. INJ.CEFOZON 500 mg 500mg E.I.P.I.CO. MED S.R.L.

1gJ01DD12 CEFOPERAZONUM PULB. PT. SOL. INJ./PERF.I.M./I.V.CEFOZON 1 g 1g E.I.P.I.CO. MED S.R.L.

927 IMIPENEMUM + CILASTATINUMJ01DH51

J01DH51 IMIPENEMUM + CILASTATINUM PULB. PT. SOL. PERF.TIENAM I.V. MERCK SHARP & DOHME ROMANIA S.R.L.

928 LINEZOLIDUMJ01XX08

100mg/5mlJ01XX08 LINEZOLIDUM GRAN. PT. SUSP. ORALAZYVOXID® 100mg/5ml PFIZER EUROPE MA EEIG

2mg/mlJ01XX08 LINEZOLIDUM SOL. PERF.ZYVOXID® 2mg/ml PFIZER EUROPE MA EEIG

600mgJ01XX08 LINEZOLIDUM COMPR. FILM.ZYVOXID® 600mg PFIZER EUROPE MA EEIG

929 FLUCONAZOLUMJ02AC01

Prescriere limitata: Tratament de intretinere la pacienti cu meningita criptococica si imunosupresie.

Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie.

Tratamentul meningitei criptococice la pacientii care nu pot lua sau nu tolereaza amfotericina.

Tratamentul candidozelor severe si care pun in pericol viata la pacienti care nu tolereaza amfotericina.

Tratamentul candidozei orofaringiene la pacienti cu imunosupresie.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 100 mg 100mg KRKA D.D.

FLUCONAZOLE TEVA 100 mg 100mg TEVA PHARMACEUTICALS SRL

FLUCORIC 100 mg 100mg TERAPIA S.A.

FLUCOVIM 100 100mg VIM SPECTRUM SRL

FUNGOLON 100 mg 100mg BALKANPHARMA RAZGRAD AD

150mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 150 mg 150mg KRKA D.D.

DIFLUCAN 150 mg 150mg PFIZER EUROPE MA EEIG

FLUCONAZOL 150 mg 150mg OZONE LABORATORIES LTD.

FLUCONAZOL MEDICO UNO 150 mg 150mg MEDICO UNO PHARMACEUTICAL SRL

FLUCONAZOL MEDOCHEMIE 150 mg 150mg MEDOCHEMIE ROMANIA SRL

FLUCONAZOL SANDOZ® 150 150mg SANDOZ SRL

FLUCONAZOL TERAPIA 150 mg 150mg TERAPIA SA

FLUCONAZOLE TEVA 150 mg 150mg TEVA PHARMACEUTICALS SRL

FLUCORIC 150 mg 150mg TERAPIA S.A.

FLUCOVIM 150 150mg VIM SPECTRUM SRL

MYCOMAX 150 150mg ZENTIVA AS

MYCOSYST® 150 mg 150mg GEDEON RICHTER PLC.

200mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 200 mg 200mg KRKA D.D.

FLUCONAZOLE TEVA 200 mg 200mg TEVA PHARMACEUTICALS SRL

2mg/mlJ02AC01 FLUCONAZOLUM SOL. PERF.DIFLAZON® 2mg/ml KRKA D.D.

DIFLUCAN® 2mg/ml PFIZER EUROPE MA EEIG

MYCOMAX® INF 2mg/ml ZENTIVA AS

50mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 50 mg 50mg KRKA D.D.

DIFLUCAN 50 mg 50mg PFIZER EUROPE MA EEIG

FLUCONAZOL 50 mg 50mg ARENA GROUP SA

FLUCONAZOL MEDOCHEMIE 50 mg 50mg MEDOCHEMIE ROMANIA SRL

FLUCONAZOL SANDOZ® 50 50mg SANDOZ SRL

FLUCONAZOL TERAPIA 50 mg 50mg TERAPIA S.A.

FLUCONAZOLE TEVA 50 mg 50mg TEVA PHARMACEUTICALS SRL

FLUCORIC 50 mg 50mg TERAPIA S.A.

FLUCOVIM 50 50mg VIM SPECTRUM SRL

125 153/

Page 126: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

FUNGOLON 50 mg 50mg BALKANPHARMA RAZGRAD AD

50mg/5mlJ02AC01 FLUCONAZOLUM PULB. PT. SUSP. ORALADIFLUCAN® 50 mg/5 ml 50mg/5ml PFIZER EUROPE MA EEIG

930 VORICONAZOLUM ** Protocol: J012BJ02AC03

200mgJ02AC03 VORICONAZOLUM COMPR. FILM.VFEND 200mg 200mg PFIZER LTD.

200mgJ02AC03 VORICONAZOLUM PULB. PT. SOL. PERF.VFEND 200mg 200mg PFIZER LTD.

40mg/mlJ02AC03 VORICONAZOLUM PULB. PT. SUSP. ORALAVFEND 40 mg/ml 40mg/ml PFIZER LTD.

50mgJ02AC03 VORICONAZOLUM COMPR. FILM.VFEND 50mg 50mg PFIZER LTD.

932 VALGANCICLOVIRUM **J05AB14

Prescriere limitata: Tratamentul de initiere si mentinere pentru retinita cu citomegalovirus (CMV) la pacienti imunocompromisi.

450mgJ05AB14 VALGANCICLOVIRUM COMPR. FILM.VALCYTE® 450 mg 450mg ROCHE ROMANIA SRL

933 CICLOSPORINUML04AA01

Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant.

Monitorizarea atentă a pacienţilor este obligatorie.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgL04AA01 CICLOSPORINUM CAPS. MOIEQUORAL® 100 mg 100mg IVAX - PHARMACEUTICALS S.R.O.

100mg/mlL04AA01 CICLOSPORINUM SOL. ORALAEQUORAL® 100mg/ml IVAX - PHARMACEUTICALS S.R.O.

SANDIMMUN NEORAL® 100mg/ml NOVARTIS PHARMA GMBH

25mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL® 25 mg 25mg HEXAL AG

EQUORAL® 25 mg 25mg IVAX - PHARMACEUTICALS S.R.O.

SANDIMMUN NEORAL® 25mg NOVARTIS PHARMA GMBH

50mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL 50 mg 50mg HEXAL AG

EQUORAL® 50 mg 50mg IVAX - PHARMACEUTICALS S.R.O.

SANDIMMUN NEORAL® 50mg NOVARTIS PHARMA GMBH

935 TACROLIMUSUM **L04AA05

Prescriere limitata: Tratamentul rejetului de alogrefă rezistent la alte terapii imunosupresoare, la pacienţii adulţi.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

0,5mgL04AA05 TACROLIMUSUM CAPS. ELIB. PREL.ADVAGRAF 0,5mg 0,5mg ASTELLAS PHARMA GMBH

0.5mgL04AA05 TACROLIMUSUM CAPS.PROGRAF® 0,5 mg 0.5mg ASTELLAS PHARMA GMBH

Profilaxia rejetului de alogrefă la adulţii cu transplant cardiacPrescriere limitata:

1mgL04AA05 TACROLIMUSUM CAPS.PROGRAF® 1 mg 1mg ASTELLAS IRELAND CO. LTD.

Profilaxia rejetului de alogrefă la adulţii cu transplant cardiacPrescriere limitata:

1mgL04AA05 TACROLIMUSUM CAPS. ELIB. PREL.ADVAGRAF 1mg 1mg ASTELLAS PHARMA GMBH

5mgL04AA05 TACROLIMUSUM CAPS.PROGRAF® 5 mg 5mg ASTELLAS PHARMA GMBH

Profilaxia rejetului de alogrefă la adulţii cu transplant cardiacPrescriere limitata:

5mgL04AA05 TACROLIMUSUM CAPS. ELIB. PREL.ADVAGRAF 5mg 5mg ASTELLAS PHARMA GMBH

5mg/mlL04AA05 TACROLIMUSUM CONC. PT. SOL. PERF.PROGRAF® 5 mg/ml 5mg/ml ASTELLAS PHARMA GMBH

Profilaxia rejetului de alogrefă la adulţii cu transplant cardiacPrescriere limitata:

936 MYCOPHENOLATUM **L04AA06

180mgL04AA06 MYCOPHENOLATUM COMPR. FILM. GASTROREZ.MYFORTIC 180 mg 180mg NOVARTIS PHARMA GMBH

1g/5mlL04AA06 MYCOPHENOLATUM PULB. PT. SUSP. ORALACELLCEPT 1mg/5ml 1g/5ml ROCHE REGISTRATION LTD.

Profilaxia rejetului acut de grefă la pacienţii care primesc transplant alogen cardiac.Prescriere limitata:

250mgL04AA06 MYCOPHENOLATUM CAPS.CELLCEPT 250mg 250mg ROCHE REGISTRATION LTD.

MYFENAX 250mg 250mg TEVA PHARMA BV

Profilaxia rejetului acut de grefă la pacienţii care primesc transplant alogen cardiac.Prescriere limitata:

360mgL04AA06 MYCOPHENOLATUM COMPR. FILM. GASTROREZ.MYFORTIC 360 mg 360mg NOVARTIS PHARMA GMBH

500mgL04AA06 MYCOPHENOLATUM CAPS.MYFENAX 500mg 500mg TEVA PHARMA BV

500mgL04AA06 MYCOPHENOLATUM COMPR. FILM.CELLCEPT 500mg 500mg ROCHE REGISTRATION LTD.

Profilaxia rejetului acut de grefă la pacienţii care primesc transplant alogen cardiac.Prescriere limitata:

500mgL04AA06 MYCOPHENOLATUM PULB. PT. CONC. PT. SOL. PERF.CELLCEPT 500mg 500mg ROCHE REGISTRATION LTD.

Profilaxia rejetului acut de grefă la pacienţii care primesc transplant alogen cardiac.Prescriere limitata:

126 153/

Page 127: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

SUBLISTA C2-P9: PROGRAM NATIONAL DE TRANSPLANT DE ORGANE, TESUTURI SI CELULE DE ORIGINE UMANA. P9.3

TRANSPLANT HEPATIC

937 ACIDUM URSODEOXYCHOLICUMA05AA02

Nu se va prescrie in regim compensat pentru tratamentul litiazei biliare.NOTA:

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

250mgA05AA02 ACIDUM URSODEOXYCHOLICUM CAPS.URSOFALK® 250mg DR. FALK PHARMA GMBH

URSOSAN 250mg PRO. MED. CS PRAHA AS

938 ENOXAPARINUMB01AB05

2000ui

anti-Xa/0.2ml

B01AB05 ENOXAPARINUM SOL. INJ.

CLEXANE 2000ui anti-Xa/0.2ml 2000ui

anti-Xa/0.2ml

LAB. AVENTIS

4000ui

anti-Xa/0,4ml

B01AB05 ENOXAPARINUM SOL. INJ.

CLEXANE 4000ui anti-Xa/0.4ml 4000ui

anti-Xa/0,4ml

LAB. AVENTIS

6000ui

anti-Xa/0.6ml

B01AB05 ENOXAPARINUM SOL. INJ.

CLEXANE 6000ui anti-Xa/0.6ml 6000ui

anti-Xa/0.6ml

LAB. AVENTIS

8000ui

anti-Xa/0.8ml

B01AB05 ENOXAPARINUM SOL. INJ.

CLEXANE 8000ui anti-Xa/0.8ml 8000ui

anti-Xa/0.8ml

LAB. AVENTIS

2000ui

anti-Xa/0.2ml

B01AB05 ENOXAPARINUM SOL. INJ.

CLEXANE 2000ui anti-Xa/0.2ml 2000ui

anti-Xa/0.2ml

LAB. AVENTIS

4000ui

anti-Xa/0,4ml

B01AB05 ENOXAPARINUM SOL. INJ.

CLEXANE 4000ui anti-Xa/0.4ml 4000ui

anti-Xa/0,4ml

LAB. AVENTIS

6000ui

anti-Xa/0.6ml

B01AB05 ENOXAPARINUM SOL. INJ.

CLEXANE 6000ui anti-Xa/0.6ml 6000ui

anti-Xa/0.6ml

LAB. AVENTIS

939 REVIPARINUMB01AB08

1432ui/0.25mlB01AB08 REVIPARINUM SOL. INJ.CLIVARIN® 1432UI/0,25 ml 1432ui/0.25ml ABBOTT GMBH&CO.KG

3436ui/0.6mlB01AB08 REVIPARINUM SOL. INJ.CLIVARIN® 3436 UI/0,6 ml 3436ui/0.6ml ABBOTT GMBH&CO.KG

940 ILOPROSTUM **B01AC11

20µg/mlB01AC11 ILOPROSTUM CONC. PT. SOL. PERF.ILOMEDIN® 20 20µg/ml SCHERING AG

941 ALTEPLASUM **B01AD02

50mgB01AD02 ALTEPLASUM LIOF. + SOLV. PT. SOL. INJ.ACTILYSE 50mg BOEHRINGER INGELHEIM INT. GMBH

944 COMBINATII (SPIRONOLACTONUM+FUROSEMIDUM)C03EB01Electroliţii serici trebuie să fie verificaţi periodic.

C03EB01 COMBINATII

(SPIRONOLACTONUM+FUROSEMIDUM)

CAPS.

DIUREX 50 TERAPIA SA

945 DESMOPRESSINUMH01BA02

H01BA02 DESMOPRESSINUMMINIRIN 0,2 mg 0.2mg FERRING AB

0.2mgH01BA02 DESMOPRESSINUM COMPR.MINIRIN 0,2 mg 0.2mg FERRING AB

946 PIPERACILLINUM + TAZOBACTAMUMJ01CR05

J01CR05 PIPERACILLINUM + TAZOBACTAMUM LIOF. PT. SOL. INJ.TAZOCIN 2,25 WYETH LEDERLE PHARMA GMBH

TAZOCIN 4,5 WYETH LEDERLE PHARMA GMBH

947 LINEZOLIDUMJ01XX08

100mg/5mlJ01XX08 LINEZOLIDUM GRAN. PT. SUSP. ORALAZYVOXID® 100mg/5ml PFIZER EUROPE MA EEIG

2mg/mlJ01XX08 LINEZOLIDUM SOL. PERF.ZYVOXID® 2mg/ml PFIZER EUROPE MA EEIG

600mgJ01XX08 LINEZOLIDUM COMPR. FILM.ZYVOXID® 600mg PFIZER EUROPE MA EEIG

948 VORICONAZOLUM ** Protocol: J012BJ02AC03

200mgJ02AC03 VORICONAZOLUM COMPR. FILM.VFEND 200mg 200mg PFIZER LTD.

200mgJ02AC03 VORICONAZOLUM PULB. PT. SOL. PERF.VFEND 200mg 200mg PFIZER LTD.

40mg/mlJ02AC03 VORICONAZOLUM PULB. PT. SUSP. ORALAVFEND 40 mg/ml 40mg/ml PFIZER LTD.

50mgJ02AC03 VORICONAZOLUM COMPR. FILM.

127 153/

Page 128: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

VFEND 50mg 50mg PFIZER LTD.

949 CASPOFUNGINUM ** Protocol: J010DJ02AX04

50mgJ02AX04 CASPOFUNGINUM PULB. PT. CONC. PT. SOL. PERF.CANCIDAS 50 mg 50mg MERCK SHARP & DOHME LTD

70mgJ02AX04 CASPOFUNGINUM PULB. PT. CONC. PT. SOL. PERF.CANCIDAS 70 mg 70mg MERCK SHARP & DOHME LTD

951 VALGANCICLOVIRUM **J05AB14

Prescriere limitata: Tratamentul de initiere si mentinere pentru retinita cu citomegalovirus (CMV) la pacienti imunocompromisi.

450mgJ05AB14 VALGANCICLOVIRUM COMPR. FILM.VALCYTE® 450 mg 450mg ROCHE ROMANIA SRL

953 FILGRASTIMUM (G-CSF)L03AA02

30MU/0.5mlL03AA02 FILGRASTIMUM (G-CSF) SOL. INJ.NEUPOGEN® 30MU/0.5ml AMGEN EUROPE B.V.

48MU/0.5mlL03AA02 FILGRASTIMUM (G-CSF) SOL. INJ.NEUPOGEN® 48MU/0.5ml AMGEN EUROPE B.V.

954 CICLOSPORINUML04AA01

Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant.

Monitorizarea atentă a pacienţilor este obligatorie.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgL04AA01 CICLOSPORINUM CAPS. MOIEQUORAL® 100 mg 100mg IVAX - PHARMACEUTICALS S.R.O.

100mg/mlL04AA01 CICLOSPORINUM SOL. ORALAEQUORAL® 100mg/ml IVAX - PHARMACEUTICALS S.R.O.

SANDIMMUN NEORAL® 100mg/ml NOVARTIS PHARMA GMBH

25mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL® 25 mg 25mg HEXAL AG

EQUORAL® 25 mg 25mg IVAX - PHARMACEUTICALS S.R.O.

SANDIMMUN NEORAL® 25mg NOVARTIS PHARMA GMBH

50mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL 50 mg 50mg HEXAL AG

EQUORAL® 50 mg 50mg IVAX - PHARMACEUTICALS S.R.O.

SANDIMMUN NEORAL® 50mg NOVARTIS PHARMA GMBH

955 TACROLIMUSUM **L04AA05

Prescriere limitata: Tratamentul rejetului de alogrefă rezistent la alte terapii imunosupresoare, la pacienţii adulţi.

Profilaxia rejetului de grefa la pacientii care primesc transplant hepatic alogen.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

0,5mgL04AA05 TACROLIMUSUM CAPS. ELIB. PREL.ADVAGRAF 0,5mg 0,5mg ASTELLAS PHARMA GMBH

0.5mgL04AA05 TACROLIMUSUM CAPS.PROGRAF® 0,5 mg 0.5mg ASTELLAS PHARMA GMBH

1mgL04AA05 TACROLIMUSUM CAPS.PROGRAF® 1 mg 1mg ASTELLAS IRELAND CO. LTD.

1mgL04AA05 TACROLIMUSUM CAPS. ELIB. PREL.ADVAGRAF 1mg 1mg ASTELLAS PHARMA GMBH

5mgL04AA05 TACROLIMUSUM CAPS.PROGRAF® 5 mg 5mg ASTELLAS PHARMA GMBH

5mgL04AA05 TACROLIMUSUM CAPS. ELIB. PREL.ADVAGRAF 5mg 5mg ASTELLAS PHARMA GMBH

5mg/mlL04AA05 TACROLIMUSUM CONC. PT. SOL. PERF.PROGRAF® 5 mg/ml 5mg/ml ASTELLAS PHARMA GMBH

956 MYCOPHENOLATUM **L04AA06

Prescriere limitata: Profilaxia rejetului acut de grefă la pacienţii care primesc transplant alogen hepatic.

180mgL04AA06 MYCOPHENOLATUM COMPR. FILM. GASTROREZ.MYFORTIC 180 mg 180mg NOVARTIS PHARMA GMBH

1g/5mlL04AA06 MYCOPHENOLATUM PULB. PT. SUSP. ORALACELLCEPT 1mg/5ml 1g/5ml ROCHE REGISTRATION LTD.

Profilaxia rejetului acut de grefă la pacienţii care primesc transplant alogen hepaticPrescriere limitata:

250mgL04AA06 MYCOPHENOLATUM CAPS.CELLCEPT 250mg 250mg ROCHE REGISTRATION LTD.

MYFENAX 250mg 250mg TEVA PHARMA BV

Profilaxia rejetului acut de grefă la pacienţii care primesc transplant alogen hepaticPrescriere limitata:

360mgL04AA06 MYCOPHENOLATUM COMPR. FILM. GASTROREZ.MYFORTIC 360 mg 360mg NOVARTIS PHARMA GMBH

500mgL04AA06 MYCOPHENOLATUM CAPS.MYFENAX 500mg 500mg TEVA PHARMA BV

Profilaxia rejetului acut de grefă la pacienţii care primesc transplant alogen hepaticPrescriere limitata:

500mgL04AA06 MYCOPHENOLATUM COMPR. FILM.CELLCEPT 500mg 500mg ROCHE REGISTRATION LTD.

500mgL04AA06 MYCOPHENOLATUM PULB. PT. CONC. PT. SOL. PERF.CELLCEPT 500mg 500mg ROCHE REGISTRATION LTD.

957 SIROLIMUS **L04AA10

1mgL04AA10 SIROLIMUS COMPR. FILM.RAPAMUNE 1mg 1mg WYETH EUROPA LTD.

Monitorizarea atentă a pacienţilor este obligatorie

128 153/

Page 129: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

SUBLISTA C2-P9: PROGRAM NATIONAL DE TRANSPLANT DE ORGANE, TESUTURI SI CELULE DE ORIGINE UMANA. P9.4

TRANSPLANT RENAL, TRANSPLANT COMBINAT RINICHI SI PANCREAS

958 ACIDUM URSODEOXYCHOLICUMA05AA02

Nu se va prescrie in regim compensat pentru tratamentul litiazei biliareNOTA:

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

250mgA05AA02 ACIDUM URSODEOXYCHOLICUM CAPS.URSOFALK® 250mg DR. FALK PHARMA GMBH

URSOSAN 250mg PRO. MED. CS PRAHA AS

959 ALFACALCIDOLUMA11CC03

0.25µgA11CC03 ALFACALCIDOLUM CAPS. MOIALPHA D3 0,25 µg 0.25µg TEVA PHARMACEUTICALS SRL

0.50µgA11CC03 ALFACALCIDOLUM CAPS. MOIALPHA D3 0.50 µg 0.50µg TEVA PHARMACEUTICALS S.R.L.

960 ENOXAPARINUMB01AB05

2000ui

anti-Xa/0.2ml

B01AB05 ENOXAPARINUM SOL. INJ.

CLEXANE 2000ui anti-Xa/0.2ml 2000ui

anti-Xa/0.2ml

LAB. AVENTIS

4000ui

anti-Xa/0,4ml

B01AB05 ENOXAPARINUM SOL. INJ.

CLEXANE 4000ui anti-Xa/0.4ml 4000ui

anti-Xa/0,4ml

LAB. AVENTIS

6000ui

anti-Xa/0.6ml

B01AB05 ENOXAPARINUM SOL. INJ.

CLEXANE 6000ui anti-Xa/0.6ml 6000ui

anti-Xa/0.6ml

LAB. AVENTIS

8000ui

anti-Xa/0.8ml

B01AB05 ENOXAPARINUM SOL. INJ.

CLEXANE 8000ui anti-Xa/0.8ml 8000ui

anti-Xa/0.8ml

LAB. AVENTIS

2000ui

anti-Xa/0.2ml

B01AB05 ENOXAPARINUM SOL. INJ.

CLEXANE 2000ui anti-Xa/0.2ml 2000ui

anti-Xa/0.2ml

LAB. AVENTIS

4000ui

anti-Xa/0,4ml

B01AB05 ENOXAPARINUM SOL. INJ.

CLEXANE 4000ui anti-Xa/0.4ml 4000ui

anti-Xa/0,4ml

LAB. AVENTIS

6000ui

anti-Xa/0.6ml

B01AB05 ENOXAPARINUM SOL. INJ.

CLEXANE 6000ui anti-Xa/0.6ml 6000ui

anti-Xa/0.6ml

LAB. AVENTIS

961 DALTEPARINUMB01AB04

10000ui/mlB01AB04 DALTEPARINUM SOL. INJ.FRAGMIN 10000 UI/ml 10000ui/ml PFIZER EUROPE MA EEIG

15000ui/0.6mlB01AB04 DALTEPARINUM SOL. INJ.FRAGMIN15000 UI/0,6 ml 15000ui/0.6ml PFIZER EUROPE MA EEIG

2500ui/0.2mlB01AB04 DALTEPARINUM SOL. INJ.FRAGMIN 2500 UI/0,2 ml 2500ui/0.2ml PFIZER EUROPE MA EEIG

5000ui/0.2mlB01AB04 DALTEPARINUM SOL. INJ.FRAGMIN 5000 UI/0,2 ml 5000ui/0.2ml PFIZER EUROPE MA EEIG

7500ui/0.3mlB01AB04 DALTEPARINUM SOL. INJ.FRAGMIN 7500 UI/0,3 ml 7500ui/0.3ml PFIZER EUROPE MA EEIG

962 REVIPARINUMB01AB08

1432ui/0.25mlB01AB08 REVIPARINUM SOL. INJ.CLIVARIN® 1432UI/0,25 ml 1432ui/0.25ml ABBOTT GMBH&CO.KG

3436ui/0.6mlB01AB08 REVIPARINUM SOL. INJ.CLIVARIN® 3436 UI/0,6 ml 3436ui/0.6ml ABBOTT GMBH&CO.KG

963 EPOETINUM ALFAB03XA01

10000ui/mlB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 10000 UI 10000ui/ml JOHNSON & JOHNSON D.O.O.

1000UI/0.5mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 1000 UI/0,5 ml 1000UI/0.5ml RENAMED FARMA S.R.L.

EPREX® 1000 UI 1000ui/0.5ml JOHNSON & JOHNSON D.O.O.

2000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPOPHAR 2000 U.I. 2000UI GULF PHARMACEUTICAL IND. S.R.L.

2000ui/0.5mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 2000 UI/0,5 ml 2000UI/0.5ml RENAMED FARMA S.R.L.

EPREX® 2000 UI 2000ui/0.5ml JOHNSON & JOHNSON D.O.O.

2000UI/1mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 2000 UI/1 ml 2000UI/1ml RENAMED FARMA S.R.L.

3000ui/0.3mlB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 3000 UI 3000ui/0.3ml JOHNSON & JOHNSON D.O.O.

40 000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 40 000 UI 40 000UI JOHNSON & JOHNSON D.O.O.

4000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPOPHAR 4000 U.I. 4000UI GULF PHARMACEUTICAL IND. S.R.L.

4000ui/0.4mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 4000 UI/0,4 ml 4000UI/0.4ml RENAMED FARMA S.R.L.

129 153/

Page 130: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

EPREX® 4000 UI 4000ui/0.4ml JOHNSON & JOHNSON D.O.O.

4000UI/1mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 4000 UI/1 ml 4000UI/1ml RENAMED FARMA S.R.L.

B03XA01 EPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTABINOCRIT 1000UI/0,5ml SANDOZ GMBH

B03XA01 EPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTABINOCRIT 2000UI/1,0ml SANDOZ GMBH

B03XA01 EPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTABINOCRIT 3000UI/0,3ml SANDOZ GMBH

B03XA01 EPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTABINOCRIT 4000UI/0,4ml SANDOZ GMBH

964 EPOETINUM BETAB03XA01

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 10000 UI 10000UI/0,6ml ROCHE REGISTRATION L

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 1000 UI 1000UI/0,3ml ROCHE REGISTRATION L

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 2000 UI 2000UI/0,3ml ROCHE REGISTRATION L

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 4000 UI 4000UI/0,3ml ROCHE REGISTRATION L

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 5000 UI 5000UI/0,3ml ROCHE REGISTRATION L

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 500 UI 500UI/0,3ml ROCHE REGISTRATION L

965 POLYGELINUMB05AA06

3.5%B05AA06 POLYGELINUM SOL. PERF.HAEMACCEL 3.5% THERASELECT GMBH

966 OCTREOTIDUM ** Protocol: H010CH01CB02

0.1mg/mlH01CB02 OCTREOTIDUM SOL. INJ.SANDOSTATIN® 0.1mg/ml NOVARTIS PHARMA GMBH

10mgH01CB02 OCTREOTIDUM PULB.+SOLV.PT.SUSP. INJ. (I.M.) CU ELIB.

PRELUNG.SANDOSTATIN LAR 10 mg 10mg NOVARTIS PHARMA GMBH

20mgH01CB02 OCTREOTIDUM PULB. + SOLV. PT. SUSP. INJ. (I.M.) CU ELIB.

PRELUSANDOSTATIN LAR 20 mg 20mg NOVARTIS PHARMA GMBH

30mgH01CB02 OCTREOTIDUM PULB.+SOLV.PT.SUSP. INJ. (I.M.) CU ELIB.

PRELUNG.SANDOSTATIN LAR 30 mg 30mg NOVARTIS PHARMA GMBH

967 PIPERACILLINUM + TAZOBACTAMUMJ01CR05

J01CR05 PIPERACILLINUM + TAZOBACTAMUM LIOF. PT. SOL. INJ.TAZOCIN 2,25 WYETH LEDERLE PHARMA GMBH

TAZOCIN 4,5 WYETH LEDERLE PHARMA GMBH

968 TEICOPLANINUMJ01XA02

400mgJ01XA02 TEICOPLANINUM LIOF. + SOLV. PT. SOL. INJ.TARGOCID® 400 mg 400mg AVENTIS PHARMA LTD.

969 LINEZOLIDUMJ01XX08

100mg/5mlJ01XX08 LINEZOLIDUM GRAN. PT. SUSP. ORALAZYVOXID® 100mg/5ml PFIZER EUROPE MA EEIG

2mg/mlJ01XX08 LINEZOLIDUM SOL. PERF.ZYVOXID® 2mg/ml PFIZER EUROPE MA EEIG

600mgJ01XX08 LINEZOLIDUM COMPR. FILM.ZYVOXID® 600mg PFIZER EUROPE MA EEIG

970 KETOCONAZOLUMJ02AB02

Prescriere limitata: Candidoza genitala simptomatica recurenta dupa tratamentul local a cel putin doua episoade.

Candidoza orala la persoanele imunocompromise sever la care tratamentul local nu a avut rezultate

Micoze sistemice la care alte forme de terapie antifungica nu au avut efect.

A fost raportată hepatotoxicitate la ketoconazol.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

200mgJ02AB02 KETOCONAZOLUM COMPR.KEFUNGIN 200mg ANTIBIOTICE SA

KETOCONAZOL 200 mg 200mg MAGISTRA C & C

KETOSTIN 200 mg 200mg AC HELCOR SRL

NIZORAL 200mg JANSSEN PHARMACEUTICA NV

NIZORAL 200 mg 200mg TERAPIA SA

200mgJ02AB02 KETOCONAZOLUM COMPR.KEFUNGIN 200mg ANTIBIOTICE SA

KETOCONAZOL 200 mg 200mg MAGISTRA C & C

KETOSTIN 200 mg 200mg AC HELCOR SRL

NIZORAL 200mg JANSSEN PHARMACEUTICA NV

NIZORAL 200 mg 200mg TERAPIA SA

971 FLUCONAZOLUMJ02AC01

Prescriere limitata: Tratament de intretinere la pacienti cu meningita criptococica si imunosupresie.

Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie.

Tratamentul meningitei criptococice la pacientii care nu pot lua sau nu tolereaza amfotericina.

Tratamentul candidozelor severe si care pun in pericol viata la pacienti care nu tolereaza amfotericina.

Tratamentul candidozei orofaringiene la pacienti cu imunosupresie.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgJ02AC01 FLUCONAZOLUM CAPS.

130 153/

Page 131: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

DIFLAZON 100 mg 100mg KRKA D.D.

FLUCONAZOLE TEVA 100 mg 100mg TEVA PHARMACEUTICALS SRL

FLUCORIC 100 mg 100mg TERAPIA S.A.

FLUCOVIM 100 100mg VIM SPECTRUM SRL

FUNGOLON 100 mg 100mg BALKANPHARMA RAZGRAD AD

150mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 150 mg 150mg KRKA D.D.

DIFLUCAN 150 mg 150mg PFIZER EUROPE MA EEIG

FLUCONAZOL 150 mg 150mg OZONE LABORATORIES LTD.

FLUCONAZOL MEDICO UNO 150 mg 150mg MEDICO UNO PHARMACEUTICAL SRL

FLUCONAZOL MEDOCHEMIE 150 mg 150mg MEDOCHEMIE ROMANIA SRL

FLUCONAZOL SANDOZ® 150 150mg SANDOZ SRL

FLUCONAZOL TERAPIA 150 mg 150mg TERAPIA SA

FLUCONAZOLE TEVA 150 mg 150mg TEVA PHARMACEUTICALS SRL

FLUCORIC 150 mg 150mg TERAPIA S.A.

FLUCOVIM 150 150mg VIM SPECTRUM SRL

MYCOMAX 150 150mg ZENTIVA AS

MYCOSYST® 150 mg 150mg GEDEON RICHTER PLC.

200mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 200 mg 200mg KRKA D.D.

FLUCONAZOLE TEVA 200 mg 200mg TEVA PHARMACEUTICALS SRL

2mg/mlJ02AC01 FLUCONAZOLUM SOL. PERF.DIFLAZON® 2mg/ml KRKA D.D.

DIFLUCAN® 2mg/ml PFIZER EUROPE MA EEIG

MYCOMAX® INF 2mg/ml ZENTIVA AS

50mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 50 mg 50mg KRKA D.D.

DIFLUCAN 50 mg 50mg PFIZER EUROPE MA EEIG

FLUCONAZOL 50 mg 50mg ARENA GROUP SA

FLUCONAZOL MEDOCHEMIE 50 mg 50mg MEDOCHEMIE ROMANIA SRL

FLUCONAZOL SANDOZ® 50 50mg SANDOZ SRL

FLUCONAZOL TERAPIA 50 mg 50mg TERAPIA S.A.

FLUCONAZOLE TEVA 50 mg 50mg TEVA PHARMACEUTICALS SRL

FLUCORIC 50 mg 50mg TERAPIA S.A.

FLUCOVIM 50 50mg VIM SPECTRUM SRL

FUNGOLON 50 mg 50mg BALKANPHARMA RAZGRAD AD

50mg/5mlJ02AC01 FLUCONAZOLUM PULB. PT. SUSP. ORALADIFLUCAN® 50 mg/5 ml 50mg/5ml PFIZER EUROPE MA EEIG

972 ITRACONAZOLUMJ02AC02

100mgJ02AC02 ITRACONAZOLUM CAPS.ITRACONAZOL 100 mg 100mg TERAPIA S.A.

OMICRAL 100 mg 100mg MEDICO UNO PHARMACEUTICAL S.R.L.

ORUNGAL 100mg JANSSEN PHARMACEUTICA NV

SPORILIN 100 mg 100mg GEDEON RICHTER ROMANIA S.A.

Sporotricoza sistemicaPrescriere limitata:

Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresiePrescriere limitata:

Tratamentul candidozei orofaringiene la pacienti cu imunosupresiePrescriere limitata:

973 VORICONAZOLUM ** Protocol: J012BJ02AC03

200mgJ02AC03 VORICONAZOLUM COMPR. FILM.VFEND 200mg 200mg PFIZER LTD.

200mgJ02AC03 VORICONAZOLUM PULB. PT. SOL. PERF.VFEND 200mg 200mg PFIZER LTD.

40mg/mlJ02AC03 VORICONAZOLUM PULB. PT. SUSP. ORALAVFEND 40 mg/ml 40mg/ml PFIZER LTD.

50mgJ02AC03 VORICONAZOLUM COMPR. FILM.VFEND 50mg 50mg PFIZER LTD.

974 CASPOFUNGINUM ** Protocol: J010DJ02AX04

50mgJ02AX04 CASPOFUNGINUM PULB. PT. CONC. PT. SOL. PERF.CANCIDAS 50 mg 50mg MERCK SHARP & DOHME LTD

70mgJ02AX04 CASPOFUNGINUM PULB. PT. CONC. PT. SOL. PERF.CANCIDAS 70 mg 70mg MERCK SHARP & DOHME LTD

976 ACICLOVIRUMJ05AB01

200mgJ05AB01 ACICLOVIRUM CAPS.ACICLOVIR 200 mg 200mg SLAVIA PHARM SRL

EUVIROX 200 mg 200mg EUROPHARM SA

200mgJ05AB01 ACICLOVIRUM COMPR.ACICLOVIR 200 mg 200mg TERAPIA SA

CLOVIRAL 200 mg 200mg ANTIBIOTICE SA

ZOVIRAX 200mg GLAXO WELLCOME FOUNDATION LTD.

200mgJ05AB01 ACICLOVIRUM COMPR. DISP.ACICLOVIR 200 mg 200mg OZONE LABORATORIES LTD.

LOVIR 200 mg 200mg RANBAXY UK LIMITED

250mgJ05AB01 ACICLOVIRUM PULB. PT. SOL. INJ./PERF.VIROLEX 250mg KRKA D.D. NOVO MESTO

400mgJ05AB01 ACICLOVIRUM CAPS.ACICLOVIR 400 mg 400mg ARENA GROUP S.A.

400mgJ05AB01 ACICLOVIRUM COMPR.ACICLOVIR 400 mg 400mg EGIS PHARMACEUTICALS P.L.C.

400mgJ05AB01 ACICLOVIRUM COMPR. FILM.ACIKLOVIR 400mg A & G MED TRADING S.R.L.

977 VALGANCICLOVIRUM **J05AB14

Prescriere limitata: Tratamentul de initiere si mentinere pentru retinita cu citomegalovirus (CMV) la pacienti imunocompromisi.

450mgJ05AB14 VALGANCICLOVIRUM COMPR. FILM.

131 153/

Page 132: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

VALCYTE® 450 mg 450mg ROCHE ROMANIA SRL

978 VALACYCLOVIRUMJ05AB11

500mgJ05AB11 VALACYCLOVIRUM COMPR. FILM.VALTREX 500 mg 500mg THE WELLCOME FOUNDATION LTD.

Profilaxia infectiei si bolii cu citomegalovirus in urma transplantului renal la pacientii cu risc de boala cu citomegalovirusPrescriere limitata:

980 CYCLOPHOSPHAMIDUML01AA01

1gL01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. INJ./PERF.ENDOXAN® 1 g 1g BAXTER ONCOLOGY GMBH

200mgL01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. PERF./INJ. I.V.ENDOXAN 200 mg 200mg ACTAVIS S.R.L.

500mgL01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. INJ./PERF.ENDOXAN® 500 mg 500mg BAXTER ONCOLOGY GMBH

50mgL01AA01 CYCLOPHOSPHAMIDUM DRAJ.ENDOXAN® 50 mg 50mg BAXTER ONCOLOGY GMBH

981 FILGRASTIMUM (G-CSF)L03AA02

30MU/0.5mlL03AA02 FILGRASTIMUM (G-CSF) SOL. INJ.NEUPOGEN® 30MU/0.5ml AMGEN EUROPE B.V.

48MU/0.5mlL03AA02 FILGRASTIMUM (G-CSF) SOL. INJ.NEUPOGEN® 48MU/0.5ml AMGEN EUROPE B.V.

982 CICLOSPORINUML04AA01

Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant.

Monitorizarea atentă a pacienţilor este obligatorie.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgL04AA01 CICLOSPORINUM CAPS. MOIEQUORAL® 100 mg 100mg IVAX - PHARMACEUTICALS S.R.O.

100mg/mlL04AA01 CICLOSPORINUM SOL. ORALAEQUORAL® 100mg/ml IVAX - PHARMACEUTICALS S.R.O.

SANDIMMUN NEORAL® 100mg/ml NOVARTIS PHARMA GMBH

25mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL® 25 mg 25mg HEXAL AG

EQUORAL® 25 mg 25mg IVAX - PHARMACEUTICALS S.R.O.

SANDIMMUN NEORAL® 25mg NOVARTIS PHARMA GMBH

50mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL 50 mg 50mg HEXAL AG

EQUORAL® 50 mg 50mg IVAX - PHARMACEUTICALS S.R.O.

SANDIMMUN NEORAL® 50mg NOVARTIS PHARMA GMBH

984 TACROLIMUSUM **L04AA05

Prescriere limitata: Profilaxia rejetului de alogrefă la adulţii cu transplant renal.

Tratamentul rejetului de alogrefă rezistent la alte terapii imunosupresoare, la pacienţii adulţi.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

0,5mgL04AA05 TACROLIMUSUM CAPS. ELIB. PREL.ADVAGRAF 0,5mg 0,5mg ASTELLAS PHARMA GMBH

0.5mgL04AA05 TACROLIMUSUM CAPS.PROGRAF® 0,5 mg 0.5mg ASTELLAS PHARMA GMBH

1mgL04AA05 TACROLIMUSUM CAPS.PROGRAF® 1 mg 1mg ASTELLAS IRELAND CO. LTD.

1mgL04AA05 TACROLIMUSUM CAPS. ELIB. PREL.ADVAGRAF 1mg 1mg ASTELLAS PHARMA GMBH

5mgL04AA05 TACROLIMUSUM CAPS.PROGRAF® 5 mg 5mg ASTELLAS PHARMA GMBH

5mgL04AA05 TACROLIMUSUM CAPS. ELIB. PREL.ADVAGRAF 5mg 5mg ASTELLAS PHARMA GMBH

5mg/mlL04AA05 TACROLIMUSUM CONC. PT. SOL. PERF.PROGRAF® 5 mg/ml 5mg/ml ASTELLAS PHARMA GMBH

985 MYCOPHENOLATUM **L04AA06

Prescriere limitata: Profilaxia rejetului acut de grefă la pacienţii care primesc transplant alogen renal.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

180mgL04AA06 MYCOPHENOLATUM COMPR. FILM. GASTROREZ.MYFORTIC 180 mg 180mg NOVARTIS PHARMA GMBH

1g/5mlL04AA06 MYCOPHENOLATUM PULB. PT. SUSP. ORALACELLCEPT 1mg/5ml 1g/5ml ROCHE REGISTRATION LTD.

250mgL04AA06 MYCOPHENOLATUM CAPS.CELLCEPT 250mg 250mg ROCHE REGISTRATION LTD.

MYFENAX 250mg 250mg TEVA PHARMA BV

360mgL04AA06 MYCOPHENOLATUM COMPR. FILM. GASTROREZ.MYFORTIC 360 mg 360mg NOVARTIS PHARMA GMBH

500mgL04AA06 MYCOPHENOLATUM CAPS.MYFENAX 500mg 500mg TEVA PHARMA BV

500mgL04AA06 MYCOPHENOLATUM COMPR. FILM.CELLCEPT 500mg 500mg ROCHE REGISTRATION LTD.

500mgL04AA06 MYCOPHENOLATUM PULB. PT. CONC. PT. SOL. PERF.CELLCEPT 500mg 500mg ROCHE REGISTRATION LTD.

986 DACLIZUMABUM **L04AA08

Prescriere limitata: Profilaxia rejectiei acute de organ în transplantul renal alogen de novo şi se utilizează concomitent cu o schemă de tratament cu imunosupresoare,

incluzând ciclosporină şi glucocorticoizi, la pacienţii care nu sunt hiperimunizaţi.

5mg/mlL04AA08 DACLIZUMABUM CONC. PT. SOL. PERF.ZENAPAX 5 mg/ml 5mg/ml ROCHE REGISTRATION LTD.

987 BASILIXIMABUM **L04AA09

132 153/

Page 133: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

Prescriere limitata: Profilaxia rejetului acut de organ în transplantul renal alogen de novo la pacienţii adulţi şi copii. Se utilizează concomitent cu tratamentul imunosupresor cu

ciclosporină microemulsionată şi corticosteroizi, la pacienţii cu mai puţin de 80% anticorpi reactivi, sau în tratament imunosupresor de întreţinere triplu cu

ciclosporină microemulsionată, corticosteroizi şi azatioprină sau mofetil micofenolat.

20mgL04AA09 BASILIXIMABUM LIOF. + SOLV. PT. SOL. INJ./PERF.SIMULECT 20 mg 20mg NOVARTIS EUROPHARM LTD.

988 SIROLIMUS **L04AA10

Prescriere limitata: Profilaxia rejetului de organ la pacienţii adulţi cu transplant renal şi risc imunologic mic sau moderat.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

1mgL04AA10 SIROLIMUS COMPR. FILM.RAPAMUNE 1mg 1mg WYETH EUROPA LTD.

989 AZATHIOPRINUML04AX01

50mgL04AX01 AZATHIOPRINUM COMPR. FILM.IMURAN® 50mg THE WELLCOME FOUNDATION LTD.

990 ACIDUM ALENDRONICUMM05BA04

10mgM05BA04 ACIDUM ALENDRONICUM COMPR.FOSAMAX 10 mg 10mg MERCK SHARP & DOHME S.R.L.

70 mgM05BA04 ACIDUM ALENDRONICUM COMPR.TEVA NAT 70 mg TEVA PHARMACEUTICALS SRL

70mgM05BA04 ACIDUM ALENDRONICUM COMPR.FOSAMAX 70 mg 70mg MERCK SHARP & DOHME S.R.L.

991 PETHIDINUMN02AB02

50mg/mlN02AB02 PETHIDINUM SOL. INJ.MIALGIN® 100 mg/2 ml 50mg/ml ZENTIVA SA

993 REVIPARINUMB01AB08

B01AB08 REVIPARINUM SOL. INJ.CLIVARIN (R) 1432UI/0,25 ml 1432ui/0.25ml ABBOTT GMBH&CO.KG

CLIVARIN® 1432UI/0,25 ml 1432ui/0.25ml ABBOTT GMBH&CO.KG

B01AB08 REVIPARINUM SOL. INJ.CLIVARIN (R) 3436 UI/0,6 ml 3436ui/0.6ml ABBOTT GMBH&CO.KG

CLIVARIN® 3436 UI/0,6 ml 3436ui/0.6ml ABBOTT GMBH&CO.KG

994 POLYGELINUMB05AA06

3.5%B05AA06 POLYGELINUM SOL. PERF.HAEMACCEL 3.5% THERASELECT GMBH

995 LINEZOLIDUMJ01XX08

J01XX08 LINEZOLIDUM GRAN. PT. SUSP. ORALAZYVOXID (R) 100mg/5ml PFIZER EUROPE MA EEI

ZYVOXID® 100mg/5ml PFIZER EUROPE MA EEIG

J01XX08 LINEZOLIDUM SOL. PERF.ZYVOXID (R) 2mg/ml PFIZER EUROPE MA EEI

ZYVOXID® 2mg/ml PFIZER EUROPE MA EEIG

J01XX08 LINEZOLIDUM COMPR. FILM.ZYVOXID (R) 600mg PFIZER EUROPE MA EEI

ZYVOXID® 600mg PFIZER EUROPE MA EEIG

996 VORICONAZOLUM ** Protocol: J012BJ02AC03

J02AC03 VORICONAZOLUM COMPR. FILM.VFEND (R) 200mg PFIZER LIMITED

VFEND 200mg 200mg PFIZER LTD.

J02AC03 VORICONAZOLUM PULB. PT. SOL. PERF.VFEND (R) 200mg PFIZER LIMITED

VFEND 200mg 200mg PFIZER LTD.

J02AC03 VORICONAZOLUM PULB. PT. SUSP. ORALAVFEND (R) 40 mg/ml 40mg/ml PFIZER LIMITED

VFEND 40 mg/ml 40mg/ml PFIZER LTD.

J02AC03 VORICONAZOLUM COMPR. FILM.VFEND (R) 50mg PFIZER LIMITED

VFEND 50mg 50mg PFIZER LTD.

998 VALGANCICLOVIRUM **J05AB14

Prescriere limitata: Tratamentul de initiere si mentinere pentru retinita cu citomegalovirus (CMV) la pacienti imunocompromisi.

450mgJ05AB14 VALGANCICLOVIRUM COMPR. FILM.VALCYTE® 450 mg 450mg ROCHE ROMANIA SRL

J05AB14 VALGANCICLOVIRUM COMPR. FILM.VALCYTE (R) 450 mg 450mg ROCHE ROMANIA SRL

133 153/

Page 134: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

SUBLISTA C2-P9: PROGRAM NATIONAL DE TRANSPLANT DE ORGANE, TESUTURI SI CELULE DE ORIGINE UMANA. P9.6

TRANSPLANT PULMONAR

999 ENOXAPARINUMB01AB05

2000ui

anti-Xa/0.2ml

B01AB05 ENOXAPARINUM SOL. INJ.

CLEXANE 2000ui anti-Xa/0.2ml 2000ui

anti-Xa/0.2ml

LAB. AVENTIS

4000ui

anti-Xa/0,4ml

B01AB05 ENOXAPARINUM SOL. INJ.

CLEXANE 4000ui anti-Xa/0.4ml 4000ui

anti-Xa/0,4ml

LAB. AVENTIS

6000ui

anti-Xa/0.6ml

B01AB05 ENOXAPARINUM SOL. INJ.

CLEXANE 6000ui anti-Xa/0.6ml 6000ui

anti-Xa/0.6ml

LAB. AVENTIS

8000ui

anti-Xa/0.8ml

B01AB05 ENOXAPARINUM SOL. INJ.

CLEXANE 8000ui anti-Xa/0.8ml 8000ui

anti-Xa/0.8ml

LAB. AVENTIS

2000ui

anti-Xa/0.2ml

B01AB05 ENOXAPARINUM SOL. INJ.

CLEXANE 2000ui anti-Xa/0.2ml 2000ui

anti-Xa/0.2ml

LAB. AVENTIS

4000ui

anti-Xa/0,4ml

B01AB05 ENOXAPARINUM SOL. INJ.

CLEXANE 4000ui anti-Xa/0.4ml 4000ui

anti-Xa/0,4ml

LAB. AVENTIS

6000ui

anti-Xa/0.6ml

B01AB05 ENOXAPARINUM SOL. INJ.

CLEXANE 6000ui anti-Xa/0.6ml 6000ui

anti-Xa/0.6ml

LAB. AVENTIS

1000 REVIPARINUMB01AB08

1432ui/0.25mlB01AB08 REVIPARINUM SOL. INJ.CLIVARIN® 1432UI/0,25 ml 1432ui/0.25ml ABBOTT GMBH&CO.KG

3436ui/0.6mlB01AB08 REVIPARINUM SOL. INJ.CLIVARIN® 3436 UI/0,6 ml 3436ui/0.6ml ABBOTT GMBH&CO.KG

1002 EPINEPHRINUMC01CA24

1mg/mlC01CA24 EPINEPHRINUM SOL. INJ.ADRENALINA 1 mg 1mg/ml TERAPIA SA

1003 PIPERACILLINUM + TAZOBACTAMUMJ01CR05

J01CR05 PIPERACILLINUM + TAZOBACTAMUM LIOF. PT. SOL. INJ.TAZOCIN 2,25 WYETH LEDERLE PHARMA GMBH

TAZOCIN 4,5 WYETH LEDERLE PHARMA GMBH

1004 LINEZOLIDUMJ01XX08

100mg/5mlJ01XX08 LINEZOLIDUM GRAN. PT. SUSP. ORALAZYVOXID® 100mg/5ml PFIZER EUROPE MA EEIG

2mg/mlJ01XX08 LINEZOLIDUM SOL. PERF.ZYVOXID® 2mg/ml PFIZER EUROPE MA EEIG

600mgJ01XX08 LINEZOLIDUM COMPR. FILM.ZYVOXID® 600mg PFIZER EUROPE MA EEIG

1005 FLUCONAZOLUMJ02AC01

Prescriere limitata: Tratament de intretinere la pacienti cu meningita criptococica si imunosupresie.

Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie.

Tratamentul meningitei criptococice la pacientii care nu pot lua sau nu tolereaza amfotericina.

Tratamentul candidozelor severe si care pun in pericol viata la pacienti care nu tolereaza amfotericina.

Tratamentul candidozei orofaringiene la pacienti cu imunosupresie.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 100 mg 100mg KRKA D.D.

FLUCONAZOLE TEVA 100 mg 100mg TEVA PHARMACEUTICALS SRL

FLUCORIC 100 mg 100mg TERAPIA S.A.

FLUCOVIM 100 100mg VIM SPECTRUM SRL

FUNGOLON 100 mg 100mg BALKANPHARMA RAZGRAD AD

150mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 150 mg 150mg KRKA D.D.

DIFLUCAN 150 mg 150mg PFIZER EUROPE MA EEIG

FLUCONAZOL 150 mg 150mg OZONE LABORATORIES LTD.

FLUCONAZOL MEDICO UNO 150 mg 150mg MEDICO UNO PHARMACEUTICAL SRL

FLUCONAZOL MEDOCHEMIE 150 mg 150mg MEDOCHEMIE ROMANIA SRL

FLUCONAZOL SANDOZ® 150 150mg SANDOZ SRL

FLUCONAZOL TERAPIA 150 mg 150mg TERAPIA SA

FLUCONAZOLE TEVA 150 mg 150mg TEVA PHARMACEUTICALS SRL

FLUCORIC 150 mg 150mg TERAPIA S.A.

FLUCOVIM 150 150mg VIM SPECTRUM SRL

MYCOMAX 150 150mg ZENTIVA AS

MYCOSYST® 150 mg 150mg GEDEON RICHTER PLC.

200mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 200 mg 200mg KRKA D.D.

FLUCONAZOLE TEVA 200 mg 200mg TEVA PHARMACEUTICALS SRL

2mg/mlJ02AC01 FLUCONAZOLUM SOL. PERF.

134 153/

Page 135: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

DIFLAZON® 2mg/ml KRKA D.D.

DIFLUCAN® 2mg/ml PFIZER EUROPE MA EEIG

MYCOMAX® INF 2mg/ml ZENTIVA AS

50mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 50 mg 50mg KRKA D.D.

DIFLUCAN 50 mg 50mg PFIZER EUROPE MA EEIG

FLUCONAZOL 50 mg 50mg ARENA GROUP SA

FLUCONAZOL MEDOCHEMIE 50 mg 50mg MEDOCHEMIE ROMANIA SRL

FLUCONAZOL SANDOZ® 50 50mg SANDOZ SRL

FLUCONAZOL TERAPIA 50 mg 50mg TERAPIA S.A.

FLUCONAZOLE TEVA 50 mg 50mg TEVA PHARMACEUTICALS SRL

FLUCORIC 50 mg 50mg TERAPIA S.A.

FLUCOVIM 50 50mg VIM SPECTRUM SRL

FUNGOLON 50 mg 50mg BALKANPHARMA RAZGRAD AD

50mg/5mlJ02AC01 FLUCONAZOLUM PULB. PT. SUSP. ORALADIFLUCAN® 50 mg/5 ml 50mg/5ml PFIZER EUROPE MA EEIG

1006 VORICONAZOLUM ** Protocol: J012BJ02AC03

200mgJ02AC03 VORICONAZOLUM COMPR. FILM.VFEND 200mg 200mg PFIZER LTD.

200mgJ02AC03 VORICONAZOLUM PULB. PT. SOL. PERF.VFEND 200mg 200mg PFIZER LTD.

40mg/mlJ02AC03 VORICONAZOLUM PULB. PT. SUSP. ORALAVFEND 40 mg/ml 40mg/ml PFIZER LTD.

50mgJ02AC03 VORICONAZOLUM COMPR. FILM.VFEND 50mg 50mg PFIZER LTD.

1008 ACICLOVIRUMJ05AB01

200mgJ05AB01 ACICLOVIRUM CAPS.ACICLOVIR 200 mg 200mg ARENA GROUP SA

EUVIROX 200 mg 200mg EUROPHARM SA

200mgJ05AB01 ACICLOVIRUM COMPR.ACICLOVIR 200 mg 200mg TERAPIA SA

CLOVIRAL 200 mg 200mg ANTIBIOTICE SA

ZOVIRAX 200mg GLAXO WELLCOME FOUNDATION LTD.

200mgJ05AB01 ACICLOVIRUM COMPR. DISP.ACICLOVIR 200 mg 200mg OZONE LABORATORIES LTD.

LOVIR 200 mg 200mg RANBAXY UK LIMITED

250mgJ05AB01 ACICLOVIRUM PULB. PT. SOL. INJ./PERF.VIROLEX 250mg KRKA D.D. NOVO MESTO

400mgJ05AB01 ACICLOVIRUM CAPS.ACICLOVIR 400 mg 400mg ARENA GROUP S.A.

400mgJ05AB01 ACICLOVIRUM COMPR.ACICLOVIR 400 mg 400mg EGIS PHARMACEUTICALS P.L.C.

400mgJ05AB01 ACICLOVIRUM COMPR. FILM.ACIKLOVIR 400mg A & G MED TRADING S.R.L.

1009 VALGANCICLOVIRUM **J05AB14

Prescriere limitata: Tratamentul de initiere si mentinere pentru retinita cu citomegalovirus (CMV) la pacienti imunocompromisi.

450mgJ05AB14 VALGANCICLOVIRUM COMPR. FILM.VALCYTE® 450 mg 450mg ROCHE ROMANIA SRL

1010 CICLOSPORINUML04AA01

Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant.

Monitorizarea atentă a pacienţilor este obligatorie.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgL04AA01 CICLOSPORINUM CAPS. MOIEQUORAL® 100 mg 100mg IVAX - PHARMACEUTICALS S.R.O.

100mg/mlL04AA01 CICLOSPORINUM SOL. ORALAEQUORAL® 100mg/ml IVAX - PHARMACEUTICALS S.R.O.

SANDIMMUN NEORAL® 100mg/ml NOVARTIS PHARMA GMBH

25mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL® 25 mg 25mg HEXAL AG

EQUORAL® 25 mg 25mg IVAX - PHARMACEUTICALS S.R.O.

SANDIMMUN NEORAL® 25mg NOVARTIS PHARMA GMBH

50mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL 50 mg 50mg HEXAL AG

EQUORAL® 50 mg 50mg IVAX - PHARMACEUTICALS S.R.O.

SANDIMMUN NEORAL® 50mg NOVARTIS PHARMA GMBH

1012 MYCOPHENOLATUM **L04AA06

180mgL04AA06 MYCOPHENOLATUM COMPR. FILM. GASTROREZ.MYFORTIC 180 mg 180mg NOVARTIS PHARMA GMBH

1g/5mlL04AA06 MYCOPHENOLATUM PULB. PT. SUSP. ORALACELLCEPT 1mg/5ml 1g/5ml ROCHE REGISTRATION LTD.

250mgL04AA06 MYCOPHENOLATUM CAPS.CELLCEPT 250mg 250mg ROCHE REGISTRATION LTD.

MYFENAX 250mg 250mg TEVA PHARMA BV

360mgL04AA06 MYCOPHENOLATUM COMPR. FILM. GASTROREZ.MYFORTIC 360 mg 360mg NOVARTIS PHARMA GMBH

500mgL04AA06 MYCOPHENOLATUM CAPS.MYFENAX 500mg 500mg TEVA PHARMA BV

500mgL04AA06 MYCOPHENOLATUM COMPR. FILM.CELLCEPT 500mg 500mg ROCHE REGISTRATION LTD.

500mgL04AA06 MYCOPHENOLATUM PULB. PT. CONC. PT. SOL. PERF.CELLCEPT 500mg 500mg ROCHE REGISTRATION LTD.

135 153/

Page 136: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

1013 BASILIXIMABUM **L04AA09

20mgL04AA09 BASILIXIMABUM LIOF. + SOLV. PT. SOL. INJ./PERF.SIMULECT 20 mg 20mg NOVARTIS EUROPHARM LTD.

1014 AZATHIOPRINUML04AX01

50mgL04AX01 AZATHIOPRINUM COMPR. FILM.IMURAN® 50mg THE WELLCOME FOUNDATION LTD.

1015 TRAMADOLUMN02AX02

Prescriere limitata: Durere severa, care nu raspunde la analgezice non-opioide.

Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgN02AX02 TRAMADOLUM COMPR. ELIB. MODIF.TRAMADOLOR® 100 ID 100mg HEXAL AG

100mgN02AX02 TRAMADOLUM COMPR. ELIB. PREL.NOAX UNO 100 mg 100mg LABOPHARM EUROPE LIMITED

TRALGIT SR 100 100mg ZENTIVA AS

TRAMADOL® RETARD 100mg KRKA D.D.

100mgN02AX02 TRAMADOLUM COMPR. FILM. ELIB. PREL.TRAMAL RETARD 100 mg 100mg GRUNENTHAL GMBH

100mgN02AX02 TRAMADOLUM SOL. INJ.MABRON 100mg MEDOCHEMIE LTD.

TRADOLAN 100mg LANNACHER HEILMITTEL GMBH

Tratamentul de scurta durata al durerii acute.Prescriere limitata:

100mgN02AX02 TRAMADOLUM SUPOZ.TRADOLAN 100mg LANNACHER HEILMITTEL GMBH

TRAMADOL 100mg KRKA D.D.

TRAMAG 100 100mg MAGISTRA C & C

TRAMAL® 100mg GRUNENTHAL GMBH

100mg/2mlN02AX02 TRAMADOLUM SOL. INJ.TRALGIT 100 100mg/2ml ZENTIVA A.S.

Tratamentul de scurta durata al durerii acute.Prescriere limitata:

100mg/mlN02AX02 TRAMADOLUM PIC. ORALE, SOL.TRALGIT 100mg/ml ZENTIVA A.S.

100mg/mlN02AX02 TRAMADOLUM SOL. ORALATRADOLAN 100mg/ml LANNACHER HEILMITTEL GMBH

150mgN02AX02 TRAMADOLUM COMPR. ELIB. PREL.TRALGIT SR 150 150mg ZENTIVA AS

150mgN02AX02 TRAMADOLUM COMPR. FILM. ELIB. PREL.TRAMADOL RETARD 150 mg 150mg KRKA D.D. NOVO MESTO

TRAMAL RETARD 150 mg 150mg GRUNENTHAL GMBH

200mgN02AX02 TRAMADOLUM COMPR. ELIB. PREL.NOAX UNO 200 mg 200mg LABOPHARM EUROPE LIMITED

TRALGIT SR 200 200mg ZENTIVA AS

200mgN02AX02 TRAMADOLUM COMPR. FILM. ELIB. PREL.TRAMADOL RETARD 200 mg 200mg KRKA D.D. NOVO MESTO

TRAMAL RETARD 200 mg 200mg GRUNENTHAL GMBH

300mgN02AX02 TRAMADOLUM COMPR. ELIB. PREL.NOAX UNO 300 mg 300mg LABOPHARM EUROPE LIMITED

50mgN02AX02 TRAMADOLUM CAPS.K-ALMA® 50mg ANTIBIOTICE SA

MABRON 50 mg 50mg MEDOCHEMIE LTD.

TRALGIT 50 50mg ZENTIVA A.S.

TRAMACALM 50mg AC HELCOR SRL

TRAMADOL 50mg KRKA D.D.

TRAMADOL LPH 50 mg 50mg LABORMED PHARMA SA

TRAMADOL AL 50 50mg ALIUD® PHARMA GMBH & CO.KG

TRAMADOL ARENA 50mg ARENA GROUP S.A.

TRAMAL® 50mg GRUNENTHAL GMBH

URGENDOL 50mg MEDICAROM GROUP SRL

50mgN02AX02 TRAMADOLUM COMPR.TRAMADOL 50 mg 50mg OZONE LABORATORIES LTD.

TRAMADOL EEL 50mg BIO EEL SRL

TRAMAG 50 50mg MAGISTRA C & C

50mgN02AX02 TRAMADOLUM COMPR. FILM.TRADOLAN 50 mg 50mg LANNACHER HEILMITTEL GMBH

50mgN02AX02 TRAMADOLUM SOL. INJ.TRADOLAN 50 mg 50mg LANNACHER HEILMITTEL GMBH

Tratamentul de scurta durata al durerii acutePrescriere limitata:

50mg/mlN02AX02 TRAMADOLUM SOL. INJ.TRALGIT 50 50mg/ml ZENTIVA A.S.

TRAMADOL 50mg/ml KRKA D.D.

TRAMADOL® AL 100 Fiole 50mg/ml ALIUD® PHARMA GMBH & CO.KG

TRAMAL® 100 50mg/ml GRUNENTHAL GMBH

TRAMAL® 50 50mg/ml GRUNENTHAL GMBH

URGENDOL 50mg/ml MEDICAROM GROUP SRL

Tratamentul de scurta durata al durerii acutePrescriere limitata:

N02AX02 TRAMADOLUM PIC. ORALE, SOL.TRAMADOL AL PICATURI ALIUD PHARMA GMBH & CO.KG

100mg/mlN02AX02 TRAMADOLUM PICATURI ORALE-SOL.TRAMAL® 100mg/ml GRUNENTHAL GMBH

136 153/

Page 137: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

SUBLISTA C2-P9: PROGRAM NATIONAL DE TRANSPLANT DE ORGANE, TESUTURI SI CELULE DE ORIGINE UMANA. P9.7

TRATAMENTUL STARII POSTTRANSPLANT IN AMBULATORIU A PACIENTILOR TRANSPLANTATI

1016 ACIDUM URSODEOXYCHOLICUMA05AA02

Nu se va prescrie in regim compensat pentru tratamentul litiazei biliare.NOTA:

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

250mgA05AA02 ACIDUM URSODEOXYCHOLICUM CAPS.URSOFALK® 250mg DR. FALK PHARMA GMBH

URSOSAN 250mg PRO. MED. CS PRAHA AS

1017 EPOETINUM ALFA **B03XA01

10000ui/mlB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 10000 UI 10000ui/ml JOHNSON & JOHNSON D.O.O.

1000UI/0.5mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 1000 UI/0,5 ml 1000UI/0.5ml RENAMED FARMA S.R.L.

EPREX® 1000 UI 1000ui/0.5ml JOHNSON & JOHNSON D.O.O.

2000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPOPHAR 2000 U.I. 2000UI GULF PHARMACEUTICAL IND. S.R.L.

2000ui/0.5mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 2000 UI/0,5 ml 2000UI/0.5ml RENAMED FARMA S.R.L.

EPREX® 2000 UI 2000ui/0.5ml JOHNSON & JOHNSON D.O.O.

2000UI/1mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 2000 UI/1 ml 2000UI/1ml RENAMED FARMA S.R.L.

3000ui/0.3mlB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 3000 UI 3000ui/0.3ml JOHNSON & JOHNSON D.O.O.

40 000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 40 000 UI 40 000UI JOHNSON & JOHNSON D.O.O.

4000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPOPHAR 4000 U.I. 4000UI GULF PHARMACEUTICAL IND. S.R.L.

4000ui/0.4mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 4000 UI/0,4 ml 4000UI/0.4ml RENAMED FARMA S.R.L.

EPREX® 4000 UI 4000ui/0.4ml JOHNSON & JOHNSON D.O.O.

4000UI/1mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 4000 UI/1 ml 4000UI/1ml RENAMED FARMA S.R.L.

B03XA01 EPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTABINOCRIT 1000UI/0,5ml SANDOZ GMBH

B03XA01 EPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTABINOCRIT 2000UI/1,0ml SANDOZ GMBH

B03XA01 EPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTABINOCRIT 3000UI/0,3ml SANDOZ GMBH

B03XA01 EPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTABINOCRIT 4000UI/0,4ml SANDOZ GMBH

1018 EPOETINUM BETA **B03XA01

10000ui/mlB03XA01 EPOETINUM BETA SOL. INJ.EPREX® 10000 UI 10000ui/ml JOHNSON & JOHNSON D.O.O.

1000UI/0.5mlB03XA01 EPOETINUM BETA SOL. INJ.EPOKINE 1000 UI/0,5 ml 1000UI/0.5ml RENAMED FARMA S.R.L.

EPREX® 1000 UI 1000ui/0.5ml JOHNSON & JOHNSON D.O.O.

1000UI/mlB03XA01 EPOETINUM BETA LIOF. + SOLV. PT. SOL. INJ.NEORECORMON 500UI 1000UI/ml ROCHE REGISTRATION LTD.

20000UI/mlB03XA01 EPOETINUM BETA LIOF. + SOLV. PT. SOL. INJ.NEORECORMON MULTIDOZA 100 000UI/ml 20000UI/ml ROCHE REGISTRATION LTD.

2000UIB03XA01 EPOETINUM BETA SOL. INJ.EPOPHAR 2000 U.I. 2000UI GULF PHARMACEUTICAL IND. S.R.L.

2000ui/0.5mlB03XA01 EPOETINUM BETA SOL. INJ.EPOKINE 2000 UI/0,5 ml 2000UI/0.5ml RENAMED FARMA S.R.L.

EPREX® 2000 UI 2000ui/0.5ml JOHNSON & JOHNSON D.O.O.

2000UI/1mlB03XA01 EPOETINUM BETA SOL. INJ.EPOKINE 2000 UI/1 ml 2000UI/1ml RENAMED FARMA S.R.L.

3000ui/0.3mlB03XA01 EPOETINUM BETA SOL. INJ.EPREX® 3000 UI 3000ui/0.3ml JOHNSON & JOHNSON D.O.O.

40 000UIB03XA01 EPOETINUM BETA SOL. INJ.EPREX® 40 000 UI 40 000UI JOHNSON & JOHNSON D.O.O.

4000UIB03XA01 EPOETINUM BETA SOL. INJ.EPOPHAR 4000 U.I. 4000UI GULF PHARMACEUTICAL IND. S.R.L.

4000ui/0.4mlB03XA01 EPOETINUM BETA SOL. INJ.EPOKINE 4000 UI/0,4 ml 4000UI/0.4ml RENAMED FARMA S.R.L.

EPREX® 4000 UI 4000ui/0.4ml JOHNSON & JOHNSON D.O.O.

4000UI/1mlB03XA01 EPOETINUM BETA SOL. INJ.EPOKINE 4000 UI/1 ml 4000UI/1ml RENAMED FARMA S.R.L.

50000UI/mlB03XA01 EPOETINUM BETA LIOF. + SOLV. PT. SOL. INJ.NEORECORMON MULTIDOZA 50 000UI/ml 50000UI/ml ROCHE REGISTRATION LTD.

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 10000 UI 10000UI/0,6ml ROCHE REGISTRATION L

NEORECORMON 10000UI/0,6ml 10000UI/0,6ml ROCHE REGISTRATION LTD.

10000UI/mlB03XA01 EPOETINUM BETA LIOF. + SOLV. PT. SOL. INJ. IN CARTUSNEORECORMON 10000UI/ml 10000UI/ml ROCHE REGISTRATION LTD.

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 1000 UI 1000UI/0,3ml ROCHE REGISTRATION L

NEORECORMON 1000UI/0,3ml 1000UI/0,3ml ROCHE REGISTRATION LTD.

20000UI/0,6mlB03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 20000UI/0,6ml 20000UI/0,6ml ROCHE REGISTRATION LTD.

137 153/

Page 138: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

20000UI/mlB03XA01 EPOETINUM BETA LIOF. + SOLV. PT. SOL. INJ. IN CARTUSNEORECORMON 20000UI/ml 20000UI/ml ROCHE REGISTRATION LTD.

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 2000 UI 2000UI/0,3ml ROCHE REGISTRATION L

NEORECORMON 2000UI/0,3ml 2000UI/0,3ml ROCHE REGISTRATION LTD.

30000 UI/0,6mlB03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 30000UI/0,6ml 30000 UI/0,6ml ROCHE REGISTRATION LTD.

3000I/0,3mlB03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 3000UI/0,3ml 3000I/0,3ml ROCHE REGISTRATION LTD.

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 4000 UI 4000UI/0,3ml ROCHE REGISTRATION L

NEORECORMON 4000UI/0,3ml 4000UI/0,3ml ROCHE REGISTRATION LTD.

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 5000 UI 5000UI/0,3ml ROCHE REGISTRATION L

NEORECORMON 5000UI/0,3ml 5000UI/0,3ml ROCHE REGISTRATION LTD.

B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 500 UI 500UI/0,3ml ROCHE REGISTRATION L

NEORECORMON 500UI/0,3ml 500UI/0,3ml ROCHE REGISTRATION LTD.

60000UI/mlB03XA01 EPOETINUM BETA LIOF. + SOLV. PT. SOL. INJ. IN CARTUSNEORECORMON 60000UI/ml 60000UI/ml ROCHE REGISTRATION LTD.

6000UI/0,3mlB03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 6000UI/0,3ml 6000UI/0,3ml ROCHE REGISTRATION LTD.

1019 DARBEPOETINUM ALFA **B03XA02

10µg/0.4mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 10µg/0.4ml 10µg/0.4ml AMGEN EUROPE BV

100µg/0.5mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 100µg/0.5ml 100µg/0.5ml AMGEN EUROPE BV

15µg/0.375mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 15µg/0.375ml 15µg/0.375ml AMGEN EUROPE BV

150µg/0.3mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 150µg/0.3ml 150µg/0.3ml AMGEN EUROPE BV

20µg/0.5mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 20µg/0.5ml 20µg/0.5ml AMGEN EUROPE BV

30µg/0.3mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 30µg/0.3ml 30µg/0.3ml AMGEN EUROPE BV

300µg/0.6mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 300µg/0.6ml 300µg/0.6ml AMGEN EUROPE BV

40µg/0.4mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 40µg/0.4ml 40µg/0.4ml AMGEN EUROPE BV

50µg/0.5mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 50µg/0.5ml 50µg/0.5ml AMGEN EUROPE BV

500µg/mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 500µg/ml 500µg/ml AMGEN EUROPE BV

60µg/0.3mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 60µg/0.3ml 60µg/0.3ml AMGEN EUROPE BV

80µg/0.4mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 80µg/0.4ml 80µg/0.4ml AMGEN EUROPE BV

1021 METHYLPREDNISOLONUMH02AB04

125mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 125 mg 125mg HEMOFARM S.R.L.

125mg/2mlH02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV.PT.SOL.INJSOLU - MEDROL ACT-O-VIAL 125mg/2ml PFIZER EUROPE MA EEIG

16mgH02AB04 METHYLPREDNISOLONUM COMPR.MEDROL A 16 16mg PFIZER EUROPE MA EEIG

20mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 20 mg 20mg HEMOFARM S.R.L.

250mg/4mlH02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV.PT.SOL.INJSOLU - MEDROL ACT-O-VIAL 250mg/4ml PFIZER EUROPE MA EEIG

32mgH02AB04 METHYLPREDNISOLONUM COMPR.MEDROL 32 32mg PFIZER EUROPE MA EEIG

40mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 40 mg 40mg HEMOFARM S.R.L.

40mg/1mlH02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV.PT.SOL.INJSOLU - MEDROL ACT-O-VIAL 40mg/1ml PFIZER EUROPE MA EEIG

4mgH02AB04 METHYLPREDNISOLONUM COMPR.MEDROL 4 mg 4mg PFIZER EUROPE MA EEIG

500mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 500 mg 500mg HEMOFARM S.R.L.

500mg/7.8mlH02AB04 METHYLPREDNISOLONUM LIOF. + SOLV. PT. SOL. INJ.SOLU - MEDROL 500 mg/7,8 ml 500mg/7.8ml PFIZER EUROPE MA EEIG

1022 PREDNISONUMH02AB07

5mgH02AB07 PREDNISONUM COMPR.N - PREDNISON 5mg MEDUMAN SA

PREDNISON 5 mg 5mg SINTOFARM SA

PREDNISON ARENA 5 mg 5mg ARENA GROUP SA

PREDNISON GEDEON RICHTER 5 mg 5mg GEDEON RICHTER ROMANIA SA

PREDNISON MAGISTRA 5 mg 5mg MAGISTRA C & C

1023 SULFAMETHOXAZOLUM + TRIMETHOPRIMUMJ01EE01Exista un risc crescut de reactie adversa severa la administrarea acestui medicament la persoane in varsta.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

138 153/

Page 139: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

200mg/40mg

/5ml

J01EE01 SULFAMETHOXAZOLUM +

TRIMETHOPRIMUM

SUSP. ORALA

EPITRIM 200mg/40mg /5ml E.I.P.I.CO. MED S.R.L.

25mg/5mg/mlJ01EE01 SULFAMETHOXAZOLUM +

TRIMETHOPRIMUM

SIROP

SUMETROLIM 25mg/5mg/ml EGIS PHARMACEUTICALS P.L.C.

400mg/80mgJ01EE01 SULFAMETHOXAZOLUM +

TRIMETHOPRIMUM

COMPR.

BISEPTRIM 400mg/80mg EUROPHARM SA

CO - TRIM ELL 400mg/80mg BIO EEL SRL

SUMETROLIM 400mg/80mg EGIS PHARMACEUTICALS P.L.C.

TAGREMIN 400mg/80mg ZENTIVA S.A.

400mg/80mgJ01EE01 SULFAMETHOXAZOLUM +

TRIMETHOPRIMUM

SOL. PERF.

SEPTRIN 400mg/80mg THE WELLCOME FOUNDATION LTD.

1024 FLUCONAZOLUMJ02AC01

Prescriere limitata: Tratament de intretinere la pacienti cu meningita criptococica si imunosupresie.

Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie.

Tratamentul meningitei criptococice la pacientii care nu pot lua sau nu tolereaza amfotericina.

Tratamentul candidozelor severe si care pun in pericol viata la pacienti care nu tolereaza amfotericina.

Tratamentul candidozei orofaringiene la pacienti cu imunosupresie.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 100 mg 100mg KRKA D.D.

FLUCONAZOLE TEVA 100 mg 100mg TEVA PHARMACEUTICALS SRL

FLUCORIC 100 mg 100mg TERAPIA S.A.

FLUCOVIM 100 100mg VIM SPECTRUM SRL

FUNGOLON 100 mg 100mg BALKANPHARMA RAZGRAD AD

150mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 150 mg 150mg KRKA D.D.

DIFLUCAN 150 mg 150mg PFIZER EUROPE MA EEIG

FLUCONAZOL 150 mg 150mg OZONE LABORATORIES LTD.

FLUCONAZOL MEDICO UNO 150 mg 150mg MEDICO UNO PHARMACEUTICAL SRL

FLUCONAZOL MEDOCHEMIE 150 mg 150mg MEDOCHEMIE ROMANIA SRL

FLUCONAZOL SANDOZ® 150 150mg SANDOZ SRL

FLUCONAZOL TERAPIA 150 mg 150mg TERAPIA SA

FLUCONAZOLE TEVA 150 mg 150mg TEVA PHARMACEUTICALS SRL

FLUCORIC 150 mg 150mg TERAPIA S.A.

FLUCOVIM 150 150mg VIM SPECTRUM SRL

MYCOMAX 150 150mg ZENTIVA AS

MYCOSYST® 150 mg 150mg GEDEON RICHTER PLC.

200mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 200 mg 200mg KRKA D.D.

FLUCONAZOLE TEVA 200 mg 200mg TEVA PHARMACEUTICALS SRL

2mg/mlJ02AC01 FLUCONAZOLUM SOL. PERF.DIFLAZON® 2mg/ml KRKA D.D.

DIFLUCAN® 2mg/ml PFIZER EUROPE MA EEIG

MYCOMAX® INF 2mg/ml ZENTIVA AS

50mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 50 mg 50mg KRKA D.D.

DIFLUCAN 50 mg 50mg PFIZER EUROPE MA EEIG

FLUCONAZOL 50 mg 50mg ARENA GROUP SA

FLUCONAZOL MEDOCHEMIE 50 mg 50mg MEDOCHEMIE ROMANIA SRL

FLUCONAZOL SANDOZ® 50 50mg SANDOZ SRL

FLUCONAZOL TERAPIA 50 mg 50mg TERAPIA S.A.

FLUCONAZOLE TEVA 50 mg 50mg TEVA PHARMACEUTICALS SRL

FLUCORIC 50 mg 50mg TERAPIA S.A.

FLUCOVIM 50 50mg VIM SPECTRUM SRL

FUNGOLON 50 mg 50mg BALKANPHARMA RAZGRAD AD

50mg/5mlJ02AC01 FLUCONAZOLUM PULB. PT. SUSP. ORALADIFLUCAN® 50 mg/5 ml 50mg/5ml PFIZER EUROPE MA EEIG

1025 VORICONAZOLUMJ02AC03

J02AC03 VORICONAZOLUM PULB. PT. SOL. PERF.VFEND (R) 200mg PFIZER LIMITED

VFEND 200mg 200mg PFIZER LTD.

50mgJ02AC03 VORICONAZOLUM COMPR. FILM.VFEND 50mg 50mg PFIZER LTD.

J02AC03 VORICONAZOLUM PULB. PT. SUSP. ORALAVFEND (R) 40 mg/ml 40mg/ml PFIZER LIMITED

1026 POSACONAZOLUM **J02AC04

Prescriere limitata: Profilaxia si tratamentul infectiilor fungice invazive la pacientii aflati sub chimioterapie de inductie-remisie pentru LAM sau pentru sindroame mielodisplazice si care

prezinta risc inalt de a dezvolta infectii fungice masive.

Profilaxia si tratamentul infectiilor fungice invazive la pacientii in procedura de transplant medular si aflati sub terapie imunosupresoare cu doze mari, cu risc mare de

a dezvolta infectii fungice masive.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

40mg/mlJ02AC04 POSACONAZOLUM SUSP. ORALANOXAFIL SP 40mg/ml 40mg/ml SP EUROPE

1027 ACICLOVIRUMJ05AB01

200mgJ05AB01 ACICLOVIRUM CAPS.ACICLOVIR 200 mg 200mg SLAVIA PHARM SRL

EUVIROX 200 mg 200mg EUROPHARM SA

200mgJ05AB01 ACICLOVIRUM COMPR.ACICLOVIR 200 mg 200mg EGIS PHARMACEUTICALS P.L.C.

139 153/

Page 140: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

CLOVIRAL 200 mg 200mg ANTIBIOTICE SA

ZOVIRAX 200mg GLAXO WELLCOME FOUNDATION LTD.

200mgJ05AB01 ACICLOVIRUM COMPR. DISP.ACICLOVIR 200 mg 200mg OZONE LABORATORIES LTD.

LOVIR 200 mg 200mg RANBAXY UK LIMITED

250mgJ05AB01 ACICLOVIRUM PULB. PT. SOL. INJ./PERF.VIROLEX 250mg KRKA D.D. NOVO MESTO

400mgJ05AB01 ACICLOVIRUM CAPS.ACICLOVIR 400 mg 400mg ARENA GROUP S.A.

400mgJ05AB01 ACICLOVIRUM COMPR.ACICLOVIR 400 mg 400mg EGIS PHARMACEUTICALS P.L.C.

400mgJ05AB01 ACICLOVIRUM COMPR. FILM.ACIKLOVIR 400mg A & G MED TRADING S.R.L.

1028 VALGANCICLOVIRUM **J05AB14

Prescriere limitata: Tratamentul de initiere si mentinere pentru retinita cu citomegalovirus (CMV) la pacienti imunocompromisi.

450mgJ05AB14 VALGANCICLOVIRUM COMPR. FILM.VALCYTE® 450 mg 450mg ROCHE ROMANIA SRL

1029 LAMIVUDINUMJ05AF05

100mgJ05AF05 LAMIVUDINUM COMPR. FILM.ZEFFIX 100 mg 100mg GLAXO GROUP LTD.

10mg/mlJ05AF05 LAMIVUDINUM SOL. ORALAEPIVIR 10mg/ml 10mg/ml GLAXO GROUP LTD.

150mgJ05AF05 LAMIVUDINUM COMPR. FILM.EPIVIR 150mg 150mg GLAXO GROUP LTD.

5mg/mlJ05AF05 LAMIVUDINUM SOL. ORALAZEFFIX 5 mg/ml 5mg/ml GLAXO GROUP LTD.

1030 CICLOSPORINUML04AA01

Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant.

Monitorizarea atentă a pacienţilor este obligatorie.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mgL04AA01 CICLOSPORINUM CAPS. MOIEQUORAL® 100 mg 100mg IVAX - PHARMACEUTICALS S.R.O.

100mg/mlL04AA01 CICLOSPORINUM SOL. ORALAEQUORAL® 100mg/ml IVAX - PHARMACEUTICALS S.R.O.

SANDIMMUN NEORAL® 100mg/ml NOVARTIS PHARMA GMBH

25mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL® 25 mg 25mg HEXAL AG

EQUORAL® 25 mg 25mg IVAX - PHARMACEUTICALS S.R.O.

SANDIMMUN NEORAL® 25mg NOVARTIS PHARMA GMBH

50mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL 50 mg 50mg HEXAL AG

EQUORAL® 50 mg 50mg IVAX - PHARMACEUTICALS S.R.O.

SANDIMMUN NEORAL® 50mg NOVARTIS PHARMA GMBH

1031 TACROLIMUSUM **L04AA05

Prescriere limitata: Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant alogen renal.

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant alogen cardiac.

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant alogen hepatic.

Monitorizarea atentă a pacienţilor este obligatorie.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

0,5mgL04AA05 TACROLIMUSUM CAPS. ELIB. PREL.ADVAGRAF 0,5mg 0,5mg ASTELLAS PHARMA GMBH

0.5mgL04AA05 TACROLIMUSUM CAPS.PROGRAF® 0,5 mg 0.5mg ASTELLAS PHARMA GMBH

1mgL04AA05 TACROLIMUSUM CAPS.PROGRAF® 1 mg 1mg ASTELLAS IRELAND CO. LTD.

1mgL04AA05 TACROLIMUSUM CAPS. ELIB. PREL.ADVAGRAF 1mg 1mg ASTELLAS PHARMA GMBH

5mgL04AA05 TACROLIMUSUM CAPS.PROGRAF® 5 mg 5mg ASTELLAS PHARMA GMBH

5mgL04AA05 TACROLIMUSUM CAPS. ELIB. PREL.ADVAGRAF 5mg 5mg ASTELLAS PHARMA GMBH

5mg/mlL04AA05 TACROLIMUSUM CONC. PT. SOL. PERF.PROGRAF® 5 mg/ml 5mg/ml ASTELLAS PHARMA GMBH

1032 MYCOPHENOLATUM **L04AA06

Prescriere limitata: Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant alogen renal.

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant alogen cardiac.

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant alogen hepatic.

Monitorizarea atentă a pacienţilor este obligatorie.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

180mgL04AA06 MYCOPHENOLATUM COMPR. FILM. GASTROREZ.MYFORTIC 180 mg 180mg NOVARTIS PHARMA GMBH

1g/5mlL04AA06 MYCOPHENOLATUM PULB. PT. SUSP. ORALACELLCEPT 1mg/5ml 1g/5ml ROCHE REGISTRATION LTD.

250mgL04AA06 MYCOPHENOLATUM CAPS.CELLCEPT 250mg 250mg ROCHE REGISTRATION LTD.

MYFENAX 250mg 250mg TEVA PHARMA BV

360mgL04AA06 MYCOPHENOLATUM COMPR. FILM. GASTROREZ.MYFORTIC 360 mg 360mg NOVARTIS PHARMA GMBH

500mgL04AA06 MYCOPHENOLATUM CAPS.MYFENAX 500mg 500mg TEVA PHARMA BV

140 153/

Page 141: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

500mgL04AA06 MYCOPHENOLATUM COMPR. FILM.CELLCEPT 500mg 500mg ROCHE REGISTRATION LTD.

500mgL04AA06 MYCOPHENOLATUM PULB. PT. CONC. PT. SOL. PERF.CELLCEPT 500mg 500mg ROCHE REGISTRATION LTD.

1033 SIROLIMUS **L04AA10

Prescriere limitata: Terapie de menţinere, urmare a iniţierii şi stabilizarii tratamentului cu sirolimus. Monitorizarea si revizuirea terapiei va fi efectuata in unităţi de transplant.

Monitorizarea atentă a pacienţilor este obligatorie.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

1mgL04AA10 SIROLIMUS COMPR. FILM.RAPAMUNE 1mg 1mg WYETH EUROPA LTD.

1034 AZATHIOPRINUM *L04AX01

50mgL04AX01 AZATHIOPRINUM COMPR. FILM.IMURAN® 50mg THE WELLCOME FOUNDATION LTD.

141 153/

Page 142: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

SUBLISTA C2-P10: PROGRAM NATIONAL DE SUPLEERE A FUNCTIEI RENALE LA BOLNAVII CU INSUFICIENTA RENALA

CRONICA.

1035 ALFACALCIDOLUM Protocol: A007EA11CC03

0.25µgA11CC03 ALFACALCIDOLUM CAPS. MOIALPHA D3 0,25 µg 0.25µg TEVA PHARMACEUTICALS SRL

0.50µgA11CC03 ALFACALCIDOLUM CAPS. MOIALPHA D3 0.50 µg 0.50µg TEVA PHARMACEUTICALS S.R.L.

1036 CALCITRIOLUM ** Protocol: A006EA11CC04

0.25µgA11CC04 CALCITRIOLUM CAPS. MOIROCALTROL 0.25µg ROCHE ROMANIA S.R.L.

1037 PARICALCITOLUM ** Protocol: A005EA11CC07

5 µg/mlA11CC07 PARICALCITOLUM SOL. INJ.ZEMPLAR 5 µg/ml ABBOTT LABORATORIES S.A.

1038 HEPARINUM **B01AB01

5000ui/mlB01AB01 HEPARINUM SOL. INJ.HEPARIN 5000ui/ml POLIPHARMA INDUSTRIES S.R.L.

HEPARIN SANDOZ® 25000 UI/5 ml 5000ui/ml SANDOZ GMBH

HEPARINE SODIQUE PANPHARMA 5000ui/ml LAB. PANPHARMA

1039 ENOXAPARINUM **B01AB05

2000ui

anti-Xa/0.2ml

B01AB05 ENOXAPARINUM SOL. INJ.

CLEXANE 2000ui anti-Xa/0.2ml 2000ui

anti-Xa/0.2ml

LAB. AVENTIS

4000ui

anti-Xa/0,4ml

B01AB05 ENOXAPARINUM SOL. INJ.

CLEXANE 4000ui anti-Xa/0.4ml 4000ui

anti-Xa/0,4ml

LAB. AVENTIS

6000ui

anti-Xa/0.6ml

B01AB05 ENOXAPARINUM SOL. INJ.

CLEXANE 6000ui anti-Xa/0.6ml 6000ui

anti-Xa/0.6ml

LAB. AVENTIS

8000ui

anti-Xa/0.8ml

B01AB05 ENOXAPARINUM SOL. INJ.

CLEXANE 8000ui anti-Xa/0.8ml 8000ui

anti-Xa/0.8ml

LAB. AVENTIS

2000ui

anti-Xa/0.2ml

B01AB05 ENOXAPARINUM SOL. INJ.

CLEXANE 2000ui anti-Xa/0.2ml 2000ui

anti-Xa/0.2ml

LAB. AVENTIS

4000ui

anti-Xa/0,4ml

B01AB05 ENOXAPARINUM SOL. INJ.

CLEXANE 4000ui anti-Xa/0.4ml 4000ui

anti-Xa/0,4ml

LAB. AVENTIS

6000ui

anti-Xa/0.6ml

B01AB05 ENOXAPARINUM SOL. INJ.

CLEXANE 6000ui anti-Xa/0.6ml 6000ui

anti-Xa/0.6ml

LAB. AVENTIS

1040 NADROPARINUM **B01AB06

11400

uiAXa/0.6ml

B01AB06 NADROPARINUM SOL. INJ.

FRAXODI 11400 UI anti-factor Xa/0,6ml 11400 uiAXa/0.6ml GLAXO GROUP LTD.

15200

uiAXa/0.8ml

B01AB06 NADROPARINUM SOL. INJ.

FRAXODI 15200 UI anti-factor Xa/0,8ml 15200 uiAXa/0.8ml GLAXO GROUP LTD.

2850 ui

AFXa/0.3ml

B01AB06 NADROPARINUM SOL. INJ.

FRAXIPARINE® 2850 UI anti-factor Xa/0,3 ml 2850 ui

AFXa/0.3ml

GLAXO GROUP LTD.

3800 ui

AFXa/0.4ml

B01AB06 NADROPARINUM SOL. INJ.

FRAXIPARINE® 3800 UI anti-factor Xa/0,4 ml 3800 ui

AFXa/0.4ml

GLAXO GROUP LTD.

5700 ui

AFXa/0.6ml

B01AB06 NADROPARINUM SOL. INJ.

FRAXIPARINE® 5700 UI anti-factor Xa/0,6 ml 5700 ui

AFXa/0.6ml

GLAXO GROUP LTD.

7600 ui

AXa/0.8ml

B01AB06 NADROPARINUM SOL. INJ.

FRAXIPARINE® 7600 UI anti-factor Xa/0,8 ml 7600 ui AXa/0.8ml GLAXO GROUP LTD.

1041 REVIPARINUM **B01AB08

1432ui/0.25mlB01AB08 REVIPARINUM SOL. INJ.CLIVARIN® 1432UI/0,25 ml 1432ui/0.25ml ABBOTT GMBH&CO.KG

3436ui/0.6mlB01AB08 REVIPARINUM SOL. INJ.CLIVARIN® 3436 UI/0,6 ml 3436ui/0.6ml ABBOTT GMBH&CO.KG

1042 TINZAPARINUM **B01AB10

10000u ANTIF.

Xa/ml

B01AB10 TINZAPARINUM SOL. INJ.

142 153/

Page 143: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

INNOHEP 10000u ANTIF.

Xa/ml

LEO PHARMACEUTICAL PRODUCTS

20000u ANTIF.

Xa/ml

B01AB10 TINZAPARINUM SOL. INJ.

INNOHEP 20000u ANTIF.

Xa/ml

LEO PHARMACEUTICAL PRODUCTS

1043 COMPLEX DE HIDROXID DE FER (III) SUCROZA Protocol: A010NB03AC02

20mg/mlB03AC02 COMPLEX DE HIDROXID DE FER (III)

SUCROZA

SOL. INJ./PERF.

VENOFER® 20mg/ml VIFOR FRANCE S.A.

1044 EPOETINUM ALFA ** Protocol: B010NB03XA01

10000ui/mlB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 10000 UI 10000ui/ml JOHNSON & JOHNSON D.O.O.

1000UI/0,3mlB03XA01 EPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAEPREX® 1000 UI 1000ui/0.5ml JOHNSON & JOHNSON D.O.O.

1000UI/0,5mlB03XA01 EPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTABINOCRIT 1000UI/0,5ml 1000UI/0,5ml SANDOZ GMBH

EPOKINE 1000 UI/0,5 ml 1000UI/0.5ml RENAMED FARMA S.R.L.

20000UI/0,5mlB03XA01 EPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAEPOKINE 2000 UI/0,5 ml 2000UI/0.5ml RENAMED FARMA S.R.L.

2000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPOPHAR 2000 U.I. 2000UI GULF PHARMACEUTICAL IND. S.R.L.

EPREX® 2000 UI 2000ui/0.5ml JOHNSON & JOHNSON D.O.O.

2000UI/1,0mlB03XA01 EPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTABINOCRIT 2000UI/1,0ml 2000UI/1,0ml SANDOZ GMBH

EPOKINE 2000 UI/1 ml 2000UI/1ml RENAMED FARMA S.R.L.

3000UI/0,3mlB03XA01 EPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTABINOCRIT 3000UI/0,3ml 3000UI/0,3ml SANDOZ GMBH

3000ui/0.3mlB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 3000 UI 3000ui/0.3ml JOHNSON & JOHNSON D.O.O.

40 000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 40 000 UI 40 000UI JOHNSON & JOHNSON D.O.O.

4000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPOPHAR 4000 U.I. 4000UI GULF PHARMACEUTICAL IND. S.R.L.

4000UI/0,4mlB03XA01 EPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTABINOCRIT 4000UI/0,4ml 4000UI/0,4ml SANDOZ GMBH

EPOKINE 4000 UI/0,4 ml 4000UI/0.4ml RENAMED FARMA S.R.L.

EPREX® 4000 UI 4000ui/0.4ml JOHNSON & JOHNSON D.O.O.

4000UI/1mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 4000 UI/1 ml 4000UI/1ml RENAMED FARMA S.R.L.

1045 EPOETINUM BETA ** Protocol: B009NB03XA01

10000UI/0,6mlB03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 10000UI/0,6ml 10000UI/0,6ml ROCHE REGISTRATION LTD.

1000UI/0,3mlB03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 1000UI/0,3ml 1000UI/0,3ml ROCHE REGISTRATION LTD.

2000UI/0,3mlB03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 2000UI/0,3ml 2000UI/0,3ml ROCHE REGISTRATION LTD.

4000UI/0,3mlB03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 4000UI/0,3ml 4000UI/0,3ml ROCHE REGISTRATION LTD.

5000UI/0,3mlB03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 5000UI/0,3ml 5000UI/0,3ml ROCHE REGISTRATION LTD.

500UI/0,3mlB03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 500UI/0,3ml 500UI/0,3ml ROCHE REGISTRATION LTD.

1046 DARBEPOETINUM ALFA ** Protocol: B011NB03XA02

10µg/0.4mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 10µg/0.4ml 10µg/0.4ml AMGEN EUROPE BV

100µg/0.5mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 100µg/0.5ml 100µg/0.5ml AMGEN EUROPE BV

15µg/0.375mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 15µg/0.375ml 15µg/0.375ml AMGEN EUROPE BV

150µg/0.3mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 150µg/0.3ml 150µg/0.3ml AMGEN EUROPE BV

20µg/0.5mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 20µg/0.5ml 20µg/0.5ml AMGEN EUROPE BV

30µg/0.3mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 30µg/0.3ml 30µg/0.3ml AMGEN EUROPE BV

300µg/0.6mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 300µg/0.6ml 300µg/0.6ml AMGEN EUROPE BV

40µg/0.4mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 40µg/0.4ml 40µg/0.4ml AMGEN EUROPE BV

50µg/0.5mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 50µg/0.5ml 50µg/0.5ml AMGEN EUROPE BV

500µg/mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 500µg/ml 500µg/ml AMGEN EUROPE BV

60µg/0.3mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 60µg/0.3ml 60µg/0.3ml AMGEN EUROPE BV

80µg/0.4mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 80µg/0.4ml 80µg/0.4ml AMGEN EUROPE BV

1049 SEVELAMER ** Protocol: V003DV03AE02

800mgV03AE02 SEVELAMER COMPR. FILM.

143 153/

Page 144: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

RENAGEL 800mg 800mg GENZYME EUROPE BV

1050 CINACALCETUM **** Protocol: H003NH05BX01

30mgH05BX01 CINACALCETUM COMPR. FILM.MIMPARA 30 mg 30mg AMGEN EUROPE B.V.

60mgH05BX01 CINACALCETUM COMPR. FILM.MIMPARA 60 mg 60mg AMGEN EUROPE B.V.

90mgH05BX01 CINACALCETUM COMPR. FILM.MIMPARA 90 mg 90mg AMGEN EUROPE B.V.

SUBLISTA C2-P11: PROGRAM NATIONAL DE SANATATE MINTALA. SUBPROGRAMUL TRATAMENTUL

TOXICODEPENDENTELOR

1051 NALTREXONUMN07BB04

50mgN07BB04 NALTREXONUM COMPR. FILM.REVIA 50mg TORREX CHIESI PHARMA GMBH

Naltrexone hydrochloride este contraindicata la pacientii tratati cu medicamente opioide

1052 METHADONUMN07BC02Risc inalt de aparitie a dependentei.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

2.5mgN07BC02 METHADONUM COMPR.SINTALGON 2,5 mg 2.5mg ZENTIVA S.A.

1053 COMBINATII ( BUPRENORPHINUM + NALAXONE)N07BC51

Prescriere limitata: Tratamentul dependentei de opioide in cadrul terapiei medicale, sociale si psihologice.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

2mg/0,5mgN07BC51 COMBINATII ( BUPRENORPHINUM +

NALAXONE)

COMPR. SUBLING.

SUBOXONE 2mg/0,5mg 2mg/0,5mg SP EUROPE

8mg/2mgN07BC51 COMBINATII ( BUPRENORPHINUM +

NALAXONE)

COMPR. SUBLING.

SUBOXONE 8mg/2mg 8mg/2mg SP EUROPE

144 153/

Page 145: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

SUBLISTA C3 - DCI-URI CORESPUNZĂTOARE MEDICAMENTELOR DE CARE BENEFICIAZĂ COPIII PANĂ LA 18 ANI, TINERII

DE LA 18 LA 26 ANI DACA SUNT ELEVI, UCENICI SAU STUDENTI DACĂ NU REALIZEAZĂ VENITURI PRECUM SI GRAVIDE SI

LEHUZE, IN TRATAMENTUL AMBULATORIU IN REGIM DE COMPENSARE 100% DIN PRETUL DE REFERINTĂ

1056 DROTAVERINUMA03AD02

40mg/2mlA03AD02 DROTAVERINUM SOL. INJ.NO - SPA 40 mg/2 ml 40mg/2ml CHINOIN PRIVATE CO. LTD.

1057 ATROPINUMA03BA01

1mg/mlA03BA01 ATROPINUM SOL. INJ.SULFAT DE ATROPINA 1mg/ml ZENTIVA S.A.

1058 BUTYLSCOPOLAMMONII BROMIDUMA03BB01

10mg/mlA03BB01 BUTYLSCOPOLAMMONII BROMIDUM SOL. INJ.SCOBUTIL 10 mg/ml 10mg/ml ZENTIVA SA

20mg/mlA03BB01 BUTYLSCOPOLAMMONII BROMIDUM SOL. INJ.BUSCOPAN 20 mg/ml 20mg/ml BOEHRINGER INGELHEIM INT. GMBH

FARCORELAXIN 20mg/ml PHARCO IMPEX 93 S.R.L.

1059 COMBINATIIA03DA02

A03DA02 COMBINATII COMPR.ALGIFEN COMPRIMATE ZENTIVA SA

PIAFEN ANTIBIOTICE SA

A03DA02 COMBINATII SOL. INJ.ALGIFEN SOLUTIE INJECTABILA ZENTIVA SA

A03DA02 COMBINATII SUPOZ.PIAFEN ANTIBIOTICE SA

1060 COMBINATIIA05BAN3

A05BAN3 COMBINATII SOL. INJ.ASPATOFORT® TERAPIA SA

1061 COMBINATIIA06AD65

A06AD65 COMBINATII PULB. PT. SOL. ORALAENDOFALK DR. FALK PHARMA GMBH

1062 NIFUROXAZIDUMA07AX03

200mgA07AX03 NIFUROXAZIDUM CAPS.ERCEFURYL® 200 mg 200mg SANOFI-SYNTHELABO OTC

1063 RETINOLUMA11CA01

1500000ui/gA11CA01 RETINOLUM PIC. ORALE, SOL.VITAMINA A 1500000ui/g BIOFARM SA

50000uiA11CA01 RETINOLUM CAPS. MOIVITAMINA A FORTE 50000ui BIOFARM SA

1064 DIHYDROTACHYSTEROLUMA11CC02

0.1mg/mlA11CC02 DIHYDROTACHYSTEROLUM PICATURI ORALE-SOL.TACHYSTIN 0.1mg/ml CHAUVIN ANKERPHARM GMBH

1mg/mlA11CC02 DIHYDROTACHYSTEROLUM PICATURI ORALE-SOL.A.T. 10® 1mg/ml MERCK KGAA

1065 CALCITRIOLUMA11CC04

0.25µgA11CC04 CALCITRIOLUM CAPS. MOIROCALTROL 0.25µg ROCHE ROMANIA S.R.L.

1066 COLECALCIFEROLUMA11CC05

0,45mg/mlA11CC05 COLECALCIFEROLUM PIC. ORALE, SOL.VITAMINA D3 0,45mg/ml BIOFARM S.A.

0.5mg/mlA11CC05 COLECALCIFEROLUM PIC. ORALE, SOL.VIGANTOL OIL 0.5mg/ml MERCK KGAA

1000UIA11CC05 COLECALCIFEROLUM COMPR.VIGANTOLETTEN 1000 1000UI MERCK KGAA

500UIA11CC05 COLECALCIFEROLUM COMPR.VIGANTOLETTEN 500 500UI MERCK KGAA

1067 COMBINATIIA11CC20

A11CC20 COMBINATII COMPR.FLUOR VIGANTOLETTEN 1000 MERCK KGAA

FLUOR VIGANTOLETTEN 500 MERCK KGAA

1068 THIAMINUMA11DA01

100mg/2mlA11DA01 THIAMINUM SOL. INJ.SICOVIT® B1 100 mg/2 ml 100mg/2ml ZENTIVA SA

10mgA11DA01 THIAMINUM COMPR.SICOVIT® B1 10 mg 10mg ZENTIVA SA

1069 BENFOTIAMINUMA11DA03

50mgA11DA03 BENFOTIAMINUM DRAJ.BENFOGAMMA 50mg WORWAG PHARMA GMBH & CO. KG

1070 COMBINATIIA11DBN1

A11DBN1 COMBINATII CAPS. MOIMILGAMMA® N WORWAG PHARMA GMBH & CO. KG

A11DBN1 COMBINATII SOL. INJ.MILGAMMA® N WORWAG PHARMA GMBH & CO. KG

1071 COMBINATIIA11DBN2

A11DBN2 COMBINATII COMPR. FILM.NEUROMULTIVIT® LANNACHER HEILMITTEL GMBH

1072 ACIDUM ASCORBICUMA11GA01

750mgA11GA01 ACIDUM ASCORBICUM SOL. INJ.

145 153/

Page 146: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

VITAMINA C ARENA 750 mg 750mg ARENA GROUP S.A.

1073 PYRIDOXINUMA11HA02

250 mgA11HA02 PYRIDOXINUM COMPR.VITAMINA B6 250 mg 250 mg ARENA GROUP SA

250mgA11HA02 PYRIDOXINUM COMPR.SICOVIT B6 250 mg 250mg ZENTIVA SA

250mg/5mlA11HA02 PYRIDOXINUM SOL. INJ.SICOVIT B6 250 mg/5 ml 250mg/5ml ZENTIVA SA

50mg/2mlA11HA02 PYRIDOXINUM SOL. INJ.SICOVIT B6 50 mg/2ml 50mg/2ml ZENTIVA SA

1074 TOCOFEROLUMA11HA03

200mgA11HA03 TOCOFEROLUM CAPS. MOIVITAMIN E 200 200mg ZENTIVA AS

400mgA11HA03 TOCOFEROLUM CAPS. MOIVITAMIN E 400 400mg ZENTIVA AS

1076 CALCII GLUCONASA12AA03

A12AA03 CALCII GLUCONAS SOL. INJ.GLUCONAT DE CALCIU ZENTIVA SA

GLUCONAT DE CALCIU 10% 10% B. BRAUN MELSUNGEN AG

10,00%A12AA03 CALCII GLUCONAS SOL. INJ.GLUCONAT DE CALCIU ZENTIVA SA

GLUCONAT DE CALCIU 10% 10% B. BRAUN MELSUNGEN AG

1077 METANDIENONUMA14AA03

5mgA14AA03 METANDIENONUM COMPR.NAPOSIM 5 mg 5mg TERAPIA SA

1078 LEVOCARNITINUMA16AA01

100mg/mlA16AA01 LEVOCARNITINUM SOL. ORALACARNIL® 100mg/ml ANFARM HELLAS S.A. PHARMACEUTICALS

10%A16AA01 LEVOCARNITINUM SOL. ORALAMIOCOR 10% ECOBI PHARMACEUTICI

1079 DIVERSEA16AXN1

200mgA16AXN1 DIVERSE DRAJ.ACTOVEGIN® 200mg NYCOMED AUSTRIA GMBH

200mg/5mlA16AXN1 DIVERSE SOL. INJ.ACTOVEGIN® 200mg/5ml NYCOMED AUSTRIA GMBH

80mg/2mlA16AXN1 DIVERSE SOL. INJ.ACTOVEGIN® 80mg/2ml NYCOMED AUSTRIA GMBH

1080 ETAMSYLATUMB02BX01

250mg/2mlB02BX01 ETAMSYLATUM SOL. INJ.ETAMSILAT 250mg/2ml 250mg/2ml ZENTIVA S.A

1081 CARBAZOCHROMI SALICYLASB02BX02

0.3mg/mlB02BX02 CARBAZOCHROMI SALICYLAS SOL. INJ.ADRENOSTAZIN 0.3mg/ml TERAPIA SA

1082 FERROSI FUMARASB03AA02

3,00%B03AA02 FERROSI FUMARAS SUSP. ORALAFERRONAT® 3% IVAX - PHARMACEUTICALS S.R.O.

1083 FERROSI GLUCONASB03AA03

B03AA03 FERROSI GLUCONAS COMPR.ASCOFER ARENA GROUP SA

1084 FERROCHOLINATUMB03ABN1

24mg Fe/mlB03ABN1 FERROCHOLINATUM SOL. ORALA IN PICATURIFER-SOL 24mg Fe/ml E.I.P.I.CO. MED S.R.L.

1085 COMBINATIIB03AD02

B03AD02 COMBINATII CAPS. ELIB. PREL.FERRETAB® LANNACHER HEILMITTEL GMBH

1086 COMBINATIIB03AD03

B03AD03 COMBINATII CAPS.FERRO SANOL GYN SCHWARZ PHARMA AG

B03AD03 COMBINATII DRAJ. ELIB. PREL.TARDYFERON FOL® LAB. PIERRE FABRE

1087 COMBINATIIB03AD04

B03AD04 COMBINATII COMPR. MAST.MALTOFER FOL VIFOR FRANCE S.A.

1088 COMBINATIIB03AE01

B03AE01 COMBINATII CAPS. MOIFERRO - FOLGAMMA® WORWAG PHARMA GMBH & CO. KG

1089 COMBINATIIB03AE10

B03AE10 COMBINATII SOL. ORALATOT'HEMA LAB. INNOTHERA

1090 CYANOCOBALAMINUMB03BA01

1000µg/mlB03BA01 CYANOCOBALAMINUM SOL. INJ.SICOVIT® B12 1000µg/ml 1000µg/ml ZENTIVA S.A.

50µg/mlB03BA01 CYANOCOBALAMINUM SOL. INJ.SICOVIT B12 50µg/ml 50µg/ml ZENTIVA SA

1091 COMBINATIIB03BA51

B03BA51 COMBINATII DRAJ.MILGAMMA® WORWAG PHARMA GMBH & CO. KG

146 153/

Page 147: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

1092 ALPROSTADILUM **C01EA01

500µgC01EA01 ALPROSTADILUM CONC. PT. SOL. PERF.ALPROSTADIL "PINT" 500 µg 500µg PINT-PHARMA GMBH

1093 COMBINATIIC02LA51

C02LA51 COMBINATII DRAJ.NEOCRYSTEPIN ZENTIVA AS

1094 CODERGOCRINUMC04AE01

0.1%C04AE01 CODERGOCRINUM SOL. ORALA IN PICATURICO-DERGOCRIN 0.1% TERAPIA SA

1mg/mlC04AE01 CODERGOCRINUM SOL. ORALA IN PICATURISECATOXIN 1mg/ml IVAX - PHARMACEUTICALS S.R.O.

0.1%C04AE01 CODERGOCRINUM PICATURI ORALE-SOL.REDERGIN 1 mg/ml 0.1% LEK PHARMACEUTICALS D.D.

1095 COMBINATIIC05AA01

C05AA01 COMBINATII UNGUENTHEMORZON ANTIBIOTICE SA

1096 COMBINATIIC05AA08

C05AA08 COMBINATII SUPOZ.ULTRAPROCT® INTENDIS GmbH

C05AA08 COMBINATII UNGUENT RECTALULTRAPROCT® INTENDIS GmbH

1097 COMBINATIIC05AD01

C05AD01 COMBINATII UNGUENT RECTALDOXIPROCT OM PORTUGUESA S.A.

DOXIPROCT PLUS OM PORTUGUESA S.A.

1098 CALCII DOBESILASC05BX01

500mgC05BX01 CALCII DOBESILAS CAPS.DOXILEK 500mg LEK PHARMACEUTICALS D.D.

DOXIUM 500 500mg OM PORTUGUESA S.A.

1099 TROXERUTINUM (COMBINATII)C05CA54

C05CA54 TROXERUTINUM (COMBINATII) CAPS.GINKOR FORT BEAUFOUR IPSEN PHARMA

1100 CELIPROLOLUMC07AB08

100mgC07AB08 CELIPROLOLUM COMPR. FILM.CELIPRES® 100mg RANBAXY U.K. LIMITED

200mgC07AB08 CELIPROLOLUM COMPR. FILM.CELIPRES® 200mg RANBAXY U.K. LIMITED

1101 COMBINATIIC07NAN1

C07NAN1 COMBINATII CAPS.CALMOGEN EUROPHARM SA

C07NAN1 COMBINATII COMPR.DISTONOVAL FABIOL S.A.

C07NAN1 COMBINATII COMPR. FILM.DISTONOCALM® ZENTIVA S.A.

1102 NIMODIPINUMC08CA06

10mg/50mlC08CA06 NIMODIPINUM SOL. PERF.DILCEREN® 10mg/50ml SLOVAKOFARMA

NIMOTOP® 10mg/50ml BAYER HEALTHCARE AG

30mgC08CA06 NIMODIPINUM COMPR. FILM.NIMOTOP® 30mg BAYER HEALTHCARE AG

1103 ACIDUM NICOTINICUMC10AD02

1000mgC10AD02 ACIDUM NICOTINICUM COMPR. ELIB. PREL.NIASPAN 1000 mg 1000mg MERCK KGAA

375mgC10AD02 ACIDUM NICOTINICUM COMPR. ELIB. PREL.NIASPAN 375 mg 375mg MERCK KGAA

500mgC10AD02 ACIDUM NICOTINICUM COMPR. ELIB. PREL.NIASPAN 500 mg 500mg MERCK KGAA

750mgC10AD02 ACIDUM NICOTINICUM COMPR. ELIB. PREL.NIASPAN 750 mg 750mg MERCK KGAA

1104 ISOCONAZOLUMD01AC05

10mg/1gD01AC05 ISOCONAZOLUM CREMATRAVOGEN 10mg/1g INTENDIS GmbH

1105 KETOCONAZOLUMD01AC08

20mg/gD01AC08 KETOCONAZOLUM CREMAKETOCONAZOL CREMA 20mg/g SC HYPERION SA

2mg/100mgD01AC08 KETOCONAZOLUM CREMAKEFUNGIN 2mg/100mg 2mg/100mg ANTIBIOTICE S.A.

2%D01AC08 KETOCONAZOLUM CREMAKETOCONAZOL 2% TIS FARMACEUTIC SA

NIZORAL 2% JANSSEN PHARMACEUTICA NV

1106 COMBINATIID01AC52

D01AC52 COMBINATII CREMAMYCOHEAL® HC DAR AL DAWA PHARMA S.R.L

1108 DITHRANOLUMD05AC01

0.5%D05AC01 DITHRANOLUM UNGUENTPSORIANOL 0,5% 0.5% HYPERION SA

1%D05AC01 DITHRANOLUM UNGUENT

147 153/

Page 148: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

PSORIANOL 1% 1% HYPERION SA

1109 COMBINATIID05AXN1

D05AXN1 COMBINATII SOL. CUT.ASORIAN BIOFARM SA

1110 ALCLOMETAZONUM Protocol: D001LD07AB10

0.5mg/gD07AB10 ALCLOMETAZONUM CREMAAFLODERM 0.5mg/g A & G MED TRADING S.R.L.

0.5mg/gD07AB10 ALCLOMETAZONUM UNGUENTAFLODERM 0.5mg/g A & G MED TRADING S.R.L.

1111 FLUOCINOLONI ACETONIDUM Protocol: D001LD07AC04

25,00%D07AC04 FLUOCINOLONI ACETONIDUM UNGUENTFLUOCINOLON ACETONID 0,025% 0.025% LAROPHARM SRL

1112 FLUOCORTOLONUM Protocol: D001LD07AC05

0.25%D07AC05 FLUOCORTOLONUM CREMAULTRALAN CREMA 0.25% INTENDIS GMBH

0.25%D07AC05 FLUOCORTOLONUM UNGUENTULTRALAN UNGUENT 0.25% SCHERING AG

1113 COMBINATII Protocol: D001LD07CB01

D07CB01 COMBINATII CREMANIDOFLOR ANTIBIOTICE SA

D07CB01 COMBINATII UNGUENTPANDERM GULF PHARMACEUTICAL INDUSTRIES S.R.L.

1114 COMBINATII Protocol: D001LD07CC02

D07CC02 COMBINATII UNGUENTFLUOCINOLON N ANTIBIOTICE SA

1115 COMBINATII Protocol: D001LD07XB02

D07XB02 COMBINATII CREMATRIAMCINOLON S ANTIBIOTICE SA

1116 COMBINATII Protocol: D001LD07XC01

D07XC01 COMBINATII SOL. CUT.BELOSALIC A & G MED TRADING S.R.L.

DIPROSALIC SCHERING-PLOUGH EUROPE

D07XC01 COMBINATII UNGUENTBELOSALIC A & G MED TRADING S.R.L.

DIPROSALIC SCHERING-PLOUGH EUROPE

1117 COMBINATII Protocol: D001LD07XC04

D07XC04 COMBINATII CREMATRAVOCORT INTENDIS GmbH

1119 TRETINOINUMD10AD01

0.05%D10AD01 TRETINOINUM CREMARETIN - A® 0.05% JOHNSON & JOHNSON D.O.O.

1121 ERYTHROMYCINUMD10AF02

4gD10AF02 ERYTHROMYCINUM SOL. CUT.ERYFLUID 4g PIERRE FABRE DERMATOLOGIE

1122 COMBINATIID10AF52

40mg/12mg/mlD10AF52 COMBINATII PULB. + SOLV. SOL. CUT.ZINERYT 40mg/12mg/ml ASTELLAS PHARMA EUROPE B.V.

1124 METRONIDAZOLUMG01AF01

500mgG01AF01 METRONIDAZOLUM OVULEFLAGYL 500mg LAB. AVENTIS

1126 COMBINATIIG01AXN1

G01AXN1 COMBINATII COMPR. VAG.COLPOSEPTINE® LAB. THERAMEX

1127 COMBINATIIG01BDN1

G01BDN1 COMBINATII COMPR. VAG.TERGYNAN LAB. BOUCHARA-RECORDATI

1128 MEDROXYPROGESTERONUMG03AC06

150mgG03AC06 MEDROXYPROGESTERONUM SUSP. INJ.DEPO-PROVERA 150mg PFIZER EUROPE MA EEIG

1129 NOMEGESTROLUMG03DB04

5mgG03DB04 NOMEGESTROLUM COMPR.LUTENYL® 5mg LAB. THERAMEX

1130 GONADOTROPHINUM CHORIONICUMG03GA01

Prescriere limitata: Infertilitate anovulatorie.

Pentru tratamentul infertilitatii masculine ca urmare a hipogonadismului hipogonadotrop;

Pentru tratamentul infertilitatii masculine asociata cu deficit de LH;

Pentru tratamentul barbatilor care au insuficienta combinata de GH si gonadotropine si la care absenta caracterelor sexuale secundare indica o intarziere de maturare.

Pentru tratamentul baietilor de peste 16 ani care au manifestari clinice ale hipogonadismului sau ale pubertatii intarziate. Tratamentul nu trebuie sa depaseasca 6 luni.

Cu excepţia cazurilor de hipopituitarism sau amenoree primara, pacienta trebuie sa fi fost tratata anterior cu citrat de clomifen si/sau gonadorelin, iar tratamentul sa fi ramas fără

efect (sarcina nu a fost obţinuta). Femeile care au urmat tratament pentru inducerea ovulaţiei cu alte clase de medicamente si nu au obţinut o sarcina necesita evaluare

laparoscopică pentru a exclude alte cauze care împiedica apariţia unei sarcini. Oligomenoreea trebuie sa fie prezenta de cel puţin douăsprezece luni sau amenoreea sa fie

prezenta de cel puţin sase luni înaintea tratamentului. Înaintea acestui tratament pacientele cu hiperprolactinemie trebuie sa fi urmat tratament specific medical sau chirurgical.

NOTA:

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

5000ui/mlG03GA01 GONADOTROPHINUM CHORIONICUM LIOF. + SOLV. PT. SOL. INJ.PREGNYL 5000 5000ui/ml NV ORGANON

500ui/mlG03GA01 GONADOTROPHINUM CHORIONICUM LIOF. + SOLV. PT. SOL. INJ.PREGNYL 500 500ui/ml ORGANON NV

148 153/

Page 149: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

1131 MENOTROPINUMG03GA02

75ui FSH / 75ui

LH

G03GA02 MENOTROPINUM LIOF. SI SOLV.PT.SOL.INJ

MENOGON 75ui FSH / 75ui LH FERING GMBH

G03GA02 MENOTROPINUM LIOF. + SOLV. PT. SOL. INJ.MENOPUR FERRING LAEGEMIDLER A/S

1132 COMBINATIIG04BCN1

G04BCN1 COMBINATII GRAN. ORALEURALYT-U MADAUS GMBH

1133 COMBINATIIH03AA03

100µg+20µgH03AA03 COMBINATII COMPR.NOVOTHYRAL® 100 100µg+20µg MERCK KGAA

1134 COMBINATIIJ01CR50

1g+1gJ01CR50 COMBINATII PULB. PT. SOL. INJ.SULPERAZON® 2 g 1g+1g PFIZER EUROPE MA EEIG

250mg+250 mgJ01CR50 COMBINATII CAPS.AMPICLOX 250mg+250 mg EUROPHARM SA

1135 CEFAZOLINUMJ01DB04

1gJ01DB04 CEFAZOLINUM PULB. PT. SOL. INJ.LYZOLIN 1g MEDICAROM GROUP S.R.L.

1136 CEFPIROMUMJ01DE02

1gJ01DE02 CEFPIROMUM PULB. PT. SOL. INJ./PERF.CEFROM® 1 g 1g LAB. AVENTIS

2gJ01DE02 CEFPIROMUM PULB. PT. SOL. INJ./PERF.CEFROM® 2 g 2g LAB. AVENTIS

1137 SULFAFURAZOLUMJ01EB05

500mgJ01EB05 SULFAFURAZOLUM COMPR.NEOXAZOL® 500 mg 500mg ZENTIVA S.A.

SULFAFURAZOL 500mg ARENA GROUP SA

1138 ROXITHROMYCINUMJ01FA06

150mgJ01FA06 ROXITHROMYCINUM COMPR. FILM.ROXAMED® 150 150mg DAR AL DAWA PHARMA S.R.L

1139 GENTAMICINUMJ01GB03

Prescriere limitata: Infectii cu agent patogen sensibil confirmat pentru acest tip de antibiotic.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

40mg/mlJ01GB03 GENTAMICINUM SOL. INJ.GENTAMICIN KRKA 40mg/ml KRKA D.D. NOVO MESTO

GENTAMICINA SANDOZ® 40 mg/ml 40mg/ml SANDOZ GMBH

40mg/mlJ01GB03 GENTAMICINUM SOL. INJ.GENTAMICIN KRKA 40mg/ml KRKA D.D. NOVO MESTO

GENTAMICINA SANDOZ® 40 mg/ml 40mg/ml SANDOZ GMBH

40mg/mlJ01GB03 GENTAMICINUM SOL. PARENT.LYRAMYCIN 40mg/ml MEDICAROM GROUP S.R.L.

80mg/2mlJ01GB03 GENTAMICINUM SOL. INJ.GENTAMICIN KRKA 80mg/2ml KRKA D.D. NOVO MESTO

80mg/2mlJ01GB03 GENTAMICINUM SOL.INJ.PAN - GENTAMICINE 80mg/2ml LAB. PANPHARMA

1140 NETILMICINUMJ01GB07

150mg/1.5mlJ01GB07 NETILMICINUM SOL. INJ.NETROMYCINE® 150mg/1.5ml SCHERING PLOUGH EUROPE

200mg/2mlJ01GB07 NETILMICINUM SOL. INJ.NETROMYCINE® 200mg/2ml SCHERING PLOUGH EUROPE

50mg/2mlJ01GB07 NETILMICINUM SOL. INJ.NETROMYCINE® 50mg/2ml SCHERING PLOUGH EUROPE

1143 VORICONAZOLUM ** Protocol: J012BJ02AC03

200mgJ02AC03 VORICONAZOLUM COMPR. FILM.VFEND 200mg 200mg PFIZER LTD.

40mg/mlJ02AC03 VORICONAZOLUM PULB. PT. SUSP. ORALAVFEND 40 mg/ml 40mg/ml PFIZER LTD.

50mgJ02AC03 VORICONAZOLUM COMPR. FILM.VFEND 50mg 50mg PFIZER LTD.

1144 COMBINATIIM01AB55

M01AB55 COMBINATII COMPR. GASTROREZ.ARTHROTEC 75 PFIZER EUROPE MA EEIG

M01AB55 COMBINATII SOL. PERF.NEODOLPASSE FRESENIUS KABI AUSTRIA GMBH

M01AB55 COMBINATII SUPOZ.ACECLOFEN ANTIBIOTICE SA

1145 IBUPROFENUMM01AE01A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

100mg/5mlM01AE01 IBUPROFENUM SUSP. ORALAIBALGIN BABY 100mg/5ml ZENTIVA AS

IBUGESIC® 100mg/5ml DAR AL DAWA PHARMA S.R.L.

NUROFEN® PENTRU COPII, cu aroma de capsuni 100mg/5ml RECKITT BENCKISER HEALTHCARE INTERNATIONAL LIMITED

NUROFEN® PENTRU COPII, cu aroma de portocala 100mg/5ml RECKITT BENCKISER HEALTHCARE INTERNATIONAL LIMITED

300mgM01AE01 IBUPROFENUM CAPS. ELIB. PREL.PADUDEN® SR 300 mg 300mg TERAPIA SA

149 153/

Page 150: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

400mgM01AE01 IBUPROFENUM CAPS.MARCOFEN® 400mg EUROPHARM SA

400mgM01AE01 IBUPROFENUM COMPR. FILM.IBUPROFEN 400 400mg CIPLA (UK) LIMITED

PROFINAL 400mg GULF PHARMACEUTICAL INDUSTRIES S.R.L.

REUPROFEN® 400 mg 400mg AC HELCOR SRL

400mgM01AE01 IBUPROFENUM DRAJ.NUROFEN FORTE 400mg RECKITT BENCKISER HEALTHCARE INT. LTD.

600mgM01AE01 IBUPROFENUM COMPR. FILM.IBUPROFEN 600 600mg CIPLA (UK) LIMITED

PROFINAL 600mg GULF PHARMACEUTICAL INDUSTRIES S.R.L.

400mgM01AE01 IBUPROFENUM CAPS.MARCOFEN® 400mg EUROPHARM SA

400mgM01AE01 IBUPROFENUM COMPR. FILM.IBUPROFEN 400 400mg CIPLA (UK) LIMITED

PROFINAL 400mg GULF PHARMACEUTICAL INDUSTRIES S.R.L.

REUPROFEN® 400 mg 400mg AC HELCOR SRL

400mgM01AE01 IBUPROFENUM DRAJ.NUROFEN FORTE 400mg RECKITT BENCKISER HEALTHCARE INT. LTD.

1146 NAPROXENUMM01AE02A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

250mgM01AE02 NAPROXENUM COMPR.REUXEN 250 mg 250mg AC HELCOR PHARMA SRL

500mgM01AE02 NAPROXENUM COMPR.REUXEN 500 mg 500mg AC HELCOR PHARMA SRL

1147 ACIDUM MEFENAMICUMM01AG01A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale.

Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

500mgM01AG01 ACIDUM MEFENAMICUM COMPR. FILM.VIDAN 500mg VIANEX SA

1148 PARECOXIBUMM01AH04

Prescriere limitata: Tratamentul simptomatic antiinflamator la pacientii cu intoleranta la AINS neselective.

40mgM01AH04 PARECOXIBUM PULB. + SOLV. PT. SOL. INJ.DYNASTAT 40mg 40mg PFIZER LIMITED

40mgM01AH04 PARECOXIBUM PULB. PT. SOL. INJ.DYNASTAT 40mg 40mg PFIZER LIMITED

1149 ACIDUM NIFLUMICUMM01AX02A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale.

250mgM01AX02 ACIDUM NIFLUMICUM CAPS.NIFLURIL 250mg BRISTOL MYERS SQUIBB KFT

1150 PHENYLBUTAZONUMM01AA01

250mgM01AA01 PHENYLBUTAZONUM SUPOZ.FENILBUTAZONA 250 mg 250mg SINTOFARM SA

1155 COMBINATIIM02ACN3

M02ACN3 COMBINATII GELPERCUTALGINE LABORATOIRES CHEMINEAU

1156 CHLORZOXAZONUMM03BB03

250mgM03BB03 CHLORZOXAZONUM COMPR.CLORZOXAZON 250 mg 250mg GEDEON RICHTER ROMANIA SA

CLORZOXAZONA 250mg SINTOFARM SA

CLORZOXAZONA 250 mg 250mg ARENA GROUP SA

1157 TOLPERISONUMM03BX04

100mg/mlM03BX04 TOLPERISONUM SOL. INJ.MYDOCALM 100mg/ml GEDEON RICHTER LTD.

150mgM03BX04 TOLPERISONUM COMPR. FILM.MYDOCALM 150mg GEDEON RICHTER LTD.

50mgM03BX04 TOLPERISONUM COMPR. FILM.MYDOCALM 50mg GEDEON RICHTER LTD.

50mgM03BX04 TOLPERISONUM DRAJ.TOLPERISON 50 mg 50mg TERAPIA SA

1158 ACIDUM HIALURONICUMM09AX01

20mg/2mlM09AX01 ACIDUM HIALURONICUM SOL. INJ.HYALGAN® 20mg/2ml CSC PHARMACEUTICALS HANDELS GMBH

1159 COMBINATIIN02AA59

30mg+500mgN02AA59 COMBINATII COMPR.PARADOREN 500mg/30mg 30mg+500mg ARENA GROUP S.A.

60mg+500mgN02AA59 COMBINATII COMPR.PARADOREN 500mg/60mg 60mg+500mg ARENA GROUP S.A.

1160 COMBINATIIN02BA71

N02BA71 COMBINATII COMPR.FASCONAL P GEDEON RICHTER ROMANIA SA

FASCOREM REMEDIA SRL

1161 METAMIZOLUM NATRIUMN02BB02

1g/2mlN02BB02 METAMIZOLUM NATRIUM SOL. INJ.ALGOCALMIN® 1 g/2 ml 1g/2ml ZENTIVA S.A.

500mg/mlN02BB02 METAMIZOLUM NATRIUM PIC. ORALE, SOL.NEVRALGIN 500mg/ml TERAPIA S.A.

150 153/

Page 151: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

1162 CLORAZEPAS DIKALIIN05BA05

10mgN05BA05 CLORAZEPAS DIKALII CAPS.TRANXENE 10 mg 10mg SANOFI-AVENTIS FRANCE

5mgN05BA05 CLORAZEPAS DIKALII CAPS.TRANXENE 5 mg 5mg SANOFI-AVENTIS FRANCE

1163 TOFISOPAMUMN05BA23

50mgN05BA23 TOFISOPAMUM COMPR.GRANDAXIN 50mg EGIS PHARMACEUTICALS LTD.

1164 MIDAZOLAMUMN05CD08

1mg/mlN05CD08 MIDAZOLAMUM SOL. INJ.DORMICUM® 1mg/ml ROCHE ROMANIA S.R.L.

MIDAZOLAM TORREX 1 mg/ml 1mg/ml TORREX CHIESI PHARMA GMBH

5mg/mlN05CD08 MIDAZOLAMUM SOL. INJ.FULSED 5 mg/ml 5mg/ml TERAPIA S.A.

MIDAZOLAM 5 mg/ml 5mg/ml TERAPIA SA

MIDAZOLAM TORREX 5 mg/ml 5mg/ml TORREX CHIESI PHARMA GMBH

7.5mgN05CD08 MIDAZOLAMUM COMPR. FILM.DORMICUM® 7.5mg ROCHE ROMANIA S.R.L.

DORMICUM® 7,5 mg 7.5mg TERAPIA SA

1165 CINOLAZEPAMUMN05CD13

40mgN05CD13 CINOLAZEPAMUM COMPR.GERODORM® 40mg GEROT PHARMAZEUTIKA GMBH

1166 METHYLFENIDATUM ***N06BA04

18mgN06BA04 METHYLFENIDATUM COMPR. FILM. ELIB. PREL.CONCERTA XL 18 mg 18mg JANSSEN PHARMACEUTICA N.V.

Utilizare in tulburare cu deficit de atentie si hiperactivitate.Prescriere limitata:

36mgN06BA04 METHYLFENIDATUM COMPR. FILM. ELIB. PREL.CONCERTA XL 36 mg 36mg JANSSEN PHARMACEUTICA N.V.

Utilizare in tulburare cu deficit de atentie si hiperactivitate.Prescriere limitata:

54mgN06BA04 METHYLFENIDATUM COMPR. FILM. ELIB. PREL.CONCERTA XL 54 mg 54mg JANSSEN PHARMACEUTICA N.V.

Utilizare in tulburare cu deficit de atentie si hiperactivitate.Prescriere limitata:

1167 ATOMOXETINUM ***N06BA09

10mgN06BA09 ATOMOXETINUM CAPS.STRATTERA 10 mg 10mg ELI LILLY AND COMPANY LIMITED

Utilizare in tulburare cu deficit de atentie si hiperactivitate.Prescriere limitata:

18mgN06BA09 ATOMOXETINUM CAPS.STRATTERA 18 mg 18mg ELI LILLY AND COMPANY LIMITED

Utilizare in tulburare cu deficit de atentie si hiperactivitate.Prescriere limitata:

25mgN06BA09 ATOMOXETINUM CAPS.STRATTERA 25 mg 25mg ELI LILLY AND COMPANY LIMITED

Utilizare in tulburare cu deficit de atentie si hiperactivitate.Prescriere limitata:

40mgN06BA09 ATOMOXETINUM CAPS.STRATTERA 40 mg 40mg ELI LILLY AND COMPANY LIMITED

Utilizare in tulburare cu deficit de atentie si hiperactivitate.Prescriere limitata:

60mgN06BA09 ATOMOXETINUM CAPS.STRATTERA 60 mg 60mg ELI LILLY AND COMPANY LIMITED

Utilizare in tulburare cu deficit de atentie si hiperactivitate.Prescriere limitata:

1168 PYRITINOLUMN06BX02

100mgN06BX02 PYRITINOLUM DRAJ.ENCEPHABOL® 100 mg 100mg MERCK KGAA

200mgN06BX02 PYRITINOLUM DRAJ.ENCEPHABOL® FORTE 200mg MERCK KGAA

80.5mg/5mlN06BX02 PYRITINOLUM SUSP. ORALAENCEPHABOL® SUSPENSIE 80.5mg/5ml MERCK KGAA

1169 PIRACETAMUMN06BX03

1200mgN06BX03 PIRACETAMUM COMPR. FILM.LUCETAM® 1200 mg 1200mg EGIS PHARMACEUTICALS LTD.

NOOTROPIL® 1200 mg 1200mg U.C.B. SA

12gN06BX03 PIRACETAMUM SOL. PERF.NOOTROPIL 12g U.C.B. SA

1gN06BX03 PIRACETAMUM SOL. INJ.NOOTROPIL 1g U.C.B. SA

1g/5mlN06BX03 PIRACETAMUM SOL. INJ.LUCETAM® 1 g 1g/5ml EGIS PHARMACEUTICALS LTD.

MEMOTAL1 g/5 ml 1g/5ml ZENTIVA SA

3g/15mlN06BX03 PIRACETAMUM SOL. INJ.LUCETAM® 3 g 3g/15ml EGIS PHARMACEUTICALS LTD.

400 mgN06BX03 PIRACETAMUM COMPR.PIRACETAM 400 mg 400 mg ANTIBIOTICE SA

400mgN06BX03 PIRACETAMUM COMPR.MEMOTAL 400mg 400mg ZENTIVA S.A

N - PIRACETAM 400mg MEDUMAN SA

PIRACETAM 400mg MAGISTRA C & C

PIRACETAM 400 mg 400mg LAROPHARM SRL

PIRACETAM FARMEX 400 mg 400mg FARMEX COMPANY SRL

400mgN06BX03 PIRACETAMUM COMPR. FILM.LUCETAM 400mg EGIS PHARMACEUTICALS PLC

PIRACETAM 400 mg 400mg GEDEON RICHTER ROMANIA SA

PIRACETAM LPH® 400 mg 400mg LABORMED PHARMA SA

151 153/

Page 152: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

800mgN06BX03 PIRACETAMUM COMPR. FILM.LUCETAM 800mg EGIS PHARMACEUTICALS PLC

NOOTROPIL® 800 mg 800mg U.C.B. SA

PIRACETAM 800 mg 800mg GEDEON RICHTER ROMANIA SA

PIRACETAM LPH 800 mg 800mg LABORMED PHARMA SA

20%N06BX03 PIRACETAMUM SOL. ORALANOOTROPIL® 20% U.C.B. SA

1170 CINNARIZINUMN07CA02

25mgN07CA02 CINNARIZINUM COMPR.CINARIZIN 25 mg 25mg LAROPHARM SRL

CINARIZINA 25 mg 25mg OZONE LABORATORIES

N-CINARIZINA 25mg MEDUMAN SA

STUGERON 25 mg 25mg TERAPIA SA

1172 TENONITROZOLUMP01AX08

250mgP01AX08 TENONITROZOLUM CAPS. MOI GASTROREZ.ATRICAN 250 mg 250mg LAB. INNOTECH INT.

1173 PYRANTELUMP02CC01

125mgP02CC01 PYRANTELUM COMPR. FILM.HELMINTOX® 125 mg 125mg LAB. INNOTECH INT.

250mgP02CC01 PYRANTELUM COMPR. FILM.HELMINTOX® 250 mg 250mg LAB. INNOTECH INT.

1174 SULFURP03AAN1

8,00%P03AAN1 SULFUR UNGUENTUNGUENT CU SULF 8% 8% GEDEON RICHTER ROMANIA SA

1175 PERMETHRINUMP03AC04

1,00%P03AC04 PERMETHRINUM CREMA CAPILARANIX 1% GLAXO WELLCOME UK LTD.

1176 BENZYLUM BENZOICUMP03AX01

25,00%P03AX01 BENZYLUM BENZOICUM CREMABENZOAT DE BENZIL MK 25% FITERMAN PHARMA S.R.L.

1177 TIXOCORTOLUMR01AD07

1,00%R01AD07 TIXOCORTOLUM SUSP. NAZALAPIVALONE 1% 1% PFIZER EUROPE MA EEG

1178 COMBINATIIR01ADN1

R01ADN1 COMBINATII SPRAY NAZ.,SUSP.BIORINIL FARMILA FARMACEUTICI MILANO SPA

R01ADN1 COMBINATII SUSP. INHAL.FLUORORINIL FARMILA - THEA FARMACEUTICI SPA

1179 COMBINATIIR01BA52

R01BA52 COMBINATII COMPR. ELIB. MODIF.CLARINASE® SCHERING PLOUGH EUROPE

1180 FUSAFUNGINUMR02AB03

50mg/10mlR02AB03 FUSAFUNGINUM SPRAY BUCOFARINGIAN SI NAZAL-SOL.BIOPAROX 50mg/10ml LES LABORATOIRES SERVIER

1181 EPHEDRINI HYDROCHLORIDUMR03CA02

10mg/mlR03CA02 EPHEDRINI HYDROCHLORIDUM SOL. INJ.EFEDRINA 10 mg/ ml 10mg/ml ZENTIVA S.A.

50mg/mlR03CA02 EPHEDRINI HYDROCHLORIDUM SOL. INJ.EFEDRINA 50 mg/ ml 50mg/ml ZENTIVA S.A.

1182 TERBUTALINUMR03CC03

1.5mg/5mlR03CC03 TERBUTALINUM SIROPAIRONYL 1.5mg/5ml SEDICO IMPEX S.R.L.

1183 ACETYLCYSTEINUMR05CB01

300mg/3mlR05CB01 ACETYLCYSTEINUM SOL. INJ.ACC INJECT 300mg/3ml 300mg/3ml HEXAL AG

1184 CARBOCISTEINUMR05CB03

100mg/5mlR05CB03 CARBOCISTEINUM SIROPHUMEX EXPECTORANT PENTRU COPII SI SUGARI 100mg/5ml LAB. URGO

100mg/5mlR05CB03 CARBOCISTEINUM SOL. ORALAFLUIDOL 100mg/5ml 100mg/5ml TIS FARMACEUTIC SA

20mg/mlR05CB03 CARBOCISTEINUM SIROPMUCOTREIS 20mg/ml ECOBI PHARMACEUTICI SAS

2%R05CB03 CARBOCISTEINUM SIROPRHINATHIOL 2% pentru copii si sugari 2% SANOFI-AVENTIS OTC

1186 PROMETHAZINUMR06AD02

30mgR06AD02 PROMETHAZINUM COMPR. FILM.PROMETAZINA ARENA 30 mg 30mg ARENA GROUP S.A.

Pot aparea efecte secundare semnificative

1187 MEQUITAZINUMR06AD07

10mgR06AD07 MEQUITAZINUM COMPR.PRIMALAN® 10 mg 10mg LAB. PIERRE FABRE

1188 MECLOZINUMR06AE05

30mgR06AE05 MECLOZINUM COMPR.EMETOSTOP 30mg SPECIFAR SA

1189 CYPROHEPTADINUMR06AX02

2mg/5mlR06AX02 CYPROHEPTADINUM SIROPBIOHEPT 2mg/5ml BIOFARM S.A.

152 153/

Page 153: Anexa 2 - casnt.rocasnt.ro/protocoale/protocoale_anexa_2.pdf · Cod restrictie 2269: Boala Crohn in cazul in care exista intoleranta la sulfasalazinum A07EC02 MESALAZINUM SUPOZ. 500mg

FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.

PERITOL 2mg/5ml EGIS PHARMACEUTICALS LTD.

4mgR06AX02 CYPROHEPTADINUM COMPR.PERITOL 4mg EGIS PHARMACEUTICALS LTD.

1190 LORATADINUMR06AX13

1mg/mlR06AX13 LORATADINUM SIROPCLARITINE 1mg/ml SCHERING-PLOUGH EUROPE

SYMPHORAL® 1 mg/ml 1mg/ml GEDEON RICHTER ROMANIA SA

5mg/5mlR06AX13 LORATADINUM SIROPLORATADINA BIOFARM 5mg/5ml 5mg/5ml BIOFARM S.A.

5mg/5mlR06AX13 LORATADINUM SUSP. ORALAFLONIDAN 5mg/5ml LEK PHARMACEUTICALS D.D.

1191 CHLORAMPHENICOLUMS01AA01

0.4%S01AA01 CHLORAMPHENICOLUM PULB. + SOLV. PT. SOL. OFT.SIFICETINA 0.4% S.I.F.I. SPA

1192 ACIDUM FUSIDICUMS01AA13

1,00%S01AA13 ACIDUM FUSIDICUM GEL OFT.FUCITHALMIC® 1% LEO PHARMACEUTICAL PRODUCTS

1193 KANAMYCINUMS01AA24

1,00%S01AA24 KANAMYCINUM UNG. OFT.KANAMICINA SULFAT 1% 1% ANTIBIOTICE SA

1194 COMBINATIIS01AA30

S01AA30 COMBINATII PICATURI OFT.-SOL.ANTIBIOPTAL FARMILA FARMACEUTICI

S01AA30 COMBINATII PULB. + SOLV. PT. SOL. OFT.COLBIOCIN S.I.F.I. SPA

S01AA30 COMBINATII UNG. OFT.ENBECIN POLIPHARMA INDUSTRIES S.R.L.

1195 FLUOROMETHOLONUMS01BA07

1mg/gS01BA07 FLUOROMETHOLONUM UNG. OFT.FLUMETOL S UNGUENT OFTALMIC 1mg/g FARMILA - THEA FARMACEUTICI SPA

2mg/mlS01BA07 FLUOROMETHOLONUM PICATURI OFT.SUSP.FLUMETOL S 2mg/ml FARMILA - THEA FARMACEUTICI SPA

1196 DESONIDUMS01BA11

0.25%S01BA11 DESONIDUM PICATURI OFT.-SOL.PRENACID 0.25% S.I.F.I. SPA

1197 INDOMETACINUMS01BC01

0.1%S01BC01 INDOMETACINUM PICATURI OFT.-SOL.INDOCOLLYRE® 0.1% 0.1% LAB. CHAUVIN

1198 PIROXICAMUMS01BC06

0.5%S01BC06 PIROXICAMUM PIC. OFT., SOL.BRUXICAM 0,5% 0.5% BRUSCHETTINI S.R.L.

1199 PILOCARPINUMS01EB01

2,00%S01EB01 PILOCARPINUM PICATURI OFT.-SOL.DROPIL® 2% BRUSCHETTINI

1200 EMEDASTINUMS01GX06

0.5mg/mlS01GX06 EMEDASTINUM PICATURI OFT.-SOL.EMADINE 0.05% 0.5mg/ml ALCON LABORATORIES LTD.

1201 KETOTIFENUMS01GX08

0.25mg/mlS01GX08 KETOTIFENUM PICATURI OFT.-SOL.ZADITEN 0,25 mg/ml 0.25mg/ml NOVARTIS PHARMA GMBH

1203 NANDROLONUMS01XA11

1,00%S01XA11 NANDROLONUM PICATURI OFT.-SOL.KERATYL® 1% 1% LAB. CHAUVIN

1204 DEXPANTHENOLUMS01XA12

5,00%S01XA12 DEXPANTHENOLUM GEL OFT.CORNEREGEL® 5% DR. GERHARD MANN CHEM-PHARM. FABRIK GMBH

1205 COMBINATIIS02CA05

S02CA05 COMBINATII SOL. AURICULARA

SOLUTIE AURICULARA CU CLORAMFENICOL SI

FLUOCINOLON

BIOFARM SA

1206 OMALIZUMABUM **R03DX05

Prescriere limitata: Tratamentul adjuvant pentru îmbunătăţirea controlului astmului bronşic la pacienţii adulţi şi adolescenţi (cu vârsta de 12 ani şi peste) cu astm alergic persistent sever

care prezintă test cutanat pozitiv sau hiperreactivitate in vitro la un alergen permanent şi care au funcţia pulmonară redusă (FEV1 <80%), precum şi simptome

frecvente în timpul zilei sau treziri bruşte în cursul nopţii şi care au avut multiple exacerbări astmatice confirmate, în ciuda administrării pe cale inhalatorie de doze

mari de corticosteroizi şi agonişti beta2-adrenergici cu acţiune de lungă durată.

Tratamentul cu Xolair trebuie avut în vedere la pacienţii cu astm bronşic mediat cu certitudine prin intermediul IgE.NOTA:

150mgR03DX05 OMALIZUMABUM PULB+SOLV.PT.SOL.INJ.XOLAIR 150 mg 150mg NOVARTIS EUROPHARM LTD.

75mgR03DX05 OMALIZUMABUM PULB+SOLV.PT.SOL.INJ.XOLAIR 150 mg 150mg NOVARTIS EUROPHARM LTD.

XOLAIR 75 mg 75mg NOVARTIS EUROPHARM LTD.

153 153/